TestFile: BRNPUT.KHDRBS2.genes.txt 
BackgroundFile: BRNPUT.background.txt 
Geneset: data/c2.all.v6.1.symbols.gmt SaveFile: c2.txt
test_inset	test_notinset	background_inset	background_notinset	oddsratio	pvalue	bonferroni-adjusted	testgenes_in_set
KOYAMA_SEMA3B_TARGETS_DN 	0	11	358	16669	0.0	1.0	1	
SASAI_TARGETS_OF_CXCR6_AND_PTCH1_UP 	0	11	13	17014	0.0	1.0	1	
LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP 	0	11	163	16864	0.0	1.0	1	
MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP 	0	11	63	16964	0.0	1.0	1	
PID_CASPASE_PATHWAY 	0	11	50	16977	0.0	1.0	1	
PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP 	0	11	61	16966	0.0	1.0	1	
SCHLOSSER_SERUM_RESPONSE_UP 	0	11	116	16911	0.0	1.0	1	
HEDENFALK_BREAST_CANCER_HEREDITARY_VS_SPORADIC 	0	11	46	16981	0.0	1.0	1	
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP 	0	11	15	17012	0.0	1.0	1	
URS_ADIPOCYTE_DIFFERENTIATION_DN 	0	11	29	16998	0.0	1.0	1	
CORRE_MULTIPLE_MYELOMA_DN 	0	11	57	16970	0.0	1.0	1	
CHEBOTAEV_GR_TARGETS_DN 	0	11	109	16918	0.0	1.0	1	
KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION 	0	11	102	16925	0.0	1.0	1	
YANAGISAWA_LUNG_CANCER_RECURRENCE 	0	11	8	17019	0.0	1.0	1	
NIKOLSKY_BREAST_CANCER_22Q13_AMPLICON 	0	11	14	17013	0.0	1.0	1	
ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN 	0	11	229	16798	0.0	1.0	1	
KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_DN 	0	11	22	17005	0.0	1.0	1	
WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP 	0	11	17	17010	0.0	1.0	1	
REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS 	0	11	63	16964	0.0	1.0	1	
PID_IL8_CXCR2_PATHWAY 	0	11	33	16994	0.0	1.0	1	
ZEMBUTSU_SENSITIVITY_TO_MITOMYCIN 	0	11	14	17013	0.0	1.0	1	
REACTOME_GLUCONEOGENESIS 	0	11	27	17000	0.0	1.0	1	
SMIRNOV_RESPONSE_TO_IR_6HR_DN 	0	11	96	16931	0.0	1.0	1	
ASTIER_INTEGRIN_SIGNALING 	0	11	52	16975	0.0	1.0	1	
LIM_MAMMARY_LUMINAL_PROGENITOR_UP 	0	11	43	16984	0.0	1.0	1	
PRAMOONJAGO_SOX4_TARGETS_DN 	0	11	47	16980	0.0	1.0	1	
LIU_TARGETS_OF_VMYB_VS_CMYB_DN 	0	11	35	16992	0.0	1.0	1	
HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP 	0	11	56	16971	0.0	1.0	1	
PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN 	0	11	13	17014	0.0	1.0	1	
NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP 	0	11	250	16777	0.0	1.0	1	
DORN_ADENOVIRUS_INFECTION_48HR_DN 	0	11	38	16989	0.0	1.0	1	
VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 	0	11	57	16970	0.0	1.0	1	
LE_NEURONAL_DIFFERENTIATION_UP 	0	11	17	17010	0.0	1.0	1	
GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP 	0	11	135	16892	0.0	1.0	1	
REACTOME_REGULATION_OF_APOPTOSIS 	0	11	55	16972	0.0	1.0	1	
KRIEG_KDM3A_TARGETS_NOT_HYPOXIA 	0	11	178	16849	0.0	1.0	1	
SASSON_RESPONSE_TO_GONADOTROPHINS_DN 	0	11	86	16941	0.0	1.0	1	
MACLACHLAN_BRCA1_TARGETS_DN 	0	11	15	17012	0.0	1.0	1	
WENG_POR_TARGETS_LIVER_DN 	0	11	17	17010	0.0	1.0	1	
REACTOME_IRON_UPTAKE_AND_TRANSPORT 	0	11	33	16994	0.0	1.0	1	
GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN 	0	11	70	16957	0.0	1.0	1	
BIOCARTA_BCELLSURVIVAL_PATHWAY 	0	11	16	17011	0.0	1.0	1	
HOEGERKORP_CD44_TARGETS_TEMPORAL_DN 	0	11	20	17007	0.0	1.0	1	
BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP 	0	11	24	17003	0.0	1.0	1	
KANG_CISPLATIN_RESISTANCE_DN 	0	11	7	17020	0.0	1.0	1	
SHEPARD_CRUSH_AND_BURN_MUTANT_UP 	0	11	177	16850	0.0	1.0	1	
PID_ERBB1_DOWNSTREAM_PATHWAY 	0	11	104	16923	0.0	1.0	1	
ZWANG_DOWN_BY_2ND_EGF_PULSE 	0	11	199	16828	0.0	1.0	1	
TCGA_GLIOBLASTOMA_MUTATED 	0	11	8	17019	0.0	1.0	1	
MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP 	0	11	18	17009	0.0	1.0	1	
OZANNE_AP1_TARGETS_UP 	0	11	13	17014	0.0	1.0	1	
KUMAR_TARGETS_OF_MLL_AF9_FUSION 	1	10	338	16689	4.937573964497042	0.19839228782159082	1	MAG
IGARASHI_ATF4_TARGETS_UP 	0	11	5	17022	0.0	1.0	1	
ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION 	0	11	112	16915	0.0	1.0	1	
KIM_GERMINAL_CENTER_T_HELPER_DN 	0	11	21	17006	0.0	1.0	1	
REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS 	0	11	60	16967	0.0	1.0	1	
KEGG_ERBB_SIGNALING_PATHWAY 	0	11	83	16944	0.0	1.0	1	
NIELSEN_GIST_VS_SYNOVIAL_SARCOMA_DN 	0	11	19	17008	0.0	1.0	1	
PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY 	0	11	35	16992	0.0	1.0	1	
REACTOME_SIGNAL_ATTENUATION 	0	11	12	17015	0.0	1.0	1	
SENESE_HDAC3_TARGETS_DN 	0	11	472	16555	0.0	1.0	1	
COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN 	0	11	28	16999	0.0	1.0	1	
KASLER_HDAC7_TARGETS_1_UP 	1	10	177	16850	9.519774011299434	0.10913127439585975	1	CAPN3
ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP 	0	11	28	16999	0.0	1.0	1	
LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP 	0	11	69	16958	0.0	1.0	1	
BIOCARTA_PDGF_PATHWAY 	0	11	32	16995	0.0	1.0	1	
WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH 	0	11	56	16971	0.0	1.0	1	
HORTON_SREBF_TARGETS 	0	11	24	17003	0.0	1.0	1	
HELLER_SILENCED_BY_METHYLATION_UP 	1	10	234	16793	7.176495726495727	0.14171655988456805	1	CAPN3
RAHMAN_TP53_TARGETS_PHOSPHORYLATED 	0	11	21	17006	0.0	1.0	1	
WANG_ESOPHAGUS_CANCER_PROGRESSION_UP 	0	11	6	17021	0.0	1.0	1	
CLAUS_PGR_POSITIVE_MENINGIOMA_UP 	0	11	10	17017	0.0	1.0	1	
CHUANG_OXIDATIVE_STRESS_RESPONSE_UP 	0	11	26	17001	0.0	1.0	1	
NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER 	0	11	78	16949	0.0	1.0	1	
WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_DN 	0	11	4	17023	0.0	1.0	1	
REACTOME_SIGNALING_BY_NODAL 	0	11	17	17010	0.0	1.0	1	
INAMURA_LUNG_CANCER_SCC_UP 	0	11	8	17019	0.0	1.0	1	
CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN 	0	11	430	16597	0.0	1.0	1	
TESAR_ALK_TARGETS_EPISC_4D_UP 	0	11	7	17020	0.0	1.0	1	
DAUER_STAT3_TARGETS_UP 	0	11	42	16985	0.0	1.0	1	
HUMMERICH_SKIN_CANCER_PROGRESSION_UP 	0	11	79	16948	0.0	1.0	1	
BIOCARTA_NUCLEARRS_PATHWAY 	0	11	10	17017	0.0	1.0	1	
BIOCARTA_CHREBP2_PATHWAY 	0	11	39	16988	0.0	1.0	1	
REACTOME_G1_S_TRANSITION 	0	11	101	16926	0.0	1.0	1	
REACTOME_RNA_POL_II_PRE_TRANSCRIPTION_EVENTS 	0	11	51	16976	0.0	1.0	1	
MIZUKAMI_HYPOXIA_UP 	0	11	12	17015	0.0	1.0	1	
DALESSIO_TSA_RESPONSE 	0	11	19	17008	0.0	1.0	1	
GAJATE_RESPONSE_TO_TRABECTEDIN_UP 	0	11	63	16964	0.0	1.0	1	
VANDESLUIS_COMMD1_TARGETS_GROUP_4_UP 	0	11	16	17011	0.0	1.0	1	
CAIRO_HEPATOBLASTOMA_UP 	0	11	199	16828	0.0	1.0	1	
LEE_TARGETS_OF_PTCH1_AND_SUFU_DN 	0	11	82	16945	0.0	1.0	1	
PID_TCR_RAS_PATHWAY 	0	11	14	17013	0.0	1.0	1	
KEGG_PRION_DISEASES 	0	11	29	16998	0.0	1.0	1	
NADLER_OBESITY_DN 	0	11	44	16983	0.0	1.0	1	
PID_PDGFRA_PATHWAY 	0	11	20	17007	0.0	1.0	1	
REACTOME_RNA_POL_II_TRANSCRIPTION_PRE_INITIATION_AND_PROMOTER_OPENING 	0	11	39	16988	0.0	1.0	1	
ST_P38_MAPK_PATHWAY 	0	11	37	16990	0.0	1.0	1	
GOZGIT_ESR1_TARGETS_UP 	0	11	122	16905	0.0	1.0	1	
REACTOME_INTEGRIN_ALPHAIIB_BETA3_SIGNALING 	0	11	24	17003	0.0	1.0	1	
LIANG_SILENCED_BY_METHYLATION_2 	0	11	40	16987	0.0	1.0	1	
BIOCARTA_PLATELETAPP_PATHWAY 	0	11	10	17017	0.0	1.0	1	
BILD_E2F3_ONCOGENIC_SIGNATURE 	0	11	220	16807	0.0	1.0	1	
KAPOSI_LIVER_CANCER_MET_DN 	0	11	5	17022	0.0	1.0	1	
MOREIRA_RESPONSE_TO_TSA_UP 	0	11	26	17001	0.0	1.0	1	
ROME_INSULIN_TARGETS_IN_MUSCLE_DN 	1	10	149	16878	11.32751677852349	0.09271608155864663	1	CNTN2
CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN 	0	11	35	16992	0.0	1.0	1	
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_DN 	0	11	23	17004	0.0	1.0	1	
NIELSEN_LEIOMYOSARCOMA_CNN1_DN 	0	11	20	17007	0.0	1.0	1	
DASU_IL6_SIGNALING_SCAR_DN 	0	11	15	17012	0.0	1.0	1	
HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY 	0	11	22	17005	0.0	1.0	1	
MIKI_COEXPRESSED_WITH_CYP19A1 	0	11	5	17022	0.0	1.0	1	
BROWNE_HCMV_INFECTION_2HR_DN 	0	11	45	16982	0.0	1.0	1	
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS 	0	11	104	16923	0.0	1.0	1	
GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP 	0	11	63	16964	0.0	1.0	1	
RIGGINS_TAMOXIFEN_RESISTANCE_DN 	1	10	207	16820	8.1256038647343	0.12641898098009247	1	C9orf3
WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN 	0	11	31	16996	0.0	1.0	1	
NIELSEN_LIPOSARCOMA_DN 	0	11	19	17008	0.0	1.0	1	
NADLER_HYPERGLYCEMIA_AT_OBESITY 	0	11	53	16974	0.0	1.0	1	
REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS 	0	11	26	17001	0.0	1.0	1	
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN 	0	11	21	17006	0.0	1.0	1	
GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP 	0	11	1031	15996	0.0	1.0	1	
BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN 	0	11	115	16912	0.0	1.0	1	
GERHOLD_ADIPOGENESIS_UP 	0	11	46	16981	0.0	1.0	1	
DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN 	0	11	275	16752	0.0	1.0	1	
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP 	0	11	120	16907	0.0	1.0	1	
MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_4 	0	11	20	17007	0.0	1.0	1	
YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP 	0	11	66	16961	0.0	1.0	1	
ZHANG_GATA6_TARGETS_UP 	0	11	14	17013	0.0	1.0	1	
SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER 	0	11	24	17003	0.0	1.0	1	
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN 	0	11	19	17008	0.0	1.0	1	
MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN 	0	11	259	16768	0.0	1.0	1	
LY_AGING_OLD_UP 	0	11	4	17023	0.0	1.0	1	
REACTOME_ENDOGENOUS_STEROLS 	0	11	11	17016	0.0	1.0	1	
PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP 	1	10	283	16744	5.91660777385159	0.16885825675538135	1	C9orf3
KORKOLA_CORRELATED_WITH_POU5F1 	0	11	21	17006	0.0	1.0	1	
BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN 	0	11	28	16999	0.0	1.0	1	
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN 	0	11	500	16527	0.0	1.0	1	
REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS 	0	11	26	17001	0.0	1.0	1	
REACTOME_DESTABILIZATION_OF_MRNA_BY_KSRP 	0	11	17	17010	0.0	1.0	1	
MULLIGHAN_MLL_SIGNATURE_2_UP 	0	11	379	16648	0.0	1.0	1	
MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP 	0	11	23	17004	0.0	1.0	1	
MOSERLE_IFNA_RESPONSE 	0	11	31	16996	0.0	1.0	1	
PID_REG_GR_PATHWAY 	0	11	65	16962	0.0	1.0	1	
SEMBA_FHIT_TARGETS_DN 	0	11	9	17018	0.0	1.0	1	
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0 	0	11	71	16956	0.0	1.0	1	
VILIMAS_NOTCH1_TARGETS_DN 	0	11	13	17014	0.0	1.0	1	
REACTOME_METABOLISM_OF_PORPHYRINS 	0	11	13	17014	0.0	1.0	1	
BIOCARTA_CLASSIC_PATHWAY 	0	11	11	17016	0.0	1.0	1	
OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN 	0	11	239	16788	0.0	1.0	1	
MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN 	0	11	55	16972	0.0	1.0	1	
GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP 	0	11	43	16984	0.0	1.0	1	
BIOCARTA_DNAFRAGMENT_PATHWAY 	0	11	9	17018	0.0	1.0	1	
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN 	0	11	158	16869	0.0	1.0	1	
BIOCARTA_ERK5_PATHWAY 	0	11	17	17010	0.0	1.0	1	
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP 	0	11	56	16971	0.0	1.0	1	
SUBTIL_PROGESTIN_TARGETS 	0	11	36	16991	0.0	1.0	1	
MISSIAGLIA_REGULATED_BY_METHYLATION_DN 	0	11	108	16919	0.0	1.0	1	
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP 	0	11	139	16888	0.0	1.0	1	
FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN 	0	11	46	16981	0.0	1.0	1	
NUYTTEN_EZH2_TARGETS_DN 	0	11	894	16133	0.0	1.0	1	
AMUNDSON_RESPONSE_TO_ARSENITE 	1	10	207	16820	8.1256038647343	0.12641898098009247	1	CDC42EP1
HEIDENBLAD_AMPLICON_12P11_12_UP 	0	11	30	16997	0.0	1.0	1	
GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11 	0	11	62	16965	0.0	1.0	1	
FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN 	0	11	59	16968	0.0	1.0	1	
JEON_SMAD6_TARGETS_DN 	0	11	16	17011	0.0	1.0	1	
LI_CISPLATIN_RESISTANCE_DN 	0	11	25	17002	0.0	1.0	1	
VECCHI_GASTRIC_CANCER_EARLY_DN 	1	10	274	16753	6.114233576642336	0.16393232300566457	1	PLLP
DORN_ADENOVIRUS_INFECTION_12HR_UP 	0	11	27	17000	0.0	1.0	1	
CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP 	0	11	153	16874	0.0	1.0	1	
WATTEL_AUTONOMOUS_THYROID_ADENOMA_UP 	0	11	65	16962	0.0	1.0	1	
KANG_FLUOROURACIL_RESISTANCE_DN 	0	11	15	17012	0.0	1.0	1	
SMIRNOV_RESPONSE_TO_IR_2HR_UP 	0	11	47	16980	0.0	1.0	1	
DELACROIX_RAR_TARGETS_DN 	0	11	22	17005	0.0	1.0	1	
WINNEPENNINCKX_MELANOMA_METASTASIS_DN 	0	11	33	16994	0.0	1.0	1	
REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS 	0	11	65	16962	0.0	1.0	1	
BEIER_GLIOMA_STEM_CELL_UP 	0	11	33	16994	0.0	1.0	1	
BROWNE_HCMV_INFECTION_20HR_DN 	0	11	88	16939	0.0	1.0	1	
NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_DN 	0	11	114	16913	0.0	1.0	1	
BOYLAN_MULTIPLE_MYELOMA_PCA3_DN 	0	11	60	16967	0.0	1.0	1	
REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS 	0	11	11	17016	0.0	1.0	1	
REACTOME_ACTIVATED_POINT_MUTANTS_OF_FGFR2 	0	11	11	17016	0.0	1.0	1	
GUO_HEX_TARGETS_UP 	0	11	81	16946	0.0	1.0	1	
VIETOR_IFRD1_TARGETS 	0	11	20	17007	0.0	1.0	1	
BIOCARTA_TRKA_PATHWAY 	0	11	12	17015	0.0	1.0	1	
PID_HNF3B_PATHWAY 	0	11	31	16996	0.0	1.0	1	
REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES 	0	11	167	16860	0.0	1.0	1	
BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES 	0	11	66	16961	0.0	1.0	1	
EPPERT_CE_HSC_LSC 	0	11	35	16992	0.0	1.0	1	
WHITESIDE_CISPLATIN_RESISTANCE_UP 	0	11	11	17016	0.0	1.0	1	
REACTOME_METABOLISM_OF_PROTEINS 	0	11	397	16630	0.0	1.0	1	
SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP 	2	9	408	16619	9.051742919389978	0.02752046099104882	1	TMC7,PLLP
KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP 	0	11	122	16905	0.0	1.0	1	
KIM_MYCN_AMPLIFICATION_TARGETS_UP 	0	11	80	16947	0.0	1.0	1	
REACTOME_PI_3K_CASCADE 	0	11	48	16979	0.0	1.0	1	
REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT 	0	11	8	17019	0.0	1.0	1	
BIOCARTA_CELL2CELL_PATHWAY 	0	11	13	17014	0.0	1.0	1	
BIOCARTA_IL1R_PATHWAY 	0	11	29	16998	0.0	1.0	1	
MIKKELSEN_IPS_LCP_WITH_H3K27ME3 	0	11	6	17021	0.0	1.0	1	
REACTOME_M_G1_TRANSITION 	0	11	72	16955	0.0	1.0	1	
MOTAMED_RESPONSE_TO_ANDROGEN_UP 	0	11	4	17023	0.0	1.0	1	
BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP 	0	11	35	16992	0.0	1.0	1	
BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_UP 	0	11	20	17007	0.0	1.0	1	
YAMANAKA_GLIOBLASTOMA_SURVIVAL_UP 	0	11	9	17018	0.0	1.0	1	
BIOCARTA_BIOPEPTIDES_PATHWAY 	0	11	38	16989	0.0	1.0	1	
KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN 	0	11	810	16217	0.0	1.0	1	
BIOCARTA_MEF2D_PATHWAY 	0	11	17	17010	0.0	1.0	1	
VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN 	0	11	98	16929	0.0	1.0	1	
REACTOME_BASE_EXCISION_REPAIR 	0	11	19	17008	0.0	1.0	1	
DELACROIX_RARG_BOUND_MEF 	0	11	330	16697	0.0	1.0	1	
MIKKELSEN_NPC_HCP_WITH_H3K27ME3 	1	10	239	16788	7.0242677824267785	0.14452257243127153	1	CNTN2
CHANG_POU5F1_TARGETS_DN 	0	11	7	17020	0.0	1.0	1	
JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN 	0	11	37	16990	0.0	1.0	1	
AMIT_SERUM_RESPONSE_120_MCF10A 	0	11	61	16966	0.0	1.0	1	
REACTOME_SIGNALING_BY_PDGF 	0	11	115	16912	0.0	1.0	1	
WELCH_GATA1_TARGETS 	0	11	17	17010	0.0	1.0	1	
KAAB_FAILED_HEART_ATRIUM_DN 	0	11	135	16892	0.0	1.0	1	
REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE 	0	11	19	17008	0.0	1.0	1	
BIOCARTA_INSULIN_PATHWAY 	0	11	21	17006	0.0	1.0	1	
BRUNO_HEMATOPOIESIS 	0	11	58	16969	0.0	1.0	1	
REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS 	0	11	49	16978	0.0	1.0	1	
BIOCARTA_INTEGRIN_PATHWAY 	0	11	36	16991	0.0	1.0	1	
SABATES_COLORECTAL_ADENOMA_SIZE_DN 	0	11	12	17015	0.0	1.0	1	
REACTOME_AMYLOIDS 	0	11	39	16988	0.0	1.0	1	
PHONG_TNF_TARGETS_UP 	0	11	57	16970	0.0	1.0	1	
DORSAM_HOXA9_TARGETS_UP 	0	11	34	16993	0.0	1.0	1	
ROSS_AML_WITH_AML1_ETO_FUSION 	0	11	66	16961	0.0	1.0	1	
NATSUME_RESPONSE_TO_INTERFERON_BETA_DN 	0	11	49	16978	0.0	1.0	1	
MORI_PRE_BI_LYMPHOCYTE_DN 	0	11	68	16959	0.0	1.0	1	
ZHENG_IL22_SIGNALING_UP 	0	11	46	16981	0.0	1.0	1	
GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP 	0	11	9	17018	0.0	1.0	1	
BIOCARTA_GLYCOLYSIS_PATHWAY 	0	11	10	17017	0.0	1.0	1	
KIM_PTEN_TARGETS_UP 	0	11	17	17010	0.0	1.0	1	
PID_RANBP2_PATHWAY 	0	11	11	17016	0.0	1.0	1	
MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN 	0	11	69	16958	0.0	1.0	1	
PAL_PRMT5_TARGETS_DN 	0	11	23	17004	0.0	1.0	1	
HSIAO_LIVER_SPECIFIC_GENES 	0	11	166	16861	0.0	1.0	1	
RADMACHER_AML_PROGNOSIS 	0	11	68	16959	0.0	1.0	1	
REACTOME_RNA_POL_I_TRANSCRIPTION_INITIATION 	0	11	23	17004	0.0	1.0	1	
BIOCARTA_NKT_PATHWAY 	0	11	16	17011	0.0	1.0	1	
AMIT_EGF_RESPONSE_60_HELA 	0	11	43	16984	0.0	1.0	1	
SCHMIDT_POR_TARGETS_IN_LIMB_BUD_DN 	0	11	7	17020	0.0	1.0	1	
LU_AGING_BRAIN_UP 	0	11	255	16772	0.0	1.0	1	
RIZKI_TUMOR_INVASIVENESS_3D_DN 	0	11	235	16792	0.0	1.0	1	
MIKKELSEN_MEF_LCP_WITH_H3K27ME3 	0	11	42	16985	0.0	1.0	1	
JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP 	0	11	89	16938	0.0	1.0	1	
PID_IGF1_PATHWAY 	0	11	29	16998	0.0	1.0	1	
REACTOME_PLATELET_CALCIUM_HOMEOSTASIS 	0	11	15	17012	0.0	1.0	1	
REACTOME_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT 	0	11	47	16980	0.0	1.0	1	
HOFFMAN_CLOCK_TARGETS_DN 	0	11	7	17020	0.0	1.0	1	
BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN 	0	11	16	17011	0.0	1.0	1	
BIOCARTA_ARF_PATHWAY 	0	11	17	17010	0.0	1.0	1	
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_UP 	0	11	9	17018	0.0	1.0	1	
SENESE_HDAC1_AND_HDAC2_TARGETS_DN 	0	11	202	16825	0.0	1.0	1	
WANG_TARGETS_OF_MLL_CBP_FUSION_UP 	0	11	38	16989	0.0	1.0	1	
SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN 	0	11	29	16998	0.0	1.0	1	
PARENT_MTOR_SIGNALING_DN 	0	11	38	16989	0.0	1.0	1	
ZHU_SKIL_TARGETS_UP 	0	11	19	17008	0.0	1.0	1	
KANG_AR_TARGETS_DN 	0	11	15	17012	0.0	1.0	1	
BIOCARTA_AHSP_PATHWAY 	0	11	11	17016	0.0	1.0	1	
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A 	1	10	733	16294	2.222919508867667	0.3840181169421347	1	MAG
REACTOME_DIABETES_PATHWAYS 	0	11	110	16917	0.0	1.0	1	
SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP 	0	11	80	16947	0.0	1.0	1	
WINTER_HYPOXIA_METAGENE 	0	11	216	16811	0.0	1.0	1	
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP 	0	11	67	16960	0.0	1.0	1	
REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE 	0	11	23	17004	0.0	1.0	1	
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9 	0	11	68	16959	0.0	1.0	1	
CREIGHTON_AKT1_SIGNALING_VIA_MTOR_DN 	0	11	23	17004	0.0	1.0	1	
NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON 	0	11	273	16754	0.0	1.0	1	
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C 	0	11	80	16947	0.0	1.0	1	
GROSS_HYPOXIA_VIA_ELK3_DN 	0	11	144	16883	0.0	1.0	1	
CHIN_BREAST_CANCER_COPY_NUMBER_DN 	0	11	13	17014	0.0	1.0	1	
LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS 	0	11	16	17011	0.0	1.0	1	
REACTOME_SIGNALING_BY_FGFR3_MUTANTS 	0	11	8	17019	0.0	1.0	1	
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B 	0	11	463	16564	0.0	1.0	1	
YANG_BCL3_TARGETS_UP 	0	11	321	16706	0.0	1.0	1	
FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP 	0	11	21	17006	0.0	1.0	1	
HWANG_PROSTATE_CANCER_MARKERS 	0	11	26	17001	0.0	1.0	1	
SHIPP_DLBCL_CURED_VS_FATAL_DN 	0	11	41	16986	0.0	1.0	1	
ST_INTERFERON_GAMMA_PATHWAY 	0	11	7	17020	0.0	1.0	1	
LUND_SILENCED_BY_METHYLATION 	0	11	15	17012	0.0	1.0	1	
REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY 	0	11	19	17008	0.0	1.0	1	
TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_DN 	0	11	7	17020	0.0	1.0	1	
VANDESLUIS_COMMD1_TARGETS_GROUP_3_DN 	0	11	33	16994	0.0	1.0	1	
REACTOME_DEADENYLATION_OF_MRNA 	0	11	17	17010	0.0	1.0	1	
JAATINEN_HEMATOPOIETIC_STEM_CELL_UP 	0	11	277	16750	0.0	1.0	1	
CASTELLANO_HRAS_TARGETS_UP 	0	11	4	17023	0.0	1.0	1	
MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 	3	8	962	16065	6.262344074844075	0.021221042014495616	1	CNTN2,CDC42EP1,PLLP
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8 	0	11	44	16983	0.0	1.0	1	
NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON 	0	11	112	16915	0.0	1.0	1	
BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP 	0	11	760	16267	0.0	1.0	1	
XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR 	0	11	25	17002	0.0	1.0	1	
WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP 	0	11	242	16785	0.0	1.0	1	
WORSCHECH_TUMOR_REJECTION_DN 	0	11	9	17018	0.0	1.0	1	
CHESLER_BRAIN_HIGHEST_GENETIC_VARIANCE 	0	11	30	16997	0.0	1.0	1	
BROWNE_HCMV_INFECTION_4HR_DN 	0	11	234	16793	0.0	1.0	1	
MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP 	0	11	14	17013	0.0	1.0	1	
MARKEY_RB1_CHRONIC_LOF_UP 	0	11	106	16921	0.0	1.0	1	
CHEN_METABOLIC_SYNDROM_NETWORK 	1	10	1063	15964	1.5017873941674507	0.5081277655488163	1	C9orf3
RIZ_ERYTHROID_DIFFERENTIATION_6HR 	0	11	23	17004	0.0	1.0	1	
GAVIN_FOXP3_TARGETS_CLUSTER_P3 	0	11	142	16885	0.0	1.0	1	
TSENG_IRS1_TARGETS_UP 	1	10	100	16927	16.927	0.06332647256447224	1	C9orf3
REACTOME_SIGNAL_TRANSDUCTION_BY_L1 	0	11	34	16993	0.0	1.0	1	
KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION 	0	11	155	16872	0.0	1.0	1	
REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21 	0	11	53	16974	0.0	1.0	1	
HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP 	0	11	37	16990	0.0	1.0	1	
KIM_WT1_TARGETS_12HR_UP 	0	11	153	16874	0.0	1.0	1	
BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS 	0	11	6	17021	0.0	1.0	1	
FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP 	0	11	47	16980	0.0	1.0	1	
CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP 	0	11	67	16960	0.0	1.0	1	
PHESSE_TARGETS_OF_APC_AND_MBD2_DN 	0	11	12	17015	0.0	1.0	1	
ABBUD_LIF_SIGNALING_2_DN 	0	11	5	17022	0.0	1.0	1	
LEONARD_HYPOXIA 	0	11	45	16982	0.0	1.0	1	
OZANNE_AP1_TARGETS_DN 	0	11	5	17022	0.0	1.0	1	
BIOCARTA_EXTRINSIC_PATHWAY 	0	11	8	17019	0.0	1.0	1	
REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS 	0	11	12	17015	0.0	1.0	1	
KEGG_RETINOL_METABOLISM 	0	11	26	17001	0.0	1.0	1	
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP 	0	11	38	16989	0.0	1.0	1	
EHRLICH_ICF_SYNDROM_UP 	0	11	10	17017	0.0	1.0	1	
MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER 	0	11	35	16992	0.0	1.0	1	
REACTOME_FGFR4_LIGAND_BINDING_AND_ACTIVATION 	0	11	8	17019	0.0	1.0	1	
REACTOME_GLYCOSAMINOGLYCAN_METABOLISM 	0	11	101	16926	0.0	1.0	1	
GERHOLD_ADIPOGENESIS_DN 	0	11	61	16966	0.0	1.0	1	
KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP 	0	11	723	16304	0.0	1.0	1	
BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER 	0	11	22	17005	0.0	1.0	1	
XU_HGF_TARGETS_REPRESSED_BY_AKT1_UP 	0	11	8	17019	0.0	1.0	1	
LINDSTEDT_DENDRITIC_CELL_MATURATION_D 	0	11	61	16966	0.0	1.0	1	
BIOCARTA_COMP_PATHWAY 	0	11	15	17012	0.0	1.0	1	
CASORELLI_APL_SECONDARY_VS_DE_NOVO_DN 	0	11	9	17018	0.0	1.0	1	
ONGUSAHA_BRCA1_TARGETS_UP 	0	11	12	17015	0.0	1.0	1	
BERENJENO_TRANSFORMED_BY_RHOA_DN 	0	11	374	16653	0.0	1.0	1	
PID_CXCR4_PATHWAY 	0	11	96	16931	0.0	1.0	1	
ZHANG_TLX_TARGETS_36HR_DN 	0	11	171	16856	0.0	1.0	1	
REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR 	0	11	21	17006	0.0	1.0	1	
MORI_PRE_BI_LYMPHOCYTE_UP 	0	11	65	16962	0.0	1.0	1	
HUNSBERGER_EXERCISE_REGULATED_GENES 	0	11	29	16998	0.0	1.0	1	
NIKOLSKY_BREAST_CANCER_5P15_AMPLICON 	0	11	22	17005	0.0	1.0	1	
REACTOME_ACTIVATION_OF_IRF3_IRF7_MEDIATED_BY_TBK1_IKK_EPSILON 	0	11	13	17014	0.0	1.0	1	
BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN 	0	11	29	16998	0.0	1.0	1	
SENESE_HDAC3_TARGETS_UP 	0	11	451	16576	0.0	1.0	1	
OHM_EMBRYONIC_CARCINOMA_DN 	0	11	8	17019	0.0	1.0	1	
GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN 	0	11	82	16945	0.0	1.0	1	
LEE_LIVER_CANCER_MYC_E2F1_UP 	0	11	49	16978	0.0	1.0	1	
SCHOEN_NFKB_SIGNALING 	0	11	31	16996	0.0	1.0	1	
LOPEZ_MESOTELIOMA_SURVIVAL_TIME_UP 	0	11	11	17016	0.0	1.0	1	
MATZUK_MALE_REPRODUCTION_SERTOLI 	0	11	25	17002	0.0	1.0	1	
SUMI_HNF4A_TARGETS 	0	11	19	17008	0.0	1.0	1	
KEGG_BASAL_CELL_CARCINOMA 	0	11	53	16974	0.0	1.0	1	
YAMASHITA_LIVER_CANCER_STEM_CELL_UP 	0	11	41	16986	0.0	1.0	1	
QI_PLASMACYTOMA_UP 	0	11	230	16797	0.0	1.0	1	
NIKOLSKY_BREAST_CANCER_1Q32_AMPLICON 	0	11	6	17021	0.0	1.0	1	
PASTURAL_RIZ1_TARGETS_DN 	0	11	5	17022	0.0	1.0	1	
FIGUEROA_AML_METHYLATION_CLUSTER_5_UP 	0	11	10	17017	0.0	1.0	1	
BIOCARTA_SARS_PATHWAY 	0	11	9	17018	0.0	1.0	1	
BIOCARTA_HCMV_PATHWAY 	0	11	17	17010	0.0	1.0	1	
RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_DN 	0	11	7	17020	0.0	1.0	1	
EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN 	0	11	44	16983	0.0	1.0	1	
REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT 	0	11	48	16979	0.0	1.0	1	
REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE 	0	11	15	17012	0.0	1.0	1	
LI_INDUCED_T_TO_NATURAL_KILLER_UP 	0	11	271	16756	0.0	1.0	1	
MAYBURD_RESPONSE_TO_L663536_DN 	0	11	51	16976	0.0	1.0	1	
TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP 	0	11	16	17011	0.0	1.0	1	
REACTOME_3_UTR_MEDIATED_TRANSLATIONAL_REGULATION 	0	11	104	16923	0.0	1.0	1	
NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_DN 	0	11	20	17007	0.0	1.0	1	
SHEPARD_CRUSH_AND_BURN_MUTANT_DN 	1	10	152	16875	11.101973684210526	0.09448791023174792	1	RTKN
SCHLOSSER_SERUM_RESPONSE_DN 	0	11	658	16369	0.0	1.0	1	
DING_LUNG_CANCER_BY_MUTATION_RATE 	0	11	19	17008	0.0	1.0	1	
BIOCARTA_CSK_PATHWAY 	0	11	18	17009	0.0	1.0	1	
CASTELLANO_HRAS_AND_NRAS_TARGETS_DN 	0	11	7	17020	0.0	1.0	1	
HUMMERICH_SKIN_CANCER_PROGRESSION_DN 	0	11	95	16932	0.0	1.0	1	
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP 	0	11	22	17005	0.0	1.0	1	
HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP 	0	11	25	17002	0.0	1.0	1	
HUANG_DASATINIB_RESISTANCE_DN 	0	11	65	16962	0.0	1.0	1	
FIGUEROA_AML_METHYLATION_CLUSTER_1_DN 	0	11	38	16989	0.0	1.0	1	
MARKS_HDAC_TARGETS_DN 	0	11	13	17014	0.0	1.0	1	
MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN 	0	11	26	17001	0.0	1.0	1	
REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS 	0	11	15	17012	0.0	1.0	1	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_22 	0	11	11	17016	0.0	1.0	1	
WEST_ADRENOCORTICAL_TUMOR_UP 	0	11	270	16757	0.0	1.0	1	
ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN 	0	11	32	16995	0.0	1.0	1	
ZWANG_EGF_PERSISTENTLY_UP 	0	11	29	16998	0.0	1.0	1	
BRACHAT_RESPONSE_TO_CISPLATIN 	0	11	20	17007	0.0	1.0	1	
GOZGIT_ESR1_TARGETS_DN 	2	9	634	16393	5.7458815282159135	0.06121339125321654	1	C9orf3,PLLP
REACTOME_AQUAPORIN_MEDIATED_TRANSPORT 	0	11	42	16985	0.0	1.0	1	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_24 	0	11	12	17015	0.0	1.0	1	
CHESLER_BRAIN_D6MIT150_QTL_TRANS 	0	11	7	17020	0.0	1.0	1	
PID_TCR_PATHWAY 	0	11	62	16965	0.0	1.0	1	
REACTOME_SIGNALING_BY_ILS 	0	11	96	16931	0.0	1.0	1	
ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN 	0	11	38	16989	0.0	1.0	1	
SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP 	0	11	26	17001	0.0	1.0	1	
SA_FAS_SIGNALING 	0	11	8	17019	0.0	1.0	1	
BIOCARTA_EPHA4_PATHWAY 	0	11	9	17018	0.0	1.0	1	
REACTOME_ORC1_REMOVAL_FROM_CHROMATIN 	0	11	63	16964	0.0	1.0	1	
EHRLICH_ICF_SYNDROM_DN 	0	11	11	17016	0.0	1.0	1	
BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2 	0	11	71	16956	0.0	1.0	1	
BIOCARTA_PGC1A_PATHWAY 	0	11	22	17005	0.0	1.0	1	
BIOCARTA_NGF_PATHWAY 	0	11	18	17009	0.0	1.0	1	
WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_UP 	0	11	18	17009	0.0	1.0	1	
JAIN_NFKB_SIGNALING 	0	11	71	16956	0.0	1.0	1	
REACTOME_EXTRINSIC_PATHWAY_FOR_APOPTOSIS 	0	11	11	17016	0.0	1.0	1	
BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP 	1	10	25	17002	68.008	0.016663368377630234	1	PLLP
ROVERSI_GLIOMA_LOH_REGIONS 	0	11	35	16992	0.0	1.0	1	
RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_DN 	0	11	10	17017	0.0	1.0	1	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_29 	0	11	5	17022	0.0	1.0	1	
UDAYAKUMAR_MED1_TARGETS_DN 	0	11	222	16805	0.0	1.0	1	
SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES 	0	11	65	16962	0.0	1.0	1	
LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT 	0	11	75	16952	0.0	1.0	1	
PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP 	0	11	124	16903	0.0	1.0	1	
PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP 	0	11	163	16864	0.0	1.0	1	
PID_ERBB4_PATHWAY 	0	11	36	16991	0.0	1.0	1	
RODWELL_AGING_KIDNEY_DN 	0	11	126	16901	0.0	1.0	1	
LI_WILMS_TUMOR 	0	11	19	17008	0.0	1.0	1	
ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP 	0	11	29	16998	0.0	1.0	1	
HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS 	0	11	76	16951	0.0	1.0	1	
PID_TCR_CALCIUM_PATHWAY 	0	11	20	17007	0.0	1.0	1	
REACTOME_INTEGRATION_OF_PROVIRUS 	0	11	8	17019	0.0	1.0	1	
KEGG_CELL_ADHESION_MOLECULES_CAMS 	2	9	109	16918	34.491335372069315	0.0022263411185200616	1	CNTN2,MAG
PID_RHODOPSIN_PATHWAY 	0	11	15	17012	0.0	1.0	1	
REACTOME_CELL_CYCLE 	0	11	343	16684	0.0	1.0	1	
KEGG_TYPE_II_DIABETES_MELLITUS 	0	11	41	16986	0.0	1.0	1	
REACTOME_G_ALPHA1213_SIGNALLING_EVENTS 	0	11	71	16956	0.0	1.0	1	
MURAKAMI_UV_RESPONSE_6HR_UP 	0	11	36	16991	0.0	1.0	1	
DING_LUNG_CANCER_MUTATED_FREQUENTLY 	0	11	12	17015	0.0	1.0	1	
STEINER_ERYTHROCYTE_MEMBRANE_GENES 	0	11	10	17017	0.0	1.0	1	
REACTOME_FGFR2C_LIGAND_BINDING_AND_ACTIVATION 	0	11	8	17019	0.0	1.0	1	
BAELDE_DIABETIC_NEPHROPATHY_UP 	1	10	75	16952	22.602666666666668	0.048000740653493607	1	CAPN3
LANDIS_ERBB2_BREAST_TUMORS_65_DN 	0	11	34	16993	0.0	1.0	1	
REACTOME_ABACAVIR_TRANSPORT_AND_METABOLISM 	0	11	7	17020	0.0	1.0	1	
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP 	0	11	26	17001	0.0	1.0	1	
REACTOME_SIGNALING_BY_SCF_KIT 	0	11	74	16953	0.0	1.0	1	
BRUECKNER_TARGETS_OF_MIRLET7A3_DN 	0	11	69	16958	0.0	1.0	1	
KEGG_CIRCADIAN_RHYTHM_MAMMAL 	0	11	13	17014	0.0	1.0	1	
KRISHNAN_FURIN_TARGETS_UP 	0	11	9	17018	0.0	1.0	1	
BIOCARTA_IGF1R_PATHWAY 	0	11	22	17005	0.0	1.0	1	
WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP 	0	11	323	16704	0.0	1.0	1	
KEGG_SMALL_CELL_LUNG_CANCER 	0	11	82	16945	0.0	1.0	1	
PID_IL6_7_PATHWAY 	0	11	43	16984	0.0	1.0	1	
BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP 	0	11	26	17001	0.0	1.0	1	
RODRIGUES_DCC_TARGETS_DN 	0	11	115	16912	0.0	1.0	1	
BIOCARTA_KERATINOCYTE_PATHWAY 	0	11	43	16984	0.0	1.0	1	
MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3 	0	11	40	16987	0.0	1.0	1	
PID_ECADHERIN_NASCENT_AJ_PATHWAY 	0	11	38	16989	0.0	1.0	1	
CALVET_IRINOTECAN_SENSITIVE_VS_RESISTANT_UP 	0	11	4	17023	0.0	1.0	1	
SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1B 	0	11	18	17009	0.0	1.0	1	
SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A 	0	11	19	17008	0.0	1.0	1	
NGUYEN_NOTCH1_TARGETS_UP 	0	11	28	16999	0.0	1.0	1	
ZHAN_EARLY_DIFFERENTIATION_GENES_DN 	0	11	37	16990	0.0	1.0	1	
BROWNE_HCMV_INFECTION_12HR_UP 	0	11	99	16928	0.0	1.0	1	
FRIDMAN_SENESCENCE_UP 	1	10	72	16955	23.54861111111111	0.04614641608972104	1	C9orf3
VANDESLUIS_NORMAL_EMBRYOS_DN 	0	11	19	17008	0.0	1.0	1	
CHANG_CYCLING_GENES 	0	11	124	16903	0.0	1.0	1	
CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN 	0	11	32	16995	0.0	1.0	1	
REACTOME_E2F_MEDIATED_REGULATION_OF_DNA_REPLICATION 	0	11	30	16997	0.0	1.0	1	
KIM_ALL_DISORDERS_DURATION_CORR_DN 	0	11	142	16885	0.0	1.0	1	
LI_DCP2_BOUND_MRNA 	0	11	85	16942	0.0	1.0	1	
PID_INTEGRIN2_PATHWAY 	0	11	22	17005	0.0	1.0	1	
CAIRO_LIVER_DEVELOPMENT_DN 	0	11	172	16855	0.0	1.0	1	
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN 	0	11	290	16737	0.0	1.0	1	
AIYAR_COBRA1_TARGETS_DN 	0	11	27	17000	0.0	1.0	1	
ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF 	0	11	37	16990	0.0	1.0	1	
REACTOME_GABA_A_RECEPTOR_ACTIVATION 	0	11	12	17015	0.0	1.0	1	
REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS 	0	11	114	16913	0.0	1.0	1	
SERVITJA_ISLET_HNF1A_TARGETS_DN 	0	11	77	16950	0.0	1.0	1	
DANG_BOUND_BY_MYC 	1	10	1010	16017	1.585841584158416	0.4898693943711998	1	CNTN2
ZIRN_TRETINOIN_RESPONSE_WT1_DN 	0	11	5	17022	0.0	1.0	1	
REACTOME_PHOSPHORYLATION_OF_THE_APC_C 	0	11	16	17011	0.0	1.0	1	
REACTOME_HS_GAG_DEGRADATION 	0	11	20	17007	0.0	1.0	1	
AFFAR_YY1_TARGETS_UP 	0	11	189	16838	0.0	1.0	1	
SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP 	0	11	33	16994	0.0	1.0	1	
HOLLMANN_APOPTOSIS_VIA_CD40_UP 	0	11	183	16844	0.0	1.0	1	
DER_IFN_GAMMA_RESPONSE_DN 	0	11	10	17017	0.0	1.0	1	
GU_PDEF_TARGETS_DN 	0	11	28	16999	0.0	1.0	1	
CHUNG_BLISTER_CYTOTOXICITY_DN 	0	11	40	16987	0.0	1.0	1	
MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP 	0	11	167	16860	0.0	1.0	1	
BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP 	0	11	22	17005	0.0	1.0	1	
SYED_ESTRADIOL_RESPONSE 	0	11	19	17008	0.0	1.0	1	
ACEVEDO_LIVER_CANCER_UP 	1	10	886	16141	1.821783295711061	0.44472028341888176	1	C9orf3
BIOCARTA_CXCR4_PATHWAY 	0	11	22	17005	0.0	1.0	1	
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_UP 	0	11	16	17011	0.0	1.0	1	
YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP 	0	11	50	16977	0.0	1.0	1	
BILANGES_SERUM_SENSITIVE_VIA_TSC1 	0	11	20	17007	0.0	1.0	1	
CHANDRAN_METASTASIS_UP 	0	11	188	16839	0.0	1.0	1	
REACTOME_SEMAPHORIN_INTERACTIONS 	0	11	64	16963	0.0	1.0	1	
REACTOME_COMMON_PATHWAY 	0	11	6	17021	0.0	1.0	1	
KEGG_PYRUVATE_METABOLISM 	0	11	34	16993	0.0	1.0	1	
ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF 	0	11	424	16603	0.0	1.0	1	
KANG_GLIS3_TARGETS 	0	11	26	17001	0.0	1.0	1	
REACTOME_PLC_BETA_MEDIATED_EVENTS 	0	11	38	16989	0.0	1.0	1	
OHM_EMBRYONIC_CARCINOMA_UP 	0	11	6	17021	0.0	1.0	1	
BIOCARTA_TOLL_PATHWAY 	0	11	36	16991	0.0	1.0	1	
REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION 	0	11	23	17004	0.0	1.0	1	
CHICAS_RB1_TARGETS_SENESCENT 	0	11	499	16528	0.0	1.0	1	
CERIBELLI_PROMOTERS_INACTIVE_AND_BOUND_BY_NFY 	1	10	20	17007	85.035	0.013478615710072554	1	SOX10
MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_7 	0	11	16	17011	0.0	1.0	1	
CHIBA_RESPONSE_TO_TSA_UP 	0	11	49	16978	0.0	1.0	1	
REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL 	0	11	42	16985	0.0	1.0	1	
ENK_UV_RESPONSE_EPIDERMIS_DN 	1	10	469	16558	3.5304904051172707	0.26493388165917714	1	PLLP
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1 	0	11	39	16988	0.0	1.0	1	
MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_DN 	0	11	11	17016	0.0	1.0	1	
OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN 	0	11	25	17002	0.0	1.0	1	
MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5 	0	11	21	17006	0.0	1.0	1	
KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION 	0	11	43	16984	0.0	1.0	1	
REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_ATF6_ALPHA 	0	11	9	17018	0.0	1.0	1	
REACTOME_SHC_RELATED_EVENTS 	0	11	16	17011	0.0	1.0	1	
SHARMA_ASTROCYTOMA_WITH_NF1_SYNDROM 	0	11	3	17024	0.0	1.0	1	
FUNG_IL2_SIGNALING_1 	0	11	8	17019	0.0	1.0	1	
FUNG_IL2_SIGNALING_2 	0	11	7	17020	0.0	1.0	1	
BLUM_RESPONSE_TO_SALIRASIB_DN 	0	11	317	16710	0.0	1.0	1	
MIKKELSEN_MCV6_HCP_WITH_H3K27ME3 	1	10	337	16690	4.9525222551928785	0.19786393473485303	1	CNTN2
TOOKER_GEMCITABINE_RESISTANCE_UP 	0	11	75	16952	0.0	1.0	1	
SILIGAN_BOUND_BY_EWS_FLT1_FUSION 	0	11	43	16984	0.0	1.0	1	
REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA 	0	11	23	17004	0.0	1.0	1	
KEGG_PHENYLALANINE_METABOLISM 	0	11	15	17012	0.0	1.0	1	
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_5 	0	11	9	17018	0.0	1.0	1	
KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN 	0	11	62	16965	0.0	1.0	1	
REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS 	0	11	14	17013	0.0	1.0	1	
KIM_MYCL1_AMPLIFICATION_TARGETS_UP 	0	11	11	17016	0.0	1.0	1	
JIANG_AGING_CEREBRAL_CORTEX_UP 	0	11	34	16993	0.0	1.0	1	
REACTOME_ETHANOL_OXIDATION 	0	11	5	17022	0.0	1.0	1	
FURUKAWA_DUSP6_TARGETS_PCI35_UP 	0	11	62	16965	0.0	1.0	1	
WANG_LSD1_TARGETS_DN 	0	11	32	16995	0.0	1.0	1	
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7 	0	11	353	16674	0.0	1.0	1	
RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_DN 	0	11	8	17019	0.0	1.0	1	
KIM_GLIS2_TARGETS_UP 	0	11	76	16951	0.0	1.0	1	
REACTOME_PYRIMIDINE_METABOLISM 	0	11	22	17005	0.0	1.0	1	
TESAR_JAK_TARGETS_MOUSE_ES_D3_UP 	0	11	2	17025	0.0	1.0	1	
CAMPS_COLON_CANCER_COPY_NUMBER_UP 	0	11	70	16957	0.0	1.0	1	
TOMLINS_METASTASIS_DN 	0	11	18	17009	0.0	1.0	1	
DAIRKEE_CANCER_PRONE_RESPONSE_BPA 	0	11	46	16981	0.0	1.0	1	
REACTOME_GPCR_DOWNSTREAM_SIGNALING 	0	11	341	16686	0.0	1.0	1	
ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN 	0	11	45	16982	0.0	1.0	1	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_30 	0	11	4	17023	0.0	1.0	1	
BIDUS_METASTASIS_DN 	0	11	145	16882	0.0	1.0	1	
ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER 	0	11	107	16920	0.0	1.0	1	
BIOCARTA_MCM_PATHWAY 	0	11	17	17010	0.0	1.0	1	
REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1 	0	11	61	16966	0.0	1.0	1	
REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0 	0	11	49	16978	0.0	1.0	1	
BIOCARTA_KREB_PATHWAY 	0	11	8	17019	0.0	1.0	1	
PARENT_MTOR_SIGNALING_UP 	0	11	524	16503	0.0	1.0	1	
KEGG_O_GLYCAN_BIOSYNTHESIS 	0	11	24	17003	0.0	1.0	1	
PID_IL2_STAT5_PATHWAY 	0	11	25	17002	0.0	1.0	1	
CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN 	0	11	39	16988	0.0	1.0	1	
LIAN_LIPA_TARGETS_3M 	0	11	46	16981	0.0	1.0	1	
PID_RHOA_REG_PATHWAY 	0	11	44	16983	0.0	1.0	1	
PID_EPHRINB_REV_PATHWAY 	0	11	26	17001	0.0	1.0	1	
KEGG_LYSOSOME 	0	11	113	16914	0.0	1.0	1	
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN 	0	11	38	16989	0.0	1.0	1	
HASINA_NOL7_TARGETS_UP 	0	11	12	17015	0.0	1.0	1	
REACTOME_HIV_INFECTION 	0	11	181	16846	0.0	1.0	1	
REACTOME_CHOLESTEROL_BIOSYNTHESIS 	0	11	20	17007	0.0	1.0	1	
WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER 	0	11	51	16976	0.0	1.0	1	
FERRANDO_LYL1_NEIGHBORS 	0	11	15	17012	0.0	1.0	1	
SABATES_COLORECTAL_ADENOMA_SIZE_UP 	0	11	17	17010	0.0	1.0	1	
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN 	0	11	145	16882	0.0	1.0	1	
REACTOME_CELL_CELL_JUNCTION_ORGANIZATION 	0	11	41	16986	0.0	1.0	1	
JACKSON_DNMT1_TARGETS_DN 	0	11	23	17004	0.0	1.0	1	
REACTOME_POL_SWITCHING 	0	11	13	17014	0.0	1.0	1	
REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING 	0	11	21	17006	0.0	1.0	1	
REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING 	0	11	20	17007	0.0	1.0	1	
REACTOME_UNBLOCKING_OF_NMDA_RECEPTOR_GLUTAMATE_BINDING_AND_ACTIVATION 	0	11	15	17012	0.0	1.0	1	
JOHNSTONE_PARVB_TARGETS_2_UP 	0	11	127	16900	0.0	1.0	1	
GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_UP 	0	11	17	17010	0.0	1.0	1	
BIOCARTA_GATA3_PATHWAY 	0	11	12	17015	0.0	1.0	1	
BYSTROEM_CORRELATED_WITH_IL5_UP 	0	11	44	16983	0.0	1.0	1	
XU_GH1_EXOGENOUS_TARGETS_UP 	0	11	63	16964	0.0	1.0	1	
WANG_CLIM2_TARGETS_DN 	0	11	173	16854	0.0	1.0	1	
GUTIERREZ_MULTIPLE_MYELOMA_UP 	0	11	31	16996	0.0	1.0	1	
REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES 	0	11	24	17003	0.0	1.0	1	
LINDGREN_BLADDER_CANCER_CLUSTER_1_DN 	0	11	326	16701	0.0	1.0	1	
REACTOME_ERK_MAPK_TARGETS 	0	11	21	17006	0.0	1.0	1	
BIOCARTA_BCR_PATHWAY 	0	11	33	16994	0.0	1.0	1	
REACTOME_RAF_MAP_KINASE_CASCADE 	0	11	10	17017	0.0	1.0	1	
REACTOME_TRANSPORT_OF_RIBONUCLEOPROTEINS_INTO_THE_HOST_NUCLEUS 	0	11	26	17001	0.0	1.0	1	
TSAI_RESPONSE_TO_IONIZING_RADIATION 	0	11	138	16889	0.0	1.0	1	
REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX 	0	11	60	16967	0.0	1.0	1	
WINTER_HYPOXIA_DN 	0	11	45	16982	0.0	1.0	1	
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_UP 	0	11	14	17013	0.0	1.0	1	
WEBER_METHYLATED_HCP_IN_SPERM_UP 	0	11	11	17016	0.0	1.0	1	
KEGG_GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM 	0	11	14	17013	0.0	1.0	1	
OZEN_MIR125B1_TARGETS 	0	11	25	17002	0.0	1.0	1	
NIKOLSKY_BREAST_CANCER_21Q22_AMPLICON 	0	11	14	17013	0.0	1.0	1	
MAHADEVAN_IMATINIB_RESISTANCE_DN 	0	11	15	17012	0.0	1.0	1	
YAMAZAKI_TCEB3_TARGETS_UP 	1	10	164	16863	10.282317073170733	0.10154381329610224	1	CDC42EP1
REACTOME_PREFOLDIN_MEDIATED_TRANSFER_OF_SUBSTRATE_TO_CCT_TRIC 	0	11	25	17002	0.0	1.0	1	
RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP 	0	11	28	16999	0.0	1.0	1	
REACTOME_METABOLISM_OF_STEROID_HORMONES_AND_VITAMINS_A_AND_D 	0	11	22	17005	0.0	1.0	1	
DORSAM_HOXA9_TARGETS_DN 	0	11	31	16996	0.0	1.0	1	
BROWNE_HCMV_INFECTION_24HR_UP 	0	11	135	16892	0.0	1.0	1	
MASSARWEH_TAMOXIFEN_RESISTANCE_UP 	0	11	507	16520	0.0	1.0	1	
HINATA_NFKB_TARGETS_KERATINOCYTE_UP 	0	11	78	16949	0.0	1.0	1	
AIGNER_ZEB1_TARGETS 	0	11	32	16995	0.0	1.0	1	
BIOCARTA_IL7_PATHWAY 	0	11	16	17011	0.0	1.0	1	
BIOCARTA_HIF_PATHWAY 	0	11	14	17013	0.0	1.0	1	
ZHENG_IL22_SIGNALING_DN 	0	11	34	16993	0.0	1.0	1	
FOURNIER_ACINAR_DEVELOPMENT_EARLY_DN 	0	11	6	17021	0.0	1.0	1	
LIM_MAMMARY_LUMINAL_MATURE_DN 	1	10	95	16932	17.82315789473684	0.060279391424646486	1	SOX10
REACTOME_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING 	0	11	22	17005	0.0	1.0	1	
REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS 	0	11	12	17015	0.0	1.0	1	
RAO_BOUND_BY_SALL4_ISOFORM_A 	0	11	133	16894	0.0	1.0	1	
MARCHINI_TRABECTEDIN_RESISTANCE_DN 	1	10	45	16982	37.73777777777778	0.029309132707367236	1	CNTN2
BIOCARTA_AGPCR_PATHWAY 	0	11	11	17016	0.0	1.0	1	
NAKAJIMA_MAST_CELL 	0	11	39	16988	0.0	1.0	1	
INAMURA_LUNG_CANCER_SCC_SUBTYPES_UP 	0	11	13	17014	0.0	1.0	1	
MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN 	0	11	144	16883	0.0	1.0	1	
DAIRKEE_CANCER_PRONE_RESPONSE_E2 	0	11	27	17000	0.0	1.0	1	
DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_UP 	0	11	14	17013	0.0	1.0	1	
ST_T_CELL_SIGNAL_TRANSDUCTION 	0	11	41	16986	0.0	1.0	1	
HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER 	0	11	30	16997	0.0	1.0	1	
REACTOME_FGFR1_LIGAND_BINDING_AND_ACTIVATION 	0	11	9	17018	0.0	1.0	1	
STANELLE_E2F1_TARGETS 	0	11	27	17000	0.0	1.0	1	
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN 	0	11	30	16997	0.0	1.0	1	
GHANDHI_DIRECT_IRRADIATION_UP 	0	11	89	16938	0.0	1.0	1	
BIOCARTA_TFF_PATHWAY 	0	11	20	17007	0.0	1.0	1	
CHEN_HOXA5_TARGETS_9HR_UP 	0	11	204	16823	0.0	1.0	1	
GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN 	0	11	31	16996	0.0	1.0	1	
CHICAS_RB1_TARGETS_CONFLUENT 	0	11	515	16512	0.0	1.0	1	
KEGG_REGULATION_OF_AUTOPHAGY 	0	11	19	17008	0.0	1.0	1	
CAFFAREL_RESPONSE_TO_THC_24HR_5_UP 	0	11	30	16997	0.0	1.0	1	
BENPORATH_NANOG_TARGETS 	0	11	901	16126	0.0	1.0	1	
DEMAGALHAES_AGING_UP 	0	11	51	16976	0.0	1.0	1	
MOOTHA_VOXPHOS 	0	11	84	16943	0.0	1.0	1	
LIN_APC_TARGETS 	0	11	75	16952	0.0	1.0	1	
KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM 	0	11	29	16998	0.0	1.0	1	
CALVET_IRINOTECAN_SENSITIVE_VS_RESISTANT_DN 	0	11	5	17022	0.0	1.0	1	
MILI_PSEUDOPODIA 	0	11	42	16985	0.0	1.0	1	
ABBUD_LIF_SIGNALING_1_DN 	0	11	24	17003	0.0	1.0	1	
MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER 	0	11	47	16980	0.0	1.0	1	
REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS 	0	11	28	16999	0.0	1.0	1	
SASSON_RESPONSE_TO_GONADOTROPHINS_UP 	0	11	84	16943	0.0	1.0	1	
VALK_AML_WITH_EVI1 	0	11	20	17007	0.0	1.0	1	
NABA_MATRISOME_ASSOCIATED 	0	11	491	16536	0.0	1.0	1	
KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_UP 	0	11	12	17015	0.0	1.0	1	
HUMMERICH_BENIGN_SKIN_TUMOR_DN 	0	11	14	17013	0.0	1.0	1	
BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP 	0	11	44	16983	0.0	1.0	1	
NAKAMURA_ADIPOGENESIS_LATE_UP 	0	11	96	16931	0.0	1.0	1	
FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL 	0	11	286	16741	0.0	1.0	1	
ZIRN_TRETINOIN_RESPONSE_UP 	0	11	20	17007	0.0	1.0	1	
HSIAO_HOUSEKEEPING_GENES 	0	11	384	16643	0.0	1.0	1	
ROSS_AML_WITH_MLL_FUSIONS 	0	11	69	16958	0.0	1.0	1	
REN_ALVEOLAR_RHABDOMYOSARCOMA_DN 	0	11	399	16628	0.0	1.0	1	
REACTOME_PEPTIDE_CHAIN_ELONGATION 	0	11	84	16943	0.0	1.0	1	
AMIT_EGF_RESPONSE_20_HELA 	0	11	11	17016	0.0	1.0	1	
REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION 	0	11	29	16998	0.0	1.0	1	
WU_APOPTOSIS_BY_CDKN1A_VIA_TP53 	0	11	46	16981	0.0	1.0	1	
DEN_INTERACT_WITH_LCA5 	0	11	25	17002	0.0	1.0	1	
GOERING_BLOOD_HDL_CHOLESTEROL_QTL_TRANS 	0	11	9	17018	0.0	1.0	1	
REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE 	0	11	31	16996	0.0	1.0	1	
REACTOME_G_ALPHA_I_SIGNALLING_EVENTS 	0	11	126	16901	0.0	1.0	1	
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3 	0	11	616	16411	0.0	1.0	1	
WONG_ENDMETRIUM_CANCER_DN 	0	11	76	16951	0.0	1.0	1	
MILI_PSEUDOPODIA_HAPTOTAXIS_DN 	0	11	621	16406	0.0	1.0	1	
REACTOME_GABA_RECEPTOR_ACTIVATION 	0	11	47	16980	0.0	1.0	1	
KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP 	0	11	111	16916	0.0	1.0	1	
SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER 	0	11	36	16991	0.0	1.0	1	
WANG_BARRETTS_ESOPHAGUS_DN 	0	11	24	17003	0.0	1.0	1	
PID_IL12_2PATHWAY 	0	11	52	16975	0.0	1.0	1	
PID_BMP_PATHWAY 	0	11	39	16988	0.0	1.0	1	
KIM_WT1_TARGETS_12HR_DN 	0	11	196	16831	0.0	1.0	1	
PETROVA_PROX1_TARGETS_DN 	0	11	59	16968	0.0	1.0	1	
LIU_IL13_MEMORY_MODEL_UP 	0	11	14	17013	0.0	1.0	1	
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS 	0	11	32	16995	0.0	1.0	1	
BIOCARTA_CERAMIDE_PATHWAY 	0	11	22	17005	0.0	1.0	1	
KYNG_RESPONSE_TO_H2O2_VIA_ERCC6 	0	11	17	17010	0.0	1.0	1	
REACTOME_ACTIVATION_OF_CHAPERONES_BY_ATF6_ALPHA 	0	11	11	17016	0.0	1.0	1	
NIKOLSKY_BREAST_CANCER_17P11_AMPLICON 	0	11	10	17017	0.0	1.0	1	
CHOI_ATL_CHRONIC_VS_ACUTE_DN 	0	11	18	17009	0.0	1.0	1	
HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN 	0	11	63	16964	0.0	1.0	1	
BROWNE_HCMV_INFECTION_1HR_UP 	0	11	49	16978	0.0	1.0	1	
BIOCARTA_LAIR_PATHWAY 	0	11	12	17015	0.0	1.0	1	
REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES 	0	11	168	16859	0.0	1.0	1	
BRACHAT_RESPONSE_TO_METHOTREXATE_DN 	0	11	26	17001	0.0	1.0	1	
FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP 	0	11	80	16947	0.0	1.0	1	
ABBUD_LIF_SIGNALING_2_UP 	0	11	14	17013	0.0	1.0	1	
IM_SREBF1A_TARGETS 	0	11	5	17022	0.0	1.0	1	
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN 	0	11	322	16705	0.0	1.0	1	
MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3 	0	11	181	16846	0.0	1.0	1	
BROWNE_HCMV_INFECTION_6HR_DN 	0	11	145	16882	0.0	1.0	1	
RIGGI_EWING_SARCOMA_PROGENITOR_UP 	0	11	385	16642	0.0	1.0	1	
PID_MTOR_4PATHWAY 	0	11	69	16958	0.0	1.0	1	
REACTOME_SIGNALING_BY_ERBB4 	0	11	81	16946	0.0	1.0	1	
ALONSO_METASTASIS_DN 	0	11	22	17005	0.0	1.0	1	
GRABARCZYK_BCL11B_TARGETS_DN 	0	11	45	16982	0.0	1.0	1	
PID_S1P_S1P1_PATHWAY 	0	11	21	17006	0.0	1.0	1	
REACTOME_CLASS_A1_RHODOPSIN_LIKE_RECEPTORS 	0	11	174	16853	0.0	1.0	1	
REACTOME_SIGNALING_BY_ERBB2 	0	11	94	16933	0.0	1.0	1	
REACTOME_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX_UPON_TLR7_8_OR_9_STIMULATION 	0	11	8	17019	0.0	1.0	1	
CHAN_INTERFERON_PRODUCING_DENDRITIC_CELL 	0	11	6	17021	0.0	1.0	1	
BIOCARTA_SPPA_PATHWAY 	0	11	19	17008	0.0	1.0	1	
LOPES_METHYLATED_IN_COLON_CANCER_UP 	0	11	25	17002	0.0	1.0	1	
FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP 	0	11	507	16520	0.0	1.0	1	
GROSS_HYPOXIA_VIA_ELK3_UP 	0	11	188	16839	0.0	1.0	1	
KONG_E2F3_TARGETS 	0	11	76	16951	0.0	1.0	1	
ROSS_AML_WITH_PML_RARA_FUSION 	0	11	71	16956	0.0	1.0	1	
ZWANG_EGF_PERSISTENTLY_DN 	0	11	53	16974	0.0	1.0	1	
KEGG_INSULIN_SIGNALING_PATHWAY 	0	11	127	16900	0.0	1.0	1	
ZEMBUTSU_SENSITIVITY_TO_CYCLOPHOSPHAMIDE 	0	11	16	17011	0.0	1.0	1	
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN 	0	11	21	17006	0.0	1.0	1	
BIOCARTA_IGF1_PATHWAY 	0	11	21	17006	0.0	1.0	1	
SA_REG_CASCADE_OF_CYCLIN_EXPR 	0	11	12	17015	0.0	1.0	1	
GRADE_COLON_VS_RECTAL_CANCER_UP 	0	11	29	16998	0.0	1.0	1	
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP 	0	11	111	16916	0.0	1.0	1	
CHEN_HOXA5_TARGETS_6HR_UP 	0	11	9	17018	0.0	1.0	1	
CHOI_ATL_ACUTE_STAGE 	0	11	4	17023	0.0	1.0	1	
MARZEC_IL2_SIGNALING_UP 	0	11	100	16927	0.0	1.0	1	
LI_CYTIDINE_ANALOGS_CYCTOTOXICITY 	0	11	13	17014	0.0	1.0	1	
BIOCARTA_TGFB_PATHWAY 	0	11	19	17008	0.0	1.0	1	
REACTOME_TRYPTOPHAN_CATABOLISM 	0	11	6	17021	0.0	1.0	1	
KASLER_HDAC7_TARGETS_2_UP 	0	11	3	17024	0.0	1.0	1	
GROSS_HYPOXIA_VIA_HIF1A_DN 	0	11	100	16927	0.0	1.0	1	
ZHAN_MULTIPLE_MYELOMA_PR_UP 	0	11	30	16997	0.0	1.0	1	
BURTON_ADIPOGENESIS_10 	0	11	29	16998	0.0	1.0	1	
BURTON_ADIPOGENESIS_11 	0	11	51	16976	0.0	1.0	1	
BURTON_ADIPOGENESIS_12 	0	11	30	16997	0.0	1.0	1	
ST_B_CELL_ANTIGEN_RECEPTOR 	0	11	37	16990	0.0	1.0	1	
WANG_METASTASIS_OF_BREAST_CANCER 	0	11	11	17016	0.0	1.0	1	
KANG_IMMORTALIZED_BY_TERT_DN 	0	11	83	16944	0.0	1.0	1	
SHANK_TAL1_TARGETS_DN 	0	11	8	17019	0.0	1.0	1	
PID_HNF3A_PATHWAY 	0	11	33	16994	0.0	1.0	1	
PETRETTO_CARDIAC_HYPERTROPHY 	0	11	33	16994	0.0	1.0	1	
PID_ERBB2_ERBB3_PATHWAY 	0	11	44	16983	0.0	1.0	1	
REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX 	0	11	52	16975	0.0	1.0	1	
IGARASHI_ATF4_TARGETS_DN 	0	11	81	16946	0.0	1.0	1	
MANN_RESPONSE_TO_AMIFOSTINE_DN 	0	11	9	17018	0.0	1.0	1	
COATES_MACROPHAGE_M1_VS_M2_DN 	0	11	65	16962	0.0	1.0	1	
OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP 	0	11	115	16912	0.0	1.0	1	
HOSHIDA_LIVER_CANCER_SUBCLASS_S3 	0	11	228	16799	0.0	1.0	1	
CROONQUIST_NRAS_SIGNALING_UP 	0	11	33	16994	0.0	1.0	1	
HOSHIDA_LIVER_CANCER_SUBCLASS_S1 	0	11	229	16798	0.0	1.0	1	
BRUECKNER_TARGETS_OF_MIRLET7A3_UP 	0	11	96	16931	0.0	1.0	1	
BIOCARTA_EPONFKB_PATHWAY 	0	11	10	17017	0.0	1.0	1	
BIOCARTA_HER2_PATHWAY 	0	11	22	17005	0.0	1.0	1	
STARK_BRAIN_22Q11_DELETION 	1	10	11	17016	154.6909090909091	0.007722421543075041	1	C9orf3
PID_P73PATHWAY 	0	11	73	16954	0.0	1.0	1	
DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN 	0	11	14	17013	0.0	1.0	1	
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_RUNX1 	0	11	8	17019	0.0	1.0	1	
REACTOME_HYALURONAN_UPTAKE_AND_DEGRADATION 	0	11	9	17018	0.0	1.0	1	
REACTOME_PECAM1_INTERACTIONS 	0	11	10	17017	0.0	1.0	1	
ZUCCHI_METASTASIS_UP 	0	11	38	16989	0.0	1.0	1	
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP 	0	11	16	17011	0.0	1.0	1	
REACTOME_SIGNALING_BY_NOTCH4 	0	11	12	17015	0.0	1.0	1	
REACTOME_SIGNALING_BY_NOTCH2 	0	11	12	17015	0.0	1.0	1	
REACTOME_SIGNALING_BY_NOTCH3 	0	11	12	17015	0.0	1.0	1	
REACTOME_SIGNALING_BY_NOTCH1 	0	11	67	16960	0.0	1.0	1	
PECE_MAMMARY_STEM_CELL_UP 	0	11	131	16896	0.0	1.0	1	
ST_FAS_SIGNALING_PATHWAY 	0	11	63	16964	0.0	1.0	1	
MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6 	0	11	46	16981	0.0	1.0	1	
AFFAR_YY1_TARGETS_DN 	0	11	194	16833	0.0	1.0	1	
MORI_LARGE_PRE_BII_LYMPHOCYTE_UP 	0	11	71	16956	0.0	1.0	1	
REACTOME_REGULATION_OF_HYPOXIA_INDUCIBLE_FACTOR_HIF_BY_OXYGEN 	0	11	19	17008	0.0	1.0	1	
KEGG_ECM_RECEPTOR_INTERACTION 	0	11	77	16950	0.0	1.0	1	
KEGG_GLYCOLYSIS_GLUCONEOGENESIS 	0	11	46	16981	0.0	1.0	1	
ALFANO_MYC_TARGETS 	1	10	224	16803	7.501339285714286	0.13607941835708667	1	MAG
KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION 	0	11	81	16946	0.0	1.0	1	
REACTOME_ABORTIVE_ELONGATION_OF_HIV1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT 	0	11	19	17008	0.0	1.0	1	
REACTOME_DOUBLE_STRAND_BREAK_REPAIR 	0	11	20	17007	0.0	1.0	1	
SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM 	0	11	151	16876	0.0	1.0	1	
BASSO_HAIRY_CELL_LEUKEMIA_UP 	0	11	79	16948	0.0	1.0	1	
MUNSHI_MULTIPLE_MYELOMA_UP 	0	11	77	16950	0.0	1.0	1	
BIOCARTA_TCAPOPTOSIS_PATHWAY 	0	11	5	17022	0.0	1.0	1	
NAKAMURA_BRONCHIAL_AND_BRONCHIOLAR_EPITHELIA 	0	11	5	17022	0.0	1.0	1	
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP 	0	11	65	16962	0.0	1.0	1	
STEARMAN_TUMOR_FIELD_EFFECT_UP 	0	11	32	16995	0.0	1.0	1	
BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN 	0	11	43	16984	0.0	1.0	1	
ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY 	1	10	1040	15987	1.5372115384615384	0.5002785740671878	1	CNTN2
MATZUK_PREOVULATORY_FOLLICLE 	0	11	10	17017	0.0	1.0	1	
HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_DN 	0	11	13	17014	0.0	1.0	1	
BAE_BRCA1_TARGETS_DN 	0	11	32	16995	0.0	1.0	1	
SIMBULAN_PARP1_TARGETS_UP 	0	11	31	16996	0.0	1.0	1	
KEGG_NON_SMALL_CELL_LUNG_CANCER 	0	11	53	16974	0.0	1.0	1	
KENNY_CTNNB1_TARGETS_DN 	0	11	50	16977	0.0	1.0	1	
PEART_HDAC_PROLIFERATION_CLUSTER_UP 	0	11	56	16971	0.0	1.0	1	
MUNSHI_MULTIPLE_MYELOMA_DN 	0	11	9	17018	0.0	1.0	1	
MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_8 	0	11	13	17014	0.0	1.0	1	
CASTELLANO_NRAS_TARGETS_DN 	0	11	13	17014	0.0	1.0	1	
WINTER_HYPOXIA_UP 	0	11	84	16943	0.0	1.0	1	
PID_AR_NONGENOMIC_PATHWAY 	0	11	31	16996	0.0	1.0	1	
KAUFFMANN_MELANOMA_RELAPSE_UP 	0	11	53	16974	0.0	1.0	1	
REACTOME_BOTULINUM_NEUROTOXICITY 	0	11	18	17009	0.0	1.0	1	
SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES 	0	11	49	16978	0.0	1.0	1	
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS 	0	11	17	17010	0.0	1.0	1	
BIOCARTA_FCER1_PATHWAY 	0	11	37	16990	0.0	1.0	1	
DELACROIX_RAR_BOUND_ES 	0	11	395	16632	0.0	1.0	1	
STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN 	0	11	45	16982	0.0	1.0	1	
AGARWAL_AKT_PATHWAY_TARGETS 	0	11	9	17018	0.0	1.0	1	
KALMA_E2F1_TARGETS 	0	11	10	17017	0.0	1.0	1	
ZHAN_MULTIPLE_MYELOMA_LB_DN 	0	11	35	16992	0.0	1.0	1	
DANG_REGULATED_BY_MYC_DN 	0	11	235	16792	0.0	1.0	1	
ZHANG_RESPONSE_TO_CANTHARIDIN_DN 	0	11	66	16961	0.0	1.0	1	
QI_PLASMACYTOMA_DN 	0	11	91	16936	0.0	1.0	1	
XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN 	0	11	23	17004	0.0	1.0	1	
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP 	0	11	140	16887	0.0	1.0	1	
DOUGLAS_BMI1_TARGETS_UP 	0	11	526	16501	0.0	1.0	1	
CHENG_TAF7L_TARGETS 	0	11	4	17023	0.0	1.0	1	
HEDENFALK_BREAST_CANCER_BRACX_DN 	0	11	18	17009	0.0	1.0	1	
MARKS_ACETYLATED_NON_HISTONE_PROTEINS 	0	11	12	17015	0.0	1.0	1	
UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN 	0	11	36	16991	0.0	1.0	1	
SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN 	0	11	19	17008	0.0	1.0	1	
SERVITJA_LIVER_HNF1A_TARGETS_UP 	0	11	114	16913	0.0	1.0	1	
CAFFAREL_RESPONSE_TO_THC_24HR_5_DN 	0	11	52	16975	0.0	1.0	1	
BLALOCK_ALZHEIMERS_DISEASE_UP 	2	9	1555	15472	2.2110753840657376	0.2659665134713478	1	C9orf3,CAPN3
KEGG_STEROID_HORMONE_BIOSYNTHESIS 	0	11	24	17003	0.0	1.0	1	
REACTOME_KINESINS 	0	11	19	17008	0.0	1.0	1	
SIMBULAN_UV_RESPONSE_NORMAL_UP 	0	11	8	17019	0.0	1.0	1	
KONDO_PROSTATE_CANCER_WITH_H3K27ME3 	0	11	85	16942	0.0	1.0	1	
TARTE_PLASMA_CELL_VS_PLASMABLAST_UP 	1	10	311	16716	5.37491961414791	0.18401513788584012	1	MAG
RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_UP 	0	11	6	17021	0.0	1.0	1	
MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP 	0	11	17	17010	0.0	1.0	1	
ZEILSTRA_CD44_TARGETS_DN 	0	11	6	17021	0.0	1.0	1	
BILANGES_SERUM_SENSITIVE_VIA_TSC2 	0	11	35	16992	0.0	1.0	1	
LI_AMPLIFIED_IN_LUNG_CANCER 	0	11	158	16869	0.0	1.0	1	
COLDREN_GEFITINIB_RESISTANCE_DN 	0	11	183	16844	0.0	1.0	1	
REACTOME_SIGNALING_BY_GPCR 	0	11	428	16599	0.0	1.0	1	
FIGUEROA_AML_METHYLATION_CLUSTER_7_UP 	0	11	94	16933	0.0	1.0	1	
BIDUS_METASTASIS_UP 	0	11	193	16834	0.0	1.0	1	
ZHAN_MULTIPLE_MYELOMA_SUBGROUPS 	0	11	30	16997	0.0	1.0	1	
REACTOME_DEVELOPMENTAL_BIOLOGY 	1	10	351	16676	4.750997150997151	0.20523214785404909	1	CNTN2
POOLA_INVASIVE_BREAST_CANCER_UP 	0	11	215	16812	0.0	1.0	1	
BIOCARTA_IL2RB_PATHWAY 	0	11	36	16991	0.0	1.0	1	
REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES 	0	11	10	17017	0.0	1.0	1	
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS 	0	11	39	16988	0.0	1.0	1	
DOANE_BREAST_CANCER_CLASSES_UP 	0	11	58	16969	0.0	1.0	1	
HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN 	0	11	111	16916	0.0	1.0	1	
SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE 	0	11	61	16966	0.0	1.0	1	
BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN 	0	11	29	16998	0.0	1.0	1	
PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP 	0	11	48	16979	0.0	1.0	1	
IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR 	1	10	591	16436	2.7810490693739425	0.3223461561681245	1	PLLP
STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP 	1	10	185	16842	9.103783783783785	0.11377148003417212	1	C9orf3
LE_EGR2_TARGETS_DN 	0	11	103	16924	0.0	1.0	1	
KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION 	0	11	79	16948	0.0	1.0	1	
KORKOLA_EMBRYONAL_CARCINOMA_UP 	0	11	37	16990	0.0	1.0	1	
REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING 	0	11	56	16971	0.0	1.0	1	
POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP 	0	11	58	16969	0.0	1.0	1	
GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP 	0	11	18	17009	0.0	1.0	1	
REACTOME_P38MAPK_EVENTS 	0	11	13	17014	0.0	1.0	1	
KEGG_OXIDATIVE_PHOSPHORYLATION 	0	11	109	16918	0.0	1.0	1	
BIOCARTA_P35ALZHEIMERS_PATHWAY 	0	11	10	17017	0.0	1.0	1	
ZEMBUTSU_SENSITIVITY_TO_VINBLASTINE 	0	11	16	17011	0.0	1.0	1	
JOHNSTONE_PARVB_TARGETS_1_UP 	0	11	4	17023	0.0	1.0	1	
REACTOME_REGULATION_OF_PYRUVATE_DEHYDROGENASE_PDH_COMPLEX 	0	11	12	17015	0.0	1.0	1	
KEEN_RESPONSE_TO_ROSIGLITAZONE_UP 	0	11	37	16990	0.0	1.0	1	
REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM 	0	11	17	17010	0.0	1.0	1	
REACTOME_CRMPS_IN_SEMA3A_SIGNALING 	0	11	14	17013	0.0	1.0	1	
NOUSHMEHR_GBM_SOMATIC_MUTATED 	0	11	9	17018	0.0	1.0	1	
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP 	0	11	52	16975	0.0	1.0	1	
SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC 	0	11	97	16930	0.0	1.0	1	
DURAND_STROMA_NS_UP 	0	11	147	16880	0.0	1.0	1	
MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP 	1	10	330	16697	5.05969696969697	0.19415658956598567	1	PLLP
GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP 	0	11	17	17010	0.0	1.0	1	
KIM_HYPOXIA 	0	11	24	17003	0.0	1.0	1	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_21 	0	11	3	17024	0.0	1.0	1	
PID_SMAD2_3NUCLEAR_PATHWAY 	0	11	74	16953	0.0	1.0	1	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23 	0	11	18	17009	0.0	1.0	1	
MCBRYAN_TERMINAL_END_BUD_UP 	0	11	12	17015	0.0	1.0	1	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_25 	0	11	6	17021	0.0	1.0	1	
MURAKAMI_UV_RESPONSE_24HR 	0	11	18	17009	0.0	1.0	1	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_27 	0	11	9	17018	0.0	1.0	1	
REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES 	0	11	24	17003	0.0	1.0	1	
REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS 	0	11	16	17011	0.0	1.0	1	
ROSS_AML_WITH_CBFB_MYH11_FUSION 	0	11	46	16981	0.0	1.0	1	
PID_PTP1B_PATHWAY 	0	11	47	16980	0.0	1.0	1	
VANTVEER_BREAST_CANCER_METASTASIS_DN 	0	11	101	16926	0.0	1.0	1	
MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED 	1	10	419	16608	3.9637231503579953	0.2401530912977033	1	PLLP
WEBER_METHYLATED_LCP_IN_FIBROBLAST_UP 	0	11	2	17025	0.0	1.0	1	
POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN 	0	11	42	16985	0.0	1.0	1	
BIOCARTA_VDR_PATHWAY 	0	11	12	17015	0.0	1.0	1	
REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE 	0	11	132	16895	0.0	1.0	1	
SWEET_LUNG_CANCER_KRAS_UP 	0	11	442	16585	0.0	1.0	1	
BIOCARTA_EIF2_PATHWAY 	0	11	11	17016	0.0	1.0	1	
JAEGER_METASTASIS_UP 	0	11	38	16989	0.0	1.0	1	
LEE_LIVER_CANCER_MYC_DN 	0	11	44	16983	0.0	1.0	1	
LI_PROSTATE_CANCER_EPIGENETIC 	0	11	28	16999	0.0	1.0	1	
BIOCARTA_AKT_PATHWAY 	0	11	20	17007	0.0	1.0	1	
CHYLA_CBFA2T3_TARGETS_UP 	0	11	325	16702	0.0	1.0	1	
ST_IL_13_PATHWAY 	0	11	6	17021	0.0	1.0	1	
ONKEN_UVEAL_MELANOMA_DN 	0	11	498	16529	0.0	1.0	1	
RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN 	0	11	28	16999	0.0	1.0	1	
GROSS_HYPOXIA_VIA_ELK3_ONLY_UP 	0	11	32	16995	0.0	1.0	1	
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_DN 	0	11	8	17019	0.0	1.0	1	
FRASOR_RESPONSE_TO_ESTRADIOL_UP 	0	11	33	16994	0.0	1.0	1	
CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP 	0	11	60	16967	0.0	1.0	1	
LIU_VAV3_PROSTATE_CARCINOGENESIS_DN 	0	11	15	17012	0.0	1.0	1	
PEREZ_TP63_TARGETS 	1	10	306	16721	5.46437908496732	0.18132712106488155	1	CAPN3
BIOCARTA_ACTINY_PATHWAY 	0	11	20	17007	0.0	1.0	1	
ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN 	0	11	99	16928	0.0	1.0	1	
LUI_THYROID_CANCER_CLUSTER_5 	0	11	11	17016	0.0	1.0	1	
POS_RESPONSE_TO_HISTAMINE_UP 	0	11	11	17016	0.0	1.0	1	
KEGG_OTHER_GLYCAN_DEGRADATION 	0	11	15	17012	0.0	1.0	1	
REACTOME_FORMATION_OF_THE_HIV1_EARLY_ELONGATION_COMPLEX 	0	11	28	16999	0.0	1.0	1	
REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY 	0	11	17	17010	0.0	1.0	1	
NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON 	0	11	132	16895	0.0	1.0	1	
NAKAMURA_ADIPOGENESIS_LATE_DN 	0	11	37	16990	0.0	1.0	1	
NOUSHMEHR_GBM_SILENCED_BY_METHYLATION 	0	11	46	16981	0.0	1.0	1	
GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_DN 	0	11	5	17022	0.0	1.0	1	
NIELSEN_GIST_VS_SYNOVIAL_SARCOMA_UP 	0	11	17	17010	0.0	1.0	1	
SANCHEZ_MDM2_TARGETS 	0	11	13	17014	0.0	1.0	1	
GALLUZZI_PERMEABILIZE_MITOCHONDRIA 	0	11	41	16986	0.0	1.0	1	
GOLUB_ALL_VS_AML_DN 	0	11	22	17005	0.0	1.0	1	
REACTOME_XENOBIOTICS 	0	11	5	17022	0.0	1.0	1	
XU_GH1_AUTOCRINE_TARGETS_UP 	0	11	204	16823	0.0	1.0	1	
YAN_ESCAPE_FROM_ANOIKIS 	0	11	21	17006	0.0	1.0	1	
EINAV_INTERFERON_SIGNATURE_IN_CANCER 	0	11	26	17001	0.0	1.0	1	
PUJANA_BRCA1_PCC_NETWORK 	0	11	1466	15561	0.0	1.0	1	
REACTOME_DNA_REPAIR 	0	11	98	16929	0.0	1.0	1	
KEGG_NICOTINATE_AND_NICOTINAMIDE_METABOLISM 	0	11	21	17006	0.0	1.0	1	
REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE 	0	11	26	17001	0.0	1.0	1	
NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER 	0	11	17	17010	0.0	1.0	1	
FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP 	0	11	62	16965	0.0	1.0	1	
CONRAD_STEM_CELL 	0	11	32	16995	0.0	1.0	1	
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK 	0	11	130	16897	0.0	1.0	1	
REACTOME_TRANSPORT_OF_ORGANIC_ANIONS 	0	11	7	17020	0.0	1.0	1	
SHEN_SMARCA2_TARGETS_UP 	0	11	415	16612	0.0	1.0	1	
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP 	0	11	110	16917	0.0	1.0	1	
CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP 	0	11	50	16977	0.0	1.0	1	
OKAWA_NEUROBLASTOMA_1P36_31_DELETION 	0	11	19	17008	0.0	1.0	1	
LEE_LIVER_CANCER_ACOX1_UP 	0	11	51	16976	0.0	1.0	1	
MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3 	1	10	273	16754	6.136996336996337	0.16338336195694111	1	CNTN2
FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_DN 	0	11	8	17019	0.0	1.0	1	
SEIDEN_ONCOGENESIS_BY_MET 	0	11	84	16943	0.0	1.0	1	
MARTINEZ_TP53_TARGETS_DN 	0	11	494	16533	0.0	1.0	1	
MANN_RESPONSE_TO_AMIFOSTINE_UP 	0	11	20	17007	0.0	1.0	1	
BIOCARTA_CTL_PATHWAY 	0	11	10	17017	0.0	1.0	1	
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_DN 	0	11	7	17020	0.0	1.0	1	
REACTOME_CTNNB1_PHOSPHORYLATION_CASCADE 	0	11	15	17012	0.0	1.0	1	
REACTOME_COPI_MEDIATED_TRANSPORT 	0	11	9	17018	0.0	1.0	1	
BAKER_HEMATOPOESIS_STAT1_TARGETS 	0	11	10	17017	0.0	1.0	1	
ZHU_CMV_8_HR_UP 	0	11	45	16982	0.0	1.0	1	
REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION 	0	11	44	16983	0.0	1.0	1	
KOBAYASHI_EGFR_SIGNALING_6HR_DN 	0	11	17	17010	0.0	1.0	1	
REACTOME_SIGNALING_BY_CONSTITUTIVELY_ACTIVE_EGFR 	0	11	17	17010	0.0	1.0	1	
REACTOME_GLUCOSE_METABOLISM 	0	11	58	16969	0.0	1.0	1	
KANG_DOXORUBICIN_RESISTANCE_DN 	0	11	17	17010	0.0	1.0	1	
REACTOME_SIGNALING_BY_FGFR1_MUTANTS 	0	11	25	17002	0.0	1.0	1	
KOMMAGANI_TP63_GAMMA_TARGETS 	0	11	9	17018	0.0	1.0	1	
ITO_PTTG1_TARGETS_DN 	0	11	9	17018	0.0	1.0	1	
WHITFIELD_CELL_CYCLE_G1_S 	0	11	122	16905	0.0	1.0	1	
KEGG_PROTEASOME 	0	11	40	16987	0.0	1.0	1	
NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN 	0	11	12	17015	0.0	1.0	1	
OXFORD_RALA_OR_RALB_TARGETS_DN 	0	11	23	17004	0.0	1.0	1	
MIKKELSEN_IPS_LCP_WITH_H3K4ME3 	0	11	134	16893	0.0	1.0	1	
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL 	0	11	14	17013	0.0	1.0	1	
GRUETZMANN_PANCREATIC_CANCER_DN 	0	11	180	16847	0.0	1.0	1	
CHESLER_BRAIN_QTL_TRANS 	0	11	5	17022	0.0	1.0	1	
BIOCARTA_SALMONELLA_PATHWAY 	0	11	13	17014	0.0	1.0	1	
NAGY_PCAF_COMPONENTS_HUMAN 	0	11	9	17018	0.0	1.0	1	
KEGG_PURINE_METABOLISM 	0	11	142	16885	0.0	1.0	1	
REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA 	0	11	132	16895	0.0	1.0	1	
LEIN_OLIGODENDROCYTE_MARKERS 	3	8	68	16959	93.52389705882354	1.1171163561011649e-05	0.05292897295207319	CNTN2,SOX10,MAG
WEBER_METHYLATED_LCP_IN_FIBROBLAST_DN 	0	11	4	17023	0.0	1.0	1	
RIZ_ERYTHROID_DIFFERENTIATION_HBZ 	0	11	30	16997	0.0	1.0	1	
LEIN_LOCALIZED_TO_PROXIMAL_DENDRITES 	0	11	33	16994	0.0	1.0	1	
BRACHAT_RESPONSE_TO_METHOTREXATE_UP 	0	11	23	17004	0.0	1.0	1	
YEMELYANOV_GR_TARGETS_DN 	0	11	9	17018	0.0	1.0	1	
NOUSHMEHR_GBM_GERMLINE_MUTATED 	0	11	5	17022	0.0	1.0	1	
FEVR_CTNNB1_TARGETS_DN 	0	11	496	16531	0.0	1.0	1	
REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION 	0	11	17	17010	0.0	1.0	1	
CORRE_MULTIPLE_MYELOMA_UP 	0	11	58	16969	0.0	1.0	1	
ALCALA_APOPTOSIS 	0	11	85	16942	0.0	1.0	1	
REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES 	0	11	12	17015	0.0	1.0	1	
WAGNER_APO2_SENSITIVITY 	0	11	18	17009	0.0	1.0	1	
GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN 	0	11	1653	15374	0.0	1.0	1	
PID_ERBB_NETWORK_PATHWAY 	0	11	13	17014	0.0	1.0	1	
JIANG_VHL_TARGETS 	0	11	129	16898	0.0	1.0	1	
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_OLD 	0	11	12	17015	0.0	1.0	1	
REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN 	0	11	26	17001	0.0	1.0	1	
WHITFIELD_CELL_CYCLE_LITERATURE 	0	11	37	16990	0.0	1.0	1	
REACTOME_G_PROTEIN_ACTIVATION 	0	11	23	17004	0.0	1.0	1	
LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN 	0	11	723	16304	0.0	1.0	1	
LEE_METASTASIS_AND_RNA_PROCESSING_UP 	0	11	17	17010	0.0	1.0	1	
PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN 	0	11	369	16658	0.0	1.0	1	
MOREIRA_RESPONSE_TO_TSA_DN 	0	11	16	17011	0.0	1.0	1	
SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN 	1	10	252	16775	6.656746031746032	0.15177921888748067	1	SOX10
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP 	0	11	180	16847	0.0	1.0	1	
GROSS_HYPOXIA_VIA_HIF1A_UP 	0	11	73	16954	0.0	1.0	1	
YAGI_AML_RELAPSE_PROGNOSIS 	0	11	34	16993	0.0	1.0	1	
LEE_TARGETS_OF_PTCH1_AND_SUFU_UP 	0	11	48	16979	0.0	1.0	1	
BIOCARTA_INTRINSIC_PATHWAY 	0	11	15	17012	0.0	1.0	1	
BIOCARTA_RNA_PATHWAY 	0	11	10	17017	0.0	1.0	1	
TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_DN 	0	11	5	17022	0.0	1.0	1	
ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN 	0	11	238	16789	0.0	1.0	1	
REACTOME_PERK_REGULATED_GENE_EXPRESSION 	0	11	25	17002	0.0	1.0	1	
HOLLEMAN_DAUNORUBICIN_ALL_DN 	0	11	7	17020	0.0	1.0	1	
TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C 	0	11	389	16638	0.0	1.0	1	
LINDGREN_BLADDER_CANCER_CLUSTER_2A_UP 	0	11	6	17021	0.0	1.0	1	
SHIRAISHI_PLZF_TARGETS_DN 	0	11	9	17018	0.0	1.0	1	
REACTOME_PURINE_SALVAGE 	0	11	12	17015	0.0	1.0	1	
ST_G_ALPHA_S_PATHWAY 	0	11	14	17013	0.0	1.0	1	
REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1 	0	11	46	16981	0.0	1.0	1	
ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP 	0	11	784	16243	0.0	1.0	1	
KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS 	0	11	91	16936	0.0	1.0	1	
NAKAMURA_CANCER_MICROENVIRONMENT_UP 	0	11	16	17011	0.0	1.0	1	
BROWNE_HCMV_INFECTION_6HR_UP 	1	10	59	16968	28.759322033898304	0.038073006020596455	1	SOX10
VERRECCHIA_RESPONSE_TO_TGFB1_C3 	0	11	14	17013	0.0	1.0	1	
WILLIAMS_ESR2_TARGETS_UP 	0	11	21	17006	0.0	1.0	1	
ZAIDI_OSTEOBLAST_TRANSCRIPTION_FACTORS 	0	11	13	17014	0.0	1.0	1	
BIOCARTA_SRCRPTP_PATHWAY 	0	11	10	17017	0.0	1.0	1	
BIOCARTA_MYOSIN_PATHWAY 	0	11	30	16997	0.0	1.0	1	
HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_4HR 	0	11	31	16996	0.0	1.0	1	
BIOCARTA_IL5_PATHWAY 	0	11	5	17022	0.0	1.0	1	
REACTOME_METABOLISM_OF_POLYAMINES 	0	11	14	17013	0.0	1.0	1	
RAMASWAMY_METASTASIS_DN 	0	11	56	16971	0.0	1.0	1	
HASLINGER_B_CLL_WITH_17P13_DELETION 	0	11	20	17007	0.0	1.0	1	
LEE_AGING_MUSCLE_UP 	0	11	42	16985	0.0	1.0	1	
REACTOME_NONSENSE_MEDIATED_DECAY_ENHANCED_BY_THE_EXON_JUNCTION_COMPLEX 	0	11	105	16922	0.0	1.0	1	
PID_FRA_PATHWAY 	0	11	33	16994	0.0	1.0	1	
WANG_CLASSIC_ADIPOGENIC_TARGETS_OF_PPARG 	0	11	22	17005	0.0	1.0	1	
SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_UP 	0	11	9	17018	0.0	1.0	1	
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN 	0	11	145	16882	0.0	1.0	1	
BIOCARTA_INFLAM_PATHWAY 	0	11	14	17013	0.0	1.0	1	
ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_UP 	0	11	11	17016	0.0	1.0	1	
ZHOU_INFLAMMATORY_RESPONSE_LPS_UP 	0	11	298	16729	0.0	1.0	1	
NUYTTEN_NIPP1_TARGETS_DN 	0	11	777	16250	0.0	1.0	1	
HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_DN 	0	11	11	17016	0.0	1.0	1	
MARTINELLI_IMMATURE_NEUTROPHIL_UP 	0	11	6	17021	0.0	1.0	1	
NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN 	0	11	552	16475	0.0	1.0	1	
REACTOME_PURINE_METABOLISM 	0	11	30	16997	0.0	1.0	1	
SMID_BREAST_CANCER_BASAL_DN 	0	11	601	16426	0.0	1.0	1	
BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE 	0	11	34	16993	0.0	1.0	1	
REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE 	0	11	29	16998	0.0	1.0	1	
PIEPOLI_LGI1_TARGETS_UP 	0	11	14	17013	0.0	1.0	1	
LOPEZ_MESOTHELIOMA_SURVIVAL_DN 	0	11	11	17016	0.0	1.0	1	
KAYO_CALORIE_RESTRICTION_MUSCLE_DN 	0	11	75	16952	0.0	1.0	1	
LIM_MAMMARY_LUMINAL_MATURE_UP 	0	11	94	16933	0.0	1.0	1	
SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN 	0	11	75	16952	0.0	1.0	1	
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN 	0	11	60	16967	0.0	1.0	1	
ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN 	0	11	77	16950	0.0	1.0	1	
REACTOME_AXON_GUIDANCE 	1	10	232	16795	7.239224137931035	0.14059181401385623	1	CNTN2
KEGG_LONG_TERM_DEPRESSION 	0	11	60	16967	0.0	1.0	1	
VANHARANTA_UTERINE_FIBROID_DN 	0	11	62	16965	0.0	1.0	1	
SMID_BREAST_CANCER_RELAPSE_IN_LIVER_DN 	0	11	10	17017	0.0	1.0	1	
PHONG_TNF_RESPONSE_NOT_VIA_P38 	1	10	320	16707	5.2209375	0.18883335753575498	1	C9orf3
SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER 	0	11	38	16989	0.0	1.0	1	
BIOCARTA_GRANULOCYTES_PATHWAY 	0	11	10	17017	0.0	1.0	1	
BIOCARTA_TALL1_PATHWAY 	0	11	13	17014	0.0	1.0	1	
REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_ 	0	11	70	16957	0.0	1.0	1	
SU_KIDNEY 	0	11	8	17019	0.0	1.0	1	
MIKKELSEN_ES_ICP_WITH_H3K4ME3 	0	11	596	16431	0.0	1.0	1	
NOJIMA_SFRP2_TARGETS_DN 	0	11	22	17005	0.0	1.0	1	
MOTAMED_RESPONSE_TO_ANDROGEN_DN 	0	11	5	17022	0.0	1.0	1	
JUBAN_TARGETS_OF_SPI1_AND_FLI1_DN 	0	11	85	16942	0.0	1.0	1	
YAMAZAKI_TCEB3_TARGETS_DN 	0	11	195	16832	0.0	1.0	1	
CASTELLANO_NRAS_TARGETS_UP 	0	11	59	16968	0.0	1.0	1	
PID_RAC1_REG_PATHWAY 	0	11	38	16989	0.0	1.0	1	
TARTE_PLASMA_CELL_VS_PLASMABLAST_DN 	0	11	291	16736	0.0	1.0	1	
MASSARWEH_TAMOXIFEN_RESISTANCE_DN 	0	11	218	16809	0.0	1.0	1	
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D 	0	11	221	16806	0.0	1.0	1	
WALLACE_PROSTATE_CANCER_RACE_DN 	0	11	75	16952	0.0	1.0	1	
KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION 	0	11	31	16996	0.0	1.0	1	
PYEON_HPV_POSITIVE_TUMORS_UP 	0	11	85	16942	0.0	1.0	1	
BIOCARTA_RANMS_PATHWAY 	0	11	10	17017	0.0	1.0	1	
REACTOME_SIGNALING_BY_WNT 	0	11	61	16966	0.0	1.0	1	
REACTOME_ADP_SIGNALLING_THROUGH_P2RY1 	0	11	23	17004	0.0	1.0	1	
SABATES_COLORECTAL_ADENOMA_UP 	0	11	88	16939	0.0	1.0	1	
TIEN_INTESTINE_PROBIOTICS_6HR_DN 	0	11	154	16873	0.0	1.0	1	
CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP 	0	11	391	16636	0.0	1.0	1	
KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION 	0	11	73	16954	0.0	1.0	1	
SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES 	0	11	32	16995	0.0	1.0	1	
MEISSNER_NPC_HCP_WITH_H3K27ME3 	0	11	37	16990	0.0	1.0	1	
ONGUSAHA_TP53_TARGETS 	0	11	33	16994	0.0	1.0	1	
CROMER_METASTASIS_DN 	0	11	78	16949	0.0	1.0	1	
MCBRYAN_TERMINAL_END_BUD_DN 	0	11	6	17021	0.0	1.0	1	
REACTOME_RNA_POL_III_CHAIN_ELONGATION 	0	11	17	17010	0.0	1.0	1	
SANSOM_APC_TARGETS_REQUIRE_MYC 	0	11	184	16843	0.0	1.0	1	
HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP 	0	11	137	16890	0.0	1.0	1	
OKAMOTO_LIVER_CANCER_MULTICENTRIC_OCCURRENCE_UP 	0	11	24	17003	0.0	1.0	1	
GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_2 	0	11	10	17017	0.0	1.0	1	
REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY 	0	11	54	16973	0.0	1.0	1	
CHUNG_BLISTER_CYTOTOXICITY_UP 	0	11	123	16904	0.0	1.0	1	
MATZUK_LUTEAL_GENES 	0	11	7	17020	0.0	1.0	1	
VANDESLUIS_COMMD1_TARGETS_GROUP_4_DN 	0	11	11	17016	0.0	1.0	1	
GAJATE_RESPONSE_TO_TRABECTEDIN_DN 	0	11	17	17010	0.0	1.0	1	
BIOCARTA_CCR3_PATHWAY 	0	11	18	17009	0.0	1.0	1	
REACTOME_IKK_COMPLEX_RECRUITMENT_MEDIATED_BY_RIP1 	0	11	10	17017	0.0	1.0	1	
VALK_AML_WITH_FLT3_ITD 	0	11	28	16999	0.0	1.0	1	
SIMBULAN_PARP1_TARGETS_DN 	0	11	16	17011	0.0	1.0	1	
LINDVALL_IMMORTALIZED_BY_TERT_UP 	0	11	72	16955	0.0	1.0	1	
HALMOS_CEBPA_TARGETS_DN 	0	11	41	16986	0.0	1.0	1	
REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING 	0	11	29	16998	0.0	1.0	1	
MCBRYAN_PUBERTAL_BREAST_4_5WK_UP 	0	11	233	16794	0.0	1.0	1	
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN 	0	11	79	16948	0.0	1.0	1	
RIGGINS_TAMOXIFEN_RESISTANCE_UP 	0	11	57	16970	0.0	1.0	1	
REACTOME_PD1_SIGNALING 	0	11	15	17012	0.0	1.0	1	
REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI 	0	11	16	17011	0.0	1.0	1	
HATADA_METHYLATED_IN_LUNG_CANCER_UP 	0	11	327	16700	0.0	1.0	1	
WOTTON_RUNX_TARGETS_UP 	0	11	17	17010	0.0	1.0	1	
LY_AGING_PREMATURE_DN 	0	11	25	17002	0.0	1.0	1	
LANDIS_ERBB2_BREAST_PRENEOPLASTIC_UP 	0	11	14	17013	0.0	1.0	1	
REACTOME_DSCAM_INTERACTIONS 	0	11	11	17016	0.0	1.0	1	
BIOCARTA_G2_PATHWAY 	0	11	23	17004	0.0	1.0	1	
STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP 	1	10	44	16983	38.597727272727276	0.02868037287151854	1	PLLP
SIMBULAN_UV_RESPONSE_NORMAL_DN 	0	11	33	16994	0.0	1.0	1	
HORIUCHI_WTAP_TARGETS_UP 	1	10	275	16752	6.091636363636364	0.16448095656860573	1	PLLP
KIM_MYC_AMPLIFICATION_TARGETS_DN 	0	11	85	16942	0.0	1.0	1	
ELVIDGE_HYPOXIA_DN 	0	11	137	16890	0.0	1.0	1	
CHASSOT_SKIN_WOUND 	0	11	10	17017	0.0	1.0	1	
RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP 	0	11	86	16941	0.0	1.0	1	
TIEN_INTESTINE_PROBIOTICS_24HR_UP 	0	11	524	16503	0.0	1.0	1	
WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP 	0	11	28	16999	0.0	1.0	1	
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX3 	0	11	5	17022	0.0	1.0	1	
PID_TOLL_ENDOGENOUS_PATHWAY 	0	11	23	17004	0.0	1.0	1	
DAZARD_RESPONSE_TO_UV_SCC_UP 	0	11	108	16919	0.0	1.0	1	
REACTOME_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING 	0	11	13	17014	0.0	1.0	1	
REACTOME_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING 	0	11	12	17015	0.0	1.0	1	
NAKAMURA_ADIPOGENESIS_EARLY_UP 	0	11	59	16968	0.0	1.0	1	
PID_PRL_SIGNALING_EVENTS_PATHWAY 	0	11	23	17004	0.0	1.0	1	
BRUINS_UVC_RESPONSE_MIDDLE 	0	11	84	16943	0.0	1.0	1	
MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN 	0	11	42	16985	0.0	1.0	1	
REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT 	0	11	11	17016	0.0	1.0	1	
GALE_APL_WITH_FLT3_MUTATED_UP 	0	11	51	16976	0.0	1.0	1	
CUI_GLUCOSE_DEPRIVATION 	0	11	52	16975	0.0	1.0	1	
KEGG_TGF_BETA_SIGNALING_PATHWAY 	0	11	78	16949	0.0	1.0	1	
KEGG_WNT_SIGNALING_PATHWAY 	0	11	140	16887	0.0	1.0	1	
JOHNSTONE_PARVB_TARGETS_1_DN 	1	10	56	16971	30.305357142857144	0.03620111181319593	1	C9orf3
GROSS_ELK3_TARGETS_UP 	0	11	27	17000	0.0	1.0	1	
KORKOLA_EMBRYONAL_CARCINOMA_DN 	0	11	9	17018	0.0	1.0	1	
KIM_WT1_TARGETS_8HR_DN 	0	11	104	16923	0.0	1.0	1	
HUANG_FOXA2_TARGETS_UP 	0	11	41	16986	0.0	1.0	1	
DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN 	0	11	149	16878	0.0	1.0	1	
SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP 	0	11	452	16575	0.0	1.0	1	
REACTOME_TIE2_SIGNALING 	0	11	17	17010	0.0	1.0	1	
REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE 	0	11	19	17008	0.0	1.0	1	
FOSTER_KDM1A_TARGETS_DN 	0	11	189	16838	0.0	1.0	1	
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM 	0	11	63	16964	0.0	1.0	1	
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN 	0	11	85	16942	0.0	1.0	1	
HUANG_GATA2_TARGETS_UP 	0	11	135	16892	0.0	1.0	1	
DAIRKEE_TERT_TARGETS_DN 	0	11	109	16918	0.0	1.0	1	
REACTOME_GLOBAL_GENOMIC_NER_GG_NER 	0	11	32	16995	0.0	1.0	1	
STANHILL_HRAS_TRANSFROMATION_UP 	0	11	8	17019	0.0	1.0	1	
REACTOME_SLBP_DEPENDENT_PROCESSING_OF_REPLICATION_DEPENDENT_HISTONE_PRE_MRNAS 	0	11	11	17016	0.0	1.0	1	
YAMASHITA_SILENCED_BY_METHYLATION 	0	11	6	17021	0.0	1.0	1	
REACTOME_FORMATION_OF_THE_TERNARY_COMPLEX_AND_SUBSEQUENTLY_THE_43S_COMPLEX 	0	11	48	16979	0.0	1.0	1	
NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_UP 	2	9	139	16888	26.99920063948841	0.0035615085552900523	1	PLLP,CAPN3
NADERI_BREAST_CANCER_PROGNOSIS_UP 	0	11	36	16991	0.0	1.0	1	
DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP 	0	11	53	16974	0.0	1.0	1	
BROWNE_HCMV_INFECTION_20HR_UP 	0	11	225	16802	0.0	1.0	1	
HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP 	0	11	58	16969	0.0	1.0	1	
KEGG_AMINOACYL_TRNA_BIOSYNTHESIS 	0	11	41	16986	0.0	1.0	1	
PRAMOONJAGO_SOX4_TARGETS_UP 	0	11	51	16976	0.0	1.0	1	
BIOCARTA_MAPK_PATHWAY 	0	11	86	16941	0.0	1.0	1	
JIANG_AGING_CEREBRAL_CORTEX_DN 	1	10	53	16974	32.026415094339626	0.03432590666810184	1	MAG
CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP 	0	11	17	17010	0.0	1.0	1	
REACTOME_PI3K_AKT_ACTIVATION 	0	11	36	16991	0.0	1.0	1	
BIOCARTA_ETC_PATHWAY 	0	11	11	17016	0.0	1.0	1	
KEGG_DORSO_VENTRAL_AXIS_FORMATION 	0	11	22	17005	0.0	1.0	1	
UROSEVIC_RESPONSE_TO_IMIQUIMOD 	0	11	20	17007	0.0	1.0	1	
REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER 	0	11	20	17007	0.0	1.0	1	
HOWLIN_PUBERTAL_MAMMARY_GLAND 	0	11	54	16973	0.0	1.0	1	
KAAB_FAILED_HEART_ATRIUM_UP 	0	11	30	16997	0.0	1.0	1	
KEGG_ABC_TRANSPORTERS 	0	11	41	16986	0.0	1.0	1	
GRADE_COLON_CANCER_DN 	0	11	28	16999	0.0	1.0	1	
POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP 	0	11	41	16986	0.0	1.0	1	
FRASOR_RESPONSE_TO_ESTRADIOL_DN 	0	11	76	16951	0.0	1.0	1	
DOANE_BREAST_CANCER_CLASSES_DN 	0	11	31	16996	0.0	1.0	1	
CERIBELLI_GENES_INACTIVE_AND_BOUND_BY_NFY 	0	11	24	17003	0.0	1.0	1	
PID_NFAT_3PATHWAY 	0	11	53	16974	0.0	1.0	1	
MCCABE_HOXC6_TARGETS_UP 	0	11	9	17018	0.0	1.0	1	
IVANOVA_HEMATOPOIESIS_STEM_CELL 	0	11	223	16804	0.0	1.0	1	
MIKKELSEN_DEDIFFERENTIATED_STATE_DN 	0	11	7	17020	0.0	1.0	1	
REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC 	0	11	47	16980	0.0	1.0	1	
TERAO_AOX4_TARGETS_SKIN_DN 	0	11	21	17006	0.0	1.0	1	
ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN 	0	11	556	16471	0.0	1.0	1	
BIOCARTA_PLCE_PATHWAY 	0	11	11	17016	0.0	1.0	1	
AMIT_EGF_RESPONSE_40_MCF10A 	0	11	19	17008	0.0	1.0	1	
WELCSH_BRCA1_TARGETS_UP 	0	11	189	16838	0.0	1.0	1	
LIU_NASOPHARYNGEAL_CARCINOMA 	0	11	61	16966	0.0	1.0	1	
HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_UP 	0	11	21	17006	0.0	1.0	1	
GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN 	0	11	94	16933	0.0	1.0	1	
ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP 	0	11	38	16989	0.0	1.0	1	
PID_RET_PATHWAY 	0	11	39	16988	0.0	1.0	1	
CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN 	0	11	143	16884	0.0	1.0	1	
BIOCARTA_VEGF_PATHWAY 	0	11	29	16998	0.0	1.0	1	
SHEN_SMARCA2_TARGETS_DN 	2	9	217	16810	17.214541730670764	0.008380238567663501	1	CNTN2,SOX10
BIOCARTA_AKAPCENTROSOME_PATHWAY 	0	11	14	17013	0.0	1.0	1	
PENG_LEUCINE_DEPRIVATION_UP 	1	10	130	16897	12.997692307692308	0.0814211130212921	1	MAG
BIOCARTA_TEL_PATHWAY 	0	11	18	17009	0.0	1.0	1	
STONER_ESOPHAGEAL_CARCINOGENESIS_UP 	0	11	35	16992	0.0	1.0	1	
KEGG_NON_HOMOLOGOUS_END_JOINING 	0	11	11	17016	0.0	1.0	1	
REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT 	0	11	38	16989	0.0	1.0	1	
GHANDHI_DIRECT_IRRADIATION_DN 	0	11	31	16996	0.0	1.0	1	
MIKKELSEN_ES_LCP_WITH_H3K27ME3 	0	11	10	17017	0.0	1.0	1	
MARTINEZ_TP53_TARGETS_UP 	0	11	520	16507	0.0	1.0	1	
REACTOME_NFKB_AND_MAP_KINASES_ACTIVATION_MEDIATED_BY_TLR4_SIGNALING_REPERTOIRE 	0	11	69	16958	0.0	1.0	1	
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN 	0	11	55	16972	0.0	1.0	1	
BIOCARTA_ATRBRCA_PATHWAY 	0	11	19	17008	0.0	1.0	1	
REACTOME_PHASE_II_CONJUGATION 	0	11	43	16984	0.0	1.0	1	
AMIT_EGF_RESPONSE_60_MCF10A 	0	11	36	16991	0.0	1.0	1	
REACTOME_NEGATIVE_REGULATION_OF_FGFR_SIGNALING 	0	11	30	16997	0.0	1.0	1	
DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN 	0	11	476	16551	0.0	1.0	1	
CUI_TCF21_TARGETS_2_DN 	1	10	772	16255	2.1055699481865284	0.4000385649633212	1	TMC7
PLASARI_NFIC_TARGETS_BASAL_DN 	0	11	17	17010	0.0	1.0	1	
BIOCARTA_NTHI_PATHWAY 	0	11	22	17005	0.0	1.0	1	
YAGI_AML_FAB_MARKERS 	0	11	178	16849	0.0	1.0	1	
LEE_LIVER_CANCER_E2F1_UP 	0	11	52	16975	0.0	1.0	1	
KEGG_ACUTE_MYELOID_LEUKEMIA 	0	11	57	16970	0.0	1.0	1	
SHIN_B_CELL_LYMPHOMA_CLUSTER_2 	0	11	26	17001	0.0	1.0	1	
REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK 	0	11	7	17020	0.0	1.0	1	
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP 	0	11	16	17011	0.0	1.0	1	
SHIN_B_CELL_LYMPHOMA_CLUSTER_6 	0	11	8	17019	0.0	1.0	1	
SHIN_B_CELL_LYMPHOMA_CLUSTER_7 	0	11	26	17001	0.0	1.0	1	
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP 	0	11	100	16927	0.0	1.0	1	
SHIN_B_CELL_LYMPHOMA_CLUSTER_5 	0	11	10	17017	0.0	1.0	1	
REACTOME_SIGNALING_BY_BMP 	0	11	21	17006	0.0	1.0	1	
SHIN_B_CELL_LYMPHOMA_CLUSTER_8 	0	11	30	16997	0.0	1.0	1	
SHIN_B_CELL_LYMPHOMA_CLUSTER_9 	0	11	9	17018	0.0	1.0	1	
IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN 	0	11	301	16726	0.0	1.0	1	
PID_FOXM1_PATHWAY 	0	11	35	16992	0.0	1.0	1	
LEE_LIVER_CANCER_ACOX1_DN 	0	11	50	16977	0.0	1.0	1	
ROZANOV_MMP14_TARGETS_SUBSET 	0	11	29	16998	0.0	1.0	1	
FIGUEROA_AML_METHYLATION_CLUSTER_4_DN 	0	11	12	17015	0.0	1.0	1	
BIOCARTA_LYM_PATHWAY 	0	11	10	17017	0.0	1.0	1	
NAKAMURA_METASTASIS_MODEL_DN 	0	11	35	16992	0.0	1.0	1	
HILLION_HMGA1_TARGETS 	0	11	82	16945	0.0	1.0	1	
KEGG_NEUROTROPHIN_SIGNALING_PATHWAY 	0	11	121	16906	0.0	1.0	1	
REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING 	0	11	15	17012	0.0	1.0	1	
SONG_TARGETS_OF_IE86_CMV_PROTEIN 	0	11	57	16970	0.0	1.0	1	
TIAN_TNF_SIGNALING_NOT_VIA_NFKB 	0	11	21	17006	0.0	1.0	1	
KOHOUTEK_CCNT2_TARGETS 	0	11	47	16980	0.0	1.0	1	
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP 	0	11	21	17006	0.0	1.0	1	
REACTOME_REGULATION_OF_RHEB_GTPASE_ACTIVITY_BY_AMPK 	0	11	9	17018	0.0	1.0	1	
KEGG_COLORECTAL_CANCER 	0	11	62	16965	0.0	1.0	1	
ST_WNT_BETA_CATENIN_PATHWAY 	0	11	31	16996	0.0	1.0	1	
ZHENG_RESPONSE_TO_ARSENITE_DN 	0	11	15	17012	0.0	1.0	1	
DORN_ADENOVIRUS_INFECTION_48HR_UP 	0	11	13	17014	0.0	1.0	1	
PID_P38_ALPHA_BETA_PATHWAY 	0	11	30	16997	0.0	1.0	1	
REACTOME_GLUTATHIONE_CONJUGATION 	0	11	19	17008	0.0	1.0	1	
BIOCARTA_ALK_PATHWAY 	0	11	32	16995	0.0	1.0	1	
CHEN_PDGF_TARGETS 	1	10	16	17011	106.31875	0.01092406542820846	1	C9orf3
TSAI_RESPONSE_TO_RADIATION_THERAPY 	0	11	32	16995	0.0	1.0	1	
REACTOME_MEIOTIC_SYNAPSIS 	0	11	45	16982	0.0	1.0	1	
COLINA_TARGETS_OF_4EBP1_AND_4EBP2 	0	11	325	16702	0.0	1.0	1	
KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM 	0	11	43	16984	0.0	1.0	1	
GUILLAUMOND_KLF10_TARGETS_UP 	0	11	44	16983	0.0	1.0	1	
SANA_TNF_SIGNALING_UP 	0	11	73	16954	0.0	1.0	1	
REACTOME_GENERIC_TRANSCRIPTION_PATHWAY 	0	11	324	16703	0.0	1.0	1	
THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP 	0	11	71	16956	0.0	1.0	1	
REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR 	0	11	91	16936	0.0	1.0	1	
BASSO_B_LYMPHOCYTE_NETWORK 	0	11	135	16892	0.0	1.0	1	
KIM_ALL_DISORDERS_CALB1_CORR_DN 	0	11	22	17005	0.0	1.0	1	
REACTOME_NCAM1_INTERACTIONS 	1	10	37	16990	45.91891891891892	0.024268676613344833	1	CNTN2
BURTON_ADIPOGENESIS_PEAK_AT_8HR 	0	11	37	16990	0.0	1.0	1	
PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN 	0	11	49	16978	0.0	1.0	1	
REACTOME_LIGAND_GATED_ION_CHANNEL_TRANSPORT 	0	11	18	17009	0.0	1.0	1	
RIZ_ERYTHROID_DIFFERENTIATION_CCNE1 	0	11	35	16992	0.0	1.0	1	
GOUYER_TUMOR_INVASIVENESS 	0	11	6	17021	0.0	1.0	1	
LUCAS_HNF4A_TARGETS_DN 	0	11	8	17019	0.0	1.0	1	
ELLWOOD_MYC_TARGETS_UP 	0	11	12	17015	0.0	1.0	1	
REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS 	0	11	10	17017	0.0	1.0	1	
KOINUMA_COLON_CANCER_MSI_UP 	0	11	14	17013	0.0	1.0	1	
TAKAYAMA_BOUND_BY_AR 	0	11	9	17018	0.0	1.0	1	
REACTOME_PACKAGING_OF_TELOMERE_ENDS 	0	11	26	17001	0.0	1.0	1	
FARDIN_HYPOXIA_9 	0	11	7	17020	0.0	1.0	1	
REACTOME_PTM_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION 	0	11	22	17005	0.0	1.0	1	
MCCLUNG_COCAINE_REWARD_5D 	1	10	74	16953	22.90945945945946	0.04738299691841565	1	SOX10
REACTOME_ASSOCIATION_OF_LICENSING_FACTORS_WITH_THE_PRE_REPLICATIVE_COMPLEX 	0	11	11	17016	0.0	1.0	1	
REACTOME_TRAF6_MEDIATED_NFKB_ACTIVATION 	0	11	20	17007	0.0	1.0	1	
SHIRAISHI_PLZF_TARGETS_UP 	0	11	9	17018	0.0	1.0	1	
ZHU_CMV_ALL_DN 	0	11	120	16907	0.0	1.0	1	
MIKKELSEN_IPS_WITH_HCP_H3K27ME3 	0	11	63	16964	0.0	1.0	1	
YAMANAKA_GLIOBLASTOMA_SURVIVAL_DN 	0	11	8	17019	0.0	1.0	1	
JI_CARCINOGENESIS_BY_KRAS_AND_STK11_UP 	0	11	9	17018	0.0	1.0	1	
JUBAN_TARGETS_OF_SPI1_AND_FLI1_UP 	1	10	108	16919	15.665740740740741	0.06818312408799965	1	C9orf3
RIZ_ERYTHROID_DIFFERENTIATION_APOBEC2 	0	11	19	17008	0.0	1.0	1	
MIKKELSEN_ES_LCP_WITH_H3K4ME3 	0	11	103	16924	0.0	1.0	1	
SA_TRKA_RECEPTOR 	0	11	17	17010	0.0	1.0	1	
BIOCARTA_BARRESTIN_SRC_PATHWAY 	0	11	14	17013	0.0	1.0	1	
CAFFAREL_RESPONSE_TO_THC_24HR_3_UP 	0	11	8	17019	0.0	1.0	1	
REACTOME_REVERSIBLE_HYDRATION_OF_CARBON_DIOXIDE 	0	11	9	17018	0.0	1.0	1	
POOLA_INVASIVE_BREAST_CANCER_DN 	1	10	119	16908	14.208403361344537	0.07482364301961536	1	CAPN3
HOUSTIS_ROS 	0	11	34	16993	0.0	1.0	1	
HUTTMANN_B_CLL_POOR_SURVIVAL_UP 	0	11	240	16787	0.0	1.0	1	
MITSIADES_RESPONSE_TO_APLIDIN_DN 	0	11	230	16797	0.0	1.0	1	
SU_PLACENTA 	0	11	22	17005	0.0	1.0	1	
BIOCARTA_NFKB_PATHWAY 	0	11	22	17005	0.0	1.0	1	
ZEMBUTSU_SENSITIVITY_TO_FLUOROURACIL 	0	11	14	17013	0.0	1.0	1	
BIOCARTA_CD40_PATHWAY 	0	11	14	17013	0.0	1.0	1	
ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP 	0	11	402	16625	0.0	1.0	1	
BASAKI_YBX1_TARGETS_UP 	0	11	246	16781	0.0	1.0	1	
MIKKELSEN_MCV6_ICP_WITH_H3K27ME3 	0	11	44	16983	0.0	1.0	1	
MA_PITUITARY_FETAL_VS_ADULT_UP 	0	11	27	17000	0.0	1.0	1	
MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS 	0	11	10	17017	0.0	1.0	1	
THUM_MIR21_TARGETS_HEART_DISEASE_DN 	0	11	5	17022	0.0	1.0	1	
GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN 	0	11	150	16877	0.0	1.0	1	
PID_SMAD2_3PATHWAY 	0	11	17	17010	0.0	1.0	1	
SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_DN 	0	11	5	17022	0.0	1.0	1	
REACTOME_IMMUNE_SYSTEM 	0	11	756	16271	0.0	1.0	1	
BROWNE_HCMV_INFECTION_30MIN_UP 	0	11	43	16984	0.0	1.0	1	
PID_CD40_PATHWAY 	0	11	27	17000	0.0	1.0	1	
HU_GENOTOXIC_DAMAGE_24HR 	0	11	30	16997	0.0	1.0	1	
WHITE_NEUROBLASTOMA_WITH_1P36.3_DELETION 	0	11	18	17009	0.0	1.0	1	
REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB 	0	11	16	17011	0.0	1.0	1	
NAKAMURA_CANCER_MICROENVIRONMENT_DN 	0	11	41	16986	0.0	1.0	1	
BIOCARTA_SPRY_PATHWAY 	0	11	18	17009	0.0	1.0	1	
XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN 	0	11	67	16960	0.0	1.0	1	
VERNELL_RETINOBLASTOMA_PATHWAY_DN 	0	11	21	17006	0.0	1.0	1	
TSENG_IRS1_TARGETS_DN 	0	11	123	16904	0.0	1.0	1	
REACTOME_LIPOPROTEIN_METABOLISM 	0	11	25	17002	0.0	1.0	1	
PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP 	0	11	30	16997	0.0	1.0	1	
MONTERO_THYROID_CANCER_POOR_SURVIVAL_DN 	0	11	8	17019	0.0	1.0	1	
KEGG_CHEMOKINE_SIGNALING_PATHWAY 	0	11	143	16884	0.0	1.0	1	
SUNG_METASTASIS_STROMA_DN 	0	11	45	16982	0.0	1.0	1	
RIZKI_TUMOR_INVASIVENESS_2D_UP 	0	11	62	16965	0.0	1.0	1	
LU_EZH2_TARGETS_UP 	1	10	247	16780	6.793522267206478	0.14899484985847866	1	C9orf3
MARTINELLI_IMMATURE_NEUTROPHIL_DN 	0	11	11	17016	0.0	1.0	1	
SMID_BREAST_CANCER_RELAPSE_IN_LIVER_UP 	0	11	5	17022	0.0	1.0	1	
BENPORATH_MYC_TARGETS_WITH_EBOX 	0	11	211	16816	0.0	1.0	1	
CASTELLANO_HRAS_AND_NRAS_TARGETS_UP 	0	11	5	17022	0.0	1.0	1	
HEIDENBLAD_AMPLICON_12P11_12_DN 	0	11	20	17007	0.0	1.0	1	
REACTOME_LAGGING_STRAND_SYNTHESIS 	0	11	19	17008	0.0	1.0	1	
HUMMERICH_MALIGNANT_SKIN_TUMOR_UP 	0	11	13	17014	0.0	1.0	1	
SANSOM_APC_TARGETS_UP 	0	11	107	16920	0.0	1.0	1	
WU_ALZHEIMER_DISEASE_DN 	0	11	17	17010	0.0	1.0	1	
GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN 	0	11	17	17010	0.0	1.0	1	
REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS 	0	11	34	16993	0.0	1.0	1	
FIRESTEIN_PROLIFERATION 	0	11	156	16871	0.0	1.0	1	
KUMAMOTO_RESPONSE_TO_NUTLIN_3A_UP 	0	11	9	17018	0.0	1.0	1	
MONTERO_THYROID_CANCER_POOR_SURVIVAL_UP 	0	11	7	17020	0.0	1.0	1	
REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING 	0	11	13	17014	0.0	1.0	1	
WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN 	0	11	306	16721	0.0	1.0	1	
NADELLA_PRKAR1A_TARGETS_DN 	0	11	7	17020	0.0	1.0	1	
PYEON_HPV_POSITIVE_TUMORS_DN 	0	11	8	17019	0.0	1.0	1	
PID_ATR_PATHWAY 	0	11	37	16990	0.0	1.0	1	
MORI_MATURE_B_LYMPHOCYTE_UP 	0	11	82	16945	0.0	1.0	1	
REACTOME_REPAIR_SYNTHESIS_FOR_GAP_FILLING_BY_DNA_POL_IN_TC_NER 	0	11	14	17013	0.0	1.0	1	
UDAYAKUMAR_MED1_TARGETS_UP 	0	11	129	16898	0.0	1.0	1	
LIU_IL13_MEMORY_MODEL_DN 	0	11	5	17022	0.0	1.0	1	
REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_ 	0	11	62	16965	0.0	1.0	1	
KIM_MYCL1_AMPLIFICATION_TARGETS_DN 	1	10	17	17010	100.05882352941177	0.011563266137454307	1	CDC42EP1
KUMAR_AUTOPHAGY_NETWORK 	0	11	58	16969	0.0	1.0	1	
REACTOME_SULFUR_AMINO_ACID_METABOLISM 	0	11	24	17003	0.0	1.0	1	
BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN 	0	11	44	16983	0.0	1.0	1	
WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_36HR 	0	11	28	16999	0.0	1.0	1	
ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN 	0	11	46	16981	0.0	1.0	1	
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP 	0	11	126	16901	0.0	1.0	1	
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 	1	10	214	16813	7.856542056074766	0.1304086384276238	1	SOX10
REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK 	0	11	151	16876	0.0	1.0	1	
BIOCARTA_PAR1_PATHWAY 	0	11	34	16993	0.0	1.0	1	
KEGG_REGULATION_OF_ACTIN_CYTOSKELETON 	0	11	191	16836	0.0	1.0	1	
REACTOME_CIRCADIAN_CLOCK 	0	11	49	16978	0.0	1.0	1	
ZHENG_GLIOBLASTOMA_PLASTICITY_DN 	0	11	54	16973	0.0	1.0	1	
DARWICHE_PAPILLOMA_RISK_HIGH_VS_LOW_UP 	0	11	6	17021	0.0	1.0	1	
MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP 	0	11	74	16953	0.0	1.0	1	
MIKKELSEN_MEF_HCP_WITH_H3K27ME3 	1	10	432	16595	3.841435185185185	0.2466681080212813	1	CNTN2
ENK_UV_RESPONSE_EPIDERMIS_UP 	0	11	262	16765	0.0	1.0	1	
THUM_MIR21_TARGETS_HEART_DISEASE_UP 	0	11	16	17011	0.0	1.0	1	
PID_IL8_CXCR1_PATHWAY 	0	11	26	17001	0.0	1.0	1	
LEIN_PONS_MARKERS 	0	11	82	16945	0.0	1.0	1	
STEGER_ADIPOGENESIS_UP 	0	11	17	17010	0.0	1.0	1	
ST_MYOCYTE_AD_PATHWAY 	0	11	22	17005	0.0	1.0	1	
PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_DN 	0	11	29	16998	0.0	1.0	1	
MURAKAMI_UV_RESPONSE_6HR_DN 	0	11	19	17008	0.0	1.0	1	
BOYAULT_LIVER_CANCER_SUBCLASS_G23_DN 	0	11	10	17017	0.0	1.0	1	
ENK_UV_RESPONSE_KERATINOCYTE_UP 	0	11	478	16549	0.0	1.0	1	
TIEN_INTESTINE_PROBIOTICS_6HR_UP 	0	11	55	16972	0.0	1.0	1	
SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP 	0	11	149	16878	0.0	1.0	1	
RUNNE_GENDER_EFFECT_UP 	0	11	7	17020	0.0	1.0	1	
BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP 	0	11	105	16922	0.0	1.0	1	
GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN 	0	11	78	16949	0.0	1.0	1	
PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN 	0	11	137	16890	0.0	1.0	1	
REACTOME_TRANSPORT_OF_MATURE_MRNA_DERIVED_FROM_AN_INTRONLESS_TRANSCRIPT 	0	11	31	16996	0.0	1.0	1	
BAELDE_DIABETIC_NEPHROPATHY_DN 	0	11	420	16607	0.0	1.0	1	
BIOCARTA_P27_PATHWAY 	0	11	13	17014	0.0	1.0	1	
LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER 	0	11	205	16822	0.0	1.0	1	
ST_PHOSPHOINOSITIDE_3_KINASE_PATHWAY 	0	11	36	16991	0.0	1.0	1	
REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING 	0	11	38	16989	0.0	1.0	1	
CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP 	0	11	20	17007	0.0	1.0	1	
HATADA_METHYLATED_IN_LUNG_CANCER_DN 	0	11	18	17009	0.0	1.0	1	
FALVELLA_SMOKERS_WITH_LUNG_CANCER 	0	11	68	16959	0.0	1.0	1	
JEPSEN_SMRT_TARGETS 	0	11	33	16994	0.0	1.0	1	
BIOCARTA_RACCYCD_PATHWAY 	0	11	26	17001	0.0	1.0	1	
REACTOME_METAL_ION_SLC_TRANSPORTERS 	0	11	19	17008	0.0	1.0	1	
BERNARD_PPAPDC1B_TARGETS_DN 	0	11	49	16978	0.0	1.0	1	
LEE_LIVER_CANCER_CIPROFIBRATE_UP 	0	11	50	16977	0.0	1.0	1	
HE_PTEN_TARGETS_DN 	0	11	7	17020	0.0	1.0	1	
HELLER_SILENCED_BY_METHYLATION_DN 	0	11	95	16932	0.0	1.0	1	
BIOCARTA_HSP27_PATHWAY 	0	11	13	17014	0.0	1.0	1	
DORN_ADENOVIRUS_INFECTION_24HR_UP 	0	11	11	17016	0.0	1.0	1	
LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN 	0	11	51	16976	0.0	1.0	1	
BIOCARTA_CCR5_PATHWAY 	0	11	17	17010	0.0	1.0	1	
REACTOME_ELONGATION_ARREST_AND_RECOVERY 	0	11	24	17003	0.0	1.0	1	
MAHAJAN_RESPONSE_TO_IL1A_UP 	0	11	71	16956	0.0	1.0	1	
KEGG_RIBOSOME 	0	11	85	16942	0.0	1.0	1	
VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN 	0	11	11	17016	0.0	1.0	1	
NIKOLSKY_BREAST_CANCER_16P13_AMPLICON 	0	11	92	16935	0.0	1.0	1	
SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_UP 	0	11	10	17017	0.0	1.0	1	
KIM_WT1_TARGETS_8HR_UP 	0	11	159	16868	0.0	1.0	1	
BRUINS_UVC_RESPONSE_EARLY_LATE 	0	11	283	16744	0.0	1.0	1	
GYORFFY_MITOXANTRONE_RESISTANCE 	0	11	48	16979	0.0	1.0	1	
NABA_MATRISOME 	0	11	722	16305	0.0	1.0	1	
ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP 	0	11	75	16952	0.0	1.0	1	
MATZUK_SPERMATOZOA 	0	11	86	16941	0.0	1.0	1	
BIOCARTA_D4GDI_PATHWAY 	0	11	13	17014	0.0	1.0	1	
ST_TYPE_I_INTERFERON_PATHWAY 	0	11	7	17020	0.0	1.0	1	
ASTON_MAJOR_DEPRESSIVE_DISORDER_UP 	0	11	43	16984	0.0	1.0	1	
BIOCARTA_RAC1_PATHWAY 	0	11	23	17004	0.0	1.0	1	
CHOI_ATL_STAGE_PREDICTOR 	0	11	38	16989	0.0	1.0	1	
DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN 	0	11	25	17002	0.0	1.0	1	
DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN 	0	11	277	16750	0.0	1.0	1	
WANG_RESPONSE_TO_ANDROGEN_UP 	0	11	25	17002	0.0	1.0	1	
RICKMAN_HEAD_AND_NECK_CANCER_F 	0	11	44	16983	0.0	1.0	1	
BIOCARTA_TCRA_PATHWAY 	0	11	9	17018	0.0	1.0	1	
REACTOME_CELL_CYCLE_CHECKPOINTS 	0	11	104	16923	0.0	1.0	1	
KEGG_LINOLEIC_ACID_METABOLISM 	0	11	11	17016	0.0	1.0	1	
LIN_NPAS4_TARGETS_DN 	0	11	60	16967	0.0	1.0	1	
REACTOME_ACTIVATION_OF_RAC 	0	11	12	17015	0.0	1.0	1	
NAGASHIMA_EGF_SIGNALING_UP 	0	11	55	16972	0.0	1.0	1	
GENTILE_UV_LOW_DOSE_UP 	0	11	27	17000	0.0	1.0	1	
BIOCARTA_ACH_PATHWAY 	0	11	12	17015	0.0	1.0	1	
REACTOME_RNA_POL_I_TRANSCRIPTION_TERMINATION 	0	11	20	17007	0.0	1.0	1	
KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS 	0	11	74	16953	0.0	1.0	1	
CEBALLOS_TARGETS_OF_TP53_AND_MYC_UP 	0	11	20	17007	0.0	1.0	1	
DAIRKEE_TERT_TARGETS_UP 	0	11	339	16688	0.0	1.0	1	
VERRECCHIA_RESPONSE_TO_TGFB1_C1 	0	11	19	17008	0.0	1.0	1	
VERRECCHIA_RESPONSE_TO_TGFB1_C2 	0	11	24	17003	0.0	1.0	1	
MCLACHLAN_DENTAL_CARIES_DN 	0	11	75	16952	0.0	1.0	1	
VERRECCHIA_RESPONSE_TO_TGFB1_C4 	0	11	12	17015	0.0	1.0	1	
VERRECCHIA_RESPONSE_TO_TGFB1_C5 	0	11	20	17007	0.0	1.0	1	
VERRECCHIA_RESPONSE_TO_TGFB1_C6 	0	11	5	17022	0.0	1.0	1	
PID_PI3KCI_PATHWAY 	0	11	48	16979	0.0	1.0	1	
PID_HEDGEHOG_GLI_PATHWAY 	0	11	47	16980	0.0	1.0	1	
ZHANG_ADIPOGENESIS_BY_BMP7 	0	11	14	17013	0.0	1.0	1	
ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP 	0	11	368	16659	0.0	1.0	1	
PID_NFAT_TFPATHWAY 	0	11	33	16994	0.0	1.0	1	
WILLIAMS_ESR2_TARGETS_DN 	0	11	11	17016	0.0	1.0	1	
SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE 	0	11	95	16932	0.0	1.0	1	
PID_WNT_NONCANONICAL_PATHWAY 	0	11	32	16995	0.0	1.0	1	
KYNG_NORMAL_AGING_DN 	0	11	26	17001	0.0	1.0	1	
JOHNSTONE_PARVB_TARGETS_3_UP 	0	11	402	16625	0.0	1.0	1	
DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN 	0	11	19	17008	0.0	1.0	1	
REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS 	0	11	37	16990	0.0	1.0	1	
LEE_LIVER_CANCER_E2F1_DN 	0	11	45	16982	0.0	1.0	1	
PENG_RAPAMYCIN_RESPONSE_UP 	0	11	182	16845	0.0	1.0	1	
REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE 	0	11	24	17003	0.0	1.0	1	
WEBER_METHYLATED_ICP_IN_SPERM_UP 	0	11	1	17026	0.0	1.0	1	
REACTOME_MRNA_SPLICING_MINOR_PATHWAY 	0	11	40	16987	0.0	1.0	1	
HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_UP 	0	11	22	17005	0.0	1.0	1	
ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP 	0	11	74	16953	0.0	1.0	1	
GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_DN 	0	11	7	17020	0.0	1.0	1	
REACTOME_NEGATIVE_REGULATORS_OF_RIG_I_MDA5_SIGNALING 	0	11	30	16997	0.0	1.0	1	
OXFORD_RALA_TARGETS_UP 	0	11	8	17019	0.0	1.0	1	
GROSS_ELK3_TARGETS_DN 	0	11	29	16998	0.0	1.0	1	
FOURNIER_ACINAR_DEVELOPMENT_LATE_2 	0	11	254	16773	0.0	1.0	1	
VISALA_AGING_LYMPHOCYTE_UP 	0	11	10	17017	0.0	1.0	1	
HUANG_FOXA2_TARGETS_DN 	0	11	35	16992	0.0	1.0	1	
KAYO_AGING_MUSCLE_UP 	0	11	203	16824	0.0	1.0	1	
RODRIGUES_DCC_TARGETS_UP 	0	11	4	17023	0.0	1.0	1	
OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP 	0	11	63	16964	0.0	1.0	1	
TIAN_BHLHA15_TARGETS 	0	11	14	17013	0.0	1.0	1	
CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP 	0	11	230	16797	0.0	1.0	1	
SA_MMP_CYTOKINE_CONNECTION 	0	11	14	17013	0.0	1.0	1	
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15 	0	11	30	16997	0.0	1.0	1	
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14 	0	11	133	16894	0.0	1.0	1	
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17 	0	11	171	16856	0.0	1.0	1	
REACTOME_IL_6_SIGNALING 	0	11	10	17017	0.0	1.0	1	
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11 	0	11	95	16932	0.0	1.0	1	
KEGG_LYSINE_DEGRADATION 	0	11	39	16988	0.0	1.0	1	
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13 	0	11	164	16863	0.0	1.0	1	
REACTOME_IL_3_5_AND_GM_CSF_SIGNALING 	0	11	37	16990	0.0	1.0	1	
REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM 	0	11	230	16797	0.0	1.0	1	
HUPER_BREAST_BASAL_VS_LUMINAL_UP 	0	11	41	16986	0.0	1.0	1	
REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION 	0	11	33	16994	0.0	1.0	1	
PID_IL3_PATHWAY 	0	11	25	17002	0.0	1.0	1	
REACTOME_TRAF6_MEDIATED_INDUCTION_OF_TAK1_COMPLEX 	0	11	13	17014	0.0	1.0	1	
NUTT_GBM_VS_AO_GLIOMA_UP 	0	11	46	16981	0.0	1.0	1	
CHEN_ETV5_TARGETS_SERTOLI 	0	11	15	17012	0.0	1.0	1	
KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION 	0	11	40	16987	0.0	1.0	1	
TOMLINS_METASTASIS_UP 	0	11	14	17013	0.0	1.0	1	
ROME_INSULIN_TARGETS_IN_MUSCLE_UP 	0	11	404	16623	0.0	1.0	1	
REACTOME_MRNA_PROCESSING 	0	11	149	16878	0.0	1.0	1	
SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS 	0	11	34	16993	0.0	1.0	1	
DAZARD_RESPONSE_TO_UV_NHEK_UP 	0	11	207	16820	0.0	1.0	1	
ZERBINI_RESPONSE_TO_SULINDAC_DN 	0	11	4	17023	0.0	1.0	1	
CHESLER_BRAIN_HIGHEST_EXPRESSION 	0	11	38	16989	0.0	1.0	1	
RUAN_RESPONSE_TO_TNF_UP 	0	11	11	17016	0.0	1.0	1	
REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE 	0	11	7	17020	0.0	1.0	1	
REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT 	0	11	16	17011	0.0	1.0	1	
WANG_RECURRENT_LIVER_CANCER_UP 	0	11	20	17007	0.0	1.0	1	
PID_INTEGRIN_A9B1_PATHWAY 	0	11	21	17006	0.0	1.0	1	
REACTOME_INCRETIN_SYNTHESIS_SECRETION_AND_INACTIVATION 	0	11	13	17014	0.0	1.0	1	
WANG_TNF_TARGETS 	0	11	17	17010	0.0	1.0	1	
BASAKI_YBX1_TARGETS_DN 	0	11	352	16675	0.0	1.0	1	
KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY 	0	11	40	16987	0.0	1.0	1	
NIELSEN_LEIOMYOSARCOMA_UP 	0	11	15	17012	0.0	1.0	1	
CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP 	1	10	97	16930	17.45360824742268	0.06149930357514804	1	C9orf3
PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_UP 	0	11	31	16996	0.0	1.0	1	
LEE_AGING_CEREBELLUM_DN 	0	11	72	16955	0.0	1.0	1	
PLASARI_NFIC_TARGETS_BASAL_UP 	0	11	23	17004	0.0	1.0	1	
LEI_MYB_TARGETS 	0	11	291	16736	0.0	1.0	1	
TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_DN 	0	11	10	17017	0.0	1.0	1	
KAMMINGA_EZH2_TARGETS 	0	11	36	16991	0.0	1.0	1	
JACKSON_DNMT1_TARGETS_UP 	0	11	72	16955	0.0	1.0	1	
QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2 	0	11	36	16991	0.0	1.0	1	
KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_UP 	0	11	11	17016	0.0	1.0	1	
MILI_PSEUDOPODIA_HAPTOTAXIS_UP 	0	11	482	16545	0.0	1.0	1	
PARK_HSC_MARKERS 	0	11	42	16985	0.0	1.0	1	
VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN 	0	11	36	16991	0.0	1.0	1	
REACTOME_AMINE_DERIVED_HORMONES 	0	11	9	17018	0.0	1.0	1	
GUILLAUMOND_KLF10_TARGETS_DN 	0	11	26	17001	0.0	1.0	1	
PIONTEK_PKD1_TARGETS_UP 	0	11	32	16995	0.0	1.0	1	
REACTOME_MRNA_SPLICING 	0	11	104	16923	0.0	1.0	1	
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_2HR 	0	11	7	17020	0.0	1.0	1	
SANA_TNF_SIGNALING_DN 	0	11	87	16940	0.0	1.0	1	
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_UP 	0	11	5	17022	0.0	1.0	1	
THUM_SYSTOLIC_HEART_FAILURE_UP 	0	11	382	16645	0.0	1.0	1	
VALK_AML_CLUSTER_3 	0	11	28	16999	0.0	1.0	1	
SASAKI_TARGETS_OF_TP73_AND_TP63 	0	11	11	17016	0.0	1.0	1	
REACTOME_PHOSPHOLIPID_METABOLISM 	0	11	173	16854	0.0	1.0	1	
BIOCARTA_VITCB_PATHWAY 	0	11	10	17017	0.0	1.0	1	
SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP 	0	11	153	16874	0.0	1.0	1	
MAHADEVAN_IMATINIB_RESISTANCE_UP 	0	11	17	17010	0.0	1.0	1	
ELVIDGE_HIF1A_TARGETS_DN 	0	11	86	16941	0.0	1.0	1	
LE_SKI_TARGETS_UP 	0	11	15	17012	0.0	1.0	1	
PID_FANCONI_PATHWAY 	0	11	42	16985	0.0	1.0	1	
VALK_AML_CLUSTER_9 	0	11	32	16995	0.0	1.0	1	
VALK_AML_CLUSTER_8 	0	11	23	17004	0.0	1.0	1	
REACTOME_PHOSPHORYLATION_OF_CD3_AND_TCR_ZETA_CHAINS 	0	11	13	17014	0.0	1.0	1	
BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN 	0	11	43	16984	0.0	1.0	1	
ROZANOV_MMP14_TARGETS_UP 	1	10	244	16783	6.87827868852459	0.1473202426966194	1	C9orf3
CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN 	0	11	23	17004	0.0	1.0	1	
RAO_BOUND_BY_SALL4 	0	11	195	16832	0.0	1.0	1	
DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN 	0	11	82	16945	0.0	1.0	1	
MCGOWAN_RSP6_TARGETS_DN 	0	11	5	17022	0.0	1.0	1	
WHITFIELD_CELL_CYCLE_G2_M 	1	10	178	16849	9.465730337078652	0.10971250547316376	1	CDC42EP1
NAKAYAMA_FGF2_TARGETS 	0	11	27	17000	0.0	1.0	1	
BIOCARTA_GPCR_PATHWAY 	0	11	32	16995	0.0	1.0	1	
BROWNE_HCMV_INFECTION_2HR_UP 	0	11	35	16992	0.0	1.0	1	
REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G 	0	11	46	16981	0.0	1.0	1	
BENPORATH_ES_CORE_NINE_CORRELATED 	1	10	90	16937	18.81888888888889	0.05722330165495481	1	SOX10
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE 	0	11	73	16954	0.0	1.0	1	
REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN1_SIGNALING 	0	11	7	17020	0.0	1.0	1	
MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_DN 	0	11	18	17009	0.0	1.0	1	
LEE_LIVER_CANCER_MYC_TGFA_UP 	0	11	55	16972	0.0	1.0	1	
PID_GLYPICAN_1PATHWAY 	0	11	24	17003	0.0	1.0	1	
MAEKAWA_ATF2_TARGETS 	0	11	17	17010	0.0	1.0	1	
FISCHER_DREAM_TARGETS 	0	11	829	16198	0.0	1.0	1	
MATHEW_FANCONI_ANEMIA_GENES 	0	11	10	17017	0.0	1.0	1	
REACTOME_STEROID_HORMONES 	0	11	20	17007	0.0	1.0	1	
TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA 	0	11	75	16952	0.0	1.0	1	
PID_NOTCH_PATHWAY 	0	11	55	16972	0.0	1.0	1	
PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN 	0	11	98	16929	0.0	1.0	1	
REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES 	0	11	31	16996	0.0	1.0	1	
GU_PDEF_TARGETS_UP 	0	11	69	16958	0.0	1.0	1	
HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP 	0	11	226	16801	0.0	1.0	1	
ENK_UV_RESPONSE_KERATINOCYTE_DN 	0	11	475	16552	0.0	1.0	1	
ST_STAT3_PATHWAY 	0	11	10	17017	0.0	1.0	1	
RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP 	0	11	22	17005	0.0	1.0	1	
MAHAJAN_RESPONSE_TO_IL1A_DN 	0	11	69	16958	0.0	1.0	1	
KORKOLA_SEMINOMA_DN 	0	11	8	17019	0.0	1.0	1	
GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP 	0	11	191	16836	0.0	1.0	1	
REACTOME_SIGNALING_BY_EGFR_IN_CANCER 	0	11	103	16924	0.0	1.0	1	
MCCLUNG_DELTA_FOSB_TARGETS_2WK 	0	11	44	16983	0.0	1.0	1	
REACTOME_GAMMA_CARBOXYLATION_TRANSPORT_AND_AMINO_TERMINAL_CLEAVAGE_OF_PROTEINS 	0	11	7	17020	0.0	1.0	1	
GALIE_TUMOR_ANGIOGENESIS 	0	11	8	17019	0.0	1.0	1	
SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM 	0	11	31	16996	0.0	1.0	1	
KEGG_P53_SIGNALING_PATHWAY 	0	11	62	16965	0.0	1.0	1	
MIKKELSEN_IPS_ICP_WITH_H3K27ME3 	0	11	38	16989	0.0	1.0	1	
VALK_AML_CLUSTER_13 	0	11	28	16999	0.0	1.0	1	
PID_S1P_META_PATHWAY 	0	11	21	17006	0.0	1.0	1	
TSAI_DNAJB4_TARGETS_DN 	0	11	5	17022	0.0	1.0	1	
CAFFAREL_RESPONSE_TO_THC_24HR_3_DN 	0	11	11	17016	0.0	1.0	1	
REACTOME_CTLA4_INHIBITORY_SIGNALING 	0	11	19	17008	0.0	1.0	1	
REACTOME_INWARDLY_RECTIFYING_K_CHANNELS 	0	11	28	16999	0.0	1.0	1	
REACTOME_BASIGIN_INTERACTIONS 	1	10	22	17005	77.29545454545455	0.014753640278268828	1	MAG
WHITEFORD_PEDIATRIC_CANCER_MARKERS 	0	11	96	16931	0.0	1.0	1	
BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN 	0	11	40	16987	0.0	1.0	1	
INGA_TP53_TARGETS 	0	11	16	17011	0.0	1.0	1	
SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES 	0	11	33	16994	0.0	1.0	1	
ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP 	0	11	145	16882	0.0	1.0	1	
BHAT_ESR1_TARGETS_VIA_AKT1_UP 	3	8	253	16774	24.862648221343875	0.0005059388530010188	1	CDC42EP1,RTKN,MAG
REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION 	0	11	24	17003	0.0	1.0	1	
HARRIS_BRAIN_CANCER_PROGENITORS 	0	11	36	16991	0.0	1.0	1	
MARTINEZ_RB1_TARGETS_DN 	0	11	453	16574	0.0	1.0	1	
KOINUMA_COLON_CANCER_MSI_DN 	0	11	8	17019	0.0	1.0	1	
ELLWOOD_MYC_TARGETS_DN 	0	11	37	16990	0.0	1.0	1	
GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP 	0	11	53	16974	0.0	1.0	1	
WEBER_METHYLATED_HCP_IN_FIBROBLAST_UP 	0	11	5	17022	0.0	1.0	1	
JI_RESPONSE_TO_FSH_UP 	0	11	69	16958	0.0	1.0	1	
PETROVA_PROX1_TARGETS_UP 	0	11	23	17004	0.0	1.0	1	
SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP 	0	11	21	17006	0.0	1.0	1	
LIU_COMMON_CANCER_GENES 	0	11	66	16961	0.0	1.0	1	
KEGG_GLUTATHIONE_METABOLISM 	0	11	40	16987	0.0	1.0	1	
BIOCARTA_SET_PATHWAY 	0	11	10	17017	0.0	1.0	1	
ABBUD_LIF_SIGNALING_1_UP 	0	11	37	16990	0.0	1.0	1	
BIOCARTA_EGFR_SMRTE_PATHWAY 	0	11	11	17016	0.0	1.0	1	
AIYAR_COBRA1_TARGETS_UP 	0	11	36	16991	0.0	1.0	1	
KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP 	0	11	1127	15900	0.0	1.0	1	
KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN 	0	11	73	16954	0.0	1.0	1	
BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP 	0	11	363	16664	0.0	1.0	1	
SANA_RESPONSE_TO_IFNG_DN 	0	11	80	16947	0.0	1.0	1	
MATSUDA_NATURAL_KILLER_DIFFERENTIATION 	0	11	429	16598	0.0	1.0	1	
VANTVEER_BREAST_CANCER_METASTASIS_UP 	0	11	52	16975	0.0	1.0	1	
BAUS_TFF2_TARGETS_UP 	0	11	21	17006	0.0	1.0	1	
GRADE_COLON_VS_RECTAL_CANCER_DN 	0	11	49	16978	0.0	1.0	1	
GRABARCZYK_BCL11B_TARGETS_UP 	0	11	70	16957	0.0	1.0	1	
SA_B_CELL_RECEPTOR_COMPLEXES 	0	11	24	17003	0.0	1.0	1	
GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_UP 	0	11	34	16993	0.0	1.0	1	
CHIARETTI_T_ALL_RELAPSE_PROGNOSIS 	0	11	15	17012	0.0	1.0	1	
KUMAMOTO_RESPONSE_TO_NUTLIN_3A_DN 	0	11	8	17019	0.0	1.0	1	
WANG_THOC1_TARGETS_UP 	0	11	4	17023	0.0	1.0	1	
PID_IL2_PI3K_PATHWAY 	0	11	32	16995	0.0	1.0	1	
BENPORATH_CYCLING_GENES 	1	10	572	16455	2.8767482517482517	0.31368178829027576	1	CDC42EP1
REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES 	0	11	45	16982	0.0	1.0	1	
WONG_ADULT_TISSUE_STEM_MODULE 	0	11	648	16379	0.0	1.0	1	
REACTOME_MUSCLE_CONTRACTION 	0	11	41	16986	0.0	1.0	1	
MARCHINI_TRABECTEDIN_RESISTANCE_UP 	0	11	21	17006	0.0	1.0	1	
BIOCARTA_MPR_PATHWAY 	0	11	31	16996	0.0	1.0	1	
WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN 	0	11	62	16965	0.0	1.0	1	
KEGG_FOCAL_ADHESION 	0	11	188	16839	0.0	1.0	1	
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD 	0	11	30	16997	0.0	1.0	1	
CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70 	0	11	56	16971	0.0	1.0	1	
CHEOK_RESPONSE_TO_HD_MTX_UP 	0	11	18	17009	0.0	1.0	1	
BARRIER_COLON_CANCER_RECURRENCE_UP 	0	11	38	16989	0.0	1.0	1	
ALONSO_METASTASIS_NEURAL_UP 	0	11	16	17011	0.0	1.0	1	
MOOTHA_GLYCOGEN_METABOLISM 	0	11	18	17009	0.0	1.0	1	
REACTOME_INTERFERON_SIGNALING 	0	11	134	16893	0.0	1.0	1	
REACTOME_OPIOID_SIGNALLING 	0	11	71	16956	0.0	1.0	1	
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP 	0	11	219	16808	0.0	1.0	1	
LUI_THYROID_CANCER_PAX8_PPARG_DN 	0	11	45	16982	0.0	1.0	1	
REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS 	0	11	9	17018	0.0	1.0	1	
RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP 	0	11	300	16727	0.0	1.0	1	
VARELA_ZMPSTE24_TARGETS_UP 	0	11	37	16990	0.0	1.0	1	
REACTOME_INHIBITION_OF_INSULIN_SECRETION_BY_ADRENALINE_NORADRENALINE 	0	11	23	17004	0.0	1.0	1	
PETRETTO_HEART_MASS_QTL_CIS_DN 	0	11	22	17005	0.0	1.0	1	
VALK_AML_WITH_11Q23_REARRANGED 	0	11	17	17010	0.0	1.0	1	
SERVITJA_LIVER_HNF1A_TARGETS_DN 	0	11	104	16923	0.0	1.0	1	
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_3 	0	11	17	17010	0.0	1.0	1	
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4 	0	11	96	16931	0.0	1.0	1	
HAHTOLA_SEZARY_SYNDROM_UP 	0	11	82	16945	0.0	1.0	1	
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_6 	0	11	25	17002	0.0	1.0	1	
REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS 	0	11	8	17019	0.0	1.0	1	
BIOCARTA_TCR_PATHWAY 	0	11	42	16985	0.0	1.0	1	
KANG_IMMORTALIZED_BY_TERT_UP 	0	11	79	16948	0.0	1.0	1	
SMID_BREAST_CANCER_BASAL_UP 	2	9	527	16500	6.957621758380772	0.04395926002012534	1	SOX10,CDC42EP1
GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP 	0	11	493	16534	0.0	1.0	1	
KEGG_LIMONENE_AND_PINENE_DEGRADATION 	0	11	10	17017	0.0	1.0	1	
GRADE_COLON_AND_RECTAL_CANCER_DN 	0	11	88	16939	0.0	1.0	1	
SESTO_RESPONSE_TO_UV_C5 	0	11	45	16982	0.0	1.0	1	
SESTO_RESPONSE_TO_UV_C4 	0	11	18	17009	0.0	1.0	1	
SESTO_RESPONSE_TO_UV_C7 	0	11	58	16969	0.0	1.0	1	
SESTO_RESPONSE_TO_UV_C6 	0	11	39	16988	0.0	1.0	1	
SESTO_RESPONSE_TO_UV_C1 	0	11	65	16962	0.0	1.0	1	
SESTO_RESPONSE_TO_UV_C0 	0	11	100	16927	0.0	1.0	1	
REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING 	0	11	13	17014	0.0	1.0	1	
SESTO_RESPONSE_TO_UV_C2 	0	11	52	16975	0.0	1.0	1	
HE_PTEN_TARGETS_UP 	0	11	16	17011	0.0	1.0	1	
PID_VEGFR1_PATHWAY 	0	11	26	17001	0.0	1.0	1	
DARWICHE_PAPILLOMA_RISK_HIGH_VS_LOW_DN 	0	11	26	17001	0.0	1.0	1	
SESTO_RESPONSE_TO_UV_C8 	0	11	71	16956	0.0	1.0	1	
ZHENG_GLIOBLASTOMA_PLASTICITY_UP 	1	10	228	16799	7.367982456140351	0.13833830149679263	1	PLLP
LIU_IL13_PRIMING_MODEL 	0	11	14	17013	0.0	1.0	1	
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_UP 	0	11	8	17019	0.0	1.0	1	
SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_DN 	0	11	5	17022	0.0	1.0	1	
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN 	0	11	23	17004	0.0	1.0	1	
BALLIF_DEVELOPMENTAL_DISABILITY_P16_P12_DELETION 	0	11	11	17016	0.0	1.0	1	
TERAO_AOX4_TARGETS_HG_UP 	0	11	28	16999	0.0	1.0	1	
KEGG_ALZHEIMERS_DISEASE 	0	11	151	16876	0.0	1.0	1	
VALK_AML_CLUSTER_15 	0	11	26	17001	0.0	1.0	1	
TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_UP 	0	11	5	17022	0.0	1.0	1	
RODRIGUES_NTN1_TARGETS_DN 	0	11	138	16889	0.0	1.0	1	
PETRETTO_BLOOD_PRESSURE_UP 	0	11	10	17017	0.0	1.0	1	
KEGG_HOMOLOGOUS_RECOMBINATION 	0	11	24	17003	0.0	1.0	1	
BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN 	0	11	38	16989	0.0	1.0	1	
PID_NCADHERIN_PATHWAY 	0	11	33	16994	0.0	1.0	1	
DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP 	0	11	57	16970	0.0	1.0	1	
WELCSH_BRCA1_TARGETS_DN 	0	11	137	16890	0.0	1.0	1	
REACTOME_INTERFERON_GAMMA_SIGNALING 	0	11	54	16973	0.0	1.0	1	
BURTON_ADIPOGENESIS_PEAK_AT_16HR 	0	11	37	16990	0.0	1.0	1	
RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN 	0	11	36	16991	0.0	1.0	1	
GENTILE_UV_LOW_DOSE_DN 	0	11	64	16963	0.0	1.0	1	
CHANG_IMMORTALIZED_BY_HPV31_DN 	0	11	51	16976	0.0	1.0	1	
TOMIDA_LUNG_CANCER_POOR_SURVIVAL 	0	11	4	17023	0.0	1.0	1	
CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY 	0	11	22	17005	0.0	1.0	1	
KEGG_PROSTATE_CANCER 	0	11	85	16942	0.0	1.0	1	
PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN 	0	11	150	16877	0.0	1.0	1	
HAN_JNK_SINGALING_UP 	0	11	34	16993	0.0	1.0	1	
REACTOME_TIGHT_JUNCTION_INTERACTIONS 	0	11	19	17008	0.0	1.0	1	
MEISSNER_NPC_ICP_WITH_H3K4ME3 	0	11	16	17011	0.0	1.0	1	
ZHAN_MULTIPLE_MYELOMA_LB_UP 	0	11	40	16987	0.0	1.0	1	
NAKAMURA_METASTASIS_MODEL_UP 	0	11	39	16988	0.0	1.0	1	
EGUCHI_CELL_CYCLE_RB1_TARGETS 	0	11	19	17008	0.0	1.0	1	
REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION 	0	11	9	17018	0.0	1.0	1	
KENNY_CTNNB1_TARGETS_UP 	1	10	45	16982	37.73777777777778	0.029309132707367236	1	CAPN3
BENPORATH_MYC_MAX_TARGETS 	1	10	726	16301	2.2453168044077136	0.3811018282413936	1	CNTN2
DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP 	0	11	26	17001	0.0	1.0	1	
GENTILE_UV_RESPONSE_CLUSTER_D6 	0	11	34	16993	0.0	1.0	1	
PID_BETA_CATENIN_NUC_PATHWAY 	0	11	68	16959	0.0	1.0	1	
LEE_INTRATHYMIC_T_PROGENITOR 	0	11	18	17009	0.0	1.0	1	
MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP 	0	11	14	17013	0.0	1.0	1	
MIKKELSEN_MCV6_LCP_WITH_H3K4ME3 	0	11	130	16897	0.0	1.0	1	
ASTON_MAJOR_DEPRESSIVE_DISORDER_DN 	6	5	147	16880	137.79591836734693	2.11564766288694e-10	1.0023938626758322e-06	SOX10,CDC42EP1,CNTN2,CAPN3,MAG,PLLP
NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP 	0	11	16	17011	0.0	1.0	1	
PID_P53_REGULATION_PATHWAY 	0	11	57	16970	0.0	1.0	1	
FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP 	0	11	144	16883	0.0	1.0	1	
GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP 	0	11	25	17002	0.0	1.0	1	
GROSS_HIF1A_TARGETS_UP 	0	11	7	17020	0.0	1.0	1	
REACTOME_CGMP_EFFECTS 	0	11	17	17010	0.0	1.0	1	
MARSHALL_VIRAL_INFECTION_RESPONSE_UP 	0	11	6	17021	0.0	1.0	1	
PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP 	0	11	48	16979	0.0	1.0	1	
BOWIE_RESPONSE_TO_TAMOXIFEN 	0	11	18	17009	0.0	1.0	1	
REACTOME_MEIOSIS 	0	11	70	16957	0.0	1.0	1	
KEGG_INOSITOL_PHOSPHATE_METABOLISM 	0	11	51	16976	0.0	1.0	1	
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2 	0	11	371	16656	0.0	1.0	1	
REACTOME_ARMS_MEDIATED_ACTIVATION 	0	11	17	17010	0.0	1.0	1	
ZWANG_EGF_INTERVAL_DN 	1	10	177	16850	9.519774011299434	0.10913127439585975	1	RTKN
REACTOME_OXYGEN_DEPENDENT_PROLINE_HYDROXYLATION_OF_HYPOXIA_INDUCIBLE_FACTOR_ALPHA 	0	11	14	17013	0.0	1.0	1	
REACTOME_SPHINGOLIPID_METABOLISM 	0	11	58	16969	0.0	1.0	1	
KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES 	0	11	220	16807	0.0	1.0	1	
HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_DN 	0	11	22	17005	0.0	1.0	1	
CLIMENT_BREAST_CANCER_COPY_NUMBER_DN 	0	11	7	17020	0.0	1.0	1	
THUM_SYSTOLIC_HEART_FAILURE_DN 	0	11	208	16819	0.0	1.0	1	
BOYAULT_LIVER_CANCER_SUBCLASS_G2 	0	11	26	17001	0.0	1.0	1	
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1 	0	11	471	16556	0.0	1.0	1	
FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN 	0	11	83	16944	0.0	1.0	1	
MALIK_REPRESSED_BY_ESTROGEN 	0	11	11	17016	0.0	1.0	1	
CAIRO_PML_TARGETS_BOUND_BY_MYC_UP 	0	11	23	17004	0.0	1.0	1	
KEGG_GLYCEROPHOSPHOLIPID_METABOLISM 	0	11	60	16967	0.0	1.0	1	
IWANAGA_CARCINOGENESIS_BY_KRAS_UP 	0	11	144	16883	0.0	1.0	1	
AMIT_SERUM_RESPONSE_60_MCF10A 	0	11	52	16975	0.0	1.0	1	
ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN 	0	11	324	16703	0.0	1.0	1	
COLDREN_GEFITINIB_RESISTANCE_UP 	0	11	74	16953	0.0	1.0	1	
HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_DN 	0	11	13	17014	0.0	1.0	1	
BLALOCK_ALZHEIMERS_DISEASE_DN 	0	11	1198	15829	0.0	1.0	1	
REICHERT_MITOSIS_LIN9_TARGETS 	0	11	21	17006	0.0	1.0	1	
LEE_LIVER_CANCER_CIPROFIBRATE_DN 	0	11	45	16982	0.0	1.0	1	
ZHANG_TLX_TARGETS_DN 	0	11	78	16949	0.0	1.0	1	
WEST_ADRENOCORTICAL_TUMOR_DN 	0	11	504	16523	0.0	1.0	1	
REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION 	0	11	14	17013	0.0	1.0	1	
ALONSO_METASTASIS_EMT_DN 	0	11	4	17023	0.0	1.0	1	
PID_AJDISS_2PATHWAY 	0	11	45	16982	0.0	1.0	1	
RAY_TARGETS_OF_P210_BCR_ABL_FUSION_UP 	0	11	14	17013	0.0	1.0	1	
AMIT_SERUM_RESPONSE_480_MCF10A 	0	11	27	17000	0.0	1.0	1	
PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION 	0	11	20	17007	0.0	1.0	1	
JIANG_HYPOXIA_CANCER 	0	11	77	16950	0.0	1.0	1	
DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN 	0	11	19	17008	0.0	1.0	1	
CHYLA_CBFA2T3_TARGETS_DN 	0	11	199	16828	0.0	1.0	1	
LOPEZ_MBD_TARGETS 	3	8	868	16159	6.981134792626728	0.016134815708400148	1	CNTN2,CDC42EP1,MAG
REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING 	1	10	77	16950	22.01298701298701	0.049235135745258014	1	MAG
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN 	0	11	126	16901	0.0	1.0	1	
SIG_CD40PATHWAYMAP 	0	11	34	16993	0.0	1.0	1	
WILLIAMS_ESR1_TARGETS_UP 	0	11	21	17006	0.0	1.0	1	
MEISSNER_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3 	0	11	11	17016	0.0	1.0	1	
MA_PITUITARY_FETAL_VS_ADULT_DN 	0	11	18	17009	0.0	1.0	1	
LINDSTEDT_DENDRITIC_CELL_MATURATION_C 	0	11	63	16964	0.0	1.0	1	
DER_IFN_ALPHA_RESPONSE_UP 	0	11	72	16955	0.0	1.0	1	
DASU_IL6_SIGNALING_SCAR_UP 	0	11	30	16997	0.0	1.0	1	
WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP 	0	11	17	17010	0.0	1.0	1	
NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP 	0	11	27	17000	0.0	1.0	1	
NIKOLSKY_BREAST_CANCER_12Q24_AMPLICON 	0	11	14	17013	0.0	1.0	1	
ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP 	1	10	193	16834	8.722279792746114	0.11838970334418104	1	RTKN
SUZUKI_RESPONSE_TO_TSA 	0	11	16	17011	0.0	1.0	1	
NIKOLSKY_BREAST_CANCER_6P24_P22_AMPLICON 	0	11	20	17007	0.0	1.0	1	
NIELSEN_LIPOSARCOMA_UP 	0	11	17	17010	0.0	1.0	1	
MURATA_VIRULENCE_OF_H_PILORI 	0	11	16	17011	0.0	1.0	1	
BROCKE_APOPTOSIS_REVERSED_BY_IL6 	0	11	139	16888	0.0	1.0	1	
RUAN_RESPONSE_TO_TNF_DN 	0	11	77	16950	0.0	1.0	1	
KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS 	0	11	9	17018	0.0	1.0	1	
VERHAAK_AML_WITH_NPM1_MUTATED_UP 	0	11	146	16881	0.0	1.0	1	
MARKEY_RB1_ACUTE_LOF_UP 	0	11	211	16816	0.0	1.0	1	
DAZARD_RESPONSE_TO_UV_NHEK_DN 	0	11	294	16733	0.0	1.0	1	
LIU_TOPBP1_TARGETS 	0	11	11	17016	0.0	1.0	1	
MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN 	0	11	154	16873	0.0	1.0	1	
VERNOCHET_ADIPOGENESIS 	0	11	13	17014	0.0	1.0	1	
MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED 	0	11	163	16864	0.0	1.0	1	
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP 	0	11	33	16994	0.0	1.0	1	
BIOCARTA_AKAP13_PATHWAY 	0	11	11	17016	0.0	1.0	1	
KEGG_DNA_REPLICATION 	0	11	35	16992	0.0	1.0	1	
IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN 	0	11	21	17006	0.0	1.0	1	
REACTOME_MEIOTIC_RECOMBINATION 	0	11	46	16981	0.0	1.0	1	
KEGG_APOPTOSIS 	0	11	81	16946	0.0	1.0	1	
FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP 	0	11	66	16961	0.0	1.0	1	
GERHOLD_RESPONSE_TO_TZD_DN 	0	11	13	17014	0.0	1.0	1	
REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI 	0	11	17	17010	0.0	1.0	1	
REACTOME_EGFR_DOWNREGULATION 	0	11	24	17003	0.0	1.0	1	
CAFFAREL_RESPONSE_TO_THC_UP 	0	11	32	16995	0.0	1.0	1	
LI_ADIPOGENESIS_BY_ACTIVATED_PPARG 	0	11	14	17013	0.0	1.0	1	
DIERICK_SEROTONIN_FUNCTION_GENES 	0	11	6	17021	0.0	1.0	1	
CHENG_RESPONSE_TO_NICKEL_ACETATE 	0	11	41	16986	0.0	1.0	1	
KASLER_HDAC7_TARGETS_2_DN 	0	11	31	16996	0.0	1.0	1	
FINETTI_BREAST_CANCER_KINOME_GREEN 	0	11	16	17011	0.0	1.0	1	
LEIN_MEDULLA_MARKERS 	0	11	68	16959	0.0	1.0	1	
ST_PAC1_RECEPTOR_PATHWAY 	0	11	5	17022	0.0	1.0	1	
FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN 	0	11	48	16979	0.0	1.0	1	
GAVIN_FOXP3_TARGETS_CLUSTER_T4 	0	11	83	16944	0.0	1.0	1	
REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL 	1	10	74	16953	22.90945945945946	0.04738299691841565	1	MAG
KEGG_TYROSINE_METABOLISM 	0	11	33	16994	0.0	1.0	1	
ROSS_AML_OF_FAB_M7_TYPE 	0	11	61	16966	0.0	1.0	1	
HENDRICKS_SMARCA4_TARGETS_UP 	0	11	49	16978	0.0	1.0	1	
SINGH_NFE2L2_TARGETS 	0	11	15	17012	0.0	1.0	1	
HOWLIN_CITED1_TARGETS_1_UP 	0	11	28	16999	0.0	1.0	1	
MILI_PSEUDOPODIA_CHEMOTAXIS_UP 	0	11	70	16957	0.0	1.0	1	
GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN 	0	11	25	17002	0.0	1.0	1	
LIM_MAMMARY_LUMINAL_PROGENITOR_DN 	0	11	14	17013	0.0	1.0	1	
FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN 	0	11	26	17001	0.0	1.0	1	
MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP 	1	10	365	16662	4.564931506849315	0.21253877998112972	1	CNTN2
HOFFMAN_CLOCK_TARGETS_UP 	0	11	7	17020	0.0	1.0	1	
MORI_IMMATURE_B_LYMPHOCYTE_UP 	0	11	47	16980	0.0	1.0	1	
KRISHNAN_FURIN_TARGETS_DN 	0	11	12	17015	0.0	1.0	1	
KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_DN 	0	11	36	16991	0.0	1.0	1	
BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP 	0	11	99	16928	0.0	1.0	1	
IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP 	0	11	16	17011	0.0	1.0	1	
MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_DN 	0	11	21	17006	0.0	1.0	1	
VERHAAK_GLIOBLASTOMA_MESENCHYMAL 	0	11	210	16817	0.0	1.0	1	
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_DN 	0	11	7	17020	0.0	1.0	1	
NUTT_GBM_VS_AO_GLIOMA_DN 	0	11	44	16983	0.0	1.0	1	
RODWELL_AGING_KIDNEY_NO_BLOOD_UP 	1	10	192	16835	8.768229166666666	0.11781362438236387	1	CDC42EP1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_DN 	0	11	6	17021	0.0	1.0	1	
REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6 	0	11	45	16982	0.0	1.0	1	
VANLOO_SP3_TARGETS_DN 	0	11	75	16952	0.0	1.0	1	
BIOCARTA_WNT_PATHWAY 	0	11	26	17001	0.0	1.0	1	
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2 	1	10	134	16893	12.606716417910448	0.0838095688680535	1	RTKN
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3 	0	11	58	16969	0.0	1.0	1	
BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN 	0	11	19	17008	0.0	1.0	1	
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1 	0	11	198	16829	0.0	1.0	1	
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6 	0	11	42	16985	0.0	1.0	1	
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4 	0	11	207	16820	0.0	1.0	1	
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5 	0	11	69	16958	0.0	1.0	1	
SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN 	0	11	135	16892	0.0	1.0	1	
MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_UP 	0	11	18	17009	0.0	1.0	1	
PID_LYMPH_ANGIOGENESIS_PATHWAY 	0	11	24	17003	0.0	1.0	1	
HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP 	0	11	30	16997	0.0	1.0	1	
RUTELLA_RESPONSE_TO_HGF_DN 	0	11	224	16803	0.0	1.0	1	
TRACEY_RESISTANCE_TO_IFNA2_UP 	0	11	4	17023	0.0	1.0	1	
JI_RESPONSE_TO_FSH_DN 	0	11	54	16973	0.0	1.0	1	
MAHADEVAN_RESPONSE_TO_MP470_UP 	0	11	17	17010	0.0	1.0	1	
BOYLAN_MULTIPLE_MYELOMA_D_UP 	0	11	81	16946	0.0	1.0	1	
PID_SYNDECAN_3_PATHWAY 	0	11	15	17012	0.0	1.0	1	
ST_INTEGRIN_SIGNALING_PATHWAY 	0	11	80	16947	0.0	1.0	1	
WOO_LIVER_CANCER_RECURRENCE_UP 	0	11	100	16927	0.0	1.0	1	
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_DN 	0	11	4	17023	0.0	1.0	1	
MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP 	0	11	22	17005	0.0	1.0	1	
ENGELMANN_CANCER_PROGENITORS_DN 	0	11	58	16969	0.0	1.0	1	
PID_PI3K_PLC_TRK_PATHWAY 	0	11	36	16991	0.0	1.0	1	
REACTOME_SIGNALING_BY_NOTCH 	0	11	95	16932	0.0	1.0	1	
ZHAN_MULTIPLE_MYELOMA_CD2_DN 	0	11	44	16983	0.0	1.0	1	
MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP 	0	11	21	17006	0.0	1.0	1	
VANASSE_BCL2_TARGETS_DN 	0	11	60	16967	0.0	1.0	1	
MEISSNER_BRAIN_ICP_WITH_H3K4ME3 	0	11	28	16999	0.0	1.0	1	
PID_BETA_CATENIN_DEG_PATHWAY 	0	11	17	17010	0.0	1.0	1	
REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES 	0	11	24	17003	0.0	1.0	1	
XU_GH1_AUTOCRINE_TARGETS_DN 	0	11	126	16901	0.0	1.0	1	
KEGG_SPHINGOLIPID_METABOLISM 	0	11	33	16994	0.0	1.0	1	
OUILLETTE_CLL_13Q14_DELETION_DN 	0	11	51	16976	0.0	1.0	1	
HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN 	0	11	40	16987	0.0	1.0	1	
DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP 	0	11	238	16789	0.0	1.0	1	
KEGG_PROTEIN_EXPORT 	0	11	22	17005	0.0	1.0	1	
HASEGAWA_TUMORIGENESIS_BY_RET_C634R 	0	11	11	17016	0.0	1.0	1	
VANDESLUIS_NORMAL_EMBRYOS_UP 	0	11	3	17024	0.0	1.0	1	
DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2 	0	11	106	16921	0.0	1.0	1	
OXFORD_RALB_TARGETS_UP 	0	11	8	17019	0.0	1.0	1	
REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS 	0	11	6	17021	0.0	1.0	1	
KEGG_HISTIDINE_METABOLISM 	1	10	25	17002	68.008	0.016663368377630234	1	CNDP1
HAHTOLA_CTCL_CUTANEOUS 	0	11	22	17005	0.0	1.0	1	
GRATIAS_RETINOBLASTOMA_16Q24 	0	11	15	17012	0.0	1.0	1	
DANG_REGULATED_BY_MYC_UP 	0	11	70	16957	0.0	1.0	1	
REACTOME_E2F_ENABLED_INHIBITION_OF_PRE_REPLICATION_COMPLEX_FORMATION 	0	11	9	17018	0.0	1.0	1	
JOHNSTONE_PARVB_TARGETS_2_DN 	0	11	313	16714	0.0	1.0	1	
SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP 	0	11	31	16996	0.0	1.0	1	
NUYTTEN_NIPP1_TARGETS_UP 	1	10	668	16359	2.4489520958083832	0.35645108621061167	1	TMC7
KYNG_RESPONSE_TO_H2O2 	0	11	67	16960	0.0	1.0	1	
BIOCARTA_TCYTOTOXIC_PATHWAY 	0	11	8	17019	0.0	1.0	1	
MARZEC_IL2_SIGNALING_DN 	0	11	34	16993	0.0	1.0	1	
REACTOME_HEMOSTASIS 	1	10	382	16645	4.357329842931938	0.22132899777470713	1	MAG
GRADE_METASTASIS_DN 	0	11	41	16986	0.0	1.0	1	
HESSON_TUMOR_SUPPRESSOR_CLUSTER_3P21_3 	0	11	7	17020	0.0	1.0	1	
REACTOME_INHIBITION_OF_VOLTAGE_GATED_CA2_CHANNELS_VIA_GBETA_GAMMA_SUBUNITS 	0	11	22	17005	0.0	1.0	1	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_1 	0	11	2	17025	0.0	1.0	1	
LAMB_CCND1_TARGETS 	0	11	18	17009	0.0	1.0	1	
LIU_SOX4_TARGETS_DN 	0	11	284	16743	0.0	1.0	1	
MORI_SMALL_PRE_BII_LYMPHOCYTE_UP 	0	11	74	16953	0.0	1.0	1	
WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2 	0	11	33	16994	0.0	1.0	1	
BIOCARTA_MAL_PATHWAY 	0	11	18	17009	0.0	1.0	1	
HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN 	0	11	256	16771	0.0	1.0	1	
PUJANA_XPRSS_INT_NETWORK 	0	11	151	16876	0.0	1.0	1	
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP 	0	11	39	16988	0.0	1.0	1	
REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION 	0	11	68	16959	0.0	1.0	1	
MARTENS_TRETINOIN_RESPONSE_UP 	2	9	527	16500	6.957621758380772	0.04395926002012534	1	CNTN2,MAG
ST_ADRENERGIC 	0	11	30	16997	0.0	1.0	1	
WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_UP 	0	11	8	17019	0.0	1.0	1	
LEIN_CHOROID_PLEXUS_MARKERS 	0	11	92	16935	0.0	1.0	1	
LIM_MAMMARY_STEM_CELL_UP 	1	10	439	16588	3.7785876993166285	0.25015512063694517	1	C9orf3
PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP 	0	11	258	16769	0.0	1.0	1	
BONCI_TARGETS_OF_MIR15A_AND_MIR16_1 	0	11	83	16944	0.0	1.0	1	
CAIRO_HEPATOBLASTOMA_CLASSES_UP 	0	11	548	16479	0.0	1.0	1	
BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_DN 	0	11	20	17007	0.0	1.0	1	
REACTOME_KERATAN_SULFATE_BIOSYNTHESIS 	0	11	23	17004	0.0	1.0	1	
REACTOME_MYOGENESIS 	0	11	21	17006	0.0	1.0	1	
SAMOLS_TARGETS_OF_KHSV_MIRNAS_UP 	0	11	8	17019	0.0	1.0	1	
PECE_MAMMARY_STEM_CELL_DN 	0	11	131	16896	0.0	1.0	1	
BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX 	0	11	17	17010	0.0	1.0	1	
KYNG_NORMAL_AGING_UP 	0	11	17	17010	0.0	1.0	1	
AMUNDSON_GAMMA_RADIATION_RESPONSE 	0	11	31	16996	0.0	1.0	1	
BIOCARTA_TPO_PATHWAY 	0	11	23	17004	0.0	1.0	1	
MARTINEZ_RESPONSE_TO_TRABECTEDIN 	0	11	48	16979	0.0	1.0	1	
BIOCARTA_TOB1_PATHWAY 	0	11	12	17015	0.0	1.0	1	
YANG_BREAST_CANCER_ESR1_DN 	0	11	23	17004	0.0	1.0	1	
LABBE_TGFB1_TARGETS_DN 	1	10	77	16950	22.01298701298701	0.049235135745258014	1	CAPN3
WENG_POR_DOSAGE 	0	11	16	17011	0.0	1.0	1	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_8 	1	10	10	17017	170.17	0.0070809633057549465	1	CDC42EP1
REACTOME_SMOOTH_MUSCLE_CONTRACTION 	0	11	23	17004	0.0	1.0	1	
REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS 	0	11	97	16930	0.0	1.0	1	
BENPORATH_PRC2_TARGETS 	0	11	496	16531	0.0	1.0	1	
MARSON_BOUND_BY_FOXP3_STIMULATED 	1	10	876	16151	1.8437214611872146	0.4409255184844294	1	PLLP
REACTOME_KERATAN_SULFATE_DEGRADATION 	0	11	10	17017	0.0	1.0	1	
IRITANI_MAD1_TARGETS_UP 	0	11	10	17017	0.0	1.0	1	
RICKMAN_METASTASIS_UP 	0	11	310	16717	0.0	1.0	1	
CHEOK_RESPONSE_TO_HD_MTX_DN 	0	11	24	17003	0.0	1.0	1	
HOLLEMAN_DAUNORUBICIN_B_ALL_UP 	0	11	10	17017	0.0	1.0	1	
REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII 	0	11	15	17012	0.0	1.0	1	
HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_UP 	0	11	19	17008	0.0	1.0	1	
RIZKI_TUMOR_INVASIVENESS_3D_UP 	1	10	180	16847	9.359444444444444	0.11087393353352326	1	CAPN3
FINETTI_BREAST_CANCER_KINOME_RED 	0	11	12	17015	0.0	1.0	1	
KIM_MYC_AMPLIFICATION_TARGETS_UP 	0	11	185	16842	0.0	1.0	1	
YAO_HOXA10_TARGETS_VIA_PROGESTERONE_DN 	0	11	14	17013	0.0	1.0	1	
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR 	1	10	131	16896	12.897709923664122	0.08201875705720724	1	CAPN3
BIOCARTA_STATHMIN_PATHWAY 	0	11	15	17012	0.0	1.0	1	
MIKKELSEN_ES_HCP_WITH_H3K27ME3 	0	11	30	16997	0.0	1.0	1	
REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY 	0	11	12	17015	0.0	1.0	1	
ONDER_CDH1_TARGETS_3_UP 	0	11	17	17010	0.0	1.0	1	
NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON 	0	11	38	16989	0.0	1.0	1	
SMID_BREAST_CANCER_LUMINAL_A_DN 	0	11	12	17015	0.0	1.0	1	
BOCHKIS_FOXA2_TARGETS 	0	11	359	16668	0.0	1.0	1	
REACTOME_OPSINS 	0	11	3	17024	0.0	1.0	1	
AUJLA_IL22_AND_IL17A_SIGNALING 	0	11	6	17021	0.0	1.0	1	
BIOCARTA_LEPTIN_PATHWAY 	0	11	9	17018	0.0	1.0	1	
REACTOME_SYNTHESIS_AND_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES 	0	11	17	17010	0.0	1.0	1	
LU_TUMOR_ANGIOGENESIS_UP 	0	11	25	17002	0.0	1.0	1	
GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN 	0	11	27	17000	0.0	1.0	1	
ZHANG_TLX_TARGETS_36HR_UP 	0	11	214	16813	0.0	1.0	1	
NIKOLSKY_BREAST_CANCER_20Q11_AMPLICON 	0	11	27	17000	0.0	1.0	1	
ZHU_CMV_ALL_UP 	0	11	118	16909	0.0	1.0	1	
PUJANA_BRCA2_PCC_NETWORK 	0	11	372	16655	0.0	1.0	1	
REACTOME_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1 	0	11	12	17015	0.0	1.0	1	
REACTOME_ACTIVATED_TLR4_SIGNALLING 	0	11	89	16938	0.0	1.0	1	
HAHTOLA_CTCL_PATHOGENESIS 	0	11	11	17016	0.0	1.0	1	
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN 	1	10	154	16873	10.956493506493507	0.09566738115563377	1	C9orf3
FEVR_CTNNB1_TARGETS_UP 	1	10	569	16458	2.8924428822495605	0.3123045615157929	1	TMC7
BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN 	0	11	39	16988	0.0	1.0	1	
KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION 	0	11	196	16831	0.0	1.0	1	
ONDER_CDH1_TARGETS_2_DN 	0	11	384	16643	0.0	1.0	1	
BIOCARTA_NO2IL12_PATHWAY 	0	11	11	17016	0.0	1.0	1	
RAMASWAMY_METASTASIS_UP 	0	11	61	16966	0.0	1.0	1	
GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN 	3	8	992	16035	6.061617943548387	0.02301478241217672	1	C9orf3,TMC7,PLLP
BILD_HRAS_ONCOGENIC_SIGNATURE 	0	11	228	16799	0.0	1.0	1	
SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP 	0	11	17	17010	0.0	1.0	1	
REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT 	0	11	115	16912	0.0	1.0	1	
WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP 	0	11	102	16925	0.0	1.0	1	
JOHNSTONE_PARVB_TARGETS_3_DN 	0	11	826	16201	0.0	1.0	1	
STEIN_ESTROGEN_RESPONSE_NOT_VIA_ESRRA 	0	11	17	17010	0.0	1.0	1	
LABBE_TARGETS_OF_TGFB1_AND_WNT3A_DN 	0	11	87	16940	0.0	1.0	1	
KOBAYASHI_EGFR_SIGNALING_24HR_UP 	1	10	87	16940	19.471264367816094	0.055385313687091785	1	C9orf3
SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 	0	11	340	16687	0.0	1.0	1	
LEE_RECENT_THYMIC_EMIGRANT 	0	11	195	16832	0.0	1.0	1	
LUI_THYROID_CANCER_PAX8_PPARG_UP 	0	11	43	16984	0.0	1.0	1	
TSENG_ADIPOGENIC_POTENTIAL_UP 	0	11	29	16998	0.0	1.0	1	
KEGG_PRIMARY_IMMUNODEFICIENCY 	0	11	26	17001	0.0	1.0	1	
ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP 	0	11	80	16947	0.0	1.0	1	
TAGHAVI_NEOPLASTIC_TRANSFORMATION 	0	11	12	17015	0.0	1.0	1	
ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN 	0	11	30	16997	0.0	1.0	1	
REACTOME_METABOLISM_OF_NON_CODING_RNA 	0	11	47	16980	0.0	1.0	1	
DASU_IL6_SIGNALING_DN 	0	11	7	17020	0.0	1.0	1	
PID_ALK1_PATHWAY 	0	11	25	17002	0.0	1.0	1	
MATZUK_MEIOTIC_AND_DNA_REPAIR 	0	11	34	16993	0.0	1.0	1	
BAUS_TFF2_TARGETS_DN 	0	11	10	17017	0.0	1.0	1	
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN 	0	11	45	16982	0.0	1.0	1	
KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP 	0	11	83	16944	0.0	1.0	1	
OKUMURA_INFLAMMATORY_RESPONSE_LPS 	0	11	162	16865	0.0	1.0	1	
MIKKELSEN_PLURIPOTENT_STATE_DN 	0	11	8	17019	0.0	1.0	1	
BIOCARTA_BAD_PATHWAY 	0	11	24	17003	0.0	1.0	1	
NIELSEN_SYNOVIAL_SARCOMA_UP 	0	11	16	17011	0.0	1.0	1	
BROWNE_HCMV_INFECTION_14HR_DN 	0	11	265	16762	0.0	1.0	1	
PUJANA_CHEK2_PCC_NETWORK 	0	11	701	16326	0.0	1.0	1	
NOJIMA_SFRP2_TARGETS_UP 	0	11	27	17000	0.0	1.0	1	
TESAR_ALK_TARGETS_HUMAN_ES_5D_DN 	0	11	6	17021	0.0	1.0	1	
GROSS_HIF1A_TARGETS_DN 	0	11	22	17005	0.0	1.0	1	
BIOCARTA_CREB_PATHWAY 	0	11	26	17001	0.0	1.0	1	
REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM 	0	11	51	16976	0.0	1.0	1	
GOUYER_TATI_TARGETS_DN 	0	11	16	17011	0.0	1.0	1	
LU_AGING_BRAIN_DN 	0	11	149	16878	0.0	1.0	1	
CHANG_IMMORTALIZED_BY_HPV31_UP 	0	11	75	16952	0.0	1.0	1	
KEGG_STEROID_BIOSYNTHESIS 	0	11	15	17012	0.0	1.0	1	
BROWNE_HCMV_INFECTION_18HR_DN 	0	11	156	16871	0.0	1.0	1	
SABATES_COLORECTAL_ADENOMA_DN 	1	10	203	16824	8.28768472906404	0.12413171263975048	1	SOX10
REACTOME_RNA_POL_I_RNA_POL_III_AND_MITOCHONDRIAL_TRANSCRIPTION 	0	11	84	16943	0.0	1.0	1	
REACTOME_SYNTHESIS_OF_PIPS_AT_THE_LATE_ENDOSOME_MEMBRANE 	0	11	10	17017	0.0	1.0	1	
ZWANG_EGF_INTERVAL_UP 	0	11	70	16957	0.0	1.0	1	
YANAGIHARA_ESX1_TARGETS 	0	11	28	16999	0.0	1.0	1	
PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_UP 	0	11	12	17015	0.0	1.0	1	
COLLER_MYC_TARGETS_DN 	0	11	8	17019	0.0	1.0	1	
CROMER_METASTASIS_UP 	0	11	75	16952	0.0	1.0	1	
RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP 	0	11	16	17011	0.0	1.0	1	
OKAMOTO_LIVER_CANCER_MULTICENTRIC_OCCURRENCE_DN 	0	11	4	17023	0.0	1.0	1	
LABBE_WNT3A_TARGETS_UP 	0	11	95	16932	0.0	1.0	1	
FARMER_BREAST_CANCER_CLUSTER_3 	0	11	15	17012	0.0	1.0	1	
RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP 	0	11	110	16917	0.0	1.0	1	
LEE_CALORIE_RESTRICTION_NEOCORTEX_UP 	0	11	70	16957	0.0	1.0	1	
BIOCARTA_MET_PATHWAY 	0	11	37	16990	0.0	1.0	1	
REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH 	1	10	61	16966	27.81311475409836	0.03931909868204709	1	CNTN2
RAFFEL_VEGFA_TARGETS_UP 	0	11	9	17018	0.0	1.0	1	
REACTOME_CIRCADIAN_REPRESSION_OF_EXPRESSION_BY_REV_ERBA 	0	11	22	17005	0.0	1.0	1	
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_WS 	0	11	12	17015	0.0	1.0	1	
HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP 	0	11	21	17006	0.0	1.0	1	
UEDA_CENTRAL_CLOCK 	0	11	85	16942	0.0	1.0	1	
PID_ANGIOPOIETIN_RECEPTOR_PATHWAY 	0	11	46	16981	0.0	1.0	1	
VANOEVELEN_MYOGENESIS_SIN3A_TARGETS 	0	11	204	16823	0.0	1.0	1	
MILI_PSEUDOPODIA_CHEMOTAXIS_DN 	0	11	427	16600	0.0	1.0	1	
KIM_GLIS2_TARGETS_DN 	0	11	4	17023	0.0	1.0	1	
KEGG_TAURINE_AND_HYPOTAURINE_METABOLISM 	0	11	9	17018	0.0	1.0	1	
LEE_EARLY_T_LYMPHOCYTE_UP 	0	11	69	16958	0.0	1.0	1	
REACTOME_ADAPTIVE_IMMUNE_SYSTEM 	0	11	462	16565	0.0	1.0	1	
PARK_APL_PATHOGENESIS_DN 	0	11	45	16982	0.0	1.0	1	
REACTOME_ACTIVATED_AMPK_STIMULATES_FATTY_ACID_OXIDATION_IN_MUSCLE 	0	11	17	17010	0.0	1.0	1	
PID_IL23_PATHWAY 	0	11	26	17001	0.0	1.0	1	
LINDVALL_IMMORTALIZED_BY_TERT_DN 	0	11	73	16954	0.0	1.0	1	
KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 	0	11	30	16997	0.0	1.0	1	
FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES_T1 	0	11	4	17023	0.0	1.0	1	
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_IL3RA 	0	11	7	17020	0.0	1.0	1	
QI_HYPOXIA 	0	11	135	16892	0.0	1.0	1	
TOMLINS_PROSTATE_CANCER_UP 	0	11	39	16988	0.0	1.0	1	
LOPEZ_EPITHELIOID_MESOTHELIOMA 	0	11	13	17014	0.0	1.0	1	
KEGG_PEROXISOME 	0	11	74	16953	0.0	1.0	1	
KOBAYASHI_RESPONSE_TO_ROMIDEPSIN 	0	11	17	17010	0.0	1.0	1	
FARMER_BREAST_CANCER_CLUSTER_8 	0	11	7	17020	0.0	1.0	1	
STEGER_ADIPOGENESIS_DN 	0	11	24	17003	0.0	1.0	1	
VANTVEER_BREAST_CANCER_BRCA1_UP 	0	11	29	16998	0.0	1.0	1	
REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES 	0	11	62	16965	0.0	1.0	1	
STAEGE_EWING_FAMILY_TUMOR 	0	11	27	17000	0.0	1.0	1	
FERRARI_RESPONSE_TO_FENRETINIDE_DN 	0	11	5	17022	0.0	1.0	1	
CLIMENT_BREAST_CANCER_COPY_NUMBER_UP 	0	11	22	17005	0.0	1.0	1	
SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN 	0	11	49	16978	0.0	1.0	1	
ELVIDGE_HYPOXIA_UP 	0	11	160	16867	0.0	1.0	1	
SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP 	0	11	41	16986	0.0	1.0	1	
REACTOME_REGULATION_OF_THE_FANCONI_ANEMIA_PATHWAY 	0	11	6	17021	0.0	1.0	1	
BROWNE_INTERFERON_RESPONSIVE_GENES 	0	11	64	16963	0.0	1.0	1	
WU_HBX_TARGETS_1_DN 	0	11	22	17005	0.0	1.0	1	
RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN 	0	11	145	16882	0.0	1.0	1	
BOYLAN_MULTIPLE_MYELOMA_PCA1_UP 	0	11	78	16949	0.0	1.0	1	
REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_2_PROMOTER 	0	11	23	17004	0.0	1.0	1	
BIOCARTA_FMLP_PATHWAY 	0	11	33	16994	0.0	1.0	1	
REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING 	0	11	29	16998	0.0	1.0	1	
IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP 	0	11	114	16913	0.0	1.0	1	
REN_MIF_TARGETS_DN 	0	11	3	17024	0.0	1.0	1	
MA_MYELOID_DIFFERENTIATION_UP 	0	11	37	16990	0.0	1.0	1	
KANG_FLUOROURACIL_RESISTANCE_UP 	0	11	20	17007	0.0	1.0	1	
WILLIAMS_ESR1_TARGETS_DN 	0	11	6	17021	0.0	1.0	1	
REACTOME_HIV_LIFE_CYCLE 	0	11	105	16922	0.0	1.0	1	
WESTON_VEGFA_TARGETS 	0	11	89	16938	0.0	1.0	1	
RIZKI_TUMOR_INVASIVENESS_2D_DN 	0	11	55	16972	0.0	1.0	1	
KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY 	0	11	61	16966	0.0	1.0	1	
REACTOME_NEPHRIN_INTERACTIONS 	0	11	19	17008	0.0	1.0	1	
MODY_HIPPOCAMPUS_NEONATAL 	0	11	34	16993	0.0	1.0	1	
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP 	0	11	147	16880	0.0	1.0	1	
BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP 	0	11	26	17001	0.0	1.0	1	
LEE_LIVER_CANCER_MYC_E2F1_DN 	0	11	44	16983	0.0	1.0	1	
BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN 	0	11	28	16999	0.0	1.0	1	
REACTOME_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS 	0	11	17	17010	0.0	1.0	1	
CHEN_LUNG_CANCER_SURVIVAL 	0	11	24	17003	0.0	1.0	1	
GENTILE_RESPONSE_CLUSTER_D3 	0	11	60	16967	0.0	1.0	1	
FISCHER_DIRECT_P53_TARGETS_META_ANALYSIS 	0	11	282	16745	0.0	1.0	1	
REACTOME_BASE_FREE_SUGAR_PHOSPHATE_REMOVAL_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY 	0	11	10	17017	0.0	1.0	1	
HU_ANGIOGENESIS_DN 	0	11	35	16992	0.0	1.0	1	
CAFFAREL_RESPONSE_TO_THC_8HR_5_UP 	0	11	14	17013	0.0	1.0	1	
RIZ_ERYTHROID_DIFFERENTIATION 	0	11	66	16961	0.0	1.0	1	
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_DN 	0	11	18	17009	0.0	1.0	1	
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP 	0	11	24	17003	0.0	1.0	1	
KANG_GIST_WITH_PDGFRA_DN 	0	11	4	17023	0.0	1.0	1	
BOUDOUKHA_BOUND_BY_IGF2BP2 	0	11	101	16926	0.0	1.0	1	
DORN_ADENOVIRUS_INFECTION_12HR_DN 	0	11	31	16996	0.0	1.0	1	
KEGG_LONG_TERM_POTENTIATION 	0	11	66	16961	0.0	1.0	1	
IVANOVA_HEMATOPOIESIS_MATURE_CELL 	0	11	251	16776	0.0	1.0	1	
MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_UP 	0	11	22	17005	0.0	1.0	1	
SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN 	0	11	565	16462	0.0	1.0	1	
VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP 	0	11	71	16956	0.0	1.0	1	
WOO_LIVER_CANCER_RECURRENCE_DN 	0	11	66	16961	0.0	1.0	1	
MIKKELSEN_MEF_LCP_WITH_H3K4ME3 	0	11	107	16920	0.0	1.0	1	
KYNG_WERNER_SYNDROM_DN 	0	11	25	17002	0.0	1.0	1	
GAURNIER_PSMD4_TARGETS 	0	11	50	16977	0.0	1.0	1	
DER_IFN_BETA_RESPONSE_UP 	0	11	100	16927	0.0	1.0	1	
KEGG_NUCLEOTIDE_EXCISION_REPAIR 	0	11	43	16984	0.0	1.0	1	
KANG_CISPLATIN_RESISTANCE_UP 	0	11	18	17009	0.0	1.0	1	
REACTOME_SIGNALING_BY_INSULIN_RECEPTOR 	0	11	94	16933	0.0	1.0	1	
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_DN 	0	11	11	17016	0.0	1.0	1	
ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS 	0	11	41	16986	0.0	1.0	1	
YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_DN 	1	10	48	16979	35.37291666666667	0.03119319280300041	1	CNTN2
DAVIES_MULTIPLE_MYELOMA_VS_MGUS_UP 	0	11	11	17016	0.0	1.0	1	
FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN 	0	11	63	16964	0.0	1.0	1	
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS 	0	11	57	16970	0.0	1.0	1	
TSAI_DNAJB4_TARGETS_UP 	0	11	13	17014	0.0	1.0	1	
NABA_ECM_AFFILIATED 	0	11	120	16907	0.0	1.0	1	
ISHIDA_TARGETS_OF_SYT_SSX_FUSIONS 	0	11	6	17021	0.0	1.0	1	
BERENJENO_TRANSFORMED_BY_RHOA_UP 	0	11	492	16535	0.0	1.0	1	
HEIDENBLAD_AMPLIFIED_IN_SOFT_TISSUE_CANCER 	0	11	11	17016	0.0	1.0	1	
HOEGERKORP_CD44_TARGETS_TEMPORAL_UP 	0	11	11	17016	0.0	1.0	1	
DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN 	1	10	107	16920	15.813084112149532	0.06757729717250115	1	CAPN3
BIOCARTA_CHEMICAL_PATHWAY 	0	11	22	17005	0.0	1.0	1	
ABRAMSON_INTERACT_WITH_AIRE 	0	11	41	16986	0.0	1.0	1	
REACTOME_PROSTANOID_LIGAND_RECEPTORS 	0	11	8	17019	0.0	1.0	1	
BAFNA_MUC4_TARGETS_UP 	0	11	6	17021	0.0	1.0	1	
KEGG_BLADDER_CANCER 	0	11	38	16989	0.0	1.0	1	
GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN 	1	10	435	16592	3.8142528735632184	0.248164343054199	1	CAPN3
REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS 	0	11	25	17002	0.0	1.0	1	
TERAO_AOX4_TARGETS_SKIN_UP 	0	11	33	16994	0.0	1.0	1	
REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL 	0	11	10	17017	0.0	1.0	1	
XU_RESPONSE_TO_TRETINOIN_UP 	0	11	15	17012	0.0	1.0	1	
HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP 	0	11	32	16995	0.0	1.0	1	
LINDGREN_BLADDER_CANCER_CLUSTER_3_UP 	0	11	281	16746	0.0	1.0	1	
PID_PI3KCI_AKT_PATHWAY 	0	11	35	16992	0.0	1.0	1	
KEGG_HEDGEHOG_SIGNALING_PATHWAY 	0	11	49	16978	0.0	1.0	1	
HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN 	0	11	44	16983	0.0	1.0	1	
BIOCARTA_NDKDYNAMIN_PATHWAY 	0	11	18	17009	0.0	1.0	1	
ZHAN_MULTIPLE_MYELOMA_HP_UP 	0	11	40	16987	0.0	1.0	1	
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FLI1 	0	11	9	17018	0.0	1.0	1	
BIOCARTA_BLYMPHOCYTE_PATHWAY 	0	11	9	17018	0.0	1.0	1	
FARDIN_HYPOXIA_11 	0	11	32	16995	0.0	1.0	1	
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN 	0	11	47	16980	0.0	1.0	1	
STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN 	0	11	54	16973	0.0	1.0	1	
KAN_RESPONSE_TO_ARSENIC_TRIOXIDE 	0	11	110	16917	0.0	1.0	1	
OXFORD_RALB_TARGETS_DN 	0	11	7	17020	0.0	1.0	1	
STONER_ESOPHAGEAL_CARCINOGENESIS_DN 	0	11	6	17021	0.0	1.0	1	
LEE_AGING_NEOCORTEX_DN 	0	11	61	16966	0.0	1.0	1	
GHANDHI_BYSTANDER_IRRADIATION_UP 	0	11	72	16955	0.0	1.0	1	
MIKKELSEN_NPC_ICP_WITH_H3K4ME3 	0	11	398	16629	0.0	1.0	1	
JIANG_HYPOXIA_NORMAL 	0	11	291	16736	0.0	1.0	1	
ZEMBUTSU_SENSITIVITY_TO_DOXORUBICIN 	0	11	15	17012	0.0	1.0	1	
HUMMERICH_MALIGNANT_SKIN_TUMOR_DN 	0	11	15	17012	0.0	1.0	1	
REACTOME_NFKB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL 	0	11	10	17017	0.0	1.0	1	
RASHI_RESPONSE_TO_IONIZING_RADIATION_1 	0	11	38	16989	0.0	1.0	1	
RASHI_RESPONSE_TO_IONIZING_RADIATION_6 	0	11	70	16957	0.0	1.0	1	
RASHI_RESPONSE_TO_IONIZING_RADIATION_4 	0	11	54	16973	0.0	1.0	1	
RASHI_RESPONSE_TO_IONIZING_RADIATION_5 	0	11	134	16893	0.0	1.0	1	
BECKER_TAMOXIFEN_RESISTANCE_UP 	0	11	45	16982	0.0	1.0	1	
LENAOUR_DENDRITIC_CELL_MATURATION_UP 	0	11	101	16926	0.0	1.0	1	
TURJANSKI_MAPK1_AND_MAPK2_TARGETS 	0	11	12	17015	0.0	1.0	1	
PID_SHP2_PATHWAY 	0	11	52	16975	0.0	1.0	1	
REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_ACETYLCHOLINE 	0	11	10	17017	0.0	1.0	1	
SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP 	0	11	27	17000	0.0	1.0	1	
BROWNE_HCMV_INFECTION_8HR_UP 	0	11	95	16932	0.0	1.0	1	
SAGIV_CD24_TARGETS_UP 	0	11	21	17006	0.0	1.0	1	
SENESE_HDAC1_TARGETS_UP 	0	11	405	16622	0.0	1.0	1	
REACTOME_REGULATION_OF_IFNA_SIGNALING 	0	11	11	17016	0.0	1.0	1	
HAHTOLA_MYCOSIS_FUNGOIDES_DN 	0	11	14	17013	0.0	1.0	1	
WESTON_VEGFA_TARGETS_12HR 	0	11	28	16999	0.0	1.0	1	
HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_DN 	0	11	15	17012	0.0	1.0	1	
HELLER_HDAC_TARGETS_UP 	0	11	279	16748	0.0	1.0	1	
DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN 	0	11	63	16964	0.0	1.0	1	
SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP 	0	11	19	17008	0.0	1.0	1	
IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_DN 	0	11	11	17016	0.0	1.0	1	
SENGUPTA_EBNA1_ANTICORRELATED 	0	11	132	16895	0.0	1.0	1	
LEE_LIVER_CANCER_DENA_UP 	0	11	50	16977	0.0	1.0	1	
REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION 	0	11	221	16806	0.0	1.0	1	
BIOCARTA_PROTEASOME_PATHWAY 	0	11	28	16999	0.0	1.0	1	
BIOCARTA_BARR_MAPK_PATHWAY 	0	11	11	17016	0.0	1.0	1	
REACTOME_REGULATORY_RNA_PATHWAYS 	0	11	21	17006	0.0	1.0	1	
KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_DN 	0	11	7	17020	0.0	1.0	1	
WINNEPENNINCKX_MELANOMA_METASTASIS_UP 	0	11	140	16887	0.0	1.0	1	
KANNAN_TP53_TARGETS_UP 	0	11	55	16972	0.0	1.0	1	
KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3 	0	11	75	16952	0.0	1.0	1	
REACTOME_FORMATION_OF_TRANSCRIPTION_COUPLED_NER_TC_NER_REPAIR_COMPLEX 	0	11	28	16999	0.0	1.0	1	
ONO_AML1_TARGETS_UP 	0	11	18	17009	0.0	1.0	1	
BROWNE_HCMV_INFECTION_48HR_UP 	0	11	166	16861	0.0	1.0	1	
AMIT_EGF_RESPONSE_240_HELA 	0	11	58	16969	0.0	1.0	1	
SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_UP 	0	11	5	17022	0.0	1.0	1	
LIU_SOX4_TARGETS_UP 	0	11	123	16904	0.0	1.0	1	
PID_IL2_1PATHWAY 	0	11	52	16975	0.0	1.0	1	
WU_HBX_TARGETS_2_UP 	0	11	22	17005	0.0	1.0	1	
BIOCARTA_P53_PATHWAY 	0	11	16	17011	0.0	1.0	1	
HADDAD_B_LYMPHOCYTE_PROGENITOR 	1	10	240	16787	6.994583333333333	0.1450827731567376	1	CAPN3
FUJII_YBX1_TARGETS_DN 	0	11	181	16846	0.0	1.0	1	
MOOTHA_TCA 	0	11	16	17011	0.0	1.0	1	
ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN 	0	11	38	16989	0.0	1.0	1	
TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_UP 	0	11	12	17015	0.0	1.0	1	
CALVET_IRINOTECAN_SENSITIVE_VS_REVERTED_UP 	0	11	5	17022	0.0	1.0	1	
PLASARI_TGFB1_TARGETS_1HR_UP 	0	11	33	16994	0.0	1.0	1	
SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_DN 	0	11	17	17010	0.0	1.0	1	
PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2 	0	11	66	16961	0.0	1.0	1	
WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP 	0	11	22	17005	0.0	1.0	1	
KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP 	0	11	17	17010	0.0	1.0	1	
ROPERO_HDAC2_TARGETS 	1	10	88	16939	19.248863636363637	0.05599833796594256	1	MAG
YANG_BREAST_CANCER_ESR1_UP 	0	11	32	16995	0.0	1.0	1	
REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER 	0	11	36	16991	0.0	1.0	1	
VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_DN 	0	11	14	17013	0.0	1.0	1	
VALK_AML_CLUSTER_12 	0	11	29	16998	0.0	1.0	1	
VALK_AML_CLUSTER_11 	0	11	36	16991	0.0	1.0	1	
VALK_AML_CLUSTER_10 	0	11	30	16997	0.0	1.0	1	
VALK_AML_CLUSTER_16 	0	11	22	17005	0.0	1.0	1	
MOHANKUMAR_TLX1_TARGETS_UP 	0	11	373	16654	0.0	1.0	1	
HAHTOLA_SEZARY_SYNDROM_DN 	0	11	32	16995	0.0	1.0	1	
REACTOME_AMINO_ACID_AND_OLIGOPEPTIDE_SLC_TRANSPORTERS 	0	11	41	16986	0.0	1.0	1	
PENG_LEUCINE_DEPRIVATION_DN 	0	11	180	16847	0.0	1.0	1	
CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN 	0	11	20	17007	0.0	1.0	1	
MULLIGHAN_MLL_SIGNATURE_2_DN 	0	11	251	16776	0.0	1.0	1	
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN 	0	11	158	16869	0.0	1.0	1	
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN 	0	11	118	16909	0.0	1.0	1	
AMIT_SERUM_RESPONSE_40_MCF10A 	0	11	31	16996	0.0	1.0	1	
SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN 	0	11	74	16953	0.0	1.0	1	
FRASOR_TAMOXIFEN_RESPONSE_DN 	0	11	11	17016	0.0	1.0	1	
REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE 	0	11	76	16951	0.0	1.0	1	
ZHANG_BREAST_CANCER_PROGENITORS_DN 	1	10	133	16894	12.702255639097745	0.08321298479558735	1	SOX10
NELSON_RESPONSE_TO_ANDROGEN_UP 	0	11	79	16948	0.0	1.0	1	
SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE 	0	11	75	16952	0.0	1.0	1	
LEE_NEURAL_CREST_STEM_CELL_UP 	1	10	132	16895	12.799242424242424	0.08261604758731282	1	SOX10
SASAI_TARGETS_OF_CXCR6_AND_PTCH1_DN 	0	11	6	17021	0.0	1.0	1	
MIKKELSEN_MEF_ICP_WITH_H3K4ME3_AND_H3K27ME3 	0	11	34	16993	0.0	1.0	1	
REACTOME_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR7_8_OR_9_ACTIVATION 	0	11	73	16954	0.0	1.0	1	
GARY_CD5_TARGETS_DN 	0	11	406	16621	0.0	1.0	1	
GLINSKY_CANCER_DEATH_UP 	0	11	6	17021	0.0	1.0	1	
TANG_SENESCENCE_TP53_TARGETS_UP 	0	11	30	16997	0.0	1.0	1	
ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_DN 	0	11	269	16758	0.0	1.0	1	
MATZUK_SPERMATOCYTE 	0	11	63	16964	0.0	1.0	1	
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP 	0	11	378	16649	0.0	1.0	1	
DARWICHE_SKIN_TUMOR_PROMOTER_DN 	0	11	153	16874	0.0	1.0	1	
REACTOME_ER_PHAGOSOME_PATHWAY 	0	11	56	16971	0.0	1.0	1	
KEGG_PPAR_SIGNALING_PATHWAY 	0	11	57	16970	0.0	1.0	1	
FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN 	0	11	50	16977	0.0	1.0	1	
REACTOME_IL_2_SIGNALING 	0	11	35	16992	0.0	1.0	1	
REACTOME_G1_PHASE 	0	11	34	16993	0.0	1.0	1	
BURTON_ADIPOGENESIS_PEAK_AT_2HR 	0	11	50	16977	0.0	1.0	1	
REACTOME_SIGNALLING_TO_ERKS 	0	11	36	16991	0.0	1.0	1	
NIKOLSKY_BREAST_CANCER_7Q21_Q22_AMPLICON 	0	11	60	16967	0.0	1.0	1	
ONO_FOXP3_TARGETS_UP 	0	11	16	17011	0.0	1.0	1	
MATZUK_CUMULUS_EXPANSION 	0	11	5	17022	0.0	1.0	1	
REACTOME_REGULATION_OF_KIT_SIGNALING 	0	11	16	17011	0.0	1.0	1	
REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION 	0	11	12	17015	0.0	1.0	1	
BOYLAN_MULTIPLE_MYELOMA_C_UP 	0	11	42	16985	0.0	1.0	1	
LU_TUMOR_VASCULATURE_DN 	0	11	13	17014	0.0	1.0	1	
KEGG_ENDOMETRIAL_CANCER 	0	11	52	16975	0.0	1.0	1	
NABA_ECM_GLYCOPROTEINS 	0	11	160	16867	0.0	1.0	1	
REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS 	0	11	29	16998	0.0	1.0	1	
LEE_LIVER_CANCER_SURVIVAL_UP 	0	11	140	16887	0.0	1.0	1	
NIKOLSKY_BREAST_CANCER_7P15_AMPLICON 	0	11	0	17027	nan	1.0	1	
REACTOME_RNA_POL_I_PROMOTER_OPENING 	0	11	28	16999	0.0	1.0	1	
REACTOME_SIGNALING_BY_FGFR_MUTANTS 	0	11	38	16989	0.0	1.0	1	
REACTOME_MICRORNA_MIRNA_BIOGENESIS 	0	11	18	17009	0.0	1.0	1	
HUTTMANN_B_CLL_POOR_SURVIVAL_DN 	0	11	51	16976	0.0	1.0	1	
REACTOME_FACILITATIVE_NA_INDEPENDENT_GLUCOSE_TRANSPORTERS 	0	11	10	17017	0.0	1.0	1	
WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP 	0	11	47	16980	0.0	1.0	1	
REACTOME_METABOLISM_OF_RNA 	0	11	250	16777	0.0	1.0	1	
NABA_CORE_MATRISOME 	0	11	231	16796	0.0	1.0	1	
VILIMAS_NOTCH1_TARGETS_UP 	0	11	38	16989	0.0	1.0	1	
LEE_DOUBLE_POLAR_THYMOCYTE 	0	11	22	17005	0.0	1.0	1	
BARIS_THYROID_CANCER_UP 	0	11	23	17004	0.0	1.0	1	
KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN 	0	11	44	16983	0.0	1.0	1	
LIAN_LIPA_TARGETS_6M 	0	11	56	16971	0.0	1.0	1	
HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP 	0	11	61	16966	0.0	1.0	1	
BAKER_HEMATOPOIESIS_STAT3_TARGETS 	0	11	16	17011	0.0	1.0	1	
KONDO_HYPOXIA 	0	11	6	17021	0.0	1.0	1	
SCIBETTA_KDM5B_TARGETS_UP 	0	11	17	17010	0.0	1.0	1	
MOOTHA_FFA_OXYDATION 	0	11	22	17005	0.0	1.0	1	
PID_ATF2_PATHWAY 	0	11	53	16974	0.0	1.0	1	
REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C 	0	11	55	16972	0.0	1.0	1	
SEIKE_LUNG_CANCER_POOR_SURVIVAL 	0	11	5	17022	0.0	1.0	1	
REACTOME_SIGNAL_REGULATORY_PROTEIN_SIRP_FAMILY_INTERACTIONS 	0	11	11	17016	0.0	1.0	1	
PID_PLK1_PATHWAY 	0	11	39	16988	0.0	1.0	1	
MIKKELSEN_PLURIPOTENT_STATE_UP 	0	11	6	17021	0.0	1.0	1	
PID_LPA4_PATHWAY 	0	11	15	17012	0.0	1.0	1	
GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP 	0	11	167	16860	0.0	1.0	1	
BIOCARTA_GLEEVEC_PATHWAY 	0	11	23	17004	0.0	1.0	1	
WU_ALZHEIMER_DISEASE_UP 	0	11	10	17017	0.0	1.0	1	
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN 	0	11	43	16984	0.0	1.0	1	
LIAO_METASTASIS 	0	11	486	16541	0.0	1.0	1	
KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GANGLIO_SERIES 	0	11	15	17012	0.0	1.0	1	
DORN_ADENOVIRUS_INFECTION_32HR_UP 	0	11	10	17017	0.0	1.0	1	
KEGG_TIGHT_JUNCTION 	0	11	113	16914	0.0	1.0	1	
IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP 	0	11	146	16881	0.0	1.0	1	
JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP 	0	11	53	16974	0.0	1.0	1	
DIRMEIER_LMP1_RESPONSE_EARLY 	0	11	58	16969	0.0	1.0	1	
AMUNDSON_GAMMA_RADIATION_RESISTANCE 	0	11	15	17012	0.0	1.0	1	
BIOCARTA_STEM_PATHWAY 	0	11	6	17021	0.0	1.0	1	
KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM 	0	11	73	16954	0.0	1.0	1	
DARWICHE_PAPILLOMA_RISK_LOW_UP 	0	11	131	16896	0.0	1.0	1	
KAMIKUBO_MYELOID_CEBPA_NETWORK 	0	11	22	17005	0.0	1.0	1	
REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK 	0	11	43	16984	0.0	1.0	1	
PID_NETRIN_PATHWAY 	0	11	32	16995	0.0	1.0	1	
SUNG_METASTASIS_STROMA_UP 	0	11	103	16924	0.0	1.0	1	
NICK_RESPONSE_TO_PROC_TREATMENT_DN 	0	11	24	17003	0.0	1.0	1	
KARLSSON_TGFB1_TARGETS_UP 	0	11	116	16911	0.0	1.0	1	
LI_CYTIDINE_ANALOG_PATHWAY 	0	11	11	17016	0.0	1.0	1	
BIOCARTA_G1_PATHWAY 	0	11	28	16999	0.0	1.0	1	
PID_AP1_PATHWAY 	0	11	61	16966	0.0	1.0	1	
MORI_LARGE_PRE_BII_LYMPHOCYTE_DN 	0	11	54	16973	0.0	1.0	1	
REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_ 	0	11	79	16948	0.0	1.0	1	
HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_DN 	0	11	11	17016	0.0	1.0	1	
REACTOME_MITOTIC_PROMETAPHASE 	0	11	71	16956	0.0	1.0	1	
REACTOME_METABOLISM_OF_NUCLEOTIDES 	0	11	65	16962	0.0	1.0	1	
DE_YY1_TARGETS_UP 	0	11	13	17014	0.0	1.0	1	
REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION 	0	11	24	17003	0.0	1.0	1	
YANG_MUC2_TARGETS_DUODENUM_6MO_UP 	0	11	4	17023	0.0	1.0	1	
REACTOME_PROTEIN_FOLDING 	0	11	49	16978	0.0	1.0	1	
BIOCARTA_CBL_PATHWAY 	0	11	13	17014	0.0	1.0	1	
FURUKAWA_DUSP6_TARGETS_PCI35_DN 	0	11	59	16968	0.0	1.0	1	
IWANAGA_E2F1_TARGETS_NOT_INDUCED_BY_SERUM 	0	11	6	17021	0.0	1.0	1	
REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS 	0	11	14	17013	0.0	1.0	1	
PID_TRKR_PATHWAY 	0	11	60	16967	0.0	1.0	1	
BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP 	0	11	176	16851	0.0	1.0	1	
LEE_CALORIE_RESTRICTION_NEOCORTEX_DN 	0	11	77	16950	0.0	1.0	1	
SERVITJA_ISLET_HNF1A_TARGETS_UP 	0	11	154	16873	0.0	1.0	1	
PID_IFNG_PATHWAY 	0	11	39	16988	0.0	1.0	1	
RATTENBACHER_BOUND_BY_CELF1 	0	11	361	16666	0.0	1.0	1	
ROZANOV_MMP14_CORRELATED 	0	11	11	17016	0.0	1.0	1	
ZHANG_RESPONSE_TO_CANTHARIDIN_UP 	0	11	18	17009	0.0	1.0	1	
PID_ALPHA_SYNUCLEIN_PATHWAY 	0	11	31	16996	0.0	1.0	1	
REACTOME_PURINE_CATABOLISM 	0	11	8	17019	0.0	1.0	1	
REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS 	0	11	7	17020	0.0	1.0	1	
REACTOME_HYALURONAN_METABOLISM 	0	11	13	17014	0.0	1.0	1	
PID_TGFBR_PATHWAY 	0	11	55	16972	0.0	1.0	1	
PID_P38_MK2_PATHWAY 	0	11	21	17006	0.0	1.0	1	
COLLER_MYC_TARGETS_UP 	0	11	25	17002	0.0	1.0	1	
ST_JNK_MAPK_PATHWAY 	0	11	39	16988	0.0	1.0	1	
JAZAG_TGFB1_SIGNALING_DN 	0	11	28	16999	0.0	1.0	1	
BROWNE_HCMV_INFECTION_14HR_UP 	0	11	145	16882	0.0	1.0	1	
MMS_MOUSE_LYMPH_HIGH_4HRS_UP 	0	11	31	16996	0.0	1.0	1	
PID_MAPK_TRK_PATHWAY 	0	11	33	16994	0.0	1.0	1	
PID_PS1_PATHWAY 	0	11	45	16982	0.0	1.0	1	
KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY 	0	11	53	16974	0.0	1.0	1	
HAN_SATB1_TARGETS_DN 	0	11	406	16621	0.0	1.0	1	
TAKAO_RESPONSE_TO_UVB_RADIATION_UP 	0	11	82	16945	0.0	1.0	1	
APRELIKOVA_BRCA1_TARGETS 	0	11	46	16981	0.0	1.0	1	
REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION 	0	11	80	16947	0.0	1.0	1	
ISSAEVA_MLL2_TARGETS 	0	11	54	16973	0.0	1.0	1	
RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_DN 	0	11	14	17013	0.0	1.0	1	
ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN 	0	11	317	16710	0.0	1.0	1	
BIOCARTA_NKCELLS_PATHWAY 	0	11	19	17008	0.0	1.0	1	
HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_DN 	0	11	18	17009	0.0	1.0	1	
PALOMERO_GSI_SENSITIVITY_UP 	0	11	6	17021	0.0	1.0	1	
MURAKAMI_UV_RESPONSE_1HR_UP 	0	11	16	17011	0.0	1.0	1	
RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN 	0	11	16	17011	0.0	1.0	1	
PID_EPHA_FWDPATHWAY 	0	11	33	16994	0.0	1.0	1	
REACTOME_NOD1_2_SIGNALING_PATHWAY 	0	11	29	16998	0.0	1.0	1	
KEGG_GLYCOSAMINOGLYCAN_DEGRADATION 	0	11	18	17009	0.0	1.0	1	
GOLDRATH_IMMUNE_MEMORY 	0	11	62	16965	0.0	1.0	1	
BYSTROEM_CORRELATED_WITH_IL5_DN 	0	11	63	16964	0.0	1.0	1	
NIELSEN_LEIOMYOSARCOMA_CNN1_UP 	0	11	18	17009	0.0	1.0	1	
TOMIDA_METASTASIS_UP 	0	11	25	17002	0.0	1.0	1	
MASSARWEH_RESPONSE_TO_ESTRADIOL 	0	11	56	16971	0.0	1.0	1	
REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE 	0	11	13	17014	0.0	1.0	1	
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_DN 	0	11	9	17018	0.0	1.0	1	
MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN 	0	11	48	16979	0.0	1.0	1	
BROWNE_HCMV_INFECTION_18HR_UP 	0	11	169	16858	0.0	1.0	1	
AMIT_DELAYED_EARLY_GENES 	0	11	18	17009	0.0	1.0	1	
REACTOME_ENOS_ACTIVATION_AND_REGULATION 	0	11	19	17008	0.0	1.0	1	
SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 	0	11	39	16988	0.0	1.0	1	
SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION 	0	11	48	16979	0.0	1.0	1	
REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS 	0	11	11	17016	0.0	1.0	1	
GENTILE_UV_HIGH_DOSE_UP 	0	11	22	17005	0.0	1.0	1	
KORKOLA_SEMINOMA_UP 	0	11	38	16989	0.0	1.0	1	
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN 	0	11	84	16943	0.0	1.0	1	
WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP 	0	11	18	17009	0.0	1.0	1	
BIOCARTA_CFTR_PATHWAY 	0	11	11	17016	0.0	1.0	1	
VARELA_ZMPSTE24_TARGETS_DN 	0	11	33	16994	0.0	1.0	1	
REACTOME_GAP_JUNCTION_DEGRADATION 	0	11	10	17017	0.0	1.0	1	
RODWELL_AGING_KIDNEY_UP 	0	11	420	16607	0.0	1.0	1	
NAKAMURA_ALVEOLAR_EPITHELIUM 	0	11	5	17022	0.0	1.0	1	
AMIT_EGF_RESPONSE_120_MCF10A 	0	11	36	16991	0.0	1.0	1	
KUUSELO_PANCREATIC_CANCER_19Q13_AMPLIFICATION 	0	11	24	17003	0.0	1.0	1	
REACTOME_ACTIVATION_OF_NMDA_RECEPTOR_UPON_GLUTAMATE_BINDING_AND_POSTSYNAPTIC_EVENTS 	0	11	37	16990	0.0	1.0	1	
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN 	0	11	72	16955	0.0	1.0	1	
SCHUHMACHER_MYC_TARGETS_DN 	0	11	7	17020	0.0	1.0	1	
LY_AGING_MIDDLE_UP 	0	11	8	17019	0.0	1.0	1	
WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT 	0	11	55	16972	0.0	1.0	1	
REACTOME_REGULATION_OF_SIGNALING_BY_CBL 	0	11	18	17009	0.0	1.0	1	
MORI_IMMATURE_B_LYMPHOCYTE_DN 	0	11	75	16952	0.0	1.0	1	
HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_UP 	0	11	24	17003	0.0	1.0	1	
RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP 	0	11	579	16448	0.0	1.0	1	
REACTOME_IRAK1_RECRUITS_IKK_COMPLEX 	0	11	9	17018	0.0	1.0	1	
SASSON_RESPONSE_TO_FORSKOLIN_DN 	0	11	87	16940	0.0	1.0	1	
REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX 	0	11	26	17001	0.0	1.0	1	
SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN 	0	11	20	17007	0.0	1.0	1	
BRUINS_UVC_RESPONSE_LATE 	1	10	1006	16021	1.592544731610338	0.48846671137972136	1	RTKN
REACTOME_PI3K_CASCADE 	0	11	60	16967	0.0	1.0	1	
REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS 	0	11	6	17021	0.0	1.0	1	
CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP 	0	11	35	16992	0.0	1.0	1	
BIOCARTA_BARRESTIN_PATHWAY 	0	11	9	17018	0.0	1.0	1	
VALK_AML_CLUSTER_6 	0	11	33	16994	0.0	1.0	1	
BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP 	0	11	35	16992	0.0	1.0	1	
JIANG_TIP30_TARGETS_UP 	0	11	41	16986	0.0	1.0	1	
KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS 	0	11	20	17007	0.0	1.0	1	
HELLER_HDAC_TARGETS_DN 	0	11	265	16762	0.0	1.0	1	
NICK_RESPONSE_TO_PROC_TREATMENT_UP 	0	11	4	17023	0.0	1.0	1	
WORSCHECH_TUMOR_REJECTION_UP 	0	11	38	16989	0.0	1.0	1	
WU_HBX_TARGETS_2_DN 	0	11	13	17014	0.0	1.0	1	
BIOCARTA_NO1_PATHWAY 	0	11	27	17000	0.0	1.0	1	
WANG_LMO4_TARGETS_DN 	0	11	322	16705	0.0	1.0	1	
REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT 	0	11	31	16996	0.0	1.0	1	
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN 	0	11	49	16978	0.0	1.0	1	
CAFFAREL_RESPONSE_TO_THC_8HR_5_DN 	0	11	10	17017	0.0	1.0	1	
YAMASHITA_LIVER_CANCER_WITH_EPCAM_DN 	0	11	8	17019	0.0	1.0	1	
REACTOME_GPCR_LIGAND_BINDING 	0	11	249	16778	0.0	1.0	1	
DIRMEIER_LMP1_RESPONSE_LATE_DN 	0	11	30	16997	0.0	1.0	1	
WANG_CLIM2_TARGETS_UP 	1	10	209	16818	8.04688995215311	0.12756057767327664	1	C9orf3
ELVIDGE_HIF1A_TARGETS_UP 	0	11	63	16964	0.0	1.0	1	
REACTOME_PRE_NOTCH_TRANSCRIPTION_AND_TRANSLATION 	0	11	23	17004	0.0	1.0	1	
RAMALHO_STEMNESS_DN 	0	11	67	16960	0.0	1.0	1	
MATZUK_SPERMATID_DIFFERENTIATION 	0	11	27	17000	0.0	1.0	1	
KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN 	0	11	42	16985	0.0	1.0	1	
PID_RB_1PATHWAY 	0	11	59	16968	0.0	1.0	1	
ZHANG_PROLIFERATING_VS_QUIESCENT 	0	11	49	16978	0.0	1.0	1	
ISHIDA_E2F_TARGETS 	0	11	41	16986	0.0	1.0	1	
BROWNE_HCMV_INFECTION_24HR_DN 	0	11	139	16888	0.0	1.0	1	
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN 	0	11	152	16875	0.0	1.0	1	
WIELAND_UP_BY_HBV_INFECTION 	0	11	89	16938	0.0	1.0	1	
OXFORD_RALA_TARGETS_DN 	0	11	9	17018	0.0	1.0	1	
TIAN_TNF_SIGNALING_VIA_NFKB 	0	11	25	17002	0.0	1.0	1	
GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS 	1	10	957	16070	1.6792058516196446	0.47099694894992117	1	C9orf3
NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON 	0	11	94	16933	0.0	1.0	1	
BENPORATH_NOS_TARGETS 	0	11	163	16864	0.0	1.0	1	
REACTOME_TRIGLYCERIDE_BIOSYNTHESIS 	0	11	36	16991	0.0	1.0	1	
GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP 	0	11	24	17003	0.0	1.0	1	
REACTOME_REGULATION_OF_INSULIN_SECRETION 	0	11	77	16950	0.0	1.0	1	
CHEBOTAEV_GR_TARGETS_UP 	0	11	69	16958	0.0	1.0	1	
LINDSTEDT_DENDRITIC_CELL_MATURATION_B 	0	11	48	16979	0.0	1.0	1	
SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_DN 	0	11	17	17010	0.0	1.0	1	
LINDSTEDT_DENDRITIC_CELL_MATURATION_A 	0	11	56	16971	0.0	1.0	1	
GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN 	1	10	419	16608	3.9637231503579953	0.2401530912977033	1	C9orf3
REACTOME_CONVERSION_FROM_APC_C_CDC20_TO_APC_C_CDH1_IN_LATE_ANAPHASE 	0	11	15	17012	0.0	1.0	1	
KEGG_RENAL_CELL_CARCINOMA 	0	11	66	16961	0.0	1.0	1	
REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S 	0	11	56	16971	0.0	1.0	1	
GRANDVAUX_IRF3_TARGETS_DN 	0	11	18	17009	0.0	1.0	1	
BIOCARTA_GCR_PATHWAY 	0	11	18	17009	0.0	1.0	1	
BIOCARTA_PTDINS_PATHWAY 	0	11	23	17004	0.0	1.0	1	
GAVIN_FOXP3_TARGETS_CLUSTER_P7 	0	11	77	16950	0.0	1.0	1	
MEISSNER_BRAIN_HCP_WITH_H3K4ME2 	0	11	14	17013	0.0	1.0	1	
SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_DN 	0	11	16	17011	0.0	1.0	1	
JIANG_CORE_DUPLICON_GENES 	0	11	5	17022	0.0	1.0	1	
NABA_PROTEOGLYCANS 	0	11	28	16999	0.0	1.0	1	
MUELLER_PLURINET 	0	11	281	16746	0.0	1.0	1	
CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_UP 	0	11	29	16998	0.0	1.0	1	
HU_ANGIOGENESIS_UP 	0	11	19	17008	0.0	1.0	1	
COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP 	0	11	102	16925	0.0	1.0	1	
WEBER_METHYLATED_ICP_IN_SPERM_DN 	0	11	1	17026	0.0	1.0	1	
MCBRYAN_PUBERTAL_BREAST_3_4WK_DN 	0	11	33	16994	0.0	1.0	1	
MULLIGHAN_MLL_SIGNATURE_1_DN 	0	11	215	16812	0.0	1.0	1	
WANG_METHYLATED_IN_BREAST_CANCER 	0	11	34	16993	0.0	1.0	1	
STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP 	0	11	119	16908	0.0	1.0	1	
KEGG_OLFACTORY_TRANSDUCTION 	0	11	29	16998	0.0	1.0	1	
RIZ_ERYTHROID_DIFFERENTIATION_HEMGN 	0	11	22	17005	0.0	1.0	1	
PODAR_RESPONSE_TO_ADAPHOSTIN_DN 	0	11	18	17009	0.0	1.0	1	
KEGG_FATTY_ACID_METABOLISM 	0	11	37	16990	0.0	1.0	1	
WEBER_METHYLATED_IN_COLON_CANCER 	0	11	17	17010	0.0	1.0	1	
MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP 	0	11	39	16988	0.0	1.0	1	
BUSA_SAM68_TARGETS_UP 	0	11	7	17020	0.0	1.0	1	
BIOCARTA_DEATH_PATHWAY 	0	11	33	16994	0.0	1.0	1	
BROWNE_HCMV_INFECTION_8HR_DN 	0	11	41	16986	0.0	1.0	1	
MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA 	0	11	15	17012	0.0	1.0	1	
BIOCARTA_GH_PATHWAY 	0	11	25	17002	0.0	1.0	1	
PID_ECADHERIN_KERATINOCYTE_PATHWAY 	0	11	19	17008	0.0	1.0	1	
SAGIV_CD24_TARGETS_DN 	0	11	41	16986	0.0	1.0	1	
WIERENGA_STAT5A_TARGETS_GROUP2 	0	11	49	16978	0.0	1.0	1	
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP 	0	11	43	16984	0.0	1.0	1	
YU_MYC_TARGETS_DN 	0	11	45	16982	0.0	1.0	1	
ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN 	0	11	144	16883	0.0	1.0	1	
ZEMBUTSU_SENSITIVITY_TO_METHOTREXATE 	0	11	16	17011	0.0	1.0	1	
DELACROIX_RAR_TARGETS_UP 	0	11	42	16985	0.0	1.0	1	
BERNARD_PPAPDC1B_TARGETS_UP 	0	11	36	16991	0.0	1.0	1	
FAELT_B_CLL_WITH_VH3_21_DN 	0	11	49	16978	0.0	1.0	1	
BIOCARTA_IL4_PATHWAY 	0	11	10	17017	0.0	1.0	1	
BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_DN 	0	11	9	17018	0.0	1.0	1	
BILANGES_SERUM_SENSITIVE_GENES 	0	11	79	16948	0.0	1.0	1	
KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP 	0	11	37	16990	0.0	1.0	1	
REACTOME_IL_RECEPTOR_SHC_SIGNALING 	0	11	21	17006	0.0	1.0	1	
HAHTOLA_MYCOSIS_FUNGOIDES_UP 	0	11	14	17013	0.0	1.0	1	
PID_EPHB_FWD_PATHWAY 	0	11	40	16987	0.0	1.0	1	
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP 	0	11	237	16790	0.0	1.0	1	
SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP 	0	11	112	16915	0.0	1.0	1	
PID_VEGFR1_2_PATHWAY 	0	11	69	16958	0.0	1.0	1	
MARSHALL_VIRAL_INFECTION_RESPONSE_DN 	0	11	28	16999	0.0	1.0	1	
REACTOME_SYNTHESIS_OF_PE 	0	11	10	17017	0.0	1.0	1	
REACTOME_PLATELET_SENSITIZATION_BY_LDL 	0	11	16	17011	0.0	1.0	1	
REACTOME_SYNTHESIS_OF_PC 	0	11	16	17011	0.0	1.0	1	
GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN 	0	11	208	16819	0.0	1.0	1	
REACTOME_SYNTHESIS_OF_PA 	0	11	19	17008	0.0	1.0	1	
BIOCARTA_RELA_PATHWAY 	0	11	15	17012	0.0	1.0	1	
MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP 	0	11	115	16912	0.0	1.0	1	
LENAOUR_DENDRITIC_CELL_MATURATION_DN 	0	11	118	16909	0.0	1.0	1	
MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3 	0	11	127	16900	0.0	1.0	1	
VALK_AML_CLUSTER_2 	0	11	23	17004	0.0	1.0	1	
IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP 	0	11	21	17006	0.0	1.0	1	
KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN 	0	11	906	16121	0.0	1.0	1	
GHO_ATF5_TARGETS_DN 	0	11	15	17012	0.0	1.0	1	
MARTINEZ_RB1_TARGETS_UP 	0	11	579	16448	0.0	1.0	1	
MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_2 	0	11	8	17019	0.0	1.0	1	
KARAKAS_TGFB1_SIGNALING 	0	11	16	17011	0.0	1.0	1	
KEGG_ADHERENS_JUNCTION 	0	11	67	16960	0.0	1.0	1	
MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_1 	0	11	9	17018	0.0	1.0	1	
FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_DN 	0	11	20	17007	0.0	1.0	1	
CERVERA_SDHB_TARGETS_1_UP 	0	11	97	16930	0.0	1.0	1	
MATZUK_EMBRYONIC_GERM_CELL 	0	11	16	17011	0.0	1.0	1	
BIOCARTA_TH1TH2_PATHWAY 	0	11	12	17015	0.0	1.0	1	
CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN 	0	11	22	17005	0.0	1.0	1	
WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_DN 	0	11	12	17015	0.0	1.0	1	
KATSANOU_ELAVL1_TARGETS_DN 	0	11	129	16898	0.0	1.0	1	
BIOCARTA_EPO_PATHWAY 	0	11	18	17009	0.0	1.0	1	
KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION 	0	11	64	16963	0.0	1.0	1	
SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN 	0	11	18	17009	0.0	1.0	1	
PID_PDGFRB_PATHWAY 	0	11	127	16900	0.0	1.0	1	
WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP 	0	11	21	17006	0.0	1.0	1	
YAGI_AML_WITH_T_8_21_TRANSLOCATION 	0	11	333	16694	0.0	1.0	1	
CARD_MIR302A_TARGETS 	0	11	76	16951	0.0	1.0	1	
KIM_LRRC3B_TARGETS 	0	11	28	16999	0.0	1.0	1	
BIERIE_INFLAMMATORY_RESPONSE_TGFB1 	0	11	3	17024	0.0	1.0	1	
KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY 	0	11	82	16945	0.0	1.0	1	
MANTOVANI_VIRAL_GPCR_SIGNALING_UP 	0	11	70	16957	0.0	1.0	1	
KEGG_CARDIAC_MUSCLE_CONTRACTION 	0	11	70	16957	0.0	1.0	1	
PID_AVB3_OPN_PATHWAY 	0	11	31	16996	0.0	1.0	1	
REACTOME_G_ALPHA_S_SIGNALLING_EVENTS 	0	11	82	16945	0.0	1.0	1	
ZEMBUTSU_SENSITIVITY_TO_NIMUSTINE 	0	11	13	17014	0.0	1.0	1	
BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE 	1	10	124	16903	13.631451612903225	0.07782781452657606	1	PLLP
LEE_AGING_MUSCLE_DN 	0	11	43	16984	0.0	1.0	1	
REACTOME_COLLAGEN_FORMATION 	0	11	54	16973	0.0	1.0	1	
AMIT_SERUM_RESPONSE_240_MCF10A 	1	10	50	16977	33.954	0.032447385315775505	1	CDC42EP1
PID_SYNDECAN_4_PATHWAY 	0	11	28	16999	0.0	1.0	1	
NGUYEN_NOTCH1_TARGETS_DN 	0	11	84	16943	0.0	1.0	1	
GRADE_COLON_AND_RECTAL_CANCER_UP 	1	10	262	16765	6.398854961832061	0.15732312611848948	1	RTKN
ZERBINI_RESPONSE_TO_SULINDAC_UP 	0	11	7	17020	0.0	1.0	1	
ZHAN_LATE_DIFFERENTIATION_GENES_UP 	0	11	31	16996	0.0	1.0	1	
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS 	1	10	777	16250	2.0913770913770913	0.40206483755392464	1	RTKN
MACAEVA_PBMC_RESPONSE_TO_IR 	0	11	85	16942	0.0	1.0	1	
BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS 	0	11	28	16999	0.0	1.0	1	
WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 	0	11	38	16989	0.0	1.0	1	
CHENG_IMPRINTED_BY_ESTRADIOL 	0	11	96	16931	0.0	1.0	1	
SHIN_B_CELL_LYMPHOMA_CLUSTER_3 	0	11	25	17002	0.0	1.0	1	
HOFMANN_CELL_LYMPHOMA_UP 	0	11	43	16984	0.0	1.0	1	
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP 	0	11	73	16954	0.0	1.0	1	
BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP 	0	11	52	16975	0.0	1.0	1	
SMID_BREAST_CANCER_LUMINAL_B_UP 	0	11	148	16879	0.0	1.0	1	
BAKKER_FOXO3_TARGETS_UP 	0	11	55	16972	0.0	1.0	1	
REACTOME_TRIF_MEDIATED_TLR3_SIGNALING 	0	11	71	16956	0.0	1.0	1	
REACTOME_TRAFFICKING_AND_PROCESSING_OF_ENDOSOMAL_TLR 	0	11	11	17016	0.0	1.0	1	
WANG_METASTASIS_OF_BREAST_CANCER_ESR1_DN 	0	11	25	17002	0.0	1.0	1	
REICHERT_G1S_REGULATORS_AS_PI3K_TARGETS 	0	11	7	17020	0.0	1.0	1	
IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR 	0	11	136	16891	0.0	1.0	1	
BIOCARTA_THELPER_PATHWAY 	0	11	8	17019	0.0	1.0	1	
KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY 	0	11	96	16931	0.0	1.0	1	
REACTOME_GLYCOPROTEIN_HORMONES 	0	11	4	17023	0.0	1.0	1	
KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_LACTO_AND_NEOLACTO_SERIES 	0	11	20	17007	0.0	1.0	1	
ZHAN_MULTIPLE_MYELOMA_UP 	0	11	60	16967	0.0	1.0	1	
LEE_LIVER_CANCER_SURVIVAL_DN 	0	11	161	16866	0.0	1.0	1	
BROWN_MYELOID_CELL_DEVELOPMENT_DN 	0	11	111	16916	0.0	1.0	1	
PALOMERO_GSI_SENSITIVITY_DN 	0	11	3	17024	0.0	1.0	1	
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D 	1	10	769	16258	2.114174252275683	0.3988198071087835	1	CAPN3
NIKOLSKY_BREAST_CANCER_1Q21_AMPLICON 	0	11	35	16992	0.0	1.0	1	
KEGG_DRUG_METABOLISM_OTHER_ENZYMES 	0	11	25	17002	0.0	1.0	1	
FRIDMAN_IMMORTALIZATION_DN 	1	10	32	16995	53.109375	0.021106320801642174	1	C9orf3
MURAKAMI_UV_RESPONSE_1HR_DN 	0	11	10	17017	0.0	1.0	1	
NEWMAN_ERCC6_TARGETS_UP 	0	11	22	17005	0.0	1.0	1	
REACTOME_HDL_MEDIATED_LIPID_TRANSPORT 	0	11	14	17013	0.0	1.0	1	
REACTOME_GLUCURONIDATION 	0	11	3	17024	0.0	1.0	1	
HOSHIDA_LIVER_CANCER_SURVIVAL_DN 	0	11	97	16930	0.0	1.0	1	
MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN 	0	11	13	17014	0.0	1.0	1	
KEGG_RNA_DEGRADATION 	0	11	55	16972	0.0	1.0	1	
MCBRYAN_PUBERTAL_BREAST_6_7WK_UP 	0	11	181	16846	0.0	1.0	1	
ROY_WOUND_BLOOD_VESSEL_UP 	0	11	48	16979	0.0	1.0	1	
REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION 	0	11	179	16848	0.0	1.0	1	
YIH_RESPONSE_TO_ARSENITE_C5 	0	11	9	17018	0.0	1.0	1	
YIH_RESPONSE_TO_ARSENITE_C4 	0	11	17	17010	0.0	1.0	1	
SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY 	0	11	32	16995	0.0	1.0	1	
KORKOLA_CHORIOCARCINOMA_DN 	0	11	8	17019	0.0	1.0	1	
YIH_RESPONSE_TO_ARSENITE_C3 	0	11	35	16992	0.0	1.0	1	
YIH_RESPONSE_TO_ARSENITE_C2 	0	11	18	17009	0.0	1.0	1	
LE_SKI_TARGETS_DN 	0	11	7	17020	0.0	1.0	1	
REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING 	0	11	13	17014	0.0	1.0	1	
FIGUEROA_AML_METHYLATION_CLUSTER_5_DN 	0	11	38	16989	0.0	1.0	1	
REACTOME_FGFR_LIGAND_BINDING_AND_ACTIVATION 	0	11	16	17011	0.0	1.0	1	
SHIN_B_CELL_LYMPHOMA_CLUSTER_1 	0	11	7	17020	0.0	1.0	1	
DARWICHE_PAPILLOMA_RISK_HIGH_UP 	0	11	122	16905	0.0	1.0	1	
HANSON_HRAS_SIGNALING_VIA_NFKB 	0	11	19	17008	0.0	1.0	1	
VERHAAK_GLIOBLASTOMA_CLASSICAL 	0	11	155	16872	0.0	1.0	1	
TCGA_GLIOBLASTOMA_COPY_NUMBER_DN 	0	11	29	16998	0.0	1.0	1	
VALK_AML_CLUSTER_1 	0	11	25	17002	0.0	1.0	1	
KORKOLA_TERATOMA_UP 	0	11	16	17011	0.0	1.0	1	
REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER 	0	11	26	17001	0.0	1.0	1	
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_DN 	0	11	10	17017	0.0	1.0	1	
PID_NEPHRIN_NEPH1_PATHWAY 	0	11	30	16997	0.0	1.0	1	
PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_UP 	0	11	4	17023	0.0	1.0	1	
REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE 	0	11	35	16992	0.0	1.0	1	
MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY 	0	11	9	17018	0.0	1.0	1	
CHO_NR4A1_TARGETS 	0	11	26	17001	0.0	1.0	1	
ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_DN 	0	11	22	17005	0.0	1.0	1	
REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS 	0	11	25	17002	0.0	1.0	1	
EHLERS_ANEUPLOIDY_UP 	0	11	40	16987	0.0	1.0	1	
LEE_NEURAL_CREST_STEM_CELL_DN 	0	11	111	16916	0.0	1.0	1	
KORKOLA_CHORIOCARCINOMA 	0	11	1	17026	0.0	1.0	1	
BIOCARTA_P38MAPK_PATHWAY 	0	11	39	16988	0.0	1.0	1	
NEMETH_INFLAMMATORY_RESPONSE_LPS_UP 	0	11	84	16943	0.0	1.0	1	
BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP 	1	10	191	16836	8.814659685863875	0.11723720322748925	1	MAG
SU_TESTIS 	0	11	53	16974	0.0	1.0	1	
STREICHER_LSM1_TARGETS_DN 	0	11	16	17011	0.0	1.0	1	
WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN 	0	11	17	17010	0.0	1.0	1	
CERVERA_SDHB_TARGETS_2 	0	11	100	16927	0.0	1.0	1	
IRITANI_MAD1_TARGETS_DN 	0	11	45	16982	0.0	1.0	1	
TRAYNOR_RETT_SYNDROM_DN 	0	11	16	17011	0.0	1.0	1	
YU_MYC_TARGETS_UP 	0	11	33	16994	0.0	1.0	1	
SANSOM_APC_MYC_TARGETS 	0	11	191	16836	0.0	1.0	1	
REACTOME_P75NTR_SIGNALS_VIA_NFKB 	0	11	13	17014	0.0	1.0	1	
BROWNE_HCMV_INFECTION_4HR_UP 	0	11	47	16980	0.0	1.0	1	
LEI_HOXC8_TARGETS_DN 	0	11	16	17011	0.0	1.0	1	
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP 	0	11	345	16682	0.0	1.0	1	
CROSBY_E2F4_TARGETS 	0	11	5	17022	0.0	1.0	1	
NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_UP 	0	11	19	17008	0.0	1.0	1	
REACTOME_UNFOLDED_PROTEIN_RESPONSE 	0	11	73	16954	0.0	1.0	1	
DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP 	0	11	45	16982	0.0	1.0	1	
SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_UP 	0	11	13	17014	0.0	1.0	1	
REACTOME_ION_CHANNEL_TRANSPORT 	0	11	49	16978	0.0	1.0	1	
LIU_VMYB_TARGETS_UP 	1	10	116	16911	14.578448275862069	0.07301687232298434	1	CDC42EP1
KEGG_FOLATE_BIOSYNTHESIS 	0	11	8	17019	0.0	1.0	1	
MCCABE_HOXC6_TARGETS_CANCER_UP 	0	11	27	17000	0.0	1.0	1	
DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP 	0	11	71	16956	0.0	1.0	1	
WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN 	0	11	17	17010	0.0	1.0	1	
RICKMAN_HEAD_AND_NECK_CANCER_D 	0	11	20	17007	0.0	1.0	1	
RICKMAN_HEAD_AND_NECK_CANCER_E 	0	11	46	16981	0.0	1.0	1	
KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS 	0	11	13	17014	0.0	1.0	1	
LEE_CALORIE_RESTRICTION_MUSCLE_DN 	0	11	45	16982	0.0	1.0	1	
RICKMAN_HEAD_AND_NECK_CANCER_A 	0	11	84	16943	0.0	1.0	1	
RICKMAN_HEAD_AND_NECK_CANCER_B 	0	11	34	16993	0.0	1.0	1	
RICKMAN_HEAD_AND_NECK_CANCER_C 	0	11	69	16958	0.0	1.0	1	
KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC 	0	11	72	16955	0.0	1.0	1	
REACTOME_RAP1_SIGNALLING 	0	11	15	17012	0.0	1.0	1	
IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR 	0	11	470	16557	0.0	1.0	1	
KONDO_COLON_CANCER_HCP_WITH_H3K27ME3 	0	11	4	17023	0.0	1.0	1	
ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN 	0	11	19	17008	0.0	1.0	1	
KONDO_COLON_CANCER_HCP_WITH_H3K27ME1 	0	11	23	17004	0.0	1.0	1	
PASINI_SUZ12_TARGETS_DN 	0	11	304	16723	0.0	1.0	1	
HAMAI_APOPTOSIS_VIA_TRAIL_UP 	0	11	540	16487	0.0	1.0	1	
PUJANA_BRCA_CENTERED_NETWORK 	0	11	109	16918	0.0	1.0	1	
FOURNIER_ACINAR_DEVELOPMENT_LATE_DN 	0	11	18	17009	0.0	1.0	1	
LIU_CMYB_TARGETS_UP 	1	10	154	16873	10.956493506493507	0.09566738115563377	1	CDC42EP1
OLSSON_E2F3_TARGETS_DN 	0	11	40	16987	0.0	1.0	1	
MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN 	0	11	337	16690	0.0	1.0	1	
LIN_NPAS4_TARGETS_UP 	0	11	148	16879	0.0	1.0	1	
KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM 	0	11	30	16997	0.0	1.0	1	
DODD_NASOPHARYNGEAL_CARCINOMA_UP 	1	10	1347	15680	1.164068299925761	0.5962364333910626	1	PLLP
REACTOME_APOPTOSIS 	0	11	132	16895	0.0	1.0	1	
REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION 	0	11	95	16932	0.0	1.0	1	
FOURNIER_ACINAR_DEVELOPMENT_LATE_UP 	0	11	10	17017	0.0	1.0	1	
IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM 	1	10	261	16766	6.423754789272031	0.15677022151748593	1	MAG
CASTELLANO_HRAS_TARGETS_DN 	0	11	5	17022	0.0	1.0	1	
MCGOWAN_RSP6_TARGETS_UP 	1	10	16	17011	106.31875	0.01092406542820846	1	SOX10
REACTOME_G1_S_SPECIFIC_TRANSCRIPTION 	0	11	14	17013	0.0	1.0	1	
KEGG_CYSTEINE_AND_METHIONINE_METABOLISM 	0	11	29	16998	0.0	1.0	1	
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP 	0	11	53	16974	0.0	1.0	1	
JONES_TCOF1_TARGETS 	0	11	5	17022	0.0	1.0	1	
CHESLER_BRAIN_QTL_CIS 	0	11	68	16959	0.0	1.0	1	
REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES 	0	11	55	16972	0.0	1.0	1	
REACTOME_MITOTIC_M_M_G1_PHASES 	0	11	146	16881	0.0	1.0	1	
KYNG_DNA_DAMAGE_BY_4NQO 	0	11	36	16991	0.0	1.0	1	
GRUETZMANN_PANCREATIC_CANCER_UP 	0	11	333	16694	0.0	1.0	1	
REACTOME_TRNA_AMINOACYLATION 	0	11	42	16985	0.0	1.0	1	
RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN 	0	11	300	16727	0.0	1.0	1	
FAELT_B_CLL_WITH_VH3_21_UP 	0	11	42	16985	0.0	1.0	1	
RODRIGUES_NTN1_TARGETS_UP 	0	11	15	17012	0.0	1.0	1	
UEDA_PERIFERAL_CLOCK 	0	11	153	16874	0.0	1.0	1	
CHEN_HOXA5_TARGETS_6HR_DN 	0	11	5	17022	0.0	1.0	1	
REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS 	0	11	27	17000	0.0	1.0	1	
REACTOME_CHYLOMICRON_MEDIATED_LIPID_TRANSPORT 	0	11	13	17014	0.0	1.0	1	
BIOCARTA_CACAM_PATHWAY 	0	11	13	17014	0.0	1.0	1	
CHANG_CORE_SERUM_RESPONSE_DN 	0	11	195	16832	0.0	1.0	1	
REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES 	0	11	30	16997	0.0	1.0	1	
HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP 	0	11	172	16855	0.0	1.0	1	
LOPES_METHYLATED_IN_COLON_CANCER_DN 	0	11	27	17000	0.0	1.0	1	
BROWNE_HCMV_INFECTION_10HR_UP 	0	11	88	16939	0.0	1.0	1	
COLLIS_PRKDC_REGULATORS 	0	11	15	17012	0.0	1.0	1	
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_UP 	0	11	11	17016	0.0	1.0	1	
MEISSNER_NPC_HCP_WITH_H3K4ME2 	0	11	443	16584	0.0	1.0	1	
REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE 	0	11	10	17017	0.0	1.0	1	
PID_ENDOTHELIN_PATHWAY 	0	11	61	16966	0.0	1.0	1	
FOSTER_TOLERANT_MACROPHAGE_DN 	0	11	383	16644	0.0	1.0	1	
NIKOLSKY_BREAST_CANCER_10Q22_AMPLICON 	0	11	8	17019	0.0	1.0	1	
PID_ALK2_PATHWAY 	0	11	10	17017	0.0	1.0	1	
DELLA_RESPONSE_TO_TSA_AND_BUTYRATE 	0	11	20	17007	0.0	1.0	1	
WAESCH_ANAPHASE_PROMOTING_COMPLEX 	0	11	12	17015	0.0	1.0	1	
REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES 	0	11	77	16950	0.0	1.0	1	
REACTOME_ACTIVATION_OF_THE_AP1_FAMILY_OF_TRANSCRIPTION_FACTORS 	0	11	10	17017	0.0	1.0	1	
BIOCARTA_ATM_PATHWAY 	0	11	18	17009	0.0	1.0	1	
BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN 	0	11	44	16983	0.0	1.0	1	
KIM_WT1_TARGETS_UP 	0	11	202	16825	0.0	1.0	1	
REACTOME_SIGNAL_AMPLIFICATION 	0	11	29	16998	0.0	1.0	1	
GAVIN_FOXP3_TARGETS_CLUSTER_T7 	0	11	94	16933	0.0	1.0	1	
LINDGREN_BLADDER_CANCER_CLUSTER_3_DN 	0	11	208	16819	0.0	1.0	1	
CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN 	0	11	317	16710	0.0	1.0	1	
PID_INTEGRIN5_PATHWAY 	0	11	16	17011	0.0	1.0	1	
KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM 	0	11	31	16996	0.0	1.0	1	
XU_CREBBP_TARGETS_UP 	0	11	22	17005	0.0	1.0	1	
ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP 	0	11	187	16840	0.0	1.0	1	
YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP 	0	11	118	16909	0.0	1.0	1	
REACTOME_NOREPINEPHRINE_NEUROTRANSMITTER_RELEASE_CYCLE 	0	11	8	17019	0.0	1.0	1	
RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN 	2	9	707	16320	5.129655822725129	0.07415650914355229	1	PLLP,CAPN3
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_3 	0	11	4	17023	0.0	1.0	1	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_2 	0	11	5	17022	0.0	1.0	1	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_5 	0	11	5	17022	0.0	1.0	1	
HENDRICKS_SMARCA4_TARGETS_DN 	0	11	42	16985	0.0	1.0	1	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_7 	0	11	7	17020	0.0	1.0	1	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_6 	0	11	5	17022	0.0	1.0	1	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_9 	0	11	7	17020	0.0	1.0	1	
REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM 	0	11	48	16979	0.0	1.0	1	
FIGUEROA_AML_METHYLATION_CLUSTER_7_DN 	0	11	5	17022	0.0	1.0	1	
CERVERA_SDHB_TARGETS_1_DN 	0	11	27	17000	0.0	1.0	1	
PID_HIV_NEF_PATHWAY 	0	11	33	16994	0.0	1.0	1	
GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_DN 	0	11	7	17020	0.0	1.0	1	
REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE 	0	11	31	16996	0.0	1.0	1	
KEEN_RESPONSE_TO_ROSIGLITAZONE_DN 	0	11	98	16929	0.0	1.0	1	
BIOCARTA_RAS_PATHWAY 	0	11	23	17004	0.0	1.0	1	
GEISS_RESPONSE_TO_DSRNA_DN 	0	11	14	17013	0.0	1.0	1	
NAKAMURA_LUNG_CANCER_DIFFERENTIATION_MARKERS 	0	11	12	17015	0.0	1.0	1	
ST_WNT_CA2_CYCLIC_GMP_PATHWAY 	0	11	17	17010	0.0	1.0	1	
GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP 	0	11	38	16989	0.0	1.0	1	
ODONNELL_METASTASIS_DN 	0	11	22	17005	0.0	1.0	1	
REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS 	0	11	33	16994	0.0	1.0	1	
PASINI_SUZ12_TARGETS_UP 	0	11	90	16937	0.0	1.0	1	
REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT 	0	11	190	16837	0.0	1.0	1	
PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN 	0	11	42	16985	0.0	1.0	1	
RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN 	0	11	338	16689	0.0	1.0	1	
CAIRO_PML_TARGETS_BOUND_BY_MYC_DN 	0	11	14	17013	0.0	1.0	1	
LOPEZ_MESOTHELIOMA_SURVIVAL_UP 	0	11	11	17016	0.0	1.0	1	
WANG_NFKB_TARGETS 	0	11	14	17013	0.0	1.0	1	
CHIBA_RESPONSE_TO_TSA_DN 	0	11	22	17005	0.0	1.0	1	
KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP 	0	11	655	16372	0.0	1.0	1	
REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE 	0	11	40	16987	0.0	1.0	1	
NAKAJIMA_EOSINOPHIL 	0	11	21	17006	0.0	1.0	1	
MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN 	0	11	66	16961	0.0	1.0	1	
BROWNE_HCMV_INFECTION_1HR_DN 	0	11	193	16834	0.0	1.0	1	
SIG_BCR_SIGNALING_PATHWAY 	0	11	43	16984	0.0	1.0	1	
PID_HES_HEY_PATHWAY 	0	11	42	16985	0.0	1.0	1	
GENTILE_UV_HIGH_DOSE_DN 	0	11	293	16734	0.0	1.0	1	
KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN 	0	11	18	17009	0.0	1.0	1	
MULLIGHAN_MLL_SIGNATURE_1_UP 	0	11	341	16686	0.0	1.0	1	
FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP 	1	10	31	16996	54.825806451612905	0.02047273265945537	1	CAPN3
WOTTON_RUNX_TARGETS_DN 	0	11	26	17001	0.0	1.0	1	
GAVIN_PDE3B_TARGETS 	0	11	18	17009	0.0	1.0	1	
IVANOVSKA_MIR106B_TARGETS 	0	11	84	16943	0.0	1.0	1	
KEGG_PANCREATIC_CANCER 	0	11	67	16960	0.0	1.0	1	
LEIN_MIDBRAIN_MARKERS 	0	11	75	16952	0.0	1.0	1	
MAINA_VHL_TARGETS_UP 	0	11	8	17019	0.0	1.0	1	
DER_IFN_ALPHA_RESPONSE_DN 	0	11	4	17023	0.0	1.0	1	
ZHAN_V2_LATE_DIFFERENTIATION_GENES 	0	11	41	16986	0.0	1.0	1	
GRANDVAUX_IRF3_TARGETS_UP 	0	11	14	17013	0.0	1.0	1	
REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS 	0	11	25	17002	0.0	1.0	1	
NOUZOVA_TRETINOIN_AND_H4_ACETYLATION 	0	11	127	16900	0.0	1.0	1	
BIOCARTA_FAS_PATHWAY 	0	11	29	16998	0.0	1.0	1	
KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_BIOSYNTHESIS 	0	11	10	17017	0.0	1.0	1	
GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION 	0	11	14	17013	0.0	1.0	1	
LIU_PROSTATE_CANCER_DN 	2	9	430	16597	8.577260981912145	0.030321205510863362	1	C9orf3,PLLP
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD 	0	11	23	17004	0.0	1.0	1	
REACTOME_GLUCOSE_TRANSPORT 	0	11	34	16993	0.0	1.0	1	
KEGG_PATHWAYS_IN_CANCER 	0	11	304	16723	0.0	1.0	1	
DELPUECH_FOXO3_TARGETS_UP 	0	11	66	16961	0.0	1.0	1	
DAZARD_RESPONSE_TO_UV_SCC_DN 	0	11	117	16910	0.0	1.0	1	
MARKEY_RB1_ACUTE_LOF_DN 	0	11	205	16822	0.0	1.0	1	
ELVIDGE_HYPOXIA_BY_DMOG_UP 	0	11	124	16903	0.0	1.0	1	
THEODOROU_MAMMARY_TUMORIGENESIS 	0	11	26	17001	0.0	1.0	1	
GYORFFY_DOXORUBICIN_RESISTANCE 	0	11	44	16983	0.0	1.0	1	
MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN 	0	11	20	17007	0.0	1.0	1	
KAUFFMANN_DNA_REPLICATION_GENES 	0	11	133	16894	0.0	1.0	1	
GILMORE_CORE_NFKB_PATHWAY 	0	11	14	17013	0.0	1.0	1	
PID_NECTIN_PATHWAY 	0	11	26	17001	0.0	1.0	1	
OHASHI_AURKA_TARGETS 	0	11	4	17023	0.0	1.0	1	
ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN 	0	11	92	16935	0.0	1.0	1	
REACTOME_SIGNALLING_TO_RAS 	0	11	27	17000	0.0	1.0	1	
ROETH_TERT_TARGETS_DN 	0	11	5	17022	0.0	1.0	1	
PID_HEDGEHOG_2PATHWAY 	0	11	19	17008	0.0	1.0	1	
REACTOME_IL_7_SIGNALING 	0	11	10	17017	0.0	1.0	1	
KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN 	0	11	206	16821	0.0	1.0	1	
REACTOME_TRANSCRIPTION 	0	11	162	16865	0.0	1.0	1	
REACTOME_CYCLIN_A_B1_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION 	0	11	13	17014	0.0	1.0	1	
CAFFAREL_RESPONSE_TO_THC_DN 	0	11	26	17001	0.0	1.0	1	
XU_GH1_EXOGENOUS_TARGETS_DN 	0	11	96	16931	0.0	1.0	1	
BIOCARTA_ACE2_PATHWAY 	0	11	9	17018	0.0	1.0	1	
GALE_APL_WITH_FLT3_MUTATED_DN 	0	11	15	17012	0.0	1.0	1	
FIRESTEIN_CTNNB1_PATHWAY_AND_PROLIFERATION 	0	11	8	17019	0.0	1.0	1	
ROESSLER_LIVER_CANCER_METASTASIS_UP 	0	11	92	16935	0.0	1.0	1	
WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN 	0	11	21	17006	0.0	1.0	1	
LU_EZH2_TARGETS_DN 	0	11	341	16686	0.0	1.0	1	
WOOD_EBV_EBNA1_TARGETS_UP 	0	11	104	16923	0.0	1.0	1	
ZHOU_PANCREATIC_ENDOCRINE_PROGENITOR 	0	11	11	17016	0.0	1.0	1	
BIOCARTA_IL22BP_PATHWAY 	0	11	13	17014	0.0	1.0	1	
LAU_APOPTOSIS_CDKN2A_DN 	0	11	5	17022	0.0	1.0	1	
REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS 	0	11	9	17018	0.0	1.0	1	
SIG_CHEMOTAXIS 	0	11	42	16985	0.0	1.0	1	
WHITFIELD_CELL_CYCLE_G2 	0	11	160	16867	0.0	1.0	1	
KEGG_ASCORBATE_AND_ALDARATE_METABOLISM 	0	11	6	17021	0.0	1.0	1	
PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_DN 	0	11	5	17022	0.0	1.0	1	
PID_WNT_SIGNALING_PATHWAY 	0	11	26	17001	0.0	1.0	1	
KAYO_CALORIE_RESTRICTION_MUSCLE_UP 	0	11	88	16939	0.0	1.0	1	
CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_UP 	0	11	5	17022	0.0	1.0	1	
PID_A6B1_A6B4_INTEGRIN_PATHWAY 	0	11	46	16981	0.0	1.0	1	
TURJANSKI_MAPK7_TARGETS 	0	11	8	17019	0.0	1.0	1	
REACTOME_MYD88_MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE 	0	11	79	16948	0.0	1.0	1	
DAZARD_UV_RESPONSE_CLUSTER_G6 	0	11	135	16892	0.0	1.0	1	
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN 	0	11	37	16990	0.0	1.0	1	
PUJANA_BREAST_CANCER_LIT_INT_NETWORK 	0	11	95	16932	0.0	1.0	1	
DAZARD_UV_RESPONSE_CLUSTER_G5 	0	11	9	17018	0.0	1.0	1	
DAZARD_UV_RESPONSE_CLUSTER_G2 	0	11	26	17001	0.0	1.0	1	
DAZARD_UV_RESPONSE_CLUSTER_G3 	0	11	12	17015	0.0	1.0	1	
WILCOX_RESPONSE_TO_PROGESTERONE_UP 	0	11	125	16902	0.0	1.0	1	
DAZARD_UV_RESPONSE_CLUSTER_G1 	0	11	56	16971	0.0	1.0	1	
FOSTER_KDM1A_TARGETS_UP 	0	11	170	16857	0.0	1.0	1	
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_UP 	0	11	9	17018	0.0	1.0	1	
REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_EXPRESSION 	0	11	33	16994	0.0	1.0	1	
RODWELL_AGING_KIDNEY_NO_BLOOD_DN 	0	11	138	16889	0.0	1.0	1	
YAMASHITA_METHYLATED_IN_PROSTATE_CANCER 	0	11	36	16991	0.0	1.0	1	
BIOCARTA_MONOCYTE_PATHWAY 	0	11	10	17017	0.0	1.0	1	
REACTOME_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION 	0	11	8	17019	0.0	1.0	1	
MCDOWELL_ACUTE_LUNG_INJURY_UP 	0	11	42	16985	0.0	1.0	1	
FARMER_BREAST_CANCER_CLUSTER_4 	0	11	19	17008	0.0	1.0	1	
ROVERSI_GLIOMA_COPY_NUMBER_DN 	0	11	49	16978	0.0	1.0	1	
WNT_SIGNALING 	0	11	83	16944	0.0	1.0	1	
MCLACHLAN_DENTAL_CARIES_UP 	0	11	211	16816	0.0	1.0	1	
REACTOME_METABOLISM_OF_MRNA 	0	11	206	16821	0.0	1.0	1	
WU_APOPTOSIS_BY_CDKN1A_NOT_VIA_TP53 	0	11	10	17017	0.0	1.0	1	
KORKOLA_YOLK_SAC_TUMOR_UP 	0	11	19	17008	0.0	1.0	1	
REACTOME_CDC6_ASSOCIATION_WITH_THE_ORC_ORIGIN_COMPLEX 	0	11	9	17018	0.0	1.0	1	
HUANG_DASATINIB_RESISTANCE_UP 	0	11	77	16950	0.0	1.0	1	
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR 	0	11	106	16921	0.0	1.0	1	
CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN 	0	11	89	16938	0.0	1.0	1	
MANALO_HYPOXIA_DN 	0	11	261	16766	0.0	1.0	1	
REACTOME_ROLE_OF_DCC_IN_REGULATING_APOPTOSIS 	0	11	10	17017	0.0	1.0	1	
AKL_HTLV1_INFECTION_UP 	0	11	25	17002	0.0	1.0	1	
QUINTENS_EMBRYONIC_BRAIN_RESPONSE_TO_IR 	0	11	73	16954	0.0	1.0	1	
AMIT_EGF_RESPONSE_120_HELA 	0	11	65	16962	0.0	1.0	1	
WIKMAN_ASBESTOS_LUNG_CANCER_UP 	0	11	13	17014	0.0	1.0	1	
MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3 	0	11	28	16999	0.0	1.0	1	
REACTOME_NEP_NS2_INTERACTS_WITH_THE_CELLULAR_EXPORT_MACHINERY 	0	11	26	17001	0.0	1.0	1	
DUAN_PRDM5_TARGETS 	0	11	70	16957	0.0	1.0	1	
LEE_CALORIE_RESTRICTION_MUSCLE_UP 	0	11	35	16992	0.0	1.0	1	
LOPEZ_TRANSLATION_VIA_FN1_SIGNALING 	0	11	33	16994	0.0	1.0	1	
REACTOME_P75NTR_RECRUITS_SIGNALLING_COMPLEXES 	0	11	11	17016	0.0	1.0	1	
MORI_PLASMA_CELL_DN 	0	11	27	17000	0.0	1.0	1	
BIOCARTA_CARM_ER_PATHWAY 	0	11	35	16992	0.0	1.0	1	
KEGG_MAPK_SIGNALING_PATHWAY 	0	11	239	16788	0.0	1.0	1	
REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE 	0	11	29	16998	0.0	1.0	1	
NEWMAN_ERCC6_TARGETS_DN 	0	11	31	16996	0.0	1.0	1	
NATSUME_RESPONSE_TO_INTERFERON_BETA_UP 	0	11	64	16963	0.0	1.0	1	
BIOCARTA_PYK2_PATHWAY 	0	11	28	16999	0.0	1.0	1	
NADELLA_PRKAR1A_TARGETS_UP 	0	11	9	17018	0.0	1.0	1	
STARK_HYPPOCAMPUS_22Q11_DELETION_UP 	1	10	48	16979	35.37291666666667	0.03119319280300041	1	C9orf3
KEGG_TRYPTOPHAN_METABOLISM 	0	11	33	16994	0.0	1.0	1	
BHAT_ESR1_TARGETS_VIA_AKT1_DN 	0	11	77	16950	0.0	1.0	1	
PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY 	0	11	38	16989	0.0	1.0	1	
WEI_MYCN_TARGETS_WITH_E_BOX 	1	10	708	16319	2.304943502824859	0.37354507308195717	1	PLLP
GUO_HEX_TARGETS_DN 	0	11	55	16972	0.0	1.0	1	
LABBE_TARGETS_OF_TGFB1_AND_WNT3A_UP 	0	11	100	16927	0.0	1.0	1	
HONMA_DOCETAXEL_RESISTANCE 	0	11	31	16996	0.0	1.0	1	
MIKKELSEN_NPC_LCP_WITH_H3K4ME3 	0	11	49	16978	0.0	1.0	1	
HEIDENBLAD_AMPLIFIED_IN_BONE_CANCER 	0	11	5	17022	0.0	1.0	1	
REACTOME_UNWINDING_OF_DNA 	0	11	10	17017	0.0	1.0	1	
REACTOME_FANCONI_ANEMIA_PATHWAY 	0	11	17	17010	0.0	1.0	1	
KYNG_WERNER_SYNDROM_UP 	0	11	18	17009	0.0	1.0	1	
BILD_SRC_ONCOGENIC_SIGNATURE 	0	11	58	16969	0.0	1.0	1	
ALCALAY_AML_BY_NPM1_LOCALIZATION_DN 	0	11	166	16861	0.0	1.0	1	
PID_ARF6_TRAFFICKING_PATHWAY 	0	11	46	16981	0.0	1.0	1	
SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP 	0	11	18	17009	0.0	1.0	1	
PID_RAC1_PATHWAY 	0	11	53	16974	0.0	1.0	1	
MEISSNER_BRAIN_HCP_WITH_H3K27ME3 	0	11	126	16901	0.0	1.0	1	
DORN_ADENOVIRUS_INFECTION_24HR_DN 	0	11	41	16986	0.0	1.0	1	
REACTOME_AMINO_ACID_SYNTHESIS_AND_INTERCONVERSION_TRANSAMINATION 	0	11	15	17012	0.0	1.0	1	
GESERICK_TERT_TARGETS_DN 	0	11	21	17006	0.0	1.0	1	
KEGG_PYRIMIDINE_METABOLISM 	0	11	93	16934	0.0	1.0	1	
MODY_HIPPOCAMPUS_PRENATAL 	0	11	39	16988	0.0	1.0	1	
BIOCARTA_FREE_PATHWAY 	0	11	6	17021	0.0	1.0	1	
HOWLIN_CITED1_TARGETS_2_DN 	0	11	16	17011	0.0	1.0	1	
MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN 	0	11	62	16965	0.0	1.0	1	
KREPPEL_CD99_TARGETS_DN 	0	11	7	17020	0.0	1.0	1	
PARK_APL_PATHOGENESIS_UP 	0	11	13	17014	0.0	1.0	1	
LANDIS_BREAST_CANCER_PROGRESSION_UP 	0	11	42	16985	0.0	1.0	1	
TRAYNOR_RETT_SYNDROM_UP 	0	11	36	16991	0.0	1.0	1	
ZHAN_EARLY_DIFFERENTIATION_GENES_UP 	0	11	6	17021	0.0	1.0	1	
TSUDA_ALVEOLAR_SOFT_PART_SARCOMA 	0	11	10	17017	0.0	1.0	1	
STREICHER_LSM1_TARGETS_UP 	0	11	41	16986	0.0	1.0	1	
ZHENG_FOXP3_TARGETS_UP 	0	11	22	17005	0.0	1.0	1	
KEGG_DRUG_METABOLISM_CYTOCHROME_P450 	0	11	30	16997	0.0	1.0	1	
TCGA_GLIOBLASTOMA_COPY_NUMBER_UP 	0	11	66	16961	0.0	1.0	1	
NEMETH_INFLAMMATORY_RESPONSE_LPS_DN 	0	11	29	16998	0.0	1.0	1	
MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN 	0	11	16	17011	0.0	1.0	1	
BROWNE_HCMV_INFECTION_16HR_DN 	0	11	78	16949	0.0	1.0	1	
MAHADEVAN_RESPONSE_TO_MP470_DN 	0	11	19	17008	0.0	1.0	1	
PEREZ_TP53_TARGETS 	2	9	994	16033	3.5843952604515983	0.132369526104716	1	CNTN2,CAPN3
SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN 	0	11	58	16969	0.0	1.0	1	
IKEDA_MIR1_TARGETS_DN 	0	11	7	17020	0.0	1.0	1	
NIKOLSKY_BREAST_CANCER_19Q13.4_AMPLICON 	0	11	6	17021	0.0	1.0	1	
REACTOME_SYNTHESIS_OF_VERY_LONG_CHAIN_FATTY_ACYL_COAS 	0	11	14	17013	0.0	1.0	1	
GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP 	0	11	69	16958	0.0	1.0	1	
ABE_VEGFA_TARGETS_2HR 	0	11	28	16999	0.0	1.0	1	
LUCAS_HNF4A_TARGETS_UP 	0	11	53	16974	0.0	1.0	1	
SEIDEN_MET_SIGNALING 	0	11	19	17008	0.0	1.0	1	
NEBEN_AML_WITH_FLT3_OR_NRAS_UP 	0	11	6	17021	0.0	1.0	1	
FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP 	0	11	140	16887	0.0	1.0	1	
CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN 	0	11	20	17007	0.0	1.0	1	
ZHAN_MULTIPLE_MYELOMA_CD2_UP 	0	11	38	16989	0.0	1.0	1	
ENGELMANN_CANCER_PROGENITORS_UP 	0	11	45	16982	0.0	1.0	1	
PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN 	0	11	137	16890	0.0	1.0	1	
MARSON_FOXP3_CORE_DIRECT_TARGETS 	0	11	14	17013	0.0	1.0	1	
KEGG_AUTOIMMUNE_THYROID_DISEASE 	0	11	25	17002	0.0	1.0	1	
AMUNDSON_DNA_DAMAGE_RESPONSE_TP53 	0	11	14	17013	0.0	1.0	1	
SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP 	0	11	116	16911	0.0	1.0	1	
HAMAI_APOPTOSIS_VIA_TRAIL_DN 	0	11	156	16871	0.0	1.0	1	
GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN 	0	11	8	17019	0.0	1.0	1	
DANG_MYC_TARGETS_UP 	0	11	136	16891	0.0	1.0	1	
MARTENS_BOUND_BY_PML_RARA_FUSION 	0	11	415	16612	0.0	1.0	1	
IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS 	0	11	9	17018	0.0	1.0	1	
BIOCARTA_RB_PATHWAY 	0	11	12	17015	0.0	1.0	1	
GALIE_TUMOR_STEMNESS_GENES 	0	11	6	17021	0.0	1.0	1	
KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS 	0	11	128	16899	0.0	1.0	1	
REACTOME_AMINE_COMPOUND_SLC_TRANSPORTERS 	0	11	14	17013	0.0	1.0	1	
ROSS_ACUTE_MYELOID_LEUKEMIA_CBF 	0	11	77	16950	0.0	1.0	1	
REACTOME_CELL_JUNCTION_ORGANIZATION 	0	11	61	16966	0.0	1.0	1	
OLSSON_E2F3_TARGETS_UP 	0	11	25	17002	0.0	1.0	1	
MOOTHA_ROS 	0	11	7	17020	0.0	1.0	1	
PEREZ_TP53_AND_TP63_TARGETS 	1	10	184	16843	9.153804347826087	0.1131926584166485	1	CAPN3
ONDER_CDH1_TARGETS_2_UP 	0	11	242	16785	0.0	1.0	1	
REACTOME_RNA_POL_I_TRANSCRIPTION 	0	11	52	16975	0.0	1.0	1	
PARK_TRETINOIN_RESPONSE 	0	11	11	17016	0.0	1.0	1	
NAKAMURA_METASTASIS 	0	11	42	16985	0.0	1.0	1	
PID_SYNDECAN_2_PATHWAY 	0	11	28	16999	0.0	1.0	1	
GALI_TP53_TARGETS_APOPTOTIC_DN 	0	11	6	17021	0.0	1.0	1	
DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN 	0	11	462	16565	0.0	1.0	1	
ALCALAY_AML_BY_NPM1_LOCALIZATION_UP 	0	11	111	16916	0.0	1.0	1	
LEE_EARLY_T_LYMPHOCYTE_DN 	0	11	50	16977	0.0	1.0	1	
ZEILSTRA_CD44_TARGETS_UP 	0	11	7	17020	0.0	1.0	1	
PID_CXCR3_PATHWAY 	0	11	38	16989	0.0	1.0	1	
REACTOME_AMINE_LIGAND_BINDING_RECEPTORS 	0	11	28	16999	0.0	1.0	1	
MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH 	0	11	14	17013	0.0	1.0	1	
KYNG_DNA_DAMAGE_BY_4NQO_OR_GAMMA_RADIATION 	0	11	14	17013	0.0	1.0	1	
KEGG_PANTOTHENATE_AND_COA_BIOSYNTHESIS 	0	11	16	17011	0.0	1.0	1	
REACTOME_ADP_SIGNALLING_THROUGH_P2RY12 	0	11	19	17008	0.0	1.0	1	
PID_P38_GAMMA_DELTA_PATHWAY 	0	11	10	17017	0.0	1.0	1	
LIU_CMYB_TARGETS_DN 	0	11	7	17020	0.0	1.0	1	
ABE_VEGFA_TARGETS 	0	11	16	17011	0.0	1.0	1	
OHASHI_AURKB_TARGETS 	0	11	7	17020	0.0	1.0	1	
PID_CD8_TCR_PATHWAY 	0	11	49	16978	0.0	1.0	1	
HOELZEL_NF1_TARGETS_DN 	0	11	98	16929	0.0	1.0	1	
BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN 	0	11	26	17001	0.0	1.0	1	
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN 	0	11	30	16997	0.0	1.0	1	
TERAO_AOX4_TARGETS_HG_DN 	0	11	5	17022	0.0	1.0	1	
IKEDA_MIR30_TARGETS_UP 	0	11	112	16915	0.0	1.0	1	
TSENG_ADIPOGENIC_POTENTIAL_DN 	0	11	41	16986	0.0	1.0	1	
REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN 	0	11	10	17017	0.0	1.0	1	
IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP 	0	11	24	17003	0.0	1.0	1	
PID_IL27_PATHWAY 	0	11	19	17008	0.0	1.0	1	
INAMURA_LUNG_CANCER_SCC_DN 	0	11	13	17014	0.0	1.0	1	
MATZUK_EARLY_ANTRAL_FOLLICLE 	0	11	12	17015	0.0	1.0	1	
BIOCARTA_IL2_PATHWAY 	0	11	20	17007	0.0	1.0	1	
SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN 	0	11	28	16999	0.0	1.0	1	
IKEDA_MIR133_TARGETS_DN 	0	11	7	17020	0.0	1.0	1	
KAAB_HEART_ATRIUM_VS_VENTRICLE_UP 	0	11	239	16788	0.0	1.0	1	
REACTOME_SIGNALING_BY_FGFR_IN_DISEASE 	0	11	114	16913	0.0	1.0	1	
MIKKELSEN_ES_LCP_WITH_H3K4ME3_AND_H3K27ME3 	0	11	5	17022	0.0	1.0	1	
MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_DN 	0	11	6	17021	0.0	1.0	1	
PENG_GLUCOSE_DEPRIVATION_UP 	1	10	41	16986	41.42926829268293	0.026791871204934144	1	CAPN3
LANDEMAINE_LUNG_METASTASIS 	0	11	18	17009	0.0	1.0	1	
ST_GA12_PATHWAY 	0	11	21	17006	0.0	1.0	1	
SMID_BREAST_CANCER_LUMINAL_A_UP 	0	11	70	16957	0.0	1.0	1	
KEGG_SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT 	0	11	37	16990	0.0	1.0	1	
MARSON_FOXP3_TARGETS_UP 	0	11	61	16966	0.0	1.0	1	
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP 	0	11	175	16852	0.0	1.0	1	
BIOCARTA_IL12_PATHWAY 	0	11	16	17011	0.0	1.0	1	
BIOCARTA_NOS1_PATHWAY 	0	11	20	17007	0.0	1.0	1	
KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION 	0	11	38	16989	0.0	1.0	1	
CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_UP 	0	11	9	17018	0.0	1.0	1	
AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP 	0	11	269	16758	0.0	1.0	1	
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP 	0	11	125	16902	0.0	1.0	1	
REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA 	0	11	23	17004	0.0	1.0	1	
REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY 	0	11	13	17014	0.0	1.0	1	
LU_TUMOR_ENDOTHELIAL_MARKERS_UP 	0	11	22	17005	0.0	1.0	1	
ODONNELL_METASTASIS_UP 	1	10	61	16966	27.81311475409836	0.03931909868204709	1	SOX10
NIELSEN_GIST 	0	11	92	16935	0.0	1.0	1	
MARTINEZ_RB1_AND_TP53_TARGETS_DN 	0	11	497	16530	0.0	1.0	1	
REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC 	0	11	19	17008	0.0	1.0	1	
ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_UP 	0	11	12	17015	0.0	1.0	1	
MARSON_BOUND_BY_E2F4_UNSTIMULATED 	0	11	613	16414	0.0	1.0	1	
APPIERTO_RESPONSE_TO_FENRETINIDE_DN 	0	11	48	16979	0.0	1.0	1	
PID_E2F_PATHWAY 	0	11	67	16960	0.0	1.0	1	
KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY 	0	11	60	16967	0.0	1.0	1	
XU_CREBBP_TARGETS_DN 	0	11	38	16989	0.0	1.0	1	
STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP 	0	11	28	16999	0.0	1.0	1	
PID_ARF6_DOWNSTREAM_PATHWAY 	0	11	15	17012	0.0	1.0	1	
OHGUCHI_LIVER_HNF4A_TARGETS_UP 	0	11	38	16989	0.0	1.0	1	
REACTOME_SIGNALING_BY_ACTIVATED_POINT_MUTANTS_OF_FGFR1 	0	11	7	17020	0.0	1.0	1	
YOKOE_CANCER_TESTIS_ANTIGENS 	1	10	30	16997	56.656666666666666	0.019838771731075715	1	CAPN3
GEISS_RESPONSE_TO_DSRNA_UP 	0	11	37	16990	0.0	1.0	1	
GRESHOCK_CANCER_COPY_NUMBER_UP 	0	11	289	16738	0.0	1.0	1	
WONG_ENDMETRIUM_CANCER_UP 	0	11	15	17012	0.0	1.0	1	
DOUGLAS_BMI1_TARGETS_DN 	0	11	294	16733	0.0	1.0	1	
PID_MYC_PATHWAY 	0	11	25	17002	0.0	1.0	1	
DER_IFN_BETA_RESPONSE_DN 	0	11	6	17021	0.0	1.0	1	
KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GLOBO_SERIES 	0	11	14	17013	0.0	1.0	1	
REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING 	0	11	19	17008	0.0	1.0	1	
DURCHDEWALD_SKIN_CARCINOGENESIS_UP 	0	11	70	16957	0.0	1.0	1	
REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM 	0	11	47	16980	0.0	1.0	1	
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP 	0	11	155	16872	0.0	1.0	1	
BURTON_ADIPOGENESIS_PEAK_AT_24HR 	0	11	34	16993	0.0	1.0	1	
BIOCARTA_SKP2E2F_PATHWAY 	0	11	10	17017	0.0	1.0	1	
LIN_MELANOMA_COPY_NUMBER_UP 	0	11	62	16965	0.0	1.0	1	
WARTERS_IR_RESPONSE_5GY 	0	11	40	16987	0.0	1.0	1	
ONDER_CDH1_TARGETS_1_UP 	0	11	129	16898	0.0	1.0	1	
DIRMEIER_LMP1_RESPONSE_LATE_UP 	0	11	53	16974	0.0	1.0	1	
GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3 	0	11	13	17014	0.0	1.0	1	
BIOCARTA_FEEDER_PATHWAY 	0	11	8	17019	0.0	1.0	1	
WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN 	0	11	89	16938	0.0	1.0	1	
KEGG_OOCYTE_MEIOSIS 	0	11	98	16929	0.0	1.0	1	
HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP 	0	11	385	16642	0.0	1.0	1	
KEGG_SELENOAMINO_ACID_METABOLISM 	0	11	25	17002	0.0	1.0	1	
REACTOME_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS 	0	11	62	16965	0.0	1.0	1	
CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP 	0	11	338	16689	0.0	1.0	1	
LIAO_HAVE_SOX4_BINDING_SITES 	0	11	38	16989	0.0	1.0	1	
NAM_FXYD5_TARGETS_DN 	0	11	18	17009	0.0	1.0	1	
SANDERSON_PPARA_TARGETS 	0	11	13	17014	0.0	1.0	1	
REACTOME_INSULIN_SYNTHESIS_AND_PROCESSING 	0	11	18	17009	0.0	1.0	1	
GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN 	0	11	60	16967	0.0	1.0	1	
LIU_PROSTATE_CANCER_UP 	0	11	84	16943	0.0	1.0	1	
HOEGERKORP_CD44_TARGETS_DIRECT_DN 	0	11	11	17016	0.0	1.0	1	
MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP 	0	11	76	16951	0.0	1.0	1	
REACTOME_BIOLOGICAL_OXIDATIONS 	0	11	87	16940	0.0	1.0	1	
LU_TUMOR_ENDOTHELIAL_MARKERS_DN 	0	11	5	17022	0.0	1.0	1	
MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN 	1	10	109	16918	15.521100917431193	0.06878859314291307	1	CAPN3
MIKKELSEN_IPS_LCP_WITH_H3K4ME3_AND_H3K27ME3 	0	11	4	17023	0.0	1.0	1	
REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS 	0	11	43	16984	0.0	1.0	1	
SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP 	0	11	46	16981	0.0	1.0	1	
REACTOME_ALPHA_LINOLENIC_ACID_ALA_METABOLISM 	0	11	11	17016	0.0	1.0	1	
SMID_BREAST_CANCER_ERBB2_DN 	1	10	3	17024	567.4666666666667	0.002580189836049641	1	SOX10
RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP 	0	11	15	17012	0.0	1.0	1	
KYNG_DNA_DAMAGE_DN 	0	11	184	16843	0.0	1.0	1	
KIM_WT1_TARGETS_DN 	0	11	406	16621	0.0	1.0	1	
BIOCARTA_CARM1_PATHWAY 	0	11	12	17015	0.0	1.0	1	
HAN_SATB1_TARGETS_UP 	1	10	354	16673	4.709887005649717	0.20680302300662914	1	PLLP
RAFFEL_VEGFA_TARGETS_DN 	0	11	3	17024	0.0	1.0	1	
ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE 	0	11	60	16967	0.0	1.0	1	
YAMASHITA_LIVER_CANCER_STEM_CELL_DN 	0	11	51	16976	0.0	1.0	1	
REACTOME_TOLL_RECEPTOR_CASCADES 	0	11	109	16918	0.0	1.0	1	
WU_HBX_TARGETS_1_UP 	0	11	13	17014	0.0	1.0	1	
KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION 	0	11	51	16976	0.0	1.0	1	
SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN 	0	11	33	16994	0.0	1.0	1	
LUDWICZEK_TREATING_IRON_OVERLOAD 	0	11	6	17021	0.0	1.0	1	
YANG_MUC2_TARGETS_COLON_3MO_DN 	0	11	3	17024	0.0	1.0	1	
GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN 	0	11	50	16977	0.0	1.0	1	
BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN 	0	11	28	16999	0.0	1.0	1	
DACOSTA_UV_RESPONSE_VIA_ERCC3_UP 	0	11	294	16733	0.0	1.0	1	
ST_GA13_PATHWAY 	0	11	35	16992	0.0	1.0	1	
LEE_DIFFERENTIATING_T_LYMPHOCYTE 	0	11	171	16856	0.0	1.0	1	
KAMMINGA_SENESCENCE 	0	11	37	16990	0.0	1.0	1	
LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK 	0	11	14	17013	0.0	1.0	1	
CHEOK_RESPONSE_TO_MERCAPTOPURINE_UP 	0	11	13	17014	0.0	1.0	1	
TSUNODA_CISPLATIN_RESISTANCE_UP 	0	11	14	17013	0.0	1.0	1	
BORLAK_LIVER_CANCER_EGF_UP 	0	11	52	16975	0.0	1.0	1	
MARTIN_INTERACT_WITH_HDAC 	0	11	41	16986	0.0	1.0	1	
BIOCARTA_PTC1_PATHWAY 	0	11	10	17017	0.0	1.0	1	
PID_AMB2_NEUTROPHILS_PATHWAY 	0	11	37	16990	0.0	1.0	1	
KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS 	0	11	50	16977	0.0	1.0	1	
IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR 	0	11	466	16561	0.0	1.0	1	
KEGG_MTOR_SIGNALING_PATHWAY 	0	11	50	16977	0.0	1.0	1	
REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE 	0	11	74	16953	0.0	1.0	1	
REACTOME_LATENT_INFECTION_OF_HOMO_SAPIENS_WITH_MYCOBACTERIUM_TUBERCULOSIS 	0	11	27	17000	0.0	1.0	1	
LEE_LIVER_CANCER_HEPATOBLAST 	0	11	14	17013	0.0	1.0	1	
PID_P75_NTR_PATHWAY 	1	10	61	16966	27.81311475409836	0.03931909868204709	1	MAG
REACTOME_PASSIVE_TRANSPORT_BY_AQUAPORINS 	0	11	8	17019	0.0	1.0	1	
NIKOLSKY_BREAST_CANCER_20P13_AMPLICON 	0	11	7	17020	0.0	1.0	1	
REACTOME_PYRIMIDINE_CATABOLISM 	0	11	10	17017	0.0	1.0	1	
OUYANG_PROSTATE_CANCER_PROGRESSION_DN 	0	11	19	17008	0.0	1.0	1	
HOWLIN_CITED1_TARGETS_2_UP 	0	11	13	17014	0.0	1.0	1	
REACTOME_NEF_MEDIATES_DOWN_MODULATION_OF_CELL_SURFACE_RECEPTORS_BY_RECRUITING_THEM_TO_CLATHRIN_ADAPTERS 	0	11	18	17009	0.0	1.0	1	
REACTOME_SHC_MEDIATED_CASCADE 	0	11	22	17005	0.0	1.0	1	
HAEGERSTRAND_RESPONSE_TO_IMATINIB 	0	11	9	17018	0.0	1.0	1	
JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP 	0	11	45	16982	0.0	1.0	1	
CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN 	0	11	28	16999	0.0	1.0	1	
PID_FGF_PATHWAY 	0	11	51	16976	0.0	1.0	1	
REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS 	0	11	42	16985	0.0	1.0	1	
FISCHER_G1_S_CELL_CYCLE 	0	11	175	16852	0.0	1.0	1	
MCCABE_HOXC6_TARGETS_CANCER_DN 	0	11	19	17008	0.0	1.0	1	
KYNG_DNA_DAMAGE_BY_UV 	0	11	58	16969	0.0	1.0	1	
MAINA_VHL_TARGETS_DN 	0	11	17	17010	0.0	1.0	1	
BENPORATH_EED_TARGETS 	0	11	817	16210	0.0	1.0	1	
KANG_GIST_WITH_PDGFRA_UP 	0	11	46	16981	0.0	1.0	1	
GEORGES_CELL_CYCLE_MIR192_TARGETS 	0	11	56	16971	0.0	1.0	1	
WHITEHURST_PACLITAXEL_SENSITIVITY 	0	11	32	16995	0.0	1.0	1	
RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP 	0	11	67	16960	0.0	1.0	1	
REACTOME_EICOSANOID_LIGAND_BINDING_RECEPTORS 	0	11	14	17013	0.0	1.0	1	
REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING 	0	11	21	17006	0.0	1.0	1	
SOUCEK_MYC_TARGETS 	0	11	5	17022	0.0	1.0	1	
DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP 	0	11	1331	15696	0.0	1.0	1	
ABDULRAHMAN_KIDNEY_CANCER_VHL_DN 	0	11	13	17014	0.0	1.0	1	
EPPERT_HSC_R 	0	11	108	16919	0.0	1.0	1	
HUMMEL_BURKITTS_LYMPHOMA_UP 	0	11	37	16990	0.0	1.0	1	
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP 	0	11	15	17012	0.0	1.0	1	
KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP 	0	11	45	16982	0.0	1.0	1	
BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP 	0	11	46	16981	0.0	1.0	1	
REACTOME_PKB_MEDIATED_EVENTS 	0	11	27	17000	0.0	1.0	1	
REACTOME_HORMONE_SENSITIVE_LIPASE_HSL_MEDIATED_TRIACYLGLYCEROL_HYDROLYSIS 	0	11	11	17016	0.0	1.0	1	
REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX_ 	0	11	35	16992	0.0	1.0	1	
SA_PROGRAMMED_CELL_DEATH 	0	11	12	17015	0.0	1.0	1	
BIOCARTA_IGF1MTOR_PATHWAY 	0	11	20	17007	0.0	1.0	1	
ROVERSI_GLIOMA_COPY_NUMBER_UP 	0	11	85	16942	0.0	1.0	1	
MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_DN 	0	11	13	17014	0.0	1.0	1	
MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP 	0	11	98	16929	0.0	1.0	1	
PID_INSULIN_PATHWAY 	0	11	44	16983	0.0	1.0	1	
BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP 	0	11	26	17001	0.0	1.0	1	
SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP 	0	11	75	16952	0.0	1.0	1	
ELVIDGE_HYPOXIA_BY_DMOG_DN 	0	11	55	16972	0.0	1.0	1	
WEBER_METHYLATED_ICP_IN_FIBROBLAST 	0	11	2	17025	0.0	1.0	1	
MIKKELSEN_MCV6_LCP_WITH_H3K27ME3 	0	11	14	17013	0.0	1.0	1	
DELPUECH_FOXO3_TARGETS_DN 	0	11	36	16991	0.0	1.0	1	
WANG_ADIPOGENIC_GENES_REPRESSED_BY_SIRT1 	0	11	24	17003	0.0	1.0	1	
TENEDINI_MEGAKARYOCYTE_MARKERS 	0	11	60	16967	0.0	1.0	1	
PID_CONE_PATHWAY 	0	11	14	17013	0.0	1.0	1	
ROESSLER_LIVER_CANCER_METASTASIS_DN 	0	11	43	16984	0.0	1.0	1	
PID_MYC_REPRESS_PATHWAY 	0	11	58	16969	0.0	1.0	1	
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 	0	11	175	16852	0.0	1.0	1	
REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI 	0	11	18	17009	0.0	1.0	1	
KIM_MYCN_AMPLIFICATION_TARGETS_DN 	0	11	92	16935	0.0	1.0	1	
WEINMANN_ADAPTATION_TO_HYPOXIA_DN 	0	11	38	16989	0.0	1.0	1	
TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP 	0	11	71	16956	0.0	1.0	1	
ZHAN_MULTIPLE_MYELOMA_PR_DN 	0	11	42	16985	0.0	1.0	1	
WALLACE_JAK2_TARGETS_UP 	0	11	24	17003	0.0	1.0	1	
GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_UP 	0	11	9	17018	0.0	1.0	1	
KRIEG_HYPOXIA_NOT_VIA_KDM3A 	1	10	669	16358	2.4451420029895368	0.3568835523376199	1	CDC42EP1
SENESE_HDAC1_TARGETS_DN 	0	11	229	16798	0.0	1.0	1	
SANSOM_APC_TARGETS 	1	10	174	16853	9.685632183908046	0.10738551075475157	1	C9orf3
YEGNASUBRAMANIAN_PROSTATE_CANCER 	0	11	91	16936	0.0	1.0	1	
IGLESIAS_E2F_TARGETS_UP 	0	11	144	16883	0.0	1.0	1	
COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN 	0	11	120	16907	0.0	1.0	1	
KEGG_MISMATCH_REPAIR 	0	11	22	17005	0.0	1.0	1	
SU_THYMUS 	0	11	12	17015	0.0	1.0	1	
AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN 	0	11	215	16812	0.0	1.0	1	
DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP 	0	11	62	16965	0.0	1.0	1	
REACTOME_SIGNALLING_BY_NGF 	1	10	208	16819	8.086057692307692	0.12698994895971075	1	MAG
SCHUHMACHER_MYC_TARGETS_UP 	0	11	77	16950	0.0	1.0	1	
LEE_AGING_NEOCORTEX_UP 	1	10	83	16944	20.4144578313253	0.052929595844050555	1	MAG
YE_METASTATIC_LIVER_CANCER 	0	11	22	17005	0.0	1.0	1	
REACTOME_DNA_REPLICATION 	0	11	166	16861	0.0	1.0	1	
KEGG_RENIN_ANGIOTENSIN_SYSTEM 	0	11	10	17017	0.0	1.0	1	
PID_THROMBIN_PAR4_PATHWAY 	0	11	13	17014	0.0	1.0	1	
SCIBETTA_KDM5B_TARGETS_DN 	0	11	70	16957	0.0	1.0	1	
LIU_VAV3_PROSTATE_CARCINOGENESIS_UP 	0	11	77	16950	0.0	1.0	1	
IKEDA_MIR30_TARGETS_DN 	0	11	25	17002	0.0	1.0	1	
REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE 	0	11	4	17023	0.0	1.0	1	
DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY 	0	11	26	17001	0.0	1.0	1	
LEE_LIVER_CANCER_DENA_DN 	0	11	53	16974	0.0	1.0	1	
HINATA_NFKB_TARGETS_FIBROBLAST_UP 	0	11	76	16951	0.0	1.0	1	
NELSON_RESPONSE_TO_ANDROGEN_DN 	0	11	17	17010	0.0	1.0	1	
REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS 	0	11	19	17008	0.0	1.0	1	
PATTERSON_DOCETAXEL_RESISTANCE 	0	11	26	17001	0.0	1.0	1	
MCCLUNG_DELTA_FOSB_TARGETS_8WK 	0	11	47	16980	0.0	1.0	1	
VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP 	0	11	159	16868	0.0	1.0	1	
REACTOME_CD28_DEPENDENT_VAV1_PATHWAY 	0	11	9	17018	0.0	1.0	1	
WEIGEL_OXIDATIVE_STRESS_RESPONSE 	0	11	33	16994	0.0	1.0	1	
KANNAN_TP53_TARGETS_DN 	0	11	21	17006	0.0	1.0	1	
SANSOM_WNT_PATHWAY_REQUIRE_MYC 	0	11	56	16971	0.0	1.0	1	
KEGG_ALLOGRAFT_REJECTION 	0	11	23	17004	0.0	1.0	1	
ONDER_CDH1_SIGNALING_VIA_CTNNB1 	0	11	76	16951	0.0	1.0	1	
REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS 	0	11	18	17009	0.0	1.0	1	
REACTOME_TCR_SIGNALING 	0	11	47	16980	0.0	1.0	1	
PEDRIOLI_MIR31_TARGETS_UP 	0	11	157	16870	0.0	1.0	1	
PID_RXR_VDR_PATHWAY 	0	11	24	17003	0.0	1.0	1	
MOHANKUMAR_TLX1_TARGETS_DN 	0	11	145	16882	0.0	1.0	1	
LU_IL4_SIGNALING 	0	11	88	16939	0.0	1.0	1	
PENG_GLUTAMINE_DEPRIVATION_DN 	0	11	321	16706	0.0	1.0	1	
PID_CIRCADIAN_PATHWAY 	0	11	15	17012	0.0	1.0	1	
BENPORATH_PROLIFERATION 	0	11	125	16902	0.0	1.0	1	
NIKOLSKY_BREAST_CANCER_7P22_AMPLICON 	0	11	31	16996	0.0	1.0	1	
KEGG_BASE_EXCISION_REPAIR 	0	11	32	16995	0.0	1.0	1	
WONG_MITOCHONDRIA_GENE_MODULE 	0	11	213	16814	0.0	1.0	1	
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP 	0	11	71	16956	0.0	1.0	1	
KEGG_CELL_CYCLE 	0	11	115	16912	0.0	1.0	1	
FRASOR_TAMOXIFEN_RESPONSE_UP 	0	11	49	16978	0.0	1.0	1	
OSADA_ASCL1_TARGETS_UP 	0	11	40	16987	0.0	1.0	1	
KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP 	0	11	835	16192	0.0	1.0	1	
KEGG_ARGININE_AND_PROLINE_METABOLISM 	0	11	49	16978	0.0	1.0	1	
REACTOME_BILE_SALT_AND_ORGANIC_ANION_SLC_TRANSPORTERS 	0	11	8	17019	0.0	1.0	1	
BROWNE_HCMV_INFECTION_16HR_UP 	0	11	214	16813	0.0	1.0	1	
BENPORATH_ES_2 	0	11	30	16997	0.0	1.0	1	
BIOCARTA_CALCINEURIN_PATHWAY 	0	11	18	17009	0.0	1.0	1	
LABBE_TGFB1_TARGETS_UP 	0	11	88	16939	0.0	1.0	1	
PID_TXA2PATHWAY 	0	11	53	16974	0.0	1.0	1	
KONG_E2F1_TARGETS 	0	11	6	17021	0.0	1.0	1	
KYNG_DNA_DAMAGE_BY_4NQO_OR_UV 	0	11	60	16967	0.0	1.0	1	
REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR 	0	11	89	16938	0.0	1.0	1	
PID_TNF_PATHWAY 	0	11	43	16984	0.0	1.0	1	
MADAN_DPPA4_TARGETS 	0	11	33	16994	0.0	1.0	1	
PID_INTEGRIN4_PATHWAY 	0	11	11	17016	0.0	1.0	1	
REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX 	0	11	14	17013	0.0	1.0	1	
CALVET_IRINOTECAN_SENSITIVE_VS_REVERTED_DN 	0	11	5	17022	0.0	1.0	1	
REACTOME_STRIATED_MUSCLE_CONTRACTION 	0	11	22	17005	0.0	1.0	1	
REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS 	0	11	10	17017	0.0	1.0	1	
BIOCARTA_IL10_PATHWAY 	0	11	15	17012	0.0	1.0	1	
VECCHI_GASTRIC_CANCER_EARLY_UP 	0	11	341	16686	0.0	1.0	1	
CROONQUIST_IL6_DEPRIVATION_DN 	0	11	83	16944	0.0	1.0	1	
GARY_CD5_TARGETS_UP 	0	11	441	16586	0.0	1.0	1	
REACTOME_REGULATION_OF_WATER_BALANCE_BY_RENAL_AQUAPORINS 	0	11	37	16990	0.0	1.0	1	
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN 	0	11	71	16956	0.0	1.0	1	
REACTOME_SOS_MEDIATED_SIGNALLING 	0	11	14	17013	0.0	1.0	1	
CHANGOLKAR_H2AFY_TARGETS_DN 	0	11	34	16993	0.0	1.0	1	
ONO_FOXP3_TARGETS_DN 	0	11	29	16998	0.0	1.0	1	
REACTOME_APOBEC3G_MEDIATED_RESISTANCE_TO_HIV1_INFECTION 	0	11	5	17022	0.0	1.0	1	
BALDWIN_PRKCI_TARGETS_UP 	0	11	33	16994	0.0	1.0	1	
MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED 	0	11	40	16987	0.0	1.0	1	
MCCABE_BOUND_BY_HOXC6 	0	11	340	16687	0.0	1.0	1	
REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION 	0	11	14	17013	0.0	1.0	1	
REACTOME_SHC_MEDIATED_SIGNALLING 	0	11	15	17012	0.0	1.0	1	
CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN 	0	11	47	16980	0.0	1.0	1	
TURJANSKI_MAPK8_AND_MAPK9_TARGETS 	0	11	8	17019	0.0	1.0	1	
REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION 	0	11	91	16936	0.0	1.0	1	
YUAN_ZNF143_PARTNERS 	0	11	21	17006	0.0	1.0	1	
OSMAN_BLADDER_CANCER_DN 	0	11	351	16676	0.0	1.0	1	
PID_ERBB1_INTERNALIZATION_PATHWAY 	0	11	41	16986	0.0	1.0	1	
KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM 	0	11	80	16947	0.0	1.0	1	
REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION 	0	11	13	17014	0.0	1.0	1	
ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN 	0	11	45	16982	0.0	1.0	1	
REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING 	0	11	35	16992	0.0	1.0	1	
YANG_BREAST_CANCER_ESR1_LASER_DN 	0	11	48	16979	0.0	1.0	1	
BARIS_THYROID_CANCER_DN 	0	11	54	16973	0.0	1.0	1	
MENSSEN_MYC_TARGETS 	0	11	51	16976	0.0	1.0	1	
HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 	0	11	153	16874	0.0	1.0	1	
PID_S1P_S1P3_PATHWAY 	0	11	29	16998	0.0	1.0	1	
JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN 	0	11	44	16983	0.0	1.0	1	
BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_AND_PAX3 	0	11	7	17020	0.0	1.0	1	
ST_ERK1_ERK2_MAPK_PATHWAY 	0	11	31	16996	0.0	1.0	1	
PID_INTEGRIN1_PATHWAY 	0	11	63	16964	0.0	1.0	1	
REACTOME_GLYCOSPHINGOLIPID_METABOLISM 	0	11	33	16994	0.0	1.0	1	
BIOCARTA_ETS_PATHWAY 	0	11	18	17009	0.0	1.0	1	
ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_UP 	0	11	234	16793	0.0	1.0	1	
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN 	0	11	222	16805	0.0	1.0	1	
REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_ 	0	11	42	16985	0.0	1.0	1	
REACTOME_INFLUENZA_LIFE_CYCLE 	0	11	133	16894	0.0	1.0	1	
MOOTHA_GLUCONEOGENESIS 	0	11	28	16999	0.0	1.0	1	
CROONQUIST_NRAS_SIGNALING_DN 	0	11	61	16966	0.0	1.0	1	
REACTOME_INSULIN_RECEPTOR_RECYCLING 	0	11	19	17008	0.0	1.0	1	
REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS 	0	11	12	17015	0.0	1.0	1	
REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS 	0	11	44	16983	0.0	1.0	1	
WANG_CISPLATIN_RESPONSE_AND_XPC_DN 	0	11	215	16812	0.0	1.0	1	
MANTOVANI_NFKB_TARGETS_DN 	0	11	8	17019	0.0	1.0	1	
PETRETTO_BLOOD_PRESSURE_DN 	0	11	7	17020	0.0	1.0	1	
GERY_CEBP_TARGETS 	0	11	115	16912	0.0	1.0	1	
PHONG_TNF_RESPONSE_VIA_P38_PARTIAL 	0	11	147	16880	0.0	1.0	1	
DELYS_THYROID_CANCER_UP 	0	11	409	16618	0.0	1.0	1	
XU_AKT1_TARGETS_6HR 	0	11	24	17003	0.0	1.0	1	
JIANG_HYPOXIA_VIA_VHL 	0	11	33	16994	0.0	1.0	1	
SMID_BREAST_CANCER_NORMAL_LIKE_DN 	0	11	5	17022	0.0	1.0	1	
DARWICHE_PAPILLOMA_RISK_LOW_DN 	0	11	140	16887	0.0	1.0	1	
ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN 	0	11	63	16964	0.0	1.0	1	
REACTOME_NUCLEAR_SIGNALING_BY_ERBB4 	0	11	32	16995	0.0	1.0	1	
CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS 	0	11	46	16981	0.0	1.0	1	
REACTOME_CD28_CO_STIMULATION 	0	11	29	16998	0.0	1.0	1	
REACTOME_MITOTIC_G2_G2_M_PHASES 	0	11	75	16952	0.0	1.0	1	
LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN 	0	11	86	16941	0.0	1.0	1	
DORN_ADENOVIRUS_INFECTION_32HR_DN 	0	11	37	16990	0.0	1.0	1	
DANG_MYC_TARGETS_DN 	0	11	28	16999	0.0	1.0	1	
REACTOME_PLATELET_HOMEOSTASIS 	0	11	71	16956	0.0	1.0	1	
GREENBAUM_E2A_TARGETS_UP 	0	11	28	16999	0.0	1.0	1	
ZHENG_BOUND_BY_FOXP3 	0	11	429	16598	0.0	1.0	1	
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP 	0	11	191	16836	0.0	1.0	1	
HOLLEMAN_DAUNORUBICIN_B_ALL_DN 	0	11	12	17015	0.0	1.0	1	
WEBER_METHYLATED_LCP_IN_SPERM_UP 	0	11	3	17024	0.0	1.0	1	
GHANDHI_BYSTANDER_IRRADIATION_DN 	0	11	10	17017	0.0	1.0	1	
REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE 	0	11	57	16970	0.0	1.0	1	
ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF 	0	11	196	16831	0.0	1.0	1	
EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION 	0	11	41	16986	0.0	1.0	1	
REACTOME_MRNA_3_END_PROCESSING 	0	11	33	16994	0.0	1.0	1	
BOYLAN_MULTIPLE_MYELOMA_C_DN 	0	11	52	16975	0.0	1.0	1	
MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_UP 	0	11	6	17021	0.0	1.0	1	
BIOCARTA_RAB_PATHWAY 	0	11	12	17015	0.0	1.0	1	
ZHENG_FOXP3_TARGETS_IN_THYMUS_UP 	0	11	177	16850	0.0	1.0	1	
RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_UP 	0	11	4	17023	0.0	1.0	1	
TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN 	0	11	16	17011	0.0	1.0	1	
PID_HDAC_CLASSIII_PATHWAY 	0	11	22	17005	0.0	1.0	1	
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN 	1	10	104	16923	16.272115384615386	0.0657576673319125	1	CAPN3
PID_INSULIN_GLUCOSE_PATHWAY 	0	11	23	17004	0.0	1.0	1	
JAZAG_TGFB1_SIGNALING_UP 	0	11	100	16927	0.0	1.0	1	
OHGUCHI_LIVER_HNF4A_TARGETS_DN 	1	10	90	16937	18.81888888888889	0.05722330165495481	1	TMC7
WINZEN_DEGRADED_VIA_KHSRP 	1	10	87	16940	19.471264367816094	0.055385313687091785	1	TMC7
BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP 	0	11	42	16985	0.0	1.0	1	
ONDER_CDH1_TARGETS_3_DN 	0	11	36	16991	0.0	1.0	1	
REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS 	0	11	22	17005	0.0	1.0	1	
REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS 	0	11	7	17020	0.0	1.0	1	
FERRANDO_HOX11_NEIGHBORS 	0	11	16	17011	0.0	1.0	1	
REACTOME_BETA_DEFENSINS 	0	11	3	17024	0.0	1.0	1	
WILENSKY_RESPONSE_TO_DARAPLADIB 	0	11	27	17000	0.0	1.0	1	
JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP 	0	11	64	16963	0.0	1.0	1	
WANG_RESPONSE_TO_PACLITAXEL_VIA_MAPK8_DN 	0	11	4	17023	0.0	1.0	1	
PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN 	0	11	124	16903	0.0	1.0	1	
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN 	0	11	32	16995	0.0	1.0	1	
SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP 	0	11	65	16962	0.0	1.0	1	
MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN 	0	11	471	16556	0.0	1.0	1	
PID_WNT_CANONICAL_PATHWAY 	0	11	19	17008	0.0	1.0	1	
NIKOLSKY_BREAST_CANCER_14Q22_AMPLICON 	0	11	13	17014	0.0	1.0	1	
BROWNE_HCMV_INFECTION_48HR_DN 	0	11	430	16597	0.0	1.0	1	
ZHOU_TNF_SIGNALING_4HR 	0	11	52	16975	0.0	1.0	1	
HUMMEL_BURKITTS_LYMPHOMA_DN 	0	11	14	17013	0.0	1.0	1	
REACTOME_CALNEXIN_CALRETICULIN_CYCLE 	0	11	11	17016	0.0	1.0	1	
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_DN 	0	11	7	17020	0.0	1.0	1	
BURTON_ADIPOGENESIS_2 	0	11	70	16957	0.0	1.0	1	
BIOCARTA_STRESS_PATHWAY 	0	11	23	17004	0.0	1.0	1	
LEIN_LOCALIZED_TO_DISTAL_AND_PROXIMAL_DENDRITES 	0	11	15	17012	0.0	1.0	1	
REACTOME_INTERFERON_ALPHA_BETA_SIGNALING 	0	11	47	16980	0.0	1.0	1	
WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP 	0	11	101	16926	0.0	1.0	1	
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS 	0	11	163	16864	0.0	1.0	1	
BERGER_MBD2_TARGETS 	0	11	3	17024	0.0	1.0	1	
BIOCARTA_IL17_PATHWAY 	0	11	9	17018	0.0	1.0	1	
PILON_KLF1_TARGETS_DN 	0	11	1842	15185	0.0	1.0	1	
LUI_THYROID_CANCER_CLUSTER_1 	0	11	50	16977	0.0	1.0	1	
FINETTI_BREAST_CANCERS_KINOME_GRAY 	0	11	15	17012	0.0	1.0	1	
LUI_THYROID_CANCER_CLUSTER_3 	0	11	28	16999	0.0	1.0	1	
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN 	0	11	104	16923	0.0	1.0	1	
KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM 	0	11	22	17005	0.0	1.0	1	
LUI_THYROID_CANCER_CLUSTER_4 	0	11	11	17016	0.0	1.0	1	
PID_DNA_PK_PATHWAY 	0	11	15	17012	0.0	1.0	1	
MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP 	0	11	219	16808	0.0	1.0	1	
GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN 	0	11	76	16951	0.0	1.0	1	
PID_RETINOIC_ACID_PATHWAY 	0	11	30	16997	0.0	1.0	1	
SCHRAETS_MLL_TARGETS_UP 	0	11	32	16995	0.0	1.0	1	
AZARE_STAT3_TARGETS 	0	11	21	17006	0.0	1.0	1	
BURTON_ADIPOGENESIS_5 	0	11	116	16911	0.0	1.0	1	
REACTOME_PIP3_ACTIVATES_AKT_SIGNALING 	0	11	27	17000	0.0	1.0	1	
DOANE_BREAST_CANCER_ESR1_UP 	0	11	97	16930	0.0	1.0	1	
MACLACHLAN_BRCA1_TARGETS_UP 	0	11	20	17007	0.0	1.0	1	
AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_2G 	0	11	159	16868	0.0	1.0	1	
FORTSCHEGGER_PHF8_TARGETS_DN 	0	11	704	16323	0.0	1.0	1	
BRIDEAU_IMPRINTED_GENES 	0	11	56	16971	0.0	1.0	1	
KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE 	0	11	24	17003	0.0	1.0	1	
SCHRAMM_INHBA_TARGETS_DN 	0	11	23	17004	0.0	1.0	1	
REACTOME_INTRINSIC_PATHWAY 	0	11	11	17016	0.0	1.0	1	
WENG_POR_TARGETS_LIVER_UP 	0	11	35	16992	0.0	1.0	1	
REACTOME_TELOMERE_MAINTENANCE 	0	11	53	16974	0.0	1.0	1	
MEISSNER_NPC_ICP_WITH_H3_UNMETHYLATED 	0	11	19	17008	0.0	1.0	1	
BURTON_ADIPOGENESIS_9 	0	11	87	16940	0.0	1.0	1	
ST_G_ALPHA_I_PATHWAY 	0	11	33	16994	0.0	1.0	1	
CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN 	0	11	411	16616	0.0	1.0	1	
CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_DN 	0	11	16	17011	0.0	1.0	1	
RICKMAN_METASTASIS_DN 	0	11	238	16789	0.0	1.0	1	
WIERENGA_STAT5A_TARGETS_DN 	0	11	173	16854	0.0	1.0	1	
SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_UP 	0	11	9	17018	0.0	1.0	1	
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP 	0	11	115	16912	0.0	1.0	1	
MIKKELSEN_NPC_WITH_LCP_H3K27ME3 	0	11	2	17025	0.0	1.0	1	
PODAR_RESPONSE_TO_ADAPHOSTIN_UP 	0	11	138	16889	0.0	1.0	1	
BIOCARTA_RANKL_PATHWAY 	0	11	12	17015	0.0	1.0	1	
RAMALHO_STEMNESS_UP 	0	11	197	16830	0.0	1.0	1	
GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN 	2	9	298	16729	12.475018642803878	0.015302419222038809	1	CDC42EP1,RTKN
WANG_TUMOR_INVASIVENESS_UP 	0	11	352	16675	0.0	1.0	1	
SASAKI_ADULT_T_CELL_LEUKEMIA 	0	11	155	16872	0.0	1.0	1	
KEGG_ASTHMA 	0	11	14	17013	0.0	1.0	1	
GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP 	0	11	167	16860	0.0	1.0	1	
MALONEY_RESPONSE_TO_17AAG_DN 	0	11	75	16952	0.0	1.0	1	
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP 	0	11	31	16996	0.0	1.0	1	
REACTOME_S_PHASE 	0	11	103	16924	0.0	1.0	1	
VERHAAK_GLIOBLASTOMA_NEURAL 	0	11	122	16905	0.0	1.0	1	
WEINMANN_ADAPTATION_TO_HYPOXIA_UP 	0	11	28	16999	0.0	1.0	1	
SEMBA_FHIT_TARGETS_UP 	0	11	11	17016	0.0	1.0	1	
YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_UP 	0	11	35	16992	0.0	1.0	1	
LINDGREN_BLADDER_CANCER_CLUSTER_2B 	0	11	364	16663	0.0	1.0	1	
ZHU_CMV_24_HR_UP 	0	11	93	16934	0.0	1.0	1	
RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_DN 	0	11	8	17019	0.0	1.0	1	
PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP 	0	11	50	16977	0.0	1.0	1	
URS_ADIPOCYTE_DIFFERENTIATION_UP 	0	11	68	16959	0.0	1.0	1	
BROWNE_HCMV_INFECTION_12HR_DN 	0	11	90	16937	0.0	1.0	1	
REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION 	0	11	160	16867	0.0	1.0	1	
VANTVEER_BREAST_CANCER_ESR1_UP 	0	11	157	16870	0.0	1.0	1	
HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR 	0	11	49	16978	0.0	1.0	1	
MATTIOLI_MGUS_VS_PCL 	0	11	90	16937	0.0	1.0	1	
BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING 	0	11	217	16810	0.0	1.0	1	
CHICAS_RB1_TARGETS_GROWING 	0	11	215	16812	0.0	1.0	1	
HOOI_ST7_TARGETS_UP 	0	11	78	16949	0.0	1.0	1	
GRYDER_PAX3FOXO1_TOP_ENHANCERS 	1	10	424	16603	3.915801886792453	0.24266490423212964	1	C9orf3
REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS 	0	11	31	16996	0.0	1.0	1	
YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_UP 	0	11	18	17009	0.0	1.0	1	
REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1 	0	11	16	17011	0.0	1.0	1	
ALONSO_METASTASIS_EMT_UP 	0	11	33	16994	0.0	1.0	1	
WAKASUGI_HAVE_ZNF143_BINDING_SITES 	0	11	54	16973	0.0	1.0	1	
FIRESTEIN_CTNNB1_PATHWAY 	0	11	32	16995	0.0	1.0	1	
BIOCARTA_CDC42RAC_PATHWAY 	0	11	16	17011	0.0	1.0	1	
BOSCO_TH1_CYTOTOXIC_MODULE 	0	11	80	16947	0.0	1.0	1	
MCCOLLUM_GELDANAMYCIN_RESISTANCE_DN 	0	11	5	17022	0.0	1.0	1	
DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP 	0	11	306	16721	0.0	1.0	1	
WANG_CISPLATIN_RESPONSE_AND_XPC_UP 	1	10	167	16860	10.095808383233534	0.10329996124350806	1	CNTN2
LABBE_WNT3A_TARGETS_DN 	0	11	81	16946	0.0	1.0	1	
REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION 	0	11	68	16959	0.0	1.0	1	
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR 	0	11	71	16956	0.0	1.0	1	
HARRIS_HYPOXIA 	0	11	71	16956	0.0	1.0	1	
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN 	0	11	66	16961	0.0	1.0	1	
KEGG_LEISHMANIA_INFECTION 	0	11	64	16963	0.0	1.0	1	
REACTOME_SYNTHESIS_OF_SUBSTRATES_IN_N_GLYCAN_BIOSYTHESIS 	0	11	14	17013	0.0	1.0	1	
BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN 	0	11	35	16992	0.0	1.0	1	
BOYERINAS_ONCOFETAL_TARGETS_OF_LET7A1 	0	11	10	17017	0.0	1.0	1	
ABDULRAHMAN_KIDNEY_CANCER_VHL_UP 	0	11	4	17023	0.0	1.0	1	
REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_GLUCAGON_LIKE_PEPTIDE1 	0	11	38	16989	0.0	1.0	1	
GAL_LEUKEMIC_STEM_CELL_UP 	0	11	116	16911	0.0	1.0	1	
KEGG_VEGF_SIGNALING_PATHWAY 	0	11	64	16963	0.0	1.0	1	
REACTOME_GLYCOLYSIS 	0	11	24	17003	0.0	1.0	1	
KEGG_HUNTINGTONS_DISEASE 	0	11	167	16860	0.0	1.0	1	
HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP 	0	11	52	16975	0.0	1.0	1	
FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP 	1	10	53	16974	32.026415094339626	0.03432590666810184	1	CAPN3
BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP 	0	11	59	16968	0.0	1.0	1	
DELASERNA_MYOD_TARGETS_UP 	0	11	75	16952	0.0	1.0	1	
MATZUK_SPERMATOGONIA 	0	11	20	17007	0.0	1.0	1	
REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS 	0	11	22	17005	0.0	1.0	1	
PID_CDC42_PATHWAY 	0	11	70	16957	0.0	1.0	1	
REACTOME_LYSOSOME_VESICLE_BIOGENESIS 	0	11	22	17005	0.0	1.0	1	
SEKI_INFLAMMATORY_RESPONSE_LPS_UP 	0	11	71	16956	0.0	1.0	1	
REACTOME_DNA_STRAND_ELONGATION 	0	11	29	16998	0.0	1.0	1	
HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN 	0	11	97	16930	0.0	1.0	1	
FUKUSHIMA_TNFSF11_TARGETS 	0	11	15	17012	0.0	1.0	1	
LEIN_CEREBELLUM_MARKERS 	0	11	75	16952	0.0	1.0	1	
APPIERTO_RESPONSE_TO_FENRETINIDE_UP 	0	11	35	16992	0.0	1.0	1	
KIM_GERMINAL_CENTER_T_HELPER_UP 	0	11	61	16966	0.0	1.0	1	
KEGG_MELANOGENESIS 	0	11	95	16932	0.0	1.0	1	
BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP 	0	11	23	17004	0.0	1.0	1	
ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP 	1	10	46	16981	36.915217391304346	0.029937522510929238	1	PLLP
BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN 	0	11	41	16986	0.0	1.0	1	
KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION 	0	11	102	16925	0.0	1.0	1	
TSUTSUMI_FBXW8_TARGETS 	0	11	6	17021	0.0	1.0	1	
LANDIS_ERBB2_BREAST_TUMORS_324_DN 	0	11	138	16889	0.0	1.0	1	
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP 	0	11	114	16913	0.0	1.0	1	
LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP 	0	11	71	16956	0.0	1.0	1	
KERLEY_RESPONSE_TO_CISPLATIN_DN 	0	11	5	17022	0.0	1.0	1	
MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3 	0	11	101	16926	0.0	1.0	1	
SMID_BREAST_CANCER_NORMAL_LIKE_UP 	0	11	388	16639	0.0	1.0	1	
TESAR_JAK_TARGETS_MOUSE_ES_D3_DN 	0	11	5	17022	0.0	1.0	1	
PENG_GLUCOSE_DEPRIVATION_DN 	0	11	156	16871	0.0	1.0	1	
KEGG_RNA_POLYMERASE 	0	11	29	16998	0.0	1.0	1	
WEBER_METHYLATED_LCP_IN_SPERM_DN 	0	11	3	17024	0.0	1.0	1	
CHANDRAN_METASTASIS_TOP50_DN 	0	11	43	16984	0.0	1.0	1	
BILBAN_B_CLL_LPL_DN 	1	10	40	16987	42.4675	0.026161629274391855	1	CAPN3
ST_JAK_STAT_PATHWAY 	0	11	8	17019	0.0	1.0	1	
REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING 	0	11	9	17018	0.0	1.0	1	
WANG_TARGETS_OF_MLL_CBP_FUSION_DN 	0	11	41	16986	0.0	1.0	1	
OXFORD_RALA_AND_RALB_TARGETS_DN 	0	11	9	17018	0.0	1.0	1	
LEE_BMP2_TARGETS_UP 	1	10	667	16360	2.4527736131934033	0.35601835572151885	1	RTKN
OUILLETTE_CLL_13Q14_DELETION_UP 	0	11	67	16960	0.0	1.0	1	
SHI_SPARC_TARGETS_UP 	0	11	22	17005	0.0	1.0	1	
MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS 	0	11	32	16995	0.0	1.0	1	
REACTOME_ORGANIC_CATION_ANION_ZWITTERION_TRANSPORT 	0	11	7	17020	0.0	1.0	1	
HASLINGER_B_CLL_WITH_11Q23_DELETION 	0	11	22	17005	0.0	1.0	1	
DARWICHE_PAPILLOMA_RISK_HIGH_DN 	0	11	149	16878	0.0	1.0	1	
SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER 	0	11	74	16953	0.0	1.0	1	
WARTERS_RESPONSE_TO_IR_SKIN 	0	11	68	16959	0.0	1.0	1	
GOLDRATH_HOMEOSTATIC_PROLIFERATION 	0	11	162	16865	0.0	1.0	1	
TESAR_ALK_TARGETS_EPISC_3D_UP 	0	11	7	17020	0.0	1.0	1	
NAKAMURA_LUNG_CANCER 	0	11	6	17021	0.0	1.0	1	
SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN 	0	11	51	16976	0.0	1.0	1	
BILANGES_RAPAMYCIN_SENSITIVE_GENES 	0	11	38	16989	0.0	1.0	1	
REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1 	0	11	48	16979	0.0	1.0	1	
WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP 	0	11	17	17010	0.0	1.0	1	
SCHMAHL_PDGF_SIGNALING 	0	11	9	17018	0.0	1.0	1	
REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S 	0	11	43	16984	0.0	1.0	1	
KATSANOU_ELAVL1_TARGETS_UP 	0	11	145	16882	0.0	1.0	1	
BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN 	0	11	16	17011	0.0	1.0	1	
GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP 	0	11	469	16558	0.0	1.0	1	
PID_REELIN_PATHWAY 	0	11	29	16998	0.0	1.0	1	
KEGG_BUTANOATE_METABOLISM 	0	11	27	17000	0.0	1.0	1	
WU_HBX_TARGETS_3_DN 	0	11	13	17014	0.0	1.0	1	
REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS 	0	11	38	16989	0.0	1.0	1	
HEIDENBLAD_AMPLICON_8Q24_UP 	0	11	30	16997	0.0	1.0	1	
MATZUK_STEROIDOGENESIS 	0	11	6	17021	0.0	1.0	1	
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4 	0	11	270	16757	0.0	1.0	1	
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5 	1	10	415	16612	4.002891566265061	0.2381381906837083	1	PLLP
DITTMER_PTHLH_TARGETS_DN 	0	11	70	16957	0.0	1.0	1	
REACTOME_INFLAMMASOMES 	0	11	15	17012	0.0	1.0	1	
ZAMORA_NOS2_TARGETS_DN 	0	11	88	16939	0.0	1.0	1	
SCHURINGA_STAT5A_TARGETS_UP 	0	11	16	17011	0.0	1.0	1	
BIOCARTA_VIP_PATHWAY 	0	11	25	17002	0.0	1.0	1	
REACTOME_MAP_KINASE_ACTIVATION_IN_TLR_CASCADE 	0	11	49	16978	0.0	1.0	1	
HOEBEKE_LYMPHOID_STEM_CELL_UP 	0	11	85	16942	0.0	1.0	1	
REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM 	0	11	157	16870	0.0	1.0	1	
PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION 	0	11	26	17001	0.0	1.0	1	
GEORGES_TARGETS_OF_MIR192_AND_MIR215 	0	11	789	16238	0.0	1.0	1	
IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN 	0	11	97	16930	0.0	1.0	1	
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN 	0	11	22	17005	0.0	1.0	1	
RASHI_RESPONSE_TO_IONIZING_RADIATION_3 	0	11	44	16983	0.0	1.0	1	
TAKAO_RESPONSE_TO_UVB_RADIATION_DN 	0	11	94	16933	0.0	1.0	1	
HEDVAT_ELF4_TARGETS_UP 	0	11	11	17016	0.0	1.0	1	
MANTOVANI_VIRAL_GPCR_SIGNALING_DN 	0	11	42	16985	0.0	1.0	1	
DELASERNA_TARGETS_OF_MYOD_AND_SMARCA4 	0	11	7	17020	0.0	1.0	1	
ZHOU_PANCREATIC_EXOCRINE_PROGENITOR 	0	11	3	17024	0.0	1.0	1	
THILLAINADESAN_ZNF217_TARGETS_DN 	0	11	7	17020	0.0	1.0	1	
LUI_THYROID_CANCER_CLUSTER_2 	0	11	39	16988	0.0	1.0	1	
BAKKER_FOXO3_TARGETS_DN 	0	11	157	16870	0.0	1.0	1	
RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP 	0	11	642	16385	0.0	1.0	1	
NAGASHIMA_NRG1_SIGNALING_DN 	0	11	48	16979	0.0	1.0	1	
VANTVEER_BREAST_CANCER_POOR_PROGNOSIS 	0	11	46	16981	0.0	1.0	1	
PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP 	0	11	75	16952	0.0	1.0	1	
WACKER_HYPOXIA_TARGETS_OF_VHL 	0	11	12	17015	0.0	1.0	1	
PID_AURORA_B_PATHWAY 	0	11	34	16993	0.0	1.0	1	
FUJIWARA_PARK2_IN_LIVER_CANCER_UP 	0	11	5	17022	0.0	1.0	1	
ROY_WOUND_BLOOD_VESSEL_DN 	0	11	16	17011	0.0	1.0	1	
WANG_LMO4_TARGETS_UP 	1	10	327	16700	5.107033639143731	0.19256296428832884	1	C9orf3
BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN 	0	11	574	16453	0.0	1.0	1	
MCCLUNG_COCAIN_REWARD_4WK 	0	11	58	16969	0.0	1.0	1	
KEGG_BETA_ALANINE_METABOLISM 	1	10	21	17006	80.98095238095237	0.014116315376479614	1	CNDP1
STOSSI_RESPONSE_TO_ESTRADIOL 	0	11	38	16989	0.0	1.0	1	
PID_RAS_PATHWAY 	0	11	30	16997	0.0	1.0	1	
TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN 	0	11	34	16993	0.0	1.0	1	
GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP 	0	11	553	16474	0.0	1.0	1	
SHEPARD_BMYB_MORPHOLINO_UP 	0	11	189	16838	0.0	1.0	1	
PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP 	0	11	75	16952	0.0	1.0	1	
BROWN_MYELOID_CELL_DEVELOPMENT_UP 	1	10	129	16898	13.099224806201551	0.08082311528397125	1	CAPN3
REACTOME_ACTIVATION_OF_GENES_BY_ATF4 	0	11	22	17005	0.0	1.0	1	
IWANAGA_CARCINOGENESIS_BY_KRAS_DN 	0	11	110	16917	0.0	1.0	1	
REACTOME_RNA_POL_II_TRANSCRIPTION 	0	11	93	16934	0.0	1.0	1	
BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN 	1	10	51	16976	33.286274509803924	0.03307392789178882	1	C9orf3
KORKOLA_CHORIOCARCINOMA_UP 	0	11	6	17021	0.0	1.0	1	
NABA_COLLAGENS 	0	11	43	16984	0.0	1.0	1	
CAIRO_HEPATOBLASTOMA_CLASSES_DN 	0	11	178	16849	0.0	1.0	1	
REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GIP 	0	11	9	17018	0.0	1.0	1	
REACTOME_SEROTONIN_RECEPTORS 	0	11	11	17016	0.0	1.0	1	
MOOTHA_HUMAN_MITODB_6_2002 	0	11	406	16621	0.0	1.0	1	
DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP 	0	11	296	16731	0.0	1.0	1	
SUZUKI_CTCFL_TARGETS_UP 	0	11	10	17017	0.0	1.0	1	
PID_P38_MKK3_6PATHWAY 	0	11	26	17001	0.0	1.0	1	
FIGUEROA_AML_METHYLATION_CLUSTER_2_DN 	0	11	6	17021	0.0	1.0	1	
JI_METASTASIS_REPRESSED_BY_STK11 	0	11	22	17005	0.0	1.0	1	
HASLINGER_B_CLL_WITH_13Q14_DELETION 	0	11	24	17003	0.0	1.0	1	
ST_TUMOR_NECROSIS_FACTOR_PATHWAY 	0	11	28	16999	0.0	1.0	1	
SPIRA_SMOKERS_LUNG_CANCER_UP 	0	11	34	16993	0.0	1.0	1	
BIOCARTA_TNFR2_PATHWAY 	0	11	17	17010	0.0	1.0	1	
RIZ_ERYTHROID_DIFFERENTIATION_12HR 	0	11	35	16992	0.0	1.0	1	
PID_FOXO_PATHWAY 	0	11	47	16980	0.0	1.0	1	
OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_DN 	0	11	11	17016	0.0	1.0	1	
GOLDRATH_ANTIGEN_RESPONSE 	0	11	294	16733	0.0	1.0	1	
CUI_TCF21_TARGETS_2_UP 	0	11	384	16643	0.0	1.0	1	
KHETCHOUMIAN_TRIM24_TARGETS_UP 	0	11	45	16982	0.0	1.0	1	
REACTOME_ZINC_TRANSPORTERS 	0	11	12	17015	0.0	1.0	1	
YANG_BREAST_CANCER_ESR1_LASER_UP 	0	11	30	16997	0.0	1.0	1	
REACTOME_GAB1_SIGNALOSOME 	0	11	36	16991	0.0	1.0	1	
REACTOME_INNATE_IMMUNE_SYSTEM 	0	11	195	16832	0.0	1.0	1	
REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS 	0	11	49	16978	0.0	1.0	1	
RAY_ALZHEIMERS_DISEASE 	0	11	7	17020	0.0	1.0	1	
FU_INTERACT_WITH_ALKBH8 	0	11	13	17014	0.0	1.0	1	
MCBRYAN_PUBERTAL_BREAST_4_5WK_DN 	0	11	178	16849	0.0	1.0	1	
STEIN_ESRRA_TARGETS_UP 	0	11	359	16668	0.0	1.0	1	
CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP 	1	10	92	16935	18.407608695652176	0.05844682013142694	1	RTKN
MIKKELSEN_ES_ICP_WITH_H3K27ME3 	0	11	29	16998	0.0	1.0	1	
GROSS_HYPOXIA_VIA_HIF1A_ONLY 	0	11	7	17020	0.0	1.0	1	
REACTOME_NEURONAL_SYSTEM 	0	11	251	16776	0.0	1.0	1	
KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS 	0	11	27	17000	0.0	1.0	1	
REACTOME_SIGNALING_BY_FGFR 	0	11	100	16927	0.0	1.0	1	
LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_UP 	0	11	7	17020	0.0	1.0	1	
REACTOME_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR 	0	11	17	17010	0.0	1.0	1	
PID_UPA_UPAR_PATHWAY 	0	11	31	16996	0.0	1.0	1	
BIOCARTA_LECTIN_PATHWAY 	0	11	8	17019	0.0	1.0	1	
BIOCARTA_GSK3_PATHWAY 	0	11	26	17001	0.0	1.0	1	
TONG_INTERACT_WITH_PTTG1 	0	11	54	16973	0.0	1.0	1	
BIOCARTA_PML_PATHWAY 	0	11	14	17013	0.0	1.0	1	
CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP 	0	11	32	16995	0.0	1.0	1	
ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION 	0	11	83	16944	0.0	1.0	1	
REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION 	0	11	25	17002	0.0	1.0	1	
HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN 	0	11	59	16968	0.0	1.0	1	
IKEDA_MIR1_TARGETS_UP 	0	11	53	16974	0.0	1.0	1	
MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3 	0	11	106	16921	0.0	1.0	1	
BAE_BRCA1_TARGETS_UP 	0	11	69	16958	0.0	1.0	1	
MEDINA_SMARCA4_TARGETS 	0	11	37	16990	0.0	1.0	1	
REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING 	0	11	41	16986	0.0	1.0	1	
OSMAN_BLADDER_CANCER_UP 	0	11	382	16645	0.0	1.0	1	
FINETTI_BREAST_CANCERS_KINOME_BLUE 	0	11	20	17007	0.0	1.0	1	
REACTOME_G0_AND_EARLY_G1 	0	11	22	17005	0.0	1.0	1	
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN 	0	11	17	17010	0.0	1.0	1	
PID_IL12_STAT4_PATHWAY 	0	11	24	17003	0.0	1.0	1	
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP 	0	11	67	16960	0.0	1.0	1	
REACTOME_OTHER_SEMAPHORIN_INTERACTIONS 	0	11	15	17012	0.0	1.0	1	
THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN 	0	11	222	16805	0.0	1.0	1	
BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_DN 	0	11	9	17018	0.0	1.0	1	
PID_GMCSF_PATHWAY 	0	11	35	16992	0.0	1.0	1	
CAFFAREL_RESPONSE_TO_THC_8HR_3_DN 	0	11	10	17017	0.0	1.0	1	
PID_TAP63_PATHWAY 	0	11	53	16974	0.0	1.0	1	
HOSHIDA_LIVER_CANCER_SURVIVAL_UP 	0	11	65	16962	0.0	1.0	1	
PID_ILK_PATHWAY 	0	11	45	16982	0.0	1.0	1	
SMITH_TERT_TARGETS_UP 	0	11	140	16887	0.0	1.0	1	
ZHOU_PANCREATIC_BETA_CELL 	0	11	6	17021	0.0	1.0	1	
XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN 	0	11	17	17010	0.0	1.0	1	
LEE_BMP2_TARGETS_DN 	0	11	812	16215	0.0	1.0	1	
BIOCARTA_DREAM_PATHWAY 	0	11	13	17014	0.0	1.0	1	
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN 	0	11	107	16920	0.0	1.0	1	
GOUYER_TATI_TARGETS_UP 	0	11	7	17020	0.0	1.0	1	
JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER 	0	11	37	16990	0.0	1.0	1	
BURTON_ADIPOGENESIS_PEAK_AT_0HR 	0	11	59	16968	0.0	1.0	1	
KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP 	1	10	106	16921	15.96320754716981	0.06697111219822376	1	C9orf3
HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_UP 	0	11	10	17017	0.0	1.0	1	
STEGMEIER_PRE-MITOTIC_CELL_CYCLE_REGULATORS 	0	11	11	17016	0.0	1.0	1	
SASSON_FSH_RESPONSE 	0	11	9	17018	0.0	1.0	1	
MOOTHA_PYR 	0	11	7	17020	0.0	1.0	1	
KEGG_PARKINSONS_DISEASE 	0	11	107	16920	0.0	1.0	1	
SANA_RESPONSE_TO_IFNG_UP 	0	11	70	16957	0.0	1.0	1	
PID_AR_PATHWAY 	0	11	57	16970	0.0	1.0	1	
GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_UP 	0	11	8	17019	0.0	1.0	1	
BENPORATH_OCT4_TARGETS 	0	11	268	16759	0.0	1.0	1	
JIANG_AGING_HYPOTHALAMUS_UP 	0	11	47	16980	0.0	1.0	1	
JISON_SICKLE_CELL_DISEASE_UP 	0	11	171	16856	0.0	1.0	1	
HOOI_ST7_TARGETS_DN 	0	11	104	16923	0.0	1.0	1	
NIKOLSKY_BREAST_CANCER_15Q26_AMPLICON 	0	11	17	17010	0.0	1.0	1	
DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS 	0	11	14	17013	0.0	1.0	1	
PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_DN 	0	11	8	17019	0.0	1.0	1	
BRUNEAU_SEPTATION_VENTRICULAR 	0	11	7	17020	0.0	1.0	1	
REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS 	0	11	26	17001	0.0	1.0	1	
HOWLIN_CITED1_TARGETS_1_DN 	0	11	34	16993	0.0	1.0	1	
FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN 	0	11	413	16614	0.0	1.0	1	
XU_RESPONSE_TO_TRETINOIN_DN 	0	11	12	17015	0.0	1.0	1	
REACTOME_COMPLEMENT_CASCADE 	0	11	19	17008	0.0	1.0	1	
RHODES_CANCER_META_SIGNATURE 	0	11	62	16965	0.0	1.0	1	
WANG_RESPONSE_TO_PACLITAXEL_VIA_MAPK8_UP 	0	11	10	17017	0.0	1.0	1	
WONG_IFNA2_RESISTANCE_DN 	0	11	31	16996	0.0	1.0	1	
BIOCARTA_CTCF_PATHWAY 	0	11	22	17005	0.0	1.0	1	
NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_DN 	0	11	16	17011	0.0	1.0	1	
KEGG_DILATED_CARDIOMYOPATHY 	0	11	87	16940	0.0	1.0	1	
KEGG_MELANOMA 	0	11	62	16965	0.0	1.0	1	
BROWNE_HCMV_INFECTION_10HR_DN 	0	11	49	16978	0.0	1.0	1	
HASINA_NOL7_TARGETS_DN 	0	11	12	17015	0.0	1.0	1	
KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION 	0	11	22	17005	0.0	1.0	1	
YOSHIMURA_MAPK8_TARGETS_DN 	0	11	328	16699	0.0	1.0	1	
ZHAN_MULTIPLE_MYELOMA_MF_UP 	0	11	40	16987	0.0	1.0	1	
DODD_NASOPHARYNGEAL_CARCINOMA_DN 	1	10	1200	15827	1.3189166666666667	0.5526051612793225	1	RTKN
CADWELL_ATG16L1_TARGETS_UP 	0	11	69	16958	0.0	1.0	1	
DAWSON_METHYLATED_IN_LYMPHOMA_TCL1 	0	11	52	16975	0.0	1.0	1	
XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR 	0	11	17	17010	0.0	1.0	1	
PID_INTEGRIN_A4B1_PATHWAY 	0	11	32	16995	0.0	1.0	1	
CHIBA_RESPONSE_TO_TSA 	0	11	44	16983	0.0	1.0	1	
REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY 	0	11	12	17015	0.0	1.0	1	
BENPORATH_SUZ12_TARGETS 	1	10	825	16202	1.9638787878787878	0.42120291645587105	1	SOX10
RASHI_RESPONSE_TO_IONIZING_RADIATION_2 	1	10	118	16909	14.329661016949153	0.07422174215030897	1	CAPN3
PHONG_TNF_RESPONSE_VIA_P38_COMPLETE 	1	10	217	16810	7.746543778801843	0.13211341516246022	1	CDC42EP1
REACTOME_PEROXISOMAL_LIPID_METABOLISM 	0	11	20	17007	0.0	1.0	1	
YANG_BCL3_TARGETS_DN 	0	11	7	17020	0.0	1.0	1	
MCBRYAN_PUBERTAL_BREAST_5_6WK_DN 	0	11	127	16900	0.0	1.0	1	
CHEN_ETV5_TARGETS_TESTIS 	0	11	17	17010	0.0	1.0	1	
HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN 	0	11	25	17002	0.0	1.0	1	
STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN 	0	11	37	16990	0.0	1.0	1	
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN 	0	11	13	17014	0.0	1.0	1	
KEGG_ETHER_LIPID_METABOLISM 	0	11	20	17007	0.0	1.0	1	
FIGUEROA_AML_METHYLATION_CLUSTER_3_DN 	0	11	35	16992	0.0	1.0	1	
VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 	0	11	37	16990	0.0	1.0	1	
KORKOLA_YOLK_SAC_TUMOR 	0	11	49	16978	0.0	1.0	1	
BIOCARTA_PTEN_PATHWAY 	0	11	17	17010	0.0	1.0	1	
REACTOME_RESPIRATORY_ELECTRON_TRANSPORT 	0	11	64	16963	0.0	1.0	1	
WALLACE_PROSTATE_CANCER_DN 	0	11	6	17021	0.0	1.0	1	
SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_DN 	0	11	8	17019	0.0	1.0	1	
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN 	0	11	32	16995	0.0	1.0	1	
MCCLUNG_CREB1_TARGETS_DN 	0	11	54	16973	0.0	1.0	1	
PID_CERAMIDE_PATHWAY 	0	11	47	16980	0.0	1.0	1	
REACTOME_GAP_JUNCTION_ASSEMBLY 	0	11	12	17015	0.0	1.0	1	
GENTLES_LEUKEMIC_STEM_CELL_UP 	0	11	26	17001	0.0	1.0	1	
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_DN 	0	11	38	16989	0.0	1.0	1	
FERNANDEZ_BOUND_BY_MYC 	0	11	165	16862	0.0	1.0	1	
BIOCARTA_ARENRF2_PATHWAY 	0	11	13	17014	0.0	1.0	1	
JU_AGING_TERC_TARGETS_UP 	0	11	5	17022	0.0	1.0	1	
NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON 	0	11	127	16900	0.0	1.0	1	
NABA_BASEMENT_MEMBRANES 	0	11	37	16990	0.0	1.0	1	
ZAMORA_NOS2_TARGETS_UP 	0	11	62	16965	0.0	1.0	1	
SEMENZA_HIF1_TARGETS 	0	11	32	16995	0.0	1.0	1	
REACTOME_SIGNALING_BY_ROBO_RECEPTOR 	0	11	28	16999	0.0	1.0	1	
REACTOME_THE_ROLE_OF_NEF_IN_HIV1_REPLICATION_AND_DISEASE_PATHOGENESIS 	0	11	25	17002	0.0	1.0	1	
KAMIKUBO_MYELOID_MN1_NETWORK 	0	11	19	17008	0.0	1.0	1	
REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS 	0	11	14	17013	0.0	1.0	1	
REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS 	0	11	20	17007	0.0	1.0	1	
MCCABE_HOXC6_TARGETS_DN 	0	11	20	17007	0.0	1.0	1	
LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN 	0	11	45	16982	0.0	1.0	1	
TANG_SENESCENCE_TP53_TARGETS_DN 	0	11	44	16983	0.0	1.0	1	
GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP 	0	11	61	16966	0.0	1.0	1	
RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN 	1	10	471	16556	3.5150743099787687	0.2659096526630654	1	C9orf3
VALK_AML_WITH_T_8_21_TRANSLOCATION 	0	11	5	17022	0.0	1.0	1	
REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN 	0	11	9	17018	0.0	1.0	1	
CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP 	0	11	119	16908	0.0	1.0	1	
REACTOME_LATE_PHASE_OF_HIV_LIFE_CYCLE 	0	11	92	16935	0.0	1.0	1	
MARTENS_TRETINOIN_RESPONSE_DN 	0	11	700	16327	0.0	1.0	1	
COURTOIS_SENESCENCE_TRIGGERS 	0	11	6	17021	0.0	1.0	1	
BUSA_SAM68_TARGETS_DN 	0	11	6	17021	0.0	1.0	1	
REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING 	0	11	11	17016	0.0	1.0	1	
REACTOME_ANDROGEN_BIOSYNTHESIS 	0	11	5	17022	0.0	1.0	1	
SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6 	0	11	383	16644	0.0	1.0	1	
DAZARD_UV_RESPONSE_CLUSTER_G28 	0	11	16	17011	0.0	1.0	1	
BILBAN_B_CLL_LPL_UP 	0	11	53	16974	0.0	1.0	1	
BOYAULT_LIVER_CANCER_SUBCLASS_G56_UP 	0	11	10	17017	0.0	1.0	1	
BIOCARTA_EIF_PATHWAY 	0	11	16	17011	0.0	1.0	1	
HU_GENOTOXIC_DAMAGE_4HR 	0	11	33	16994	0.0	1.0	1	
KEGG_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI_ANCHOR_BIOSYNTHESIS 	0	11	24	17003	0.0	1.0	1	
GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION 	0	11	22	17005	0.0	1.0	1	
CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_DN 	0	11	14	17013	0.0	1.0	1	
LE_EGR2_TARGETS_UP 	0	11	97	16930	0.0	1.0	1	
WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN 	0	11	8	17019	0.0	1.0	1	
REACTOME_L1CAM_INTERACTIONS 	1	10	80	16947	21.18375	0.05108400031948391	1	CNTN2
GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN 	0	11	149	16878	0.0	1.0	1	
BIOCARTA_MCALPAIN_PATHWAY 	0	11	22	17005	0.0	1.0	1	
PLASARI_TGFB1_TARGETS_10HR_DN 	0	11	227	16800	0.0	1.0	1	
PID_HIF1_TFPATHWAY 	0	11	60	16967	0.0	1.0	1	
REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY 	0	11	7	17020	0.0	1.0	1	
WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN 	0	11	95	16932	0.0	1.0	1	
KUNINGER_IGF1_VS_PDGFB_TARGETS_UP 	0	11	63	16964	0.0	1.0	1	
REACTOME_PI_METABOLISM 	0	11	46	16981	0.0	1.0	1	
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP 	0	11	74	16953	0.0	1.0	1	
GAL_LEUKEMIC_STEM_CELL_DN 	0	11	195	16832	0.0	1.0	1	
ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN 	0	11	67	16960	0.0	1.0	1	
AMIT_EGF_RESPONSE_240_MCF10A 	0	11	20	17007	0.0	1.0	1	
KAUFFMANN_DNA_REPAIR_GENES 	0	11	213	16814	0.0	1.0	1	
MALONEY_RESPONSE_TO_17AAG_UP 	0	11	39	16988	0.0	1.0	1	
GENTILE_UV_RESPONSE_CLUSTER_D4 	0	11	53	16974	0.0	1.0	1	
SMIRNOV_RESPONSE_TO_IR_6HR_UP 	0	11	150	16877	0.0	1.0	1	
KRASNOSELSKAYA_ILF3_TARGETS_UP 	0	11	36	16991	0.0	1.0	1	
PHONG_TNF_TARGETS_DN 	0	11	7	17020	0.0	1.0	1	
REACTOME_PROTEOLYTIC_CLEAVAGE_OF_SNARE_COMPLEX_PROTEINS 	0	11	16	17011	0.0	1.0	1	
JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN 	0	11	58	16969	0.0	1.0	1	
REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS 	0	11	24	17003	0.0	1.0	1	
DE_YY1_TARGETS_DN 	0	11	88	16939	0.0	1.0	1	
LI_CISPLATIN_RESISTANCE_UP 	0	11	24	17003	0.0	1.0	1	
BILD_CTNNB1_ONCOGENIC_SIGNATURE 	0	11	76	16951	0.0	1.0	1	
CROONQUIST_STROMAL_STIMULATION_UP 	0	11	58	16969	0.0	1.0	1	
LI_WILMS_TUMOR_ANAPLASTIC_DN 	0	11	5	17022	0.0	1.0	1	
DURCHDEWALD_SKIN_CARCINOGENESIS_DN 	0	11	242	16785	0.0	1.0	1	
KEGG_PROPANOATE_METABOLISM 	0	11	29	16998	0.0	1.0	1	
DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN 	0	11	162	16865	0.0	1.0	1	
SCHAVOLT_TARGETS_OF_TP53_AND_TP63 	0	11	14	17013	0.0	1.0	1	
FIGUEROA_AML_METHYLATION_CLUSTER_6_UP 	0	11	117	16910	0.0	1.0	1	
MELLMAN_TUT1_TARGETS_UP 	0	11	16	17011	0.0	1.0	1	
HAN_JNK_SINGALING_DN 	0	11	32	16995	0.0	1.0	1	
CUI_TCF21_TARGETS_DN 	0	11	28	16999	0.0	1.0	1	
WANG_BARRETTS_ESOPHAGUS_UP 	0	11	40	16987	0.0	1.0	1	
BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN 	0	11	31	16996	0.0	1.0	1	
ALONSO_METASTASIS_UP 	0	11	175	16852	0.0	1.0	1	
BASSO_CD40_SIGNALING_UP 	0	11	89	16938	0.0	1.0	1	
BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_UP 	0	11	12	17015	0.0	1.0	1	
REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION 	0	11	14	17013	0.0	1.0	1	
KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG 	0	11	10	17017	0.0	1.0	1	
SMIRNOV_RESPONSE_TO_IR_2HR_DN 	0	11	48	16979	0.0	1.0	1	
LAU_APOPTOSIS_CDKN2A_UP 	0	11	54	16973	0.0	1.0	1	
BOYLAN_MULTIPLE_MYELOMA_PCA1_DN 	0	11	8	17019	0.0	1.0	1	
WANG_SMARCE1_TARGETS_DN 	0	11	332	16695	0.0	1.0	1	
REACTOME_PROLACTIN_RECEPTOR_SIGNALING 	0	11	10	17017	0.0	1.0	1	
DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER 	0	11	96	16931	0.0	1.0	1	
PID_INTEGRIN3_PATHWAY 	0	11	39	16988	0.0	1.0	1	
YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN 	0	11	206	16821	0.0	1.0	1	
LIN_MELANOMA_COPY_NUMBER_DN 	0	11	41	16986	0.0	1.0	1	
MARSON_FOXP3_TARGETS_STIMULATED_UP 	0	11	24	17003	0.0	1.0	1	
OXFORD_RALA_AND_RALB_TARGETS_UP 	0	11	9	17018	0.0	1.0	1	
REN_BOUND_BY_E2F 	0	11	53	16974	0.0	1.0	1	
VERHAAK_GLIOBLASTOMA_PRONEURAL 	1	10	166	16861	10.157228915662651	0.10271492563355582	1	SOX10
REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS 	0	11	14	17013	0.0	1.0	1	
WOOD_EBV_EBNA1_TARGETS_DN 	0	11	44	16983	0.0	1.0	1	
KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION 	0	11	57	16970	0.0	1.0	1	
GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN 	0	11	184	16843	0.0	1.0	1	
NIKOLSKY_BREAST_CANCER_19Q13.1_AMPLICON 	0	11	22	17005	0.0	1.0	1	
CADWELL_ATG16L1_TARGETS_DN 	0	11	59	16968	0.0	1.0	1	
LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q 	0	11	106	16921	0.0	1.0	1	
GABRIELY_MIR21_TARGETS 	0	11	274	16753	0.0	1.0	1	
WU_HBX_TARGETS_3_UP 	0	11	18	17009	0.0	1.0	1	
MOOTHA_MITOCHONDRIA 	0	11	419	16608	0.0	1.0	1	
FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN 	0	11	76	16951	0.0	1.0	1	
ZHAN_MULTIPLE_MYELOMA_SPIKED 	0	11	16	17011	0.0	1.0	1	
MATZUK_FERTILIZATION 	0	11	7	17020	0.0	1.0	1	
RADAEVA_RESPONSE_TO_IFNA1_UP 	0	11	50	16977	0.0	1.0	1	
HOEBEKE_LYMPHOID_STEM_CELL_DN 	0	11	82	16945	0.0	1.0	1	
BIOCARTA_CDMAC_PATHWAY 	0	11	15	17012	0.0	1.0	1	
KEGG_CITRATE_CYCLE_TCA_CYCLE 	0	11	29	16998	0.0	1.0	1	
GENTILE_UV_RESPONSE_CLUSTER_D8 	0	11	38	16989	0.0	1.0	1	
TERAMOTO_OPN_TARGETS_CLUSTER_3 	0	11	4	17023	0.0	1.0	1	
AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53 	0	11	98	16929	0.0	1.0	1	
RIGGI_EWING_SARCOMA_PROGENITOR_DN 	0	11	160	16867	0.0	1.0	1	
MATTHEWS_AP1_TARGETS 	0	11	16	17011	0.0	1.0	1	
BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN 	0	11	27	17000	0.0	1.0	1	
VALK_AML_CLUSTER_5 	0	11	33	16994	0.0	1.0	1	
PID_IL5_PATHWAY 	0	11	12	17015	0.0	1.0	1	
INGRAM_SHH_TARGETS_DN 	0	11	55	16972	0.0	1.0	1	
PID_P53_DOWNSTREAM_PATHWAY 	0	11	126	16901	0.0	1.0	1	
MANALO_HYPOXIA_UP 	0	11	198	16829	0.0	1.0	1	
KEGG_JAK_STAT_SIGNALING_PATHWAY 	0	11	100	16927	0.0	1.0	1	
SWEET_KRAS_TARGETS_DN 	0	11	53	16974	0.0	1.0	1	
RASHI_NFKB1_TARGETS 	0	11	18	17009	0.0	1.0	1	
LIANG_SILENCED_BY_METHYLATION_DN 	0	11	8	17019	0.0	1.0	1	
TING_SILENCED_BY_DICER 	0	11	27	17000	0.0	1.0	1	
KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS_AND_CYCLIC_RGD 	0	11	8	17019	0.0	1.0	1	
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP 	0	11	147	16880	0.0	1.0	1	
REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE 	0	11	45	16982	0.0	1.0	1	
WANG_THOC1_TARGETS_DN 	0	11	12	17015	0.0	1.0	1	
BENPORATH_ES_1 	0	11	336	16691	0.0	1.0	1	
SMITH_TERT_TARGETS_DN 	0	11	83	16944	0.0	1.0	1	
EPPERT_PROGENITOR 	0	11	119	16908	0.0	1.0	1	
WILCOX_RESPONSE_TO_PROGESTERONE_DN 	0	11	60	16967	0.0	1.0	1	
REACTOME_EXTENSION_OF_TELOMERES 	0	11	27	17000	0.0	1.0	1	
JIANG_TIP30_TARGETS_DN 	0	11	22	17005	0.0	1.0	1	
VANASSE_BCL2_TARGETS_UP 	0	11	30	16997	0.0	1.0	1	
ROETH_TERT_TARGETS_UP 	0	11	14	17013	0.0	1.0	1	
YANG_BREAST_CANCER_ESR1_BULK_DN 	0	11	17	17010	0.0	1.0	1	
BIOCARTA_SHH_PATHWAY 	0	11	15	17012	0.0	1.0	1	
SAFFORD_T_LYMPHOCYTE_ANERGY 	0	11	76	16951	0.0	1.0	1	
DOANE_RESPONSE_TO_ANDROGEN_DN 	0	11	219	16808	0.0	1.0	1	
HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN 	0	11	50	16977	0.0	1.0	1	
TERAMOTO_OPN_TARGETS_CLUSTER_8 	0	11	7	17020	0.0	1.0	1	
TERAMOTO_OPN_TARGETS_CLUSTER_6 	0	11	24	17003	0.0	1.0	1	
TERAMOTO_OPN_TARGETS_CLUSTER_7 	0	11	19	17008	0.0	1.0	1	
TERAMOTO_OPN_TARGETS_CLUSTER_4 	0	11	12	17015	0.0	1.0	1	
TERAMOTO_OPN_TARGETS_CLUSTER_5 	0	11	5	17022	0.0	1.0	1	
MUELLER_METHYLATED_IN_GLIOBLASTOMA 	0	11	26	17001	0.0	1.0	1	
TERAMOTO_OPN_TARGETS_CLUSTER_1 	0	11	11	17016	0.0	1.0	1	
SA_G1_AND_S_PHASES 	0	11	14	17013	0.0	1.0	1	
REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC 	0	11	19	17008	0.0	1.0	1	
WESTON_VEGFA_TARGETS_6HR 	0	11	49	16978	0.0	1.0	1	
DACOSTA_UV_RESPONSE_VIA_ERCC3_DN 	0	11	814	16213	0.0	1.0	1	
BIOCARTA_MITOCHONDRIA_PATHWAY 	0	11	20	17007	0.0	1.0	1	
MIZUSHIMA_AUTOPHAGOSOME_FORMATION 	0	11	18	17009	0.0	1.0	1	
YAGI_AML_WITH_T_9_11_TRANSLOCATION 	0	11	116	16911	0.0	1.0	1	
GENTILE_UV_RESPONSE_CLUSTER_D5 	0	11	35	16992	0.0	1.0	1	
HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_DN 	0	11	19	17008	0.0	1.0	1	
KEGG_TYPE_I_DIABETES_MELLITUS 	0	11	31	16996	0.0	1.0	1	
TOMLINS_PROSTATE_CANCER_DN 	0	11	40	16987	0.0	1.0	1	
KYNG_DNA_DAMAGE_UP 	0	11	207	16820	0.0	1.0	1	
SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN 	0	11	29	16998	0.0	1.0	1	
MISSIAGLIA_REGULATED_BY_METHYLATION_UP 	0	11	106	16921	0.0	1.0	1	
KEGG_VIRAL_MYOCARDITIS 	0	11	61	16966	0.0	1.0	1	
WANG_RESPONSE_TO_FORSKOLIN_UP 	0	11	20	17007	0.0	1.0	1	
INGRAM_SHH_TARGETS 	0	11	7	17020	0.0	1.0	1	
REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_ACTIVITY_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS 	0	11	10	17017	0.0	1.0	1	
ZIRN_TRETINOIN_RESPONSE_DN 	0	11	6	17021	0.0	1.0	1	
STARK_HYPPOCAMPUS_22Q11_DELETION_DN 	0	11	19	17008	0.0	1.0	1	
ZHANG_TLX_TARGETS_60HR_UP 	0	11	281	16746	0.0	1.0	1	
PHESSE_TARGETS_OF_APC_AND_MBD2_UP 	0	11	18	17009	0.0	1.0	1	
VALK_AML_WITH_CEBPA 	0	11	28	16999	0.0	1.0	1	
GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN 	0	11	712	16315	0.0	1.0	1	
REACTOME_RECEPTOR_LIGAND_BINDING_INITIATES_THE_SECOND_PROTEOLYTIC_CLEAVAGE_OF_NOTCH_RECEPTOR 	0	11	11	17016	0.0	1.0	1	
REACTOME_G2_M_CHECKPOINTS 	0	11	36	16991	0.0	1.0	1	
CHANG_CORE_SERUM_RESPONSE_UP 	0	11	196	16831	0.0	1.0	1	
FIGUEROA_AML_METHYLATION_CLUSTER_2_UP 	0	11	46	16981	0.0	1.0	1	
PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN 	1	10	158	16869	10.676582278481012	0.09802213404518414	1	RTKN
REACTOME_ENERGY_DEPENDENT_REGULATION_OF_MTOR_BY_LKB1_AMPK 	0	11	16	17011	0.0	1.0	1	
REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION 	0	11	89	16938	0.0	1.0	1	
MATZUK_OVULATION 	0	11	13	17014	0.0	1.0	1	
SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_UP 	0	11	14	17013	0.0	1.0	1	
LIU_LIVER_CANCER 	0	11	33	16994	0.0	1.0	1	
ZEMBUTSU_SENSITIVITY_TO_CISPLATIN 	0	11	16	17011	0.0	1.0	1	
LIEN_BREAST_CARCINOMA_METAPLASTIC 	0	11	34	16993	0.0	1.0	1	
REACTOME_DESTABILIZATION_OF_MRNA_BY_BRF1 	0	11	17	17010	0.0	1.0	1	
WAGSCHAL_EHMT2_TARGETS_UP 	0	11	5	17022	0.0	1.0	1	
BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING 	0	11	466	16561	0.0	1.0	1	
HOFMANN_CELL_LYMPHOMA_DN 	0	11	37	16990	0.0	1.0	1	
REACTOME_DEFENSINS 	0	11	5	17022	0.0	1.0	1	
MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN 	0	11	18	17009	0.0	1.0	1	
BHATTACHARYA_EMBRYONIC_STEM_CELL 	0	11	81	16946	0.0	1.0	1	
WALLACE_PROSTATE_CANCER_RACE_UP 	0	11	243	16784	0.0	1.0	1	
REACTOME_REGULATION_OF_COMPLEMENT_CASCADE 	0	11	10	17017	0.0	1.0	1	
PID_ER_NONGENOMIC_PATHWAY 	0	11	41	16986	0.0	1.0	1	
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP 	0	11	66	16961	0.0	1.0	1	
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5 	0	11	60	16967	0.0	1.0	1	
DARWICHE_PAPILLOMA_PROGRESSION_RISK 	0	11	59	16968	0.0	1.0	1	
COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP 	1	10	33	16994	51.4969696969697	0.02173953635380521	1	SOX10
KIM_ALL_DISORDERS_CALB1_CORR_UP 	0	11	525	16502	0.0	1.0	1	
MULLIGHAN_NPM1_SIGNATURE_3_UP 	0	11	279	16748	0.0	1.0	1	
MCDOWELL_ACUTE_LUNG_INJURY_DN 	0	11	43	16984	0.0	1.0	1	
SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL 	0	11	58	16969	0.0	1.0	1	
WIKMAN_ASBESTOS_LUNG_CANCER_DN 	0	11	23	17004	0.0	1.0	1	
KESHELAVA_MULTIPLE_DRUG_RESISTANCE 	0	11	76	16951	0.0	1.0	1	
YAGUE_PRETUMOR_DRUG_RESISTANCE_UP 	0	11	6	17021	0.0	1.0	1	
PARK_HSC_VS_MULTIPOTENT_PROGENITORS_UP 	0	11	19	17008	0.0	1.0	1	
HASLINGER_B_CLL_WITH_MUTATED_VH_GENES 	0	11	17	17010	0.0	1.0	1	
HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_UP 	0	11	35	16992	0.0	1.0	1	
BIOCARTA_41BB_PATHWAY 	0	11	13	17014	0.0	1.0	1	
LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_DN 	0	11	14	17013	0.0	1.0	1	
SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN 	0	11	76	16951	0.0	1.0	1	
REACTOME_DAG_AND_IP3_SIGNALING 	0	11	29	16998	0.0	1.0	1	
BAFNA_MUC4_TARGETS_DN 	0	11	5	17022	0.0	1.0	1	
ZHAN_MULTIPLE_MYELOMA_DN 	0	11	36	16991	0.0	1.0	1	
KIM_ALL_DISORDERS_DURATION_CORR_UP 	0	11	8	17019	0.0	1.0	1	
BIOCARTA_IL6_PATHWAY 	0	11	22	17005	0.0	1.0	1	
HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN 	0	11	44	16983	0.0	1.0	1	
IIZUKA_LIVER_CANCER_EARLY_RECURRENCE 	0	11	11	17016	0.0	1.0	1	
JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN 	0	11	16	17011	0.0	1.0	1	
NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON 	0	11	109	16918	0.0	1.0	1	
ZHU_SKIL_TARGETS_DN 	0	11	9	17018	0.0	1.0	1	
REACTOME_PEPTIDE_HORMONE_BIOSYNTHESIS 	0	11	6	17021	0.0	1.0	1	
KEGG_GALACTOSE_METABOLISM 	0	11	22	17005	0.0	1.0	1	
HUANG_GATA2_TARGETS_DN 	0	11	63	16964	0.0	1.0	1	
NIELSEN_LEIOMYOSARCOMA_DN 	0	11	14	17013	0.0	1.0	1	
BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP 	0	11	31	16996	0.0	1.0	1	
CHANDRAN_METASTASIS_DN 	0	11	275	16752	0.0	1.0	1	
BENPORATH_ES_WITH_H3K27ME3 	2	9	882	16145	4.067775258251449	0.10843899846489685	1	CNTN2,PLLP
BIOCARTA_RARRXR_PATHWAY 	0	11	15	17012	0.0	1.0	1	
PID_ERA_GENOMIC_PATHWAY 	0	11	60	16967	0.0	1.0	1	
KUWANO_RNA_STABILIZED_BY_NO 	0	11	7	17020	0.0	1.0	1	
KORKOLA_TERATOMA 	0	11	32	16995	0.0	1.0	1	
GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN 	0	11	40	16987	0.0	1.0	1	
ZHENG_RESPONSE_TO_ARSENITE_UP 	0	11	17	17010	0.0	1.0	1	
DAZARD_UV_RESPONSE_CLUSTER_G4 	0	11	19	17008	0.0	1.0	1	
BIOCARTA_EIF4_PATHWAY 	0	11	24	17003	0.0	1.0	1	
BIOCARTA_RHO_PATHWAY 	0	11	32	16995	0.0	1.0	1	
GRADE_COLON_CANCER_UP 	2	9	774	16253	4.666379557852426	0.08677767848633534	1	CDC42EP1,RTKN
MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP 	0	11	67	16960	0.0	1.0	1	
VANTVEER_BREAST_CANCER_BRCA1_DN 	0	11	41	16986	0.0	1.0	1	
PID_AVB3_INTEGRIN_PATHWAY 	0	11	73	16954	0.0	1.0	1	
REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION 	0	11	83	16944	0.0	1.0	1	
MORI_PLASMA_CELL_UP 	0	11	47	16980	0.0	1.0	1	
ABDELMOHSEN_ELAVL4_TARGETS 	0	11	15	17012	0.0	1.0	1	
PID_NFKAPPAB_ATYPICAL_PATHWAY 	0	11	17	17010	0.0	1.0	1	
REACTOME_REMOVAL_OF_THE_FLAP_INTERMEDIATE_FROM_THE_C_STRAND 	0	11	10	17017	0.0	1.0	1	
PIEPOLI_LGI1_TARGETS_DN 	0	11	11	17016	0.0	1.0	1	
LEE_LIVER_CANCER_MYC_TGFA_DN 	0	11	47	16980	0.0	1.0	1	
BIOCARTA_ARAP_PATHWAY 	0	11	17	17010	0.0	1.0	1	
LIU_TARGETS_OF_VMYB_VS_CMYB_UP 	0	11	12	17015	0.0	1.0	1	
BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP 	0	11	41	16986	0.0	1.0	1	
REACTOME_NUCLEOTIDE_EXCISION_REPAIR 	0	11	48	16979	0.0	1.0	1	
MCCLUNG_CREB1_TARGETS_UP 	0	11	97	16930	0.0	1.0	1	
IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN 	0	11	24	17003	0.0	1.0	1	
TESAR_ALK_TARGETS_HUMAN_ES_4D_DN 	0	11	5	17022	0.0	1.0	1	
WONG_IFNA2_RESISTANCE_UP 	0	11	15	17012	0.0	1.0	1	
FOSTER_TOLERANT_MACROPHAGE_UP 	0	11	131	16896	0.0	1.0	1	
PID_THROMBIN_PAR1_PATHWAY 	0	11	41	16986	0.0	1.0	1	
BIOCARTA_HDAC_PATHWAY 	0	11	26	17001	0.0	1.0	1	
REACTOME_DARPP_32_EVENTS 	0	11	23	17004	0.0	1.0	1	
REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS 	0	11	70	16957	0.0	1.0	1	
PID_SYNDECAN_1_PATHWAY 	0	11	44	16983	0.0	1.0	1	
ZHAN_MULTIPLE_MYELOMA_MF_DN 	0	11	36	16991	0.0	1.0	1	
GALI_TP53_TARGETS_APOPTOTIC_UP 	0	11	8	17019	0.0	1.0	1	
REACTOME_ACYL_CHAIN_REMODELLING_OF_PI 	0	11	9	17018	0.0	1.0	1	
CAIRO_HEPATOBLASTOMA_POOR_SURVIVAL 	0	11	11	17016	0.0	1.0	1	
GAUTSCHI_SRC_SIGNALING 	0	11	8	17019	0.0	1.0	1	
LEE_NAIVE_T_LYMPHOCYTE 	0	11	17	17010	0.0	1.0	1	
SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP 	0	11	69	16958	0.0	1.0	1	
CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN 	0	11	94	16933	0.0	1.0	1	
REACTOME_ACYL_CHAIN_REMODELLING_OF_PC 	0	11	15	17012	0.0	1.0	1	
LY_AGING_MIDDLE_DN 	0	11	13	17014	0.0	1.0	1	
REACTOME_ACYL_CHAIN_REMODELLING_OF_PE 	0	11	14	17013	0.0	1.0	1	
REACTOME_ACYL_CHAIN_REMODELLING_OF_PG 	0	11	9	17018	0.0	1.0	1	
KAAB_HEART_ATRIUM_VS_VENTRICLE_DN 	0	11	251	16776	0.0	1.0	1	
RODRIGUES_THYROID_CARCINOMA_UP 	0	11	14	17013	0.0	1.0	1	
BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN 	0	11	160	16867	0.0	1.0	1	
ST_GAQ_PATHWAY 	0	11	26	17001	0.0	1.0	1	
KEGG_CALCIUM_SIGNALING_PATHWAY 	0	11	161	16866	0.0	1.0	1	
EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP 	0	11	179	16848	0.0	1.0	1	
LAIHO_COLORECTAL_CANCER_SERRATED_DN 	0	11	74	16953	0.0	1.0	1	
HILLION_HMGA1B_TARGETS 	0	11	84	16943	0.0	1.0	1	
REACTOME_ACYL_CHAIN_REMODELLING_OF_PS 	0	11	9	17018	0.0	1.0	1	
IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_DN 	0	11	9	17018	0.0	1.0	1	
MARSON_FOXP3_TARGETS_DN 	0	11	45	16982	0.0	1.0	1	
PASTURAL_RIZ1_TARGETS_UP 	0	11	9	17018	0.0	1.0	1	
YAGI_AML_WITH_11Q23_REARRANGED 	1	10	319	16708	5.237617554858934	0.18829928002200658	1	CAPN3
CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN 	0	11	611	16416	0.0	1.0	1	
SU_SALIVARY_GLAND 	0	11	7	17020	0.0	1.0	1	
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP 	0	11	145	16882	0.0	1.0	1	
LIANG_SILENCED_BY_METHYLATION_UP 	0	11	26	17001	0.0	1.0	1	
SCHEIDEREIT_IKK_INTERACTING_PROTEINS 	0	11	55	16972	0.0	1.0	1	
KEGG_COMPLEMENT_AND_COAGULATION_CASCADES 	0	11	48	16979	0.0	1.0	1	
ZHU_CMV_8_HR_DN 	0	11	51	16976	0.0	1.0	1	
HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN 	0	11	26	17001	0.0	1.0	1	
ODONNELL_TFRC_TARGETS_DN 	0	11	102	16925	0.0	1.0	1	
YAGI_AML_SURVIVAL 	0	11	115	16912	0.0	1.0	1	
BIOCARTA_HIVNEF_PATHWAY 	0	11	56	16971	0.0	1.0	1	
HUPER_BREAST_BASAL_VS_LUMINAL_DN 	0	11	52	16975	0.0	1.0	1	
DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN 	0	11	32	16995	0.0	1.0	1	
BROWNE_HCMV_INFECTION_30MIN_DN 	0	11	120	16907	0.0	1.0	1	
LANDIS_ERBB2_BREAST_TUMORS_324_UP 	1	10	138	16889	12.23840579710145	0.08619237757961061	1	RTKN
FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN 	0	11	41	16986	0.0	1.0	1	
VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP 	0	11	64	16963	0.0	1.0	1	
KRIGE_AMINO_ACID_DEPRIVATION 	0	11	27	17000	0.0	1.0	1	
LEE_SP4_THYMOCYTE 	0	11	11	17016	0.0	1.0	1	
REACTOME_REGULATED_PROTEOLYSIS_OF_P75NTR 	0	11	10	17017	0.0	1.0	1	
HECKER_IFNB1_TARGETS 	0	11	78	16949	0.0	1.0	1	
JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_UP 	0	11	5	17022	0.0	1.0	1	
AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN 	0	11	14	17013	0.0	1.0	1	
PATIL_LIVER_CANCER 	0	11	666	16361	0.0	1.0	1	
KARLSSON_TGFB1_TARGETS_DN 	0	11	198	16829	0.0	1.0	1	
DELYS_THYROID_CANCER_DN 	0	11	215	16812	0.0	1.0	1	
SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN 	0	11	387	16640	0.0	1.0	1	
ONDER_CDH1_TARGETS_1_DN 	0	11	142	16885	0.0	1.0	1	
WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN 	0	11	23	17004	0.0	1.0	1	
PID_TCR_JNK_PATHWAY 	0	11	14	17013	0.0	1.0	1	
REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE 	0	11	16	17011	0.0	1.0	1	
REACTOME_TRANSCRIPTION_COUPLED_NER_TC_NER 	0	11	43	16984	0.0	1.0	1	
YIH_RESPONSE_TO_ARSENITE_C1 	0	11	21	17006	0.0	1.0	1	
REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS 	0	11	8	17019	0.0	1.0	1	
WILLERT_WNT_SIGNALING 	0	11	21	17006	0.0	1.0	1	
GUO_TARGETS_OF_IRS1_AND_IRS2 	0	11	89	16938	0.0	1.0	1	
ZHAN_MULTIPLE_MYELOMA_CD1_UP 	0	11	43	16984	0.0	1.0	1	
ZHANG_TLX_TARGETS_UP 	0	11	105	16922	0.0	1.0	1	
AMIT_EGF_RESPONSE_480_HELA 	0	11	156	16871	0.0	1.0	1	
RODRIGUES_THYROID_CARCINOMA_DN 	0	11	71	16956	0.0	1.0	1	
KRASNOSELSKAYA_ILF3_TARGETS_DN 	0	11	42	16985	0.0	1.0	1	
NADLER_OBESITY_UP 	0	11	58	16969	0.0	1.0	1	
KAPOSI_LIVER_CANCER_MET_UP 	0	11	17	17010	0.0	1.0	1	
NABA_SECRETED_FACTORS 	0	11	211	16816	0.0	1.0	1	
SU_LIVER 	0	11	27	17000	0.0	1.0	1	
TAVOR_CEBPA_TARGETS_UP 	0	11	44	16983	0.0	1.0	1	
RUIZ_TNC_TARGETS_UP 	0	11	149	16878	0.0	1.0	1	
FERRANDO_TAL1_NEIGHBORS 	0	11	16	17011	0.0	1.0	1	
RUIZ_TNC_TARGETS_DN 	0	11	122	16905	0.0	1.0	1	
KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY 	0	11	50	16977	0.0	1.0	1	
SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_DN 	0	11	17	17010	0.0	1.0	1	
ZHENG_FOXP3_TARGETS_DN 	0	11	5	17022	0.0	1.0	1	
REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_THE_POSTSYNAPTIC_CELL 	0	11	124	16903	0.0	1.0	1	
WATANABE_COLON_CANCER_MSI_VS_MSS_DN 	0	11	60	16967	0.0	1.0	1	
WHITFIELD_CELL_CYCLE_S 	0	11	137	16890	0.0	1.0	1	
RUTELLA_RESPONSE_TO_HGF_UP 	0	11	376	16651	0.0	1.0	1	
BIOCARTA_AGR_PATHWAY 	0	11	33	16994	0.0	1.0	1	
GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP 	0	11	106	16921	0.0	1.0	1	
FINAK_BREAST_CANCER_SDPP_SIGNATURE 	0	11	20	17007	0.0	1.0	1	
REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM 	0	11	27	17000	0.0	1.0	1	
FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES 	0	11	4	17023	0.0	1.0	1	
SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN 	0	11	45	16982	0.0	1.0	1	
PID_RHOA_PATHWAY 	0	11	45	16982	0.0	1.0	1	
PID_FCER1_PATHWAY 	0	11	57	16970	0.0	1.0	1	
PID_HDAC_CLASSII_PATHWAY 	0	11	32	16995	0.0	1.0	1	
PID_ECADHERIN_STABILIZATION_PATHWAY 	0	11	40	16987	0.0	1.0	1	
PID_TRAIL_PATHWAY 	0	11	28	16999	0.0	1.0	1	
LASTOWSKA_COAMPLIFIED_WITH_MYCN 	0	11	38	16989	0.0	1.0	1	
REACTOME_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION 	0	11	100	16927	0.0	1.0	1	
REACTOME_N_GLYCAN_ANTENNAE_ELONGATION 	0	11	14	17013	0.0	1.0	1	
LEE_LIVER_CANCER 	0	11	31	16996	0.0	1.0	1	
BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP 	0	11	57	16970	0.0	1.0	1	
NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON 	0	11	41	16986	0.0	1.0	1	
GAVIN_FOXP3_TARGETS_CLUSTER_P2 	0	11	69	16958	0.0	1.0	1	
LEE_AGING_CEREBELLUM_UP 	0	11	75	16952	0.0	1.0	1	
REACTOME_RIG_I_MDA5_MEDIATED_INDUCTION_OF_IFN_ALPHA_BETA_PATHWAYS 	0	11	57	16970	0.0	1.0	1	
GAVIN_FOXP3_TARGETS_CLUSTER_P6 	0	11	77	16950	0.0	1.0	1	
GAVIN_FOXP3_TARGETS_CLUSTER_P4 	2	9	83	16944	45.36546184738956	0.001313867790932482	1	CAPN3,C9orf3
REACTOME_P2Y_RECEPTORS 	0	11	10	17017	0.0	1.0	1	
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN 	0	11	254	16773	0.0	1.0	1	
WANG_LSD1_TARGETS_UP 	0	11	23	17004	0.0	1.0	1	
REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PLC_BETA 	0	11	18	17009	0.0	1.0	1	
POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN 	0	11	58	16969	0.0	1.0	1	
SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP 	0	11	78	16949	0.0	1.0	1	
CORRADETTI_MTOR_PATHWAY_REGULATORS_DN 	0	11	6	17021	0.0	1.0	1	
SHEPARD_BMYB_TARGETS 	1	10	59	16968	28.759322033898304	0.038073006020596455	1	RTKN
GERHOLD_RESPONSE_TO_TZD_UP 	0	11	6	17021	0.0	1.0	1	
DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_DN 	0	11	9	17018	0.0	1.0	1	
BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP 	0	11	395	16632	0.0	1.0	1	
PID_HIF1A_PATHWAY 	0	11	16	17011	0.0	1.0	1	
MATZUK_CENTRAL_FOR_FEMALE_FERTILITY 	0	11	19	17008	0.0	1.0	1	
BILANGES_SERUM_RESPONSE_TRANSLATION 	0	11	33	16994	0.0	1.0	1	
ZHOU_TNF_SIGNALING_30MIN 	0	11	51	16976	0.0	1.0	1	
REACTOME_CS_DS_DEGRADATION 	0	11	12	17015	0.0	1.0	1	
REACTOME_RNA_POL_III_TRANSCRIPTION 	0	11	33	16994	0.0	1.0	1	
MARSON_FOXP3_TARGETS_STIMULATED_DN 	0	11	9	17018	0.0	1.0	1	
LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN 	0	11	130	16897	0.0	1.0	1	
REACTOME_METABOLISM_OF_CARBOHYDRATES 	0	11	211	16816	0.0	1.0	1	
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_DN 	0	11	16	17011	0.0	1.0	1	
IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM 	0	11	29	16998	0.0	1.0	1	
FREDERICK_PRKCI_TARGETS 	0	11	6	17021	0.0	1.0	1	
BARRIER_COLON_CANCER_RECURRENCE_DN 	0	11	20	17007	0.0	1.0	1	
REACTOME_ABCA_TRANSPORTERS_IN_LIPID_HOMEOSTASIS 	0	11	16	17011	0.0	1.0	1	
REACTOME_PYRUVATE_METABOLISM 	0	11	18	17009	0.0	1.0	1	
LY_AGING_OLD_DN 	0	11	50	16977	0.0	1.0	1	
BIOCARTA_FIBRINOLYSIS_PATHWAY 	0	11	5	17022	0.0	1.0	1	
SHI_SPARC_TARGETS_DN 	0	11	11	17016	0.0	1.0	1	
LANDIS_BREAST_CANCER_PROGRESSION_DN 	0	11	67	16960	0.0	1.0	1	
PID_CD8_TCR_DOWNSTREAM_PATHWAY 	0	11	44	16983	0.0	1.0	1	
LU_TUMOR_VASCULATURE_UP 	0	11	29	16998	0.0	1.0	1	
KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3 	0	11	753	16274	0.0	1.0	1	
BOQUEST_STEM_CELL_DN 	0	11	204	16823	0.0	1.0	1	
CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP 	0	11	51	16976	0.0	1.0	1	
PID_ARF_3PATHWAY 	0	11	19	17008	0.0	1.0	1	
WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN 	0	11	185	16842	0.0	1.0	1	
GENTLES_LEUKEMIC_STEM_CELL_DN 	0	11	11	17016	0.0	1.0	1	
JAATINEN_HEMATOPOIETIC_STEM_CELL_DN 	0	11	180	16847	0.0	1.0	1	
YAGI_AML_WITH_INV_16_TRANSLOCATION 	0	11	378	16649	0.0	1.0	1	
RUAN_RESPONSE_TO_TROGLITAZONE_UP 	0	11	24	17003	0.0	1.0	1	
RAO_BOUND_BY_SALL4_ISOFORM_B 	0	11	433	16594	0.0	1.0	1	
BOYLAN_MULTIPLE_MYELOMA_C_D_DN 	0	11	207	16820	0.0	1.0	1	
PIONTEK_PKD1_TARGETS_DN 	0	11	12	17015	0.0	1.0	1	
VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_UP 	0	11	14	17013	0.0	1.0	1	
PID_MET_PATHWAY 	0	11	80	16947	0.0	1.0	1	
PID_ARF6_PATHWAY 	0	11	34	16993	0.0	1.0	1	
BIOCARTA_EDG1_PATHWAY 	0	11	26	17001	0.0	1.0	1	
OSADA_ASCL1_TARGETS_DN 	0	11	23	17004	0.0	1.0	1	
REACTOME_RNA_POL_III_TRANSCRIPTION_TERMINATION 	0	11	19	17008	0.0	1.0	1	
REACTOME_TRANSLATION 	0	11	143	16884	0.0	1.0	1	
REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS 	0	11	10	17017	0.0	1.0	1	
KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN 	0	11	51	16976	0.0	1.0	1	
MIKKELSEN_MEF_ICP_WITH_H3K27ME3 	0	11	139	16888	0.0	1.0	1	
YANG_MUC2_TARGETS_DUODENUM_6MO_DN 	0	11	14	17013	0.0	1.0	1	
VICENT_METASTASIS_UP 	0	11	14	17013	0.0	1.0	1	
BENPORATH_SOX2_TARGETS 	0	11	672	16355	0.0	1.0	1	
REACTOME_GAP_JUNCTION_TRAFFICKING 	0	11	21	17006	0.0	1.0	1	
DONATO_CELL_CYCLE_TRETINOIN 	0	11	6	17021	0.0	1.0	1	
TSUNODA_CISPLATIN_RESISTANCE_DN 	0	11	42	16985	0.0	1.0	1	
FARMER_BREAST_CANCER_CLUSTER_1 	0	11	30	16997	0.0	1.0	1	
CROONQUIST_IL6_DEPRIVATION_UP 	0	11	17	17010	0.0	1.0	1	
AUNG_GASTRIC_CANCER 	0	11	40	16987	0.0	1.0	1	
NIKOLSKY_BREAST_CANCER_16Q24_AMPLICON 	0	11	42	16985	0.0	1.0	1	
REACTOME_POTASSIUM_CHANNELS 	0	11	88	16939	0.0	1.0	1	
OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP 	0	11	202	16825	0.0	1.0	1	
BIOCARTA_ERYTH_PATHWAY 	0	11	11	17016	0.0	1.0	1	
PID_LIS1_PATHWAY 	0	11	28	16999	0.0	1.0	1	
XU_AKT1_TARGETS_48HR 	0	11	8	17019	0.0	1.0	1	
IKEDA_MIR133_TARGETS_UP 	0	11	43	16984	0.0	1.0	1	
COWLING_MYCN_TARGETS 	0	11	37	16990	0.0	1.0	1	
KEGG_AXON_GUIDANCE 	0	11	125	16902	0.0	1.0	1	
BIOCARTA_CASPASE_PATHWAY 	0	11	23	17004	0.0	1.0	1	
THILLAINADESAN_ZNF217_TARGETS_UP 	0	11	41	16986	0.0	1.0	1	
REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM 	0	11	18	17009	0.0	1.0	1	
SA_G2_AND_M_PHASES 	0	11	8	17019	0.0	1.0	1	
AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_8G 	0	11	92	16935	0.0	1.0	1	
WANG_RESPONSE_TO_FORSKOLIN_DN 	0	11	8	17019	0.0	1.0	1	
LUI_TARGETS_OF_PAX8_PPARG_FUSION 	0	11	33	16994	0.0	1.0	1	
WIERENGA_STAT5A_TARGETS_UP 	0	11	186	16841	0.0	1.0	1	
KEGG_NOTCH_SIGNALING_PATHWAY 	0	11	45	16982	0.0	1.0	1	
ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP 	0	11	159	16868	0.0	1.0	1	
CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP 	1	10	36	16991	47.19722222222222	0.02363694944752625	1	CAPN3
BOYAULT_LIVER_CANCER_SUBCLASS_G12_DN 	0	11	13	17014	0.0	1.0	1	
WONG_ENDOMETRIAL_CANCER_LATE 	0	11	5	17022	0.0	1.0	1	
NGO_MALIGNANT_GLIOMA_1P_LOH 	0	11	16	17011	0.0	1.0	1	
AMIT_SERUM_RESPONSE_20_MCF10A 	0	11	18	17009	0.0	1.0	1	
FORTSCHEGGER_PHF8_TARGETS_UP 	0	11	245	16782	0.0	1.0	1	
KAYO_AGING_MUSCLE_DN 	0	11	114	16913	0.0	1.0	1	
HOSHIDA_LIVER_CANCER_SUBCLASS_S2 	0	11	109	16918	0.0	1.0	1	
REACTOME_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE 	0	11	14	17013	0.0	1.0	1	
ZIRN_TRETINOIN_RESPONSE_WT1_UP 	0	11	22	17005	0.0	1.0	1	
HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP 	0	11	73	16954	0.0	1.0	1	
FRIDMAN_SENESCENCE_DN 	0	11	12	17015	0.0	1.0	1	
NAGY_STAGA_COMPONENTS_HUMAN 	0	11	14	17013	0.0	1.0	1	
ZHAN_MULTIPLE_MYELOMA_MS_UP 	0	11	44	16983	0.0	1.0	1	
SASSON_RESPONSE_TO_FORSKOLIN_UP 	0	11	84	16943	0.0	1.0	1	
REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION 	0	11	17	17010	0.0	1.0	1	
MOOTHA_GLYCOLYSIS 	0	11	17	17010	0.0	1.0	1	
MORI_SMALL_PRE_BII_LYMPHOCYTE_DN 	0	11	73	16954	0.0	1.0	1	
DASU_IL6_SIGNALING_UP 	0	11	55	16972	0.0	1.0	1	
WENG_POR_TARGETS_GLOBAL_UP 	0	11	15	17012	0.0	1.0	1	
WONG_PROTEASOME_GENE_MODULE 	0	11	48	16979	0.0	1.0	1	
REACTOME_MTORC1_MEDIATED_SIGNALLING 	0	11	11	17016	0.0	1.0	1	
ABE_INNER_EAR 	0	11	43	16984	0.0	1.0	1	
REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION 	0	11	69	16958	0.0	1.0	1	
STEIN_ESRRA_TARGETS 	0	11	492	16535	0.0	1.0	1	
DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP 	0	11	122	16905	0.0	1.0	1	
KEGG_CHRONIC_MYELOID_LEUKEMIA 	0	11	71	16956	0.0	1.0	1	
WU_CELL_MIGRATION 	0	11	168	16859	0.0	1.0	1	
MULLIGHAN_NPM1_SIGNATURE_3_DN 	1	10	143	16884	11.806993006993007	0.08916296550078741	1	CAPN3
HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN 	0	11	66	16961	0.0	1.0	1	
FARMER_BREAST_CANCER_BASAL_VS_LULMINAL 	0	11	295	16732	0.0	1.0	1	
CROMER_TUMORIGENESIS_UP 	0	11	50	16977	0.0	1.0	1	
WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP 	0	11	132	16895	0.0	1.0	1	
SUZUKI_AMPLIFIED_IN_ORAL_CANCER 	0	11	10	17017	0.0	1.0	1	
TURJANSKI_MAPK11_TARGETS 	0	11	5	17022	0.0	1.0	1	
BIOCARTA_UCALPAIN_PATHWAY 	0	11	16	17011	0.0	1.0	1	
ZHANG_BREAST_CANCER_PROGENITORS_UP 	0	11	387	16640	0.0	1.0	1	
MAINA_HYPOXIA_VHL_TARGETS_UP 	0	11	5	17022	0.0	1.0	1	
NABA_ECM_REGULATORS 	0	11	160	16867	0.0	1.0	1	
VANDESLUIS_COMMD1_TARGETS_GROUP_2_UP 	0	11	14	17013	0.0	1.0	1	
BIOCARTA_CK1_PATHWAY 	0	11	16	17011	0.0	1.0	1	
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FGF3 	0	11	8	17019	0.0	1.0	1	
TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_DN 	0	11	5	17022	0.0	1.0	1	
PENG_GLUTAMINE_DEPRIVATION_UP 	0	11	34	16993	0.0	1.0	1	
PID_LYSOPHOSPHOLIPID_PATHWAY 	0	11	65	16962	0.0	1.0	1	
LOPEZ_MESOTELIOMA_SURVIVAL_TIME_DN 	0	11	7	17020	0.0	1.0	1	
LIU_SMARCA4_TARGETS 	0	11	54	16973	0.0	1.0	1	
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 	0	11	71	16956	0.0	1.0	1	
IGLESIAS_E2F_TARGETS_DN 	0	11	13	17014	0.0	1.0	1	
BIOCARTA_PARKIN_PATHWAY 	0	11	12	17015	0.0	1.0	1	
SA_PTEN_PATHWAY 	0	11	17	17010	0.0	1.0	1	
JOHANSSON_GLIOMAGENESIS_BY_PDGFB_DN 	0	11	21	17006	0.0	1.0	1	
SWEET_LUNG_CANCER_KRAS_DN 	0	11	384	16643	0.0	1.0	1	
MIKKELSEN_DEDIFFERENTIATED_STATE_UP 	0	11	7	17020	0.0	1.0	1	
REACTOME_HS_GAG_BIOSYNTHESIS 	0	11	27	17000	0.0	1.0	1	
XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN 	0	11	15	17012	0.0	1.0	1	
BIOCARTA_AMI_PATHWAY 	0	11	13	17014	0.0	1.0	1	
HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2 	0	11	16	17011	0.0	1.0	1	
SCHMIDT_POR_TARGETS_IN_LIMB_BUD_UP 	0	11	25	17002	0.0	1.0	1	
KREPPEL_CD99_TARGETS_UP 	0	11	5	17022	0.0	1.0	1	
BLUM_RESPONSE_TO_SALIRASIB_UP 	0	11	232	16795	0.0	1.0	1	
MOOTHA_PGC 	0	11	397	16630	0.0	1.0	1	
AKL_HTLV1_INFECTION_DN 	0	11	58	16969	0.0	1.0	1	
MAYBURD_RESPONSE_TO_L663536_UP 	0	11	29	16998	0.0	1.0	1	
TAKADA_GASTRIC_CANCER_COPY_NUMBER_UP 	0	11	6	17021	0.0	1.0	1	
HASLINGER_B_CLL_WITH_6Q21_DELETION 	0	11	15	17012	0.0	1.0	1	
PID_KIT_PATHWAY 	0	11	50	16977	0.0	1.0	1	
LINSLEY_MIR16_TARGETS 	0	11	186	16841	0.0	1.0	1	
SCHLESINGER_METHYLATED_IN_COLON_CANCER 	0	11	8	17019	0.0	1.0	1	
MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN 	0	11	23	17004	0.0	1.0	1	
PUJANA_ATM_PCC_NETWORK 	0	11	1265	15762	0.0	1.0	1	
WANG_HCP_PROSTATE_CANCER 	0	11	102	16925	0.0	1.0	1	
PID_EPO_PATHWAY 	0	11	33	16994	0.0	1.0	1	
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN 	0	11	128	16899	0.0	1.0	1	
REACTOME_MRNA_DECAY_BY_3_TO_5_EXORIBONUCLEASE 	0	11	11	17016	0.0	1.0	1	
WATANABE_COLON_CANCER_MSI_VS_MSS_UP 	0	11	24	17003	0.0	1.0	1	
DELASERNA_MYOD_TARGETS_DN 	0	11	53	16974	0.0	1.0	1	
GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION 	0	11	37	16990	0.0	1.0	1	
KIM_PTEN_TARGETS_DN 	0	11	5	17022	0.0	1.0	1	
BAKER_HEMATOPOESIS_STAT5_TARGETS 	0	11	7	17020	0.0	1.0	1	
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP 	0	11	88	16939	0.0	1.0	1	
KEGG_ONE_CARBON_POOL_BY_FOLATE 	0	11	17	17010	0.0	1.0	1	
MARKS_HDAC_TARGETS_UP 	0	11	21	17006	0.0	1.0	1	
NAKAMURA_ADIPOGENESIS_EARLY_DN 	0	11	38	16989	0.0	1.0	1	
BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN 	0	11	44	16983	0.0	1.0	1	
REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE 	0	11	52	16975	0.0	1.0	1	
LIU_BREAST_CANCER 	0	11	22	17005	0.0	1.0	1	
MANTOVANI_NFKB_TARGETS_UP 	0	11	38	16989	0.0	1.0	1	
STEIN_ESR1_TARGETS 	0	11	78	16949	0.0	1.0	1	
ZHAN_V1_LATE_DIFFERENTIATION_GENES_DN 	0	11	14	17013	0.0	1.0	1	
REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_RAS 	0	11	27	17000	0.0	1.0	1	
LANDIS_ERBB2_BREAST_TUMORS_65_UP 	0	11	21	17006	0.0	1.0	1	
REACTOME_GABA_B_RECEPTOR_ACTIVATION 	0	11	35	16992	0.0	1.0	1	
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_DN 	0	11	11	17016	0.0	1.0	1	
SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP 	0	11	154	16873	0.0	1.0	1	
KERLEY_RESPONSE_TO_CISPLATIN_UP 	0	11	42	16985	0.0	1.0	1	
REACTOME_MITOTIC_G1_G1_S_PHASES 	0	11	123	16904	0.0	1.0	1	
REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS 	0	11	72	16955	0.0	1.0	1	
GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN 	0	11	20	17007	0.0	1.0	1	
WHITFIELD_CELL_CYCLE_M_G1 	0	11	136	16891	0.0	1.0	1	
LEIN_NEURON_MARKERS 	0	11	64	16963	0.0	1.0	1	
GILDEA_METASTASIS 	0	11	27	17000	0.0	1.0	1	
WANG_MLL_TARGETS 	0	11	239	16788	0.0	1.0	1	
DORSEY_GAB2_TARGETS 	0	11	27	17000	0.0	1.0	1	
KEGG_GLYCEROLIPID_METABOLISM 	0	11	37	16990	0.0	1.0	1	
KEGG_GRAFT_VERSUS_HOST_DISEASE 	0	11	25	17002	0.0	1.0	1	
WANG_RESPONSE_TO_BEXAROTENE_UP 	0	11	27	17000	0.0	1.0	1	
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP 	0	11	54	16973	0.0	1.0	1	
PILON_KLF1_TARGETS_UP 	2	9	427	16600	8.639084048920115	0.02993264505058636	1	TMC7,C9orf3
VERNELL_RETINOBLASTOMA_PATHWAY_UP 	0	11	63	16964	0.0	1.0	1	
WEBER_METHYLATED_HCP_IN_SPERM_DN 	0	11	11	17016	0.0	1.0	1	
FUJII_YBX1_TARGETS_UP 	0	11	36	16991	0.0	1.0	1	
EHLERS_ANEUPLOIDY_DN 	0	11	11	17016	0.0	1.0	1	
ONGUSAHA_BRCA1_TARGETS_DN 	0	11	11	17016	0.0	1.0	1	
CHICAS_RB1_TARGETS_LOW_SERUM 	0	11	79	16948	0.0	1.0	1	
PID_LKB1_PATHWAY 	0	11	46	16981	0.0	1.0	1	
ZEMBUTSU_SENSITIVITY_TO_VINCRISTINE 	0	11	14	17013	0.0	1.0	1	
NADERI_BREAST_CANCER_PROGNOSIS_DN 	0	11	16	17011	0.0	1.0	1	
KANG_DOXORUBICIN_RESISTANCE_UP 	0	11	42	16985	0.0	1.0	1	
JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_UP 	0	11	29	16998	0.0	1.0	1	
NIKOLSKY_BREAST_CANCER_19P13_AMPLICON 	0	11	5	17022	0.0	1.0	1	
RHODES_UNDIFFERENTIATED_CANCER 	0	11	59	16968	0.0	1.0	1	
BIOCARTA_CTLA4_PATHWAY 	0	11	12	17015	0.0	1.0	1	
MA_MYELOID_DIFFERENTIATION_DN 	0	11	35	16992	0.0	1.0	1	
GHO_ATF5_TARGETS_UP 	0	11	13	17014	0.0	1.0	1	
HOEGERKORP_CD44_TARGETS_DIRECT_UP 	0	11	23	17004	0.0	1.0	1	
NIELSEN_SCHWANNOMA_UP 	0	11	17	17010	0.0	1.0	1	
REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING 	0	11	26	17001	0.0	1.0	1	
CARDOSO_RESPONSE_TO_GAMMA_RADIATION_AND_3AB 	0	11	16	17011	0.0	1.0	1	
ST_INTERLEUKIN_4_PATHWAY 	0	11	22	17005	0.0	1.0	1	
LAIHO_COLORECTAL_CANCER_SERRATED_UP 	0	11	105	16922	0.0	1.0	1	
REACTOME_RAS_ACTIVATION_UOPN_CA2_INFUX_THROUGH_NMDA_RECEPTOR 	0	11	17	17010	0.0	1.0	1	
MITSIADES_RESPONSE_TO_APLIDIN_UP 	0	11	389	16638	0.0	1.0	1	
PID_DELTA_NP63_PATHWAY 	0	11	41	16986	0.0	1.0	1	
IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_UP 	0	11	10	17017	0.0	1.0	1	
CHESLER_BRAIN_D6MIT150_QTL_CIS 	0	11	5	17022	0.0	1.0	1	
YANG_MUC2_TARGETS_DUODENUM_3MO_DN 	0	11	18	17009	0.0	1.0	1	
BIOCARTA_PS1_PATHWAY 	0	11	13	17014	0.0	1.0	1	
YU_BAP1_TARGETS 	0	11	28	16999	0.0	1.0	1	
GREENBAUM_E2A_TARGETS_DN 	0	11	18	17009	0.0	1.0	1	
VERHAAK_AML_WITH_NPM1_MUTATED_DN 	0	11	214	16813	0.0	1.0	1	
DER_IFN_GAMMA_RESPONSE_UP 	0	11	68	16959	0.0	1.0	1	
KONDO_EZH2_TARGETS 	0	11	201	16826	0.0	1.0	1	
PROVENZANI_METASTASIS_UP 	1	10	178	16849	9.465730337078652	0.10971250547316376	1	PLLP
SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN 	0	11	21	17006	0.0	1.0	1	
SMID_BREAST_CANCER_ERBB2_UP 	0	11	106	16921	0.0	1.0	1	
REACTOME_MEMBRANE_TRAFFICKING 	0	11	117	16910	0.0	1.0	1	
MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP 	0	11	203	16824	0.0	1.0	1	
BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN 	1	10	55	16972	30.85818181818182	0.03557641157284497	1	CDC42EP1
MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_DN 	0	11	4	17023	0.0	1.0	1	
DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP 	0	11	26	17001	0.0	1.0	1	
NIELSEN_SCHWANNOMA_DN 	0	11	12	17015	0.0	1.0	1	
REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX 	0	11	60	16967	0.0	1.0	1	
SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_UP 	0	11	18	17009	0.0	1.0	1	
REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION 	0	11	21	17006	0.0	1.0	1	
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_UP 	0	11	11	17016	0.0	1.0	1	
CHANDRAN_METASTASIS_TOP50_UP 	0	11	35	16992	0.0	1.0	1	
HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP 	0	11	20	17007	0.0	1.0	1	
HOLLMANN_APOPTOSIS_VIA_CD40_DN 	0	11	232	16795	0.0	1.0	1	
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_DN 	0	11	28	16999	0.0	1.0	1	
BRUNEAU_SEPTATION_ATRIAL 	0	11	2	17025	0.0	1.0	1	
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_DN 	0	11	10	17017	0.0	1.0	1	
PEDRIOLI_MIR31_TARGETS_DN 	0	11	351	16676	0.0	1.0	1	
ISHIKAWA_STING_SIGNALING 	0	11	7	17020	0.0	1.0	1	
CONRAD_GERMLINE_STEM_CELL 	0	11	7	17020	0.0	1.0	1	
WENDT_COHESIN_TARGETS_UP 	0	11	33	16994	0.0	1.0	1	
YAGUE_PRETUMOR_DRUG_RESISTANCE_DN 	0	11	13	17014	0.0	1.0	1	
PID_VEGF_VEGFR_PATHWAY 	0	11	9	17018	0.0	1.0	1	
DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN 	0	11	89	16938	0.0	1.0	1	
BIOCARTA_NFAT_PATHWAY 	0	11	45	16982	0.0	1.0	1	
FIGUEROA_AML_METHYLATION_CLUSTER_1_UP 	0	11	100	16927	0.0	1.0	1	
SCHRAETS_MLL_TARGETS_DN 	0	11	26	17001	0.0	1.0	1	
AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP 	0	11	112	16915	0.0	1.0	1	
DOANE_BREAST_CANCER_ESR1_DN 	0	11	37	16990	0.0	1.0	1	
PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP 	0	11	195	16832	0.0	1.0	1	
TOOKER_GEMCITABINE_RESISTANCE_DN 	0	11	119	16908	0.0	1.0	1	
JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN 	0	11	62	16965	0.0	1.0	1	
MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN 	0	11	194	16833	0.0	1.0	1	
REACTOME_CHROMOSOME_MAINTENANCE 	0	11	86	16941	0.0	1.0	1	
DARWICHE_SKIN_TUMOR_PROMOTER_UP 	0	11	118	16909	0.0	1.0	1	
VANHARANTA_UTERINE_FIBROID_UP 	0	11	40	16987	0.0	1.0	1	
TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA 	0	11	69	16958	0.0	1.0	1	
KANG_AR_TARGETS_UP 	0	11	15	17012	0.0	1.0	1	
HOELZEL_NF1_TARGETS_UP 	0	11	122	16905	0.0	1.0	1	
MCBRYAN_PUBERTAL_BREAST_3_4WK_UP 	0	11	186	16841	0.0	1.0	1	
SCHRAMM_INHBA_TARGETS_UP 	0	11	7	17020	0.0	1.0	1	
STAMBOLSKY_BOUND_BY_MUTATED_TP53 	0	11	17	17010	0.0	1.0	1	
GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP 	0	11	28	16999	0.0	1.0	1	
TAVOR_CEBPA_TARGETS_DN 	0	11	29	16998	0.0	1.0	1	
NEBEN_AML_WITH_FLT3_OR_NRAS_DN 	0	11	12	17015	0.0	1.0	1	
MIKKELSEN_NPC_ICP_WITH_H3K27ME3 	0	11	10	17017	0.0	1.0	1	
TURJANSKI_MAPK14_TARGETS 	0	11	10	17017	0.0	1.0	1	
BIOCARTA_ECM_PATHWAY 	0	11	24	17003	0.0	1.0	1	
MATZUK_IMPLANTATION_AND_UTERINE 	0	11	17	17010	0.0	1.0	1	
DUTTA_APOPTOSIS_VIA_NFKB 	0	11	30	16997	0.0	1.0	1	
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP 	0	11	18	17009	0.0	1.0	1	
REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_DAI 	0	11	17	17010	0.0	1.0	1	
FARMER_BREAST_CANCER_CLUSTER_2 	0	11	26	17001	0.0	1.0	1	
GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP 	0	11	183	16844	0.0	1.0	1	
PENG_RAPAMYCIN_RESPONSE_DN 	0	11	230	16797	0.0	1.0	1	
REACTOME_MRNA_CAPPING 	0	11	28	16999	0.0	1.0	1	
FARMER_BREAST_CANCER_CLUSTER_6 	0	11	14	17013	0.0	1.0	1	
FARMER_BREAST_CANCER_CLUSTER_7 	0	11	17	17010	0.0	1.0	1	
OUYANG_PROSTATE_CANCER_PROGRESSION_UP 	0	11	18	17009	0.0	1.0	1	
FARMER_BREAST_CANCER_CLUSTER_5 	0	11	18	17009	0.0	1.0	1	
LIU_CDX2_TARGETS_UP 	1	10	22	17005	77.29545454545455	0.014753640278268828	1	SOX10
BIOCARTA_ASBCELL_PATHWAY 	0	11	5	17022	0.0	1.0	1	
BORCZUK_MALIGNANT_MESOTHELIOMA_DN 	1	10	80	16947	21.18375	0.05108400031948391	1	CAPN3
VANTVEER_BREAST_CANCER_ESR1_DN 	1	10	201	16826	8.371144278606964	0.12298603808775713	1	SOX10
ODONNELL_TFRC_TARGETS_UP 	1	10	335	16692	4.982686567164179	0.19680627865647238	1	RTKN
KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP 	0	11	676	16351	0.0	1.0	1	
FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_UP 	0	11	22	17005	0.0	1.0	1	
REACTOME_INTEGRATION_OF_ENERGY_METABOLISM 	0	11	102	16925	0.0	1.0	1	
HALMOS_CEBPA_TARGETS_UP 	0	11	45	16982	0.0	1.0	1	
ZHU_CMV_24_HR_DN 	0	11	85	16942	0.0	1.0	1	
LI_WILMS_TUMOR_ANAPLASTIC_UP 	0	11	16	17011	0.0	1.0	1	
ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP 	0	11	62	16965	0.0	1.0	1	
SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_DN 	0	11	14	17013	0.0	1.0	1	
JISON_SICKLE_CELL_DISEASE_DN 	0	11	166	16861	0.0	1.0	1	
BIOCARTA_PPARA_PATHWAY 	0	11	51	16976	0.0	1.0	1	
FUJIWARA_PARK2_IN_LIVER_CANCER_DN 	0	11	4	17023	0.0	1.0	1	
REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL 	0	11	7	17020	0.0	1.0	1	
PID_S1P_S1P4_PATHWAY 	0	11	14	17013	0.0	1.0	1	
KEGG_RIBOFLAVIN_METABOLISM 	0	11	13	17014	0.0	1.0	1	
TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN 	0	11	23	17004	0.0	1.0	1	
WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2 	0	11	53	16974	0.0	1.0	1	
WANG_TUMOR_INVASIVENESS_DN 	0	11	195	16832	0.0	1.0	1	
HOLLEMAN_DAUNORUBICIN_ALL_UP 	0	11	6	17021	0.0	1.0	1	
BIOCARTA_MTOR_PATHWAY 	0	11	23	17004	0.0	1.0	1	
CROMER_TUMORIGENESIS_DN 	0	11	38	16989	0.0	1.0	1	
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP 	0	11	257	16770	0.0	1.0	1	
HEIDENBLAD_AMPLICON_8Q24_DN 	0	11	42	16985	0.0	1.0	1	
KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN 	0	11	303	16724	0.0	1.0	1	
ULE_SPLICING_VIA_NOVA2 	0	11	43	16984	0.0	1.0	1	
BIOCARTA_CELLCYCLE_PATHWAY 	0	11	23	17004	0.0	1.0	1	
KEGG_ARACHIDONIC_ACID_METABOLISM 	0	11	39	16988	0.0	1.0	1	
BIOCARTA_IL3_PATHWAY 	0	11	14	17013	0.0	1.0	1	
GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP 	0	11	84	16943	0.0	1.0	1	
ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP 	0	11	26	17001	0.0	1.0	1	
STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP 	0	11	69	16958	0.0	1.0	1	
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST 	0	11	122	16905	0.0	1.0	1	
REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE 	0	11	106	16921	0.0	1.0	1	
KEGG_STARCH_AND_SUCROSE_METABOLISM 	0	11	26	17001	0.0	1.0	1	
LI_INDUCED_T_TO_NATURAL_KILLER_DN 	0	11	104	16923	0.0	1.0	1	
TIEN_INTESTINE_PROBIOTICS_24HR_DN 	0	11	204	16823	0.0	1.0	1	
XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP 	0	11	16	17011	0.0	1.0	1	
DITTMER_PTHLH_TARGETS_UP 	0	11	107	16920	0.0	1.0	1	
PID_FAK_PATHWAY 	0	11	57	16970	0.0	1.0	1	
MCCOLLUM_GELDANAMYCIN_RESISTANCE_UP 	0	11	9	17018	0.0	1.0	1	
RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_UP 	0	11	7	17020	0.0	1.0	1	
RUAN_RESPONSE_TO_TROGLITAZONE_DN 	0	11	16	17011	0.0	1.0	1	
REACTOME_CELL_CYCLE_MITOTIC 	0	11	280	16747	0.0	1.0	1	
VISALA_AGING_LYMPHOCYTE_DN 	0	11	19	17008	0.0	1.0	1	
MARSON_BOUND_BY_FOXP3_UNSTIMULATED 	0	11	1071	15956	0.0	1.0	1	
HINATA_NFKB_TARGETS_KERATINOCYTE_DN 	0	11	18	17009	0.0	1.0	1	
PID_MYC_ACTIV_PATHWAY 	0	11	77	16950	0.0	1.0	1	
TOMIDA_METASTASIS_DN 	0	11	16	17011	0.0	1.0	1	
BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE 	0	11	68	16959	0.0	1.0	1	
BIOCARTA_CYTOKINE_PATHWAY 	0	11	6	17021	0.0	1.0	1	
MATZUK_POST-IMPLANTATION_AND_POST-PARTUM 	0	11	12	17015	0.0	1.0	1	
WANG_RECURRENT_LIVER_CANCER_DN 	0	11	15	17012	0.0	1.0	1	
WESTON_VEGFA_TARGETS_3HR 	0	11	60	16967	0.0	1.0	1	
BIOCARTA_CDK5_PATHWAY 	0	11	11	17016	0.0	1.0	1	
MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP 	0	11	157	16870	0.0	1.0	1	
JU_AGING_TERC_TARGETS_DN 	0	11	3	17024	0.0	1.0	1	
PID_INTEGRIN_CS_PATHWAY 	0	11	24	17003	0.0	1.0	1	
REACTOME_EARLY_PHASE_OF_HIV_LIFE_CYCLE 	0	11	13	17014	0.0	1.0	1	
KEGG_ALPHA_LINOLENIC_ACID_METABOLISM 	0	11	9	17018	0.0	1.0	1	
PID_IL1_PATHWAY 	0	11	32	16995	0.0	1.0	1	
BIOCARTA_DC_PATHWAY 	0	11	11	17016	0.0	1.0	1	
MCBRYAN_PUBERTAL_BREAST_6_7WK_DN 	0	11	68	16959	0.0	1.0	1	
YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN 	0	11	70	16957	0.0	1.0	1	
SENESE_HDAC2_TARGETS_UP 	0	11	102	16925	0.0	1.0	1	
REACTOME_FRS2_MEDIATED_CASCADE 	0	11	30	16997	0.0	1.0	1	
WENG_POR_TARGETS_GLOBAL_DN 	0	11	21	17006	0.0	1.0	1	
PARK_HSC_AND_MULTIPOTENT_PROGENITORS 	0	11	48	16979	0.0	1.0	1	
REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS 	0	11	14	17013	0.0	1.0	1	
GNATENKO_PLATELET_SIGNATURE 	0	11	41	16986	0.0	1.0	1	
ZUCCHI_METASTASIS_DN 	0	11	36	16991	0.0	1.0	1	
GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB 	0	11	129	16898	0.0	1.0	1	
REACTOME_CELL_CELL_COMMUNICATION 	0	11	101	16926	0.0	1.0	1	
REACTOME_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE 	0	11	12	17015	0.0	1.0	1	
GAZIN_EPIGENETIC_SILENCING_BY_KRAS 	0	11	23	17004	0.0	1.0	1	
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP 	0	11	35	16992	0.0	1.0	1	
REACTOME_SIGNALING_BY_FGFR1_FUSION_MUTANTS 	0	11	18	17009	0.0	1.0	1	
CHEN_HOXA5_TARGETS_9HR_DN 	0	11	37	16990	0.0	1.0	1	
CHOW_RASSF1_TARGETS_UP 	0	11	25	17002	0.0	1.0	1	
PID_S1P_S1P2_PATHWAY 	0	11	24	17003	0.0	1.0	1	
REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTERGRINS_ 	0	11	12	17015	0.0	1.0	1	
DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN 	0	11	78	16949	0.0	1.0	1	
NUYTTEN_EZH2_TARGETS_UP 	0	11	942	16085	0.0	1.0	1	
REN_ALVEOLAR_RHABDOMYOSARCOMA_UP 	0	11	85	16942	0.0	1.0	1	
KIM_RESPONSE_TO_TSA_AND_DECITABINE_DN 	0	11	12	17015	0.0	1.0	1	
LEIN_ASTROCYTE_MARKERS 	0	11	40	16987	0.0	1.0	1	
REACTOME_APOPTOTIC_EXECUTION_PHASE 	0	11	44	16983	0.0	1.0	1	
TRACEY_RESISTANCE_TO_IFNA2_DN 	0	11	29	16998	0.0	1.0	1	
REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY 	0	11	42	16985	0.0	1.0	1	
BUDHU_LIVER_CANCER_METASTASIS_DN 	0	11	3	17024	0.0	1.0	1	
PID_HDAC_CLASSI_PATHWAY 	0	11	63	16964	0.0	1.0	1	
POS_HISTAMINE_RESPONSE_NETWORK 	0	11	29	16998	0.0	1.0	1	
STEIN_ESRRA_TARGETS_DN 	0	11	96	16931	0.0	1.0	1	
REACTOME_OLFACTORY_SIGNALING_PATHWAY 	0	11	5	17022	0.0	1.0	1	
PID_TCPTP_PATHWAY 	0	11	42	16985	0.0	1.0	1	
REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN 	0	11	28	16999	0.0	1.0	1	
YOSHIMURA_MAPK8_TARGETS_UP 	5	6	1023	16004	13.036819811013359	0.0002693085879332974	1	SOX10,CAPN3,CNTN2,PLLP,MAG
TIEN_INTESTINE_PROBIOTICS_2HR_DN 	0	11	82	16945	0.0	1.0	1	
BIOCARTA_ERK_PATHWAY 	0	11	27	17000	0.0	1.0	1	
BILD_MYC_ONCOGENIC_SIGNATURE 	0	11	185	16842	0.0	1.0	1	
PLASARI_TGFB1_TARGETS_10HR_UP 	0	11	183	16844	0.0	1.0	1	
REACTOME_DESTABILIZATION_OF_MRNA_BY_TRISTETRAPROLIN_TTP 	0	11	17	17010	0.0	1.0	1	
KORKOLA_EMBRYONAL_CARCINOMA 	0	11	7	17020	0.0	1.0	1	
ZHANG_TLX_TARGETS_60HR_DN 	0	11	242	16785	0.0	1.0	1	
REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS 	0	11	131	16896	0.0	1.0	1	
BIOCARTA_TNFR1_PATHWAY 	0	11	28	16999	0.0	1.0	1	
AMIT_EGF_RESPONSE_40_HELA 	0	11	42	16985	0.0	1.0	1	
APPEL_IMATINIB_RESPONSE 	0	11	32	16995	0.0	1.0	1	
PID_CDC42_REG_PATHWAY 	0	11	30	16997	0.0	1.0	1	
DEMAGALHAES_AGING_DN 	0	11	15	17012	0.0	1.0	1	
LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_DN 	0	11	7	17020	0.0	1.0	1	
PID_BARD1_PATHWAY 	0	11	27	17000	0.0	1.0	1	
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN 	0	11	167	16860	0.0	1.0	1	
SMID_BREAST_CANCER_LUMINAL_B_DN 	1	10	441	16586	3.7609977324263038	0.2511487112830967	1	SOX10
REACTOME_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX 	0	11	22	17005	0.0	1.0	1	
REACTOME_REGULATION_OF_AMPK_ACTIVITY_VIA_LKB1 	0	11	13	17014	0.0	1.0	1	
ST_GRANULE_CELL_SURVIVAL_PATHWAY 	0	11	26	17001	0.0	1.0	1	
PID_ATM_PATHWAY 	0	11	32	16995	0.0	1.0	1	
WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN 	0	11	12	17015	0.0	1.0	1	
REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B 	0	11	18	17009	0.0	1.0	1	
SA_CASPASE_CASCADE 	0	11	18	17009	0.0	1.0	1	
SANSOM_APC_TARGETS_DN 	1	10	306	16721	5.46437908496732	0.18132712106488155	1	CAPN3
NAGASHIMA_NRG1_SIGNALING_UP 	0	11	165	16862	0.0	1.0	1	
ZWANG_TRANSIENTLY_UP_BY_1ST_EGF_PULSE_ONLY 	0	11	1391	15636	0.0	1.0	1	
DORMOY_ELAVL1_TARGETS 	0	11	16	17011	0.0	1.0	1	
KINNEY_DNMT1_METHYLATION_TARGETS 	0	11	6	17021	0.0	1.0	1	
BIOCARTA_GABA_PATHWAY 	0	11	10	17017	0.0	1.0	1	
PLASARI_TGFB1_TARGETS_1HR_DN 	0	11	6	17021	0.0	1.0	1	
MEISSNER_ES_ICP_WITH_H3K4ME3 	0	11	29	16998	0.0	1.0	1	
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP 	0	11	524	16503	0.0	1.0	1	
BIOCARTA_P53HYPOXIA_PATHWAY 	0	11	22	17005	0.0	1.0	1	
DOANE_RESPONSE_TO_ANDROGEN_UP 	0	11	152	16875	0.0	1.0	1	
CAMPS_COLON_CANCER_COPY_NUMBER_DN 	0	11	36	16991	0.0	1.0	1	
GEORGANTAS_HSC_MARKERS 	0	11	61	16966	0.0	1.0	1	
GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP 	0	11	160	16867	0.0	1.0	1	
DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP 	0	11	279	16748	0.0	1.0	1	
ZHAN_MULTIPLE_MYELOMA_HP_DN 	0	11	43	16984	0.0	1.0	1	
WIERENGA_STAT5A_TARGETS_GROUP1 	0	11	115	16912	0.0	1.0	1	
VALK_AML_CLUSTER_7 	0	11	22	17005	0.0	1.0	1	
KEGG_VIBRIO_CHOLERAE_INFECTION 	0	11	48	16979	0.0	1.0	1	
KASLER_HDAC7_TARGETS_1_DN 	0	11	17	17010	0.0	1.0	1	
SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN 	0	11	28	16999	0.0	1.0	1	
TESAR_ALK_TARGETS_HUMAN_ES_5D_UP 	0	11	5	17022	0.0	1.0	1	
REACTOME_MEMBRANE_BINDING_AND_TARGETTING_OF_GAG_PROTEINS 	0	11	9	17018	0.0	1.0	1	
HO_LIVER_CANCER_VASCULAR_INVASION 	0	11	11	17016	0.0	1.0	1	
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN 	0	11	137	16890	0.0	1.0	1	
BIOCARTA_PITX2_PATHWAY 	0	11	14	17013	0.0	1.0	1	
OHM_METHYLATED_IN_ADULT_CANCERS 	0	11	25	17002	0.0	1.0	1	
FIGUEROA_AML_METHYLATION_CLUSTER_3_UP 	0	11	139	16888	0.0	1.0	1	
HOQUE_METHYLATED_IN_CANCER 	0	11	48	16979	0.0	1.0	1	
BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_UP 	0	11	14	17013	0.0	1.0	1	
REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES 	0	11	342	16685	0.0	1.0	1	
VALK_AML_CLUSTER_4 	0	11	24	17003	0.0	1.0	1	
BOQUEST_STEM_CELL_UP 	0	11	245	16782	0.0	1.0	1	
MCBRYAN_PUBERTAL_BREAST_5_6WK_UP 	0	11	107	16920	0.0	1.0	1	
FARMER_BREAST_CANCER_APOCRINE_VS_BASAL 	0	11	281	16746	0.0	1.0	1	
SEKI_INFLAMMATORY_RESPONSE_LPS_DN 	0	11	20	17007	0.0	1.0	1	
LINDGREN_BLADDER_CANCER_CLUSTER_1_UP 	0	11	103	16924	0.0	1.0	1	
REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY 	0	11	42	16985	0.0	1.0	1	
MENSE_HYPOXIA_UP 	0	11	95	16932	0.0	1.0	1	
ZHAN_LATE_DIFFERENTIATION_GENES_DN 	0	11	13	17014	0.0	1.0	1	
SHEPARD_BMYB_MORPHOLINO_DN 	1	10	168	16859	10.035119047619048	0.10388465006581118	1	RTKN
KOYAMA_SEMA3B_TARGETS_UP 	0	11	242	16785	0.0	1.0	1	
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP 	0	11	95	16932	0.0	1.0	1	
REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL 	0	11	12	17015	0.0	1.0	1	
CHUANG_OXIDATIVE_STRESS_RESPONSE_DN 	0	11	9	17018	0.0	1.0	1	
REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY 	0	11	16	17011	0.0	1.0	1	
FISCHER_G2_M_CELL_CYCLE 	0	11	196	16831	0.0	1.0	1	
REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS 	0	11	11	17016	0.0	1.0	1	
BOYLAN_MULTIPLE_MYELOMA_D_DN 	0	11	68	16959	0.0	1.0	1	
KHETCHOUMIAN_TRIM24_TARGETS_DN 	0	11	5	17022	0.0	1.0	1	
REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT 	0	11	26	17001	0.0	1.0	1	
SU_PANCREAS 	0	11	35	16992	0.0	1.0	1	
REACTOME_THE_ACTIVATION_OF_ARYLSULFATASES 	0	11	11	17016	0.0	1.0	1	
SPIRA_SMOKERS_LUNG_CANCER_DN 	0	11	19	17008	0.0	1.0	1	
KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_KERATAN_SULFATE 	0	11	13	17014	0.0	1.0	1	
MATZUK_MATERNAL_EFFECT 	0	11	4	17023	0.0	1.0	1	
ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP 	0	11	79	16948	0.0	1.0	1	
VANLOO_SP3_TARGETS_UP 	0	11	7	17020	0.0	1.0	1	
REACTOME_SIGNALING_BY_RHO_GTPASES 	0	11	109	16918	0.0	1.0	1	
REACTOME_TRANSLOCATION_OF_ZAP_70_TO_IMMUNOLOGICAL_SYNAPSE 	0	11	11	17016	0.0	1.0	1	
REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND 	0	11	15	17012	0.0	1.0	1	
MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_UP 	0	11	7	17020	0.0	1.0	1	
CHIN_BREAST_CANCER_COPY_NUMBER_UP 	0	11	21	17006	0.0	1.0	1	
SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN 	0	11	468	16559	0.0	1.0	1	
REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING 	0	11	19	17008	0.0	1.0	1	
REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS 	0	11	414	16613	0.0	1.0	1	
HUMMERICH_BENIGN_SKIN_TUMOR_UP 	0	11	15	17012	0.0	1.0	1	
LI_LUNG_CANCER 	0	11	39	16988	0.0	1.0	1	
SCHEIDEREIT_IKK_TARGETS 	0	11	18	17009	0.0	1.0	1	
PID_EPHA2_FWD_PATHWAY 	0	11	19	17008	0.0	1.0	1	
FERRARI_RESPONSE_TO_FENRETINIDE_UP 	0	11	21	17006	0.0	1.0	1	
BEIER_GLIOMA_STEM_CELL_DN 	0	11	62	16965	0.0	1.0	1	
REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A 	0	11	20	17007	0.0	1.0	1	
CHEN_LIVER_METABOLISM_QTL_CIS 	0	11	80	16947	0.0	1.0	1	
REACTOME_HORMONE_LIGAND_BINDING_RECEPTORS 	0	11	2	17025	0.0	1.0	1	
RAGHAVACHARI_PLATELET_SPECIFIC_GENES 	0	11	63	16964	0.0	1.0	1	
ACEVEDO_LIVER_CANCER_DN 	1	10	457	16570	3.62582056892779	0.2590544524543421	1	CNDP1
KEGG_ENDOCYTOSIS 	0	11	170	16857	0.0	1.0	1	
BIOCARTA_NEUROTRANSMITTERS_PATHWAY 	0	11	6	17021	0.0	1.0	1	
BURTON_ADIPOGENESIS_3 	0	11	87	16940	0.0	1.0	1	
SHIPP_DLBCL_CURED_VS_FATAL_UP 	0	11	30	16997	0.0	1.0	1	
BURTON_ADIPOGENESIS_1 	0	11	33	16994	0.0	1.0	1	
BURTON_ADIPOGENESIS_6 	0	11	169	16858	0.0	1.0	1	
BURTON_ADIPOGENESIS_7 	0	11	48	16979	0.0	1.0	1	
BURTON_ADIPOGENESIS_4 	0	11	42	16985	0.0	1.0	1	
INAMURA_LUNG_CANCER_SCC_SUBTYPES_DN 	0	11	5	17022	0.0	1.0	1	
KEGG_SPLICEOSOME 	0	11	123	16904	0.0	1.0	1	
BURTON_ADIPOGENESIS_8 	0	11	82	16945	0.0	1.0	1	
GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_DN 	0	11	9	17018	0.0	1.0	1	
REACTOME_NETRIN1_SIGNALING 	0	11	35	16992	0.0	1.0	1	
REACTOME_REGULATION_OF_IFNG_SIGNALING 	0	11	12	17015	0.0	1.0	1	
HUI_MAPK14_TARGETS_UP 	0	11	18	17009	0.0	1.0	1	
FIGUEROA_AML_METHYLATION_CLUSTER_4_UP 	0	11	92	16935	0.0	1.0	1	
CAFFAREL_RESPONSE_TO_THC_8HR_3_UP 	0	11	5	17022	0.0	1.0	1	
KEGG_PRIMARY_BILE_ACID_BIOSYNTHESIS 	0	11	12	17015	0.0	1.0	1	
MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED 	0	11	18	17009	0.0	1.0	1	
CAIRO_HEPATOBLASTOMA_DN 	0	11	211	16816	0.0	1.0	1	
KEGG_PENTOSE_PHOSPHATE_PATHWAY 	0	11	23	17004	0.0	1.0	1	
REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLP1 	0	11	13	17014	0.0	1.0	1	
NAGY_TFTC_COMPONENTS_HUMAN 	0	11	18	17009	0.0	1.0	1	
KRIEG_HYPOXIA_VIA_KDM3A 	0	11	46	16981	0.0	1.0	1	
REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN 	0	11	15	17012	0.0	1.0	1	
BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_UP 	0	11	14	17013	0.0	1.0	1	
DAUER_STAT3_TARGETS_DN 	0	11	49	16978	0.0	1.0	1	
REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY 	0	11	13	17014	0.0	1.0	1	
SWEET_KRAS_ONCOGENIC_SIGNATURE 	0	11	84	16943	0.0	1.0	1	
JIANG_AGING_HYPOTHALAMUS_DN 	0	11	40	16987	0.0	1.0	1	
MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP 	0	11	236	16791	0.0	1.0	1	
FIGUEROA_AML_METHYLATION_CLUSTER_6_DN 	0	11	26	17001	0.0	1.0	1	
REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS 	0	11	13	17014	0.0	1.0	1	
BASSO_HAIRY_CELL_LEUKEMIA_DN 	0	11	4	17023	0.0	1.0	1	
REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES 	0	11	64	16963	0.0	1.0	1	
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1 	0	11	63	16964	0.0	1.0	1	
PID_HIF2PATHWAY 	0	11	31	16996	0.0	1.0	1	
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_3 	0	11	12	17015	0.0	1.0	1	
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2 	1	10	70	16957	24.224285714285713	0.04490837616727746	1	CAPN3
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5 	0	11	24	17003	0.0	1.0	1	
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_4 	0	11	11	17016	0.0	1.0	1	
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7 	0	11	71	16956	0.0	1.0	1	
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6 	0	11	68	16959	0.0	1.0	1	
COLLIS_PRKDC_SUBSTRATES 	0	11	19	17008	0.0	1.0	1	
KEGG_N_GLYCAN_BIOSYNTHESIS 	0	11	46	16981	0.0	1.0	1	
CROONQUIST_STROMAL_STIMULATION_DN 	0	11	10	17017	0.0	1.0	1	
BOYLAN_MULTIPLE_MYELOMA_C_D_UP 	0	11	128	16899	0.0	1.0	1	
ELVIDGE_HIF2A_TARGETS_UP 	0	11	5	17022	0.0	1.0	1	
HEDENFALK_BREAST_CANCER_BRACX_UP 	0	11	19	17008	0.0	1.0	1	
CAIRO_LIVER_DEVELOPMENT_UP 	0	11	148	16879	0.0	1.0	1	
EPPERT_LSC_R 	0	11	38	16989	0.0	1.0	1	
SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN 	0	11	29	16998	0.0	1.0	1	
CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN 	0	11	180	16847	0.0	1.0	1	
DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP 	0	11	214	16813	0.0	1.0	1	
DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP 	0	11	315	16712	0.0	1.0	1	
MIZUKAMI_HYPOXIA_DN 	0	11	5	17022	0.0	1.0	1	
BENPORATH_ES_CORE_NINE 	0	11	8	17019	0.0	1.0	1	
XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP 	0	11	12	17015	0.0	1.0	1	
KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY 	0	11	70	16957	0.0	1.0	1	
ZHENG_FOXP3_TARGETS_IN_THYMUS_DN 	0	11	8	17019	0.0	1.0	1	
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP 	0	11	154	16873	0.0	1.0	1	
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN 	0	11	53	16974	0.0	1.0	1	
XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP 	0	11	32	16995	0.0	1.0	1	
PEART_HDAC_PROLIFERATION_CLUSTER_DN 	0	11	70	16957	0.0	1.0	1	
PID_NFKAPPAB_CANONICAL_PATHWAY 	0	11	22	17005	0.0	1.0	1	
JEON_SMAD6_TARGETS_UP 	0	11	21	17006	0.0	1.0	1	
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP 	0	11	81	16946	0.0	1.0	1	
LANG_MYB_FAMILY_TARGETS 	0	11	29	16998	0.0	1.0	1	
PID_AURORA_A_PATHWAY 	0	11	27	17000	0.0	1.0	1	
STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN 	0	11	474	16553	0.0	1.0	1	
STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_DN 	0	11	22	17005	0.0	1.0	1	
SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN 	0	11	41	16986	0.0	1.0	1	
WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D 	0	11	605	16422	0.0	1.0	1	
WALLACE_PROSTATE_CANCER_UP 	0	11	19	17008	0.0	1.0	1	
WANG_RESPONSE_TO_BEXAROTENE_DN 	0	11	27	17000	0.0	1.0	1	
LE_NEURONAL_DIFFERENTIATION_DN 	0	11	14	17013	0.0	1.0	1	
KEGG_THYROID_CANCER 	0	11	29	16998	0.0	1.0	1	
NAKAYAMA_FRA2_TARGETS 	0	11	39	16988	0.0	1.0	1	
NIELSEN_SYNOVIAL_SARCOMA_DN 	0	11	20	17007	0.0	1.0	1	
KLEIN_TARGETS_OF_BCR_ABL1_FUSION 	0	11	36	16991	0.0	1.0	1	
KEGG_GLIOMA 	0	11	63	16964	0.0	1.0	1	
GOERING_BLOOD_HDL_CHOLESTEROL_QTL_CIS 	0	11	10	17017	0.0	1.0	1	
HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN 	0	11	70	16957	0.0	1.0	1	
LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE 	0	11	46	16981	0.0	1.0	1	
GENTILE_UV_RESPONSE_CLUSTER_D9 	0	11	26	17001	0.0	1.0	1	
GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN 	0	11	34	16993	0.0	1.0	1	
BIOCARTA_EGF_PATHWAY 	0	11	31	16996	0.0	1.0	1	
PROVENZANI_METASTASIS_DN 	0	11	129	16898	0.0	1.0	1	
GENTILE_UV_RESPONSE_CLUSTER_D1 	0	11	18	17009	0.0	1.0	1	
SIG_IL4RECEPTOR_IN_B_LYPHOCYTES 	0	11	27	17000	0.0	1.0	1	
GENTILE_UV_RESPONSE_CLUSTER_D7 	0	11	37	16990	0.0	1.0	1	
BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_UP 	0	11	8	17019	0.0	1.0	1	
WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_DN 	0	11	5	17022	0.0	1.0	1	
WONG_EMBRYONIC_STEM_CELL_CORE 	0	11	318	16709	0.0	1.0	1	
BORCZUK_MALIGNANT_MESOTHELIOMA_UP 	0	11	289	16738	0.0	1.0	1	
LIU_CDX2_TARGETS_DN 	0	11	6	17021	0.0	1.0	1	
REACTOME_DOWNSTREAM_TCR_SIGNALING 	0	11	30	16997	0.0	1.0	1	
REACTOME_ERKS_ARE_INACTIVATED 	0	11	12	17015	0.0	1.0	1	
REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM 	0	11	11	17016	0.0	1.0	1	
DING_LUNG_CANCER_MUTATED_RECURRENTLY 	0	11	6	17021	0.0	1.0	1	
BIOCARTA_LONGEVITY_PATHWAY 	0	11	14	17013	0.0	1.0	1	
ZHAN_MULTIPLE_MYELOMA_MS_DN 	0	11	36	16991	0.0	1.0	1	
IVANOV_MUTATED_IN_COLON_CANCER 	0	11	13	17014	0.0	1.0	1	
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP 	0	11	27	17000	0.0	1.0	1	
SMITH_LIVER_CANCER 	0	11	39	16988	0.0	1.0	1	
KEGG_TASTE_TRANSDUCTION 	0	11	24	17003	0.0	1.0	1	
WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN 	0	11	48	16979	0.0	1.0	1	
CHANGOLKAR_H2AFY_TARGETS_UP 	0	11	42	16985	0.0	1.0	1	
REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS 	0	11	80	16947	0.0	1.0	1	
CHANG_POU5F1_TARGETS_UP 	0	11	13	17014	0.0	1.0	1	
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP 	0	11	170	16857	0.0	1.0	1	
REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION 	0	11	186	16841	0.0	1.0	1	
REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION 	0	11	17	17010	0.0	1.0	1	
REACTOME_THE_NLRP3_INFLAMMASOME 	0	11	11	17016	0.0	1.0	1	
REACTOME_IL1_SIGNALING 	0	11	36	16991	0.0	1.0	1	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_18 	0	11	5	17022	0.0	1.0	1	
ZHAN_MULTIPLE_MYELOMA_CD1_DN 	0	11	41	16986	0.0	1.0	1	
POS_RESPONSE_TO_HISTAMINE_DN 	0	11	11	17016	0.0	1.0	1	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_11 	0	11	3	17024	0.0	1.0	1	
SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP 	0	11	328	16699	0.0	1.0	1	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_13 	0	11	6	17021	0.0	1.0	1	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_12 	0	11	11	17016	0.0	1.0	1	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_15 	0	11	8	17019	0.0	1.0	1	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_14 	0	11	3	17024	0.0	1.0	1	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_17 	0	11	18	17009	0.0	1.0	1	
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_16 	0	11	9	17018	0.0	1.0	1	
NAISHIRO_CTNNB1_TARGETS_WITH_LEF1_MOTIF 	0	11	8	17019	0.0	1.0	1	
WHITESIDE_CISPLATIN_RESISTANCE_DN 	0	11	13	17014	0.0	1.0	1	
RADAEVA_RESPONSE_TO_IFNA1_DN 	0	11	7	17020	0.0	1.0	1	
FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP 	0	11	53	16974	0.0	1.0	1	
REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS 	0	11	31	16996	0.0	1.0	1	
KOHOUTEK_CCNT1_TARGETS 	0	11	45	16982	0.0	1.0	1	
LOPEZ_MBD_TARGETS_IMPRINTED_AND_X_LINKED 	0	11	16	17011	0.0	1.0	1	
PID_AR_TF_PATHWAY 	0	11	47	16980	0.0	1.0	1	
REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS 	0	11	24	17003	0.0	1.0	1	
PID_ANTHRAX_PATHWAY 	0	11	16	17011	0.0	1.0	1	
PID_FAS_PATHWAY 	0	11	37	16990	0.0	1.0	1	
BASSO_CD40_SIGNALING_DN 	0	11	60	16967	0.0	1.0	1	
INGRAM_SHH_TARGETS_UP 	1	10	111	16916	15.23963963963964	0.06999845842435672	1	CDC42EP1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12 	0	11	76	16951	0.0	1.0	1	
REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS 	0	11	16	17011	0.0	1.0	1	
BIOCARTA_TID_PATHWAY 	0	11	17	17010	0.0	1.0	1	
PID_TELOMERASE_PATHWAY 	0	11	65	16962	0.0	1.0	1	
REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY 	0	11	10	17017	0.0	1.0	1	
SENESE_HDAC2_TARGETS_DN 	0	11	112	16915	0.0	1.0	1	
PID_CMYB_PATHWAY 	0	11	77	16950	0.0	1.0	1	
BOYLAN_MULTIPLE_MYELOMA_PCA3_UP 	1	10	69	16958	24.576811594202898	0.04428880856408458	1	PLLP
DURAND_STROMA_S_UP 	0	11	269	16758	0.0	1.0	1	
KEGG_GAP_JUNCTION 	0	11	83	16944	0.0	1.0	1	
CLAUS_PGR_POSITIVE_MENINGIOMA_DN 	0	11	12	17015	0.0	1.0	1	
PACHER_TARGETS_OF_IGF1_AND_IGF2_UP 	0	11	34	16993	0.0	1.0	1	
REACTOME_HOMOLOGOUS_RECOMBINATION_REPAIR_OF_REPLICATION_INDEPENDENT_DOUBLE_STRAND_BREAKS 	0	11	14	17013	0.0	1.0	1	
BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN 	0	11	83	16944	0.0	1.0	1	
KEGG_GNRH_SIGNALING_PATHWAY 	0	11	84	16943	0.0	1.0	1	
HORIUCHI_WTAP_TARGETS_DN 	0	11	267	16760	0.0	1.0	1	
KAUFFMANN_MELANOMA_RELAPSE_DN 	0	11	6	17021	0.0	1.0	1	
REACTOME_RORA_ACTIVATES_CIRCADIAN_EXPRESSION 	0	11	23	17004	0.0	1.0	1	
LEE_LIVER_CANCER_MYC_UP 	0	11	46	16981	0.0	1.0	1	
ONO_AML1_TARGETS_DN 	0	11	25	17002	0.0	1.0	1	
PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_DN 	0	11	7	17020	0.0	1.0	1	
BIOCARTA_AT1R_PATHWAY 	0	11	32	16995	0.0	1.0	1	
BYSTRYKH_SCP2_QTL 	0	11	5	17022	0.0	1.0	1	
REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS 	0	11	19	17008	0.0	1.0	1	
AMIT_EGF_RESPONSE_20_MCF10A 	0	11	13	17014	0.0	1.0	1	
GROSS_HYPOXIA_VIA_ELK3_ONLY_DN 	0	11	39	16988	0.0	1.0	1	
AMUNDSON_GENOTOXIC_SIGNATURE 	0	11	94	16933	0.0	1.0	1	
LA_MEN1_TARGETS 	0	11	22	17005	0.0	1.0	1	
REACTOME_NFKB_ACTIVATION_THROUGH_FADD_RIP1_PATHWAY_MEDIATED_BY_CASPASE_8_AND10 	0	11	12	17015	0.0	1.0	1	
REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION 	0	11	29	16998	0.0	1.0	1	
BUDHU_LIVER_CANCER_METASTASIS_UP 	0	11	6	17021	0.0	1.0	1	
JAEGER_METASTASIS_DN 	1	10	197	16830	8.543147208121827	0.12069060093641058	1	C9orf3
MODY_HIPPOCAMPUS_POSTNATAL 	1	10	61	16966	27.81311475409836	0.03931909868204709	1	SOX10
KIM_GASTRIC_CANCER_CHEMOSENSITIVITY 	0	11	82	16945	0.0	1.0	1	
SESTO_RESPONSE_TO_UV_C3 	0	11	19	17008	0.0	1.0	1	
BIOCARTA_AKAP95_PATHWAY 	0	11	11	17016	0.0	1.0	1	
KUNINGER_IGF1_VS_PDGFB_TARGETS_DN 	0	11	39	16988	0.0	1.0	1	
ONKEN_UVEAL_MELANOMA_UP 	0	11	728	16299	0.0	1.0	1	
REACTOME_CA_DEPENDENT_EVENTS 	0	11	27	17000	0.0	1.0	1	
OSAWA_TNF_TARGETS 	0	11	9	17018	0.0	1.0	1	
ROSS_LEUKEMIA_WITH_MLL_FUSIONS 	0	11	68	16959	0.0	1.0	1	
KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_CHONDROITIN_SULFATE 	0	11	22	17005	0.0	1.0	1	
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN 	0	11	145	16882	0.0	1.0	1	
CUI_TCF21_TARGETS_UP 	0	11	35	16992	0.0	1.0	1	
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10 	0	11	64	16963	0.0	1.0	1	
JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN 	0	11	58	16969	0.0	1.0	1	
MARTINEZ_RB1_AND_TP53_TARGETS_UP 	0	11	513	16514	0.0	1.0	1	
KIM_TIAL1_TARGETS 	0	11	30	16997	0.0	1.0	1	
KEGG_BASAL_TRANSCRIPTION_FACTORS 	0	11	32	16995	0.0	1.0	1	
KOBAYASHI_EGFR_SIGNALING_24HR_DN 	1	10	212	16815	7.931603773584905	0.1292704299624726	1	CDC42EP1
REACTOME_SYNTHESIS_OF_DNA 	0	11	87	16940	0.0	1.0	1	
MORI_MATURE_B_LYMPHOCYTE_DN 	0	11	66	16961	0.0	1.0	1	
MARKEY_RB1_CHRONIC_LOF_DN 	0	11	106	16921	0.0	1.0	1	
NUMATA_CSF3_SIGNALING_VIA_STAT3 	0	11	21	17006	0.0	1.0	1	
ROZANOV_MMP14_TARGETS_DN 	0	11	29	16998	0.0	1.0	1	
ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN 	0	11	104	16923	0.0	1.0	1	
CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN 	0	11	41	16986	0.0	1.0	1	
SENESE_HDAC1_AND_HDAC2_TARGETS_UP 	0	11	203	16824	0.0	1.0	1	
PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN 	0	11	15	17012	0.0	1.0	1	
OXFORD_RALA_OR_RALB_TARGETS_UP 	0	11	42	16985	0.0	1.0	1	
LIM_MAMMARY_STEM_CELL_DN 	0	11	384	16643	0.0	1.0	1	
BIOCARTA_CARDIACEGF_PATHWAY 	0	11	18	17009	0.0	1.0	1	
FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_UP 	0	11	6	17021	0.0	1.0	1	
PAL_PRMT5_TARGETS_UP 	0	11	190	16837	0.0	1.0	1	
COATES_MACROPHAGE_M1_VS_M2_UP 	0	11	75	16952	0.0	1.0	1	
PID_ERB_GENOMIC_PATHWAY 	0	11	14	17013	0.0	1.0	1	
OUYANG_PROSTATE_CANCER_MARKERS 	0	11	18	17009	0.0	1.0	1	
WANG_SMARCE1_TARGETS_UP 	0	11	260	16767	0.0	1.0	1	
KEGG_HEMATOPOIETIC_CELL_LINEAGE 	0	11	59	16968	0.0	1.0	1	
REACTOME_SIGNALING_BY_HIPPO 	0	11	20	17007	0.0	1.0	1	
SCHURINGA_STAT5A_TARGETS_DN 	0	11	14	17013	0.0	1.0	1	
NOUZOVA_METHYLATED_IN_APL 	0	11	52	16975	0.0	1.0	1	
TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP 	0	11	58	16969	0.0	1.0	1	
TAVAZOIE_METASTASIS 	0	11	85	16942	0.0	1.0	1	
SWEET_KRAS_TARGETS_UP 	0	11	79	16948	0.0	1.0	1	
ZHANG_INTERFERON_RESPONSE 	0	11	22	17005	0.0	1.0	1	
KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY 	0	11	91	16936	0.0	1.0	1	
PID_IL4_2PATHWAY 	0	11	47	16980	0.0	1.0	1	
WEI_MIR34A_TARGETS 	0	11	142	16885	0.0	1.0	1	
TIEN_INTESTINE_PROBIOTICS_2HR_UP 	0	11	27	17000	0.0	1.0	1	
KEGG_NITROGEN_METABOLISM 	0	11	19	17008	0.0	1.0	1	
DISTECHE_ESCAPED_FROM_X_INACTIVATION 	0	11	13	17014	0.0	1.0	1	
VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP 	0	11	15	17012	0.0	1.0	1	
ABE_VEGFA_TARGETS_30MIN 	0	11	25	17002	0.0	1.0	1	
BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP 	0	11	19	17008	0.0	1.0	1	
REACTOME_RECYCLING_PATHWAY_OF_L1 	0	11	25	17002	0.0	1.0	1	
REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR 	0	11	117	16910	0.0	1.0	1	
PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_DN 	0	11	19	17008	0.0	1.0	1	
ZHANG_GATA6_TARGETS_DN 	0	11	54	16973	0.0	1.0	1	
YANG_BREAST_CANCER_ESR1_BULK_UP 	0	11	25	17002	0.0	1.0	1	
PID_BCR_5PATHWAY 	0	11	63	16964	0.0	1.0	1	
WIERENGA_PML_INTERACTOME 	0	11	38	16989	0.0	1.0	1	
BECKER_TAMOXIFEN_RESISTANCE_DN 	0	11	46	16981	0.0	1.0	1	
GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_DN 	0	11	6	17021	0.0	1.0	1	
GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP 	0	11	64	16963	0.0	1.0	1	
RODRIGUES_NTN1_AND_DCC_TARGETS 	0	11	31	16996	0.0	1.0	1	
GOLUB_ALL_VS_AML_UP 	0	11	23	17004	0.0	1.0	1	
ITO_PTTG1_TARGETS_UP 	0	11	10	17017	0.0	1.0	1	
BIOCARTA_MTA3_PATHWAY 	0	11	18	17009	0.0	1.0	1	
REACTOME_BINDING_AND_ENTRY_OF_HIV_VIRION 	0	11	4	17023	0.0	1.0	1	
MELLMAN_TUT1_TARGETS_DN 	0	11	45	16982	0.0	1.0	1	
IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM 	0	11	28	16999	0.0	1.0	1	
GENTILE_UV_RESPONSE_CLUSTER_D2 	0	11	38	16989	0.0	1.0	1	
MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED 	0	11	52	16975	0.0	1.0	1	
WANG_NEOPLASTIC_TRANSFORMATION_BY_CCND1_MYC 	0	11	17	17010	0.0	1.0	1	
LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_UP 	0	11	12	17015	0.0	1.0	1	
KOBAYASHI_EGFR_SIGNALING_6HR_UP 	0	11	7	17020	0.0	1.0	1	
AMIT_EGF_RESPONSE_480_MCF10A 	0	11	38	16989	0.0	1.0	1	
GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN 	0	11	9	17018	0.0	1.0	1	
PETRETTO_HEART_MASS_QTL_CIS_UP 	0	11	26	17001	0.0	1.0	1	
BIOCARTA_SODD_PATHWAY 	0	11	9	17018	0.0	1.0	1	
KEGG_SULFUR_METABOLISM 	0	11	12	17015	0.0	1.0	1	
CHOW_RASSF1_TARGETS_DN 	0	11	29	16998	0.0	1.0	1	
DAZARD_UV_RESPONSE_CLUSTER_G24 	0	11	25	17002	0.0	1.0	1	
LEI_HOXC8_TARGETS_UP 	0	11	8	17019	0.0	1.0	1	
KAAB_FAILED_HEART_VENTRICLE_DN 	0	11	40	16987	0.0	1.0	1	
